PERKINELMER, INC.00000317911/11/1/20232022FYfalse126,411,98518,089,645,853111,000,0001,000,000————11300,000,000300,000,000126,300,000126,241,000126,300,000126,241,000—54060—5406095100—100.070.070.070.070.070.070.070.07http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent00000317912022-01-032023-01-010000031791pki:Commonstock1parvaluepershareMember2022-01-032023-01-010000031791pki:PKIMember2022-01-032023-01-010000031791exch:XNYS2022-01-032023-01-010000031791pki:A1.875Notesdue2026Member2022-01-032023-01-010000031791pki:PKI21AMember2022-01-032023-01-0100000317912022-07-01iso4217:USDiso4217:USDxbrli:shares00000317912023-02-24xbrli:shares0000031791pki:AnalyticalFoodAndEnterpriseServicesBusinessesMember2023-01-010000031791pki:AnalyticalFoodAndEnterpriseServicesBusinessesMember2022-01-020000031791us-gaap:ProductMember2022-01-032023-01-010000031791us-gaap:ProductMember2021-01-042022-01-020000031791us-gaap:ProductMember2019-12-302021-01-030000031791us-gaap:ServiceMember2022-01-032023-01-010000031791us-gaap:ServiceMember2021-01-042022-01-020000031791us-gaap:ServiceMember2019-12-302021-01-0300000317912021-01-042022-01-0200000317912019-12-302021-01-0300000317912023-01-0100000317912022-01-020000031791us-gaap:CommonStockMember2019-12-290000031791us-gaap:AdditionalPaidInCapitalMember2019-12-290000031791us-gaap:RetainedEarningsMember2019-12-290000031791us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-2900000317912019-12-290000031791us-gaap:AccountingStandardsUpdate201602Memberus-gaap:CommonStockMember2021-01-030000031791us-gaap:AccountingStandardsUpdate201602Memberus-gaap:AdditionalPaidInCapitalMember2021-01-030000031791us-gaap:AccountingStandardsUpdate201602Memberus-gaap:RetainedEarningsMember2021-01-030000031791us-gaap:AccountingStandardsUpdate201602Member2021-01-030000031791us-gaap:CommonStockMemberpki:NetIncomeMember2021-01-030000031791us-gaap:RetainedEarningsMember2019-12-302021-01-030000031791us-gaap:CommonStockMemberpki:OtherComprehensiveLossMember2021-01-030000031791us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-302021-01-030000031791us-gaap:CommonStockMemberpki:DividendsMember2021-01-030000031791us-gaap:CommonStockMemberpki:ExerciseOfEmployeeStockOptionsAndRelatedIncomeTaxBenefitsMember2021-01-030000031791us-gaap:CommonStockMember2019-12-302021-01-030000031791us-gaap:AdditionalPaidInCapitalMember2019-12-302021-01-030000031791us-gaap:CommonStockMemberpki:IssuanceOfCommonStockForEmployeeStockPurchasePlansMember2021-01-030000031791us-gaap:CommonStockMemberpki:PurchasesOfCommonStockMember2021-01-030000031791us-gaap:CommonStockMemberpki:IssuanceOfCommonStockForLongTermIncentiveProgramMember2021-01-030000031791us-gaap:CommonStockMemberpki:StockCompensationMember2021-01-030000031791us-gaap:CommonStockMember2021-01-030000031791us-gaap:AdditionalPaidInCapitalMember2021-01-030000031791us-gaap:RetainedEarningsMember2021-01-030000031791us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-0300000317912021-01-030000031791us-gaap:CommonStockMemberpki:NetIncomeMember2022-01-020000031791us-gaap:RetainedEarningsMember2021-01-042022-01-020000031791us-gaap:CommonStockMemberpki:OtherComprehensiveLossMember2022-01-020000031791us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-042022-01-020000031791us-gaap:CommonStockMemberpki:DividendsMember2022-01-020000031791us-gaap:CommonStockMemberpki:IssuanceOfCommonStockForBusinessCombinationNetOfIssuanceCostsMember2022-01-020000031791us-gaap:CommonStockMember2021-01-042022-01-020000031791us-gaap:AdditionalPaidInCapitalMember2021-01-042022-01-020000031791us-gaap:CommonStockMemberpki:ExerciseOfEmployeeStockOptionsAndRelatedIncomeTaxBenefitsMember2022-01-020000031791us-gaap:CommonStockMemberpki:IssuanceOfCommonStockForEmployeeStockPurchasePlansMember2022-01-020000031791us-gaap:CommonStockMemberpki:PurchasesOfCommonStockMember2022-01-020000031791us-gaap:CommonStockMemberpki:IssuanceOfCommonStockForLongTermIncentiveProgramMember2022-01-020000031791us-gaap:CommonStockMemberpki:StockCompensationMember2022-01-020000031791us-gaap:CommonStockMember2022-01-020000031791us-gaap:AdditionalPaidInCapitalMember2022-01-020000031791us-gaap:RetainedEarningsMember2022-01-020000031791us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-020000031791us-gaap:CommonStockMemberpki:NetIncomeMember2023-01-010000031791us-gaap:RetainedEarningsMember2022-01-032023-01-010000031791us-gaap:CommonStockMemberpki:OtherComprehensiveLossMember2023-01-010000031791us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-032023-01-010000031791us-gaap:CommonStockMemberpki:DividendsMember2023-01-010000031791us-gaap:CommonStockMemberpki:ExerciseOfEmployeeStockOptionsAndRelatedIncomeTaxBenefitsMember2023-01-010000031791us-gaap:CommonStockMember2022-01-032023-01-010000031791us-gaap:AdditionalPaidInCapitalMember2022-01-032023-01-010000031791us-gaap:CommonStockMemberpki:IssuanceOfCommonStockForEmployeeStockPurchasePlansMember2023-01-010000031791us-gaap:CommonStockMemberpki:PurchasesOfCommonStockMember2023-01-010000031791us-gaap:CommonStockMemberpki:IssuanceOfCommonStockForLongTermIncentiveProgramMember2023-01-010000031791us-gaap:CommonStockMemberpki:StockCompensationMember2023-01-010000031791us-gaap:CommonStockMember2023-01-010000031791us-gaap:AdditionalPaidInCapitalMember2023-01-010000031791us-gaap:RetainedEarningsMember2023-01-010000031791us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-01xbrli:pure0000031791us-gaap:SubsequentEventMember2023-01-022023-12-310000031791us-gaap:BuildingMembersrt:MinimumMember2022-01-032023-01-010000031791us-gaap:BuildingMembersrt:MaximumMember2022-01-032023-01-010000031791us-gaap:ToolsDiesAndMoldsMembersrt:MinimumMember2022-01-032023-01-010000031791srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMembersrt:AmericasMember2022-01-032023-01-010000031791pki:DiagnosticsMembersrt:AmericasMember2022-01-032023-01-010000031791srt:AmericasMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMembersrt:AmericasMember2021-01-042022-01-020000031791pki:DiagnosticsMembersrt:AmericasMember2021-01-042022-01-020000031791srt:AmericasMember2021-01-042022-01-020000031791pki:DiscoveryAnalyticalSolutionsMembersrt:AmericasMember2019-12-302021-01-030000031791pki:DiagnosticsMembersrt:AmericasMember2019-12-302021-01-030000031791srt:AmericasMember2019-12-302021-01-030000031791pki:DiscoveryAnalyticalSolutionsMembersrt:EuropeMember2022-01-032023-01-010000031791srt:EuropeMemberpki:DiagnosticsMember2022-01-032023-01-010000031791srt:EuropeMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMembersrt:EuropeMember2021-01-042022-01-020000031791srt:EuropeMemberpki:DiagnosticsMember2021-01-042022-01-020000031791srt:EuropeMember2021-01-042022-01-020000031791pki:DiscoveryAnalyticalSolutionsMembersrt:EuropeMember2019-12-302021-01-030000031791srt:EuropeMemberpki:DiagnosticsMember2019-12-302021-01-030000031791srt:EuropeMember2019-12-302021-01-030000031791pki:DiscoveryAnalyticalSolutionsMembersrt:AsiaMember2022-01-032023-01-010000031791srt:AsiaMemberpki:DiagnosticsMember2022-01-032023-01-010000031791srt:AsiaMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMembersrt:AsiaMember2021-01-042022-01-020000031791srt:AsiaMemberpki:DiagnosticsMember2021-01-042022-01-020000031791srt:AsiaMember2021-01-042022-01-020000031791pki:DiscoveryAnalyticalSolutionsMembersrt:AsiaMember2019-12-302021-01-030000031791srt:AsiaMemberpki:DiagnosticsMember2019-12-302021-01-030000031791srt:AsiaMember2019-12-302021-01-030000031791pki:DiscoveryAnalyticalSolutionsMember2022-01-032023-01-010000031791pki:DiagnosticsMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMember2021-01-042022-01-020000031791pki:DiagnosticsMember2021-01-042022-01-020000031791pki:DiscoveryAnalyticalSolutionsMember2019-12-302021-01-030000031791pki:DiagnosticsMember2019-12-302021-01-030000031791pki:DiscoveryAnalyticalSolutionsMemberpki:DiagnosticsMember2022-01-032023-01-010000031791pki:DiagnosticsMemberpki:DiagnosticsMember2022-01-032023-01-010000031791pki:DiagnosticsMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberpki:DiagnosticsMember2021-01-042022-01-020000031791pki:DiagnosticsMemberpki:DiagnosticsMember2021-01-042022-01-020000031791pki:DiagnosticsMember2021-01-042022-01-020000031791pki:DiscoveryAnalyticalSolutionsMemberpki:DiagnosticsMember2019-12-302021-01-030000031791pki:DiagnosticsMemberpki:DiagnosticsMember2019-12-302021-01-030000031791pki:DiagnosticsMember2019-12-302021-01-030000031791pki:DiscoveryAnalyticalSolutionsMemberpki:LifeSciencesMember2022-01-032023-01-010000031791pki:LifeSciencesMemberpki:DiagnosticsMember2022-01-032023-01-010000031791pki:LifeSciencesMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberpki:LifeSciencesMember2021-01-042022-01-020000031791pki:LifeSciencesMemberpki:DiagnosticsMember2021-01-042022-01-020000031791pki:LifeSciencesMember2021-01-042022-01-020000031791pki:DiscoveryAnalyticalSolutionsMemberpki:LifeSciencesMember2019-12-302021-01-030000031791pki:LifeSciencesMemberpki:DiagnosticsMember2019-12-302021-01-030000031791pki:LifeSciencesMember2019-12-302021-01-030000031791pki:DiagnosticsMemberus-gaap:CustomerConcentrationRiskMember2022-01-032023-01-010000031791pki:DiagnosticsMemberus-gaap:CustomerConcentrationRiskMember2021-01-042022-01-020000031791pki:DiagnosticsMemberus-gaap:CustomerConcentrationRiskMember2019-12-302021-01-030000031791pki:FiscalYear2022AcquisitionsMembercurrency:USD2022-01-032023-01-010000031791pki:FiscalYear2022AcquisitionsMember2022-01-032023-01-010000031791currency:USDpki:BioLegendMember2021-01-042022-01-020000031791pki:BioLegendMember2021-01-042022-01-020000031791pki:BioLegendMember2021-09-170000031791pki:BioLegendMember2022-01-02pki:employees0000031791pki:BioLegendMember2019-12-302021-01-030000031791currency:USDpki:FiscalYear2021AcquisitionsExcludingBioLegendMember2021-01-042022-01-020000031791pki:OxfordImmunotecMember2022-01-020000031791pki:OxfordImmunotecMembercurrency:USD2021-01-042022-01-020000031791pki:NexcelomBioscienceMember2023-01-010000031791currency:USDpki:NexcelomBioscienceMember2021-01-042022-01-020000031791pki:FiscalYear2021OtherAcquisitionsMembercurrency:USD2021-01-042022-01-020000031791pki:FiscalYear2021AcquisitionsExcludingBioLegendMember2021-01-042022-01-020000031791pki:FiscalYear2021AcquisitionsExcludingBioLegendMember2022-01-020000031791pki:CoreTechnologyAndCloneLibraryMemberpki:BioLegendMember2022-01-020000031791pki:CoreTechnologyAndCloneLibraryMemberpki:FiscalYear2021AcquisitionsExcludingBioLegendMember2022-01-020000031791pki:TradeNamesAndPatentsMemberpki:BioLegendMember2022-01-020000031791pki:TradeNamesAndPatentsMemberpki:FiscalYear2021AcquisitionsExcludingBioLegendMember2022-01-020000031791us-gaap:LicenseMemberpki:BioLegendMember2022-01-020000031791us-gaap:LicenseMemberpki:FiscalYear2021AcquisitionsExcludingBioLegendMember2022-01-020000031791pki:CustomerRelationshipsAndBacklogMemberpki:BioLegendMember2022-01-020000031791pki:CustomerRelationshipsAndBacklogMemberpki:FiscalYear2021AcquisitionsExcludingBioLegendMember2022-01-020000031791pki:FiscalYear2020AcquisitionsMembercurrency:USD2019-12-302021-01-030000031791pki:HorizonDiscoveryGroupPlcMember2021-01-030000031791pki:HorizonDiscoveryGroupPlcMembercurrency:USD2019-12-302021-01-030000031791currency:GBPpki:HorizonDiscoveryGroupPlcMember2019-12-302021-01-030000031791pki:FiscalYear2020OtherAcquisitionsMembercurrency:USD2019-12-302021-01-030000031791pki:FiscalYear2020AcquisitionsMember2019-12-302021-01-030000031791pki:FiscalYear2020AcquisitionsMember2021-01-030000031791pki:FiscalYear2020AcquisitionsMemberpki:CoreTechnologyMember2021-01-030000031791us-gaap:TradeNamesMemberpki:FiscalYear2020AcquisitionsMember2021-01-030000031791pki:FiscalYear2020AcquisitionsMemberpki:CustomerRelationshipsAndBacklogMember2021-01-030000031791pki:FiscalYear2020AcquisitionsMemberus-gaap:InProcessResearchAndDevelopmentMember2021-01-030000031791pki:BiosenseSirionAndQognitMember2023-01-010000031791pki:BioLegendMember2022-01-032023-01-010000031791pki:AnalyticalFoodAndEnterpriseServicesBusinessesMember2022-08-010000031791pki:AnalyticalFoodAndEnterpriseServicesBusinessesMember2022-01-032023-01-010000031791pki:AnalyticalFoodAndEnterpriseServicesBusinessesMember2021-01-042022-01-020000031791pki:AnalyticalFoodAndEnterpriseServicesBusinessesMember2019-12-302021-01-030000031791us-gaap:InternalRevenueServiceIRSMember2023-01-010000031791us-gaap:StateAndLocalJurisdictionMember2023-01-010000031791us-gaap:ForeignCountryMember2023-01-010000031791us-gaap:GeneralBusinessMember2023-01-010000031791us-gaap:LandMember2023-01-010000031791us-gaap:LandMember2022-01-020000031791us-gaap:BuildingAndBuildingImprovementsMember2023-01-010000031791us-gaap:BuildingAndBuildingImprovementsMember2022-01-020000031791us-gaap:MachineryAndEquipmentMember2023-01-010000031791us-gaap:MachineryAndEquipmentMember2022-01-020000031791us-gaap:EquitySecuritiesMember2023-01-010000031791pki:AvailableForSaleSecuritiesOtherMember2023-01-010000031791us-gaap:AvailableforsaleSecuritiesMember2023-01-010000031791us-gaap:EquitySecuritiesMember2022-01-020000031791us-gaap:FixedIncomeSecuritiesMember2022-01-020000031791pki:AvailableForSaleSecuritiesOtherMember2022-01-020000031791us-gaap:AvailableforsaleSecuritiesMember2022-01-020000031791pki:DiscoveryAnalyticalSolutionsMember2021-01-030000031791pki:DiagnosticsMember2021-01-030000031791pki:DiscoveryAnalyticalSolutionsMember2022-01-020000031791pki:DiagnosticsMember2022-01-020000031791pki:DiscoveryAnalyticalSolutionsMember2023-01-010000031791pki:DiagnosticsMember2023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberus-gaap:PatentsMember2023-01-010000031791us-gaap:PatentsMemberpki:DiagnosticsMember2023-01-010000031791us-gaap:PatentsMember2023-01-010000031791pki:TradeNamesAndTrademarksMemberpki:DiscoveryAnalyticalSolutionsMember2023-01-010000031791pki:TradeNamesAndTrademarksMemberpki:DiagnosticsMember2023-01-010000031791pki:TradeNamesAndTrademarksMember2023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberus-gaap:LicensingAgreementsMember2023-01-010000031791us-gaap:LicensingAgreementsMemberpki:DiagnosticsMember2023-01-010000031791us-gaap:LicensingAgreementsMember2023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberpki:CoreTechnologyMember2023-01-010000031791pki:CoreTechnologyMemberpki:DiagnosticsMember2023-01-010000031791pki:CoreTechnologyMember2023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberus-gaap:CustomerRelationshipsMember2023-01-010000031791us-gaap:CustomerRelationshipsMemberpki:DiagnosticsMember2023-01-010000031791us-gaap:CustomerRelationshipsMember2023-01-010000031791us-gaap:InProcessResearchAndDevelopmentMemberpki:DiscoveryAnalyticalSolutionsMember2023-01-010000031791us-gaap:InProcessResearchAndDevelopmentMemberpki:DiagnosticsMember2023-01-010000031791us-gaap:InProcessResearchAndDevelopmentMember2023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberus-gaap:PatentsMember2022-01-020000031791us-gaap:PatentsMemberpki:DiagnosticsMember2022-01-020000031791us-gaap:PatentsMember2022-01-020000031791pki:TradeNamesAndTrademarksMemberpki:DiscoveryAnalyticalSolutionsMember2022-01-020000031791pki:TradeNamesAndTrademarksMemberpki:DiagnosticsMember2022-01-020000031791pki:TradeNamesAndTrademarksMember2022-01-020000031791pki:DiscoveryAnalyticalSolutionsMemberus-gaap:LicensingAgreementsMember2022-01-020000031791us-gaap:LicensingAgreementsMemberpki:DiagnosticsMember2022-01-020000031791us-gaap:LicensingAgreementsMember2022-01-020000031791pki:DiscoveryAnalyticalSolutionsMemberpki:CoreTechnologyMember2022-01-020000031791pki:CoreTechnologyMemberpki:DiagnosticsMember2022-01-020000031791pki:CoreTechnologyMember2022-01-020000031791pki:DiscoveryAnalyticalSolutionsMemberus-gaap:CustomerRelationshipsMember2022-01-020000031791us-gaap:CustomerRelationshipsMemberpki:DiagnosticsMember2022-01-020000031791us-gaap:CustomerRelationshipsMember2022-01-020000031791us-gaap:InProcessResearchAndDevelopmentMemberpki:DiscoveryAnalyticalSolutionsMember2022-01-020000031791us-gaap:InProcessResearchAndDevelopmentMemberpki:DiagnosticsMember2022-01-020000031791us-gaap:InProcessResearchAndDevelopmentMember2022-01-020000031791pki:LineOfCreditMaturingAugust242026Member2023-01-010000031791pki:A0850SeniorUnsecuredNotesDue2024Member2023-01-010000031791pki:A0850SeniorUnsecuredNotesDue2024Memberus-gaap:FairValueInputsLevel2Member2023-01-010000031791pki:A1.875PercentTenYearSeniorUnsecuredNotesMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:A1.875PercentTenYearSeniorUnsecuredNotesMember2023-01-010000031791pki:A1900SeniorUnsecuredNotesDue2028Member2023-01-010000031791pki:A1900SeniorUnsecuredNotesDue2028Memberus-gaap:FairValueInputsLevel2Member2023-01-010000031791pki:A3.3PercentTenYearSeniorUnsecuredNotesdueinSept2029Member2023-01-010000031791pki:A3.3PercentTenYearSeniorUnsecuredNotesdueinSept2029Memberus-gaap:FairValueInputsLevel2Member2023-01-010000031791pki:A255PercentSeniorUnsecuredNotesDueIn2031Member2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:A255PercentSeniorUnsecuredNotesDueIn2031Member2023-01-010000031791pki:A2250SeniorUnsecuredNotesDueIn2031Member2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:A2250SeniorUnsecuredNotesDueIn2031Member2023-01-010000031791pki:A3625PercentSeniorUnsecuredNotesDueIn2051Member2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:A3625PercentSeniorUnsecuredNotesDueIn2051Member2023-01-010000031791pki:OtherDebtFacilitiesNonCurrentMember2023-01-010000031791pki:OtherDebtFacilitiesNonCurrentMemberus-gaap:FairValueInputsLevel2Member2023-01-010000031791us-gaap:LongTermDebtMember2023-01-010000031791us-gaap:FairValueInputsLevel2Member2023-01-010000031791pki:A0550SeniorUnsecuredNotesDue2023Member2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:A0550SeniorUnsecuredNotesDue2023Member2023-01-010000031791pki:OtherDebtFacilitiesCurrentMember2023-01-010000031791pki:OtherDebtFacilitiesCurrentMemberus-gaap:FairValueInputsLevel2Member2023-01-010000031791pki:LongTermDebtCurrentPortionMember2023-01-010000031791pki:LineofCreditMaturingSeptember172024Member2022-01-020000031791pki:TermLoanCreditFacilityMaturing2024Member2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:TermLoanCreditFacilityMaturing2024Member2022-01-020000031791pki:A0550SeniorUnsecuredNotesDue2023Member2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:A0550SeniorUnsecuredNotesDue2023Member2022-01-020000031791pki:A0850SeniorUnsecuredNotesDue2024Member2022-01-020000031791pki:A0850SeniorUnsecuredNotesDue2024Memberus-gaap:FairValueInputsLevel2Member2022-01-020000031791pki:A1.875PercentTenYearSeniorUnsecuredNotesMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:A1.875PercentTenYearSeniorUnsecuredNotesMember2022-01-020000031791pki:A1900SeniorUnsecuredNotesDue2028Member2022-01-020000031791pki:A1900SeniorUnsecuredNotesDue2028Memberus-gaap:FairValueInputsLevel2Member2022-01-020000031791pki:A3.3PercentTenYearSeniorUnsecuredNotesdueinSept2029Member2022-01-020000031791pki:A3.3PercentTenYearSeniorUnsecuredNotesdueinSept2029Memberus-gaap:FairValueInputsLevel2Member2022-01-020000031791pki:A255PercentSeniorUnsecuredNotesDueIn2031Member2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:A255PercentSeniorUnsecuredNotesDueIn2031Member2022-01-020000031791pki:A2250SeniorUnsecuredNotesDueIn2031Member2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:A2250SeniorUnsecuredNotesDueIn2031Member2022-01-020000031791pki:A3625PercentSeniorUnsecuredNotesDueIn2051Member2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:A3625PercentSeniorUnsecuredNotesDueIn2051Member2022-01-020000031791pki:OtherDebtFacilitiesNonCurrentMember2022-01-020000031791pki:OtherDebtFacilitiesNonCurrentMemberus-gaap:FairValueInputsLevel2Member2022-01-020000031791us-gaap:LongTermDebtMember2022-01-020000031791us-gaap:FairValueInputsLevel2Member2022-01-020000031791pki:OtherDebtFacilitiesCurrentMember2022-01-020000031791pki:OtherDebtFacilitiesCurrentMemberus-gaap:FairValueInputsLevel2Member2022-01-020000031791pki:LineOfCreditMaturingAugust242026Member2021-08-240000031791pki:LineOfCreditMaturingAugust242026Memberpki:BaseRateOptionTwoMemberus-gaap:LineOfCreditMember2022-01-032023-01-010000031791pki:LineOfCreditMaturingAugust242026Memberpki:BaseRateOptionThreeMemberus-gaap:LineOfCreditMember2022-01-032023-01-010000031791pki:A0850SeniorUnsecuredNotesDue2024Memberus-gaap:SubsequentEventMember2023-04-020000031791pki:OtherDebtFacilitiesMember2023-01-010000031791us-gaap:PensionPlansDefinedBenefitMember2022-01-032023-01-010000031791us-gaap:PensionPlansDefinedBenefitMember2021-01-042022-01-020000031791us-gaap:PensionPlansDefinedBenefitMember2019-12-302021-01-030000031791us-gaap:ForeignPlanMember2023-01-010000031791country:US2023-01-010000031791us-gaap:ForeignPlanMember2022-01-020000031791country:US2022-01-020000031791us-gaap:ForeignPlanMember2021-01-030000031791country:US2021-01-030000031791us-gaap:ForeignPlanMember2022-01-032023-01-010000031791country:US2022-01-032023-01-010000031791us-gaap:ForeignPlanMember2021-01-042022-01-020000031791country:US2021-01-042022-01-020000031791us-gaap:OtherPensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:ForeignPlanMember2019-12-290000031791country:US2019-12-290000031791us-gaap:ForeignPlanMember2019-12-302021-01-030000031791country:US2019-12-302021-01-030000031791us-gaap:ForeignPlanMember2018-12-312019-12-290000031791country:US2018-12-312019-12-290000031791us-gaap:ForeignPlanMemberus-gaap:EquitySecuritiesMember2023-01-010000031791country:USus-gaap:EquitySecuritiesMember2023-01-010000031791us-gaap:ForeignPlanMemberus-gaap:EquitySecuritiesMember2022-01-020000031791country:USus-gaap:EquitySecuritiesMember2022-01-020000031791us-gaap:ForeignPlanMemberus-gaap:DebtSecuritiesMember2023-01-010000031791country:USus-gaap:DebtSecuritiesMember2023-01-010000031791us-gaap:ForeignPlanMemberus-gaap:DebtSecuritiesMember2022-01-020000031791country:USus-gaap:DebtSecuritiesMember2022-01-020000031791us-gaap:ForeignPlanMemberpki:OtherSecuritiesMember2023-01-010000031791country:USpki:OtherSecuritiesMember2023-01-010000031791us-gaap:ForeignPlanMemberpki:OtherSecuritiesMember2022-01-020000031791country:USpki:OtherSecuritiesMember2022-01-020000031791us-gaap:ForeignPlanMembersrt:ScenarioForecastMember2023-12-310000031791country:USsrt:ScenarioForecastMember2023-12-310000031791us-gaap:ForeignPlanMember2023-01-010000031791country:US2023-01-010000031791us-gaap:ForeignPlanMember2022-01-020000031791country:US2022-01-020000031791us-gaap:CashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2023-01-010000031791us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2023-01-010000031791pki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel1Memberpki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberpki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791pki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791pki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberpki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791pki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel1Memberpki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberpki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791pki:FixedIncomeFundsCorporateBondsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791pki:FixedIncomeFundsCorporateBondsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:FixedIncomeFundsCorporateBondsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberpki:FixedIncomeFundsCorporateBondsMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791pki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel1Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:CashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2022-01-020000031791us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesUSLargeCapMember2022-01-020000031791pki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel1Memberpki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:EquitySecuritiesInternationalLargeCapMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791pki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791pki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:EquitySecuritiesEmergingMarketsGrowthMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791pki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel1Memberpki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:FixedIncomeFundsCorporateDebtInstrumentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791pki:FixedIncomeFundsCorporateBondsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791pki:FixedIncomeFundsCorporateBondsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:FixedIncomeFundsCorporateBondsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:FixedIncomeFundsCorporateBondsMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791pki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel1Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2019-12-290000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesForeignRealEstateFundsMember2019-12-290000031791us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-290000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-290000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2019-12-302021-01-030000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesForeignRealEstateFundsMember2019-12-302021-01-030000031791us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-302021-01-030000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-302021-01-030000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-030000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesForeignRealEstateFundsMember2021-01-030000031791us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-030000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-030000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-042022-01-020000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesForeignRealEstateFundsMember2021-01-042022-01-020000031791us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-042022-01-020000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-042022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignRealEstateFundsMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-042022-01-020000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesForeignRealEstateFundsMember2022-01-020000031791us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-020000031791us-gaap:FairValueInputsLevel3Memberpki:ForeignLiabilityDrivenInvestmentMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-032023-01-010000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesForeignRealEstateFundsMember2022-01-032023-01-010000031791us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-032023-01-010000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-032023-01-010000031791us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberpki:EquitySecuritiesForeignRealEstateFundsMember2023-01-010000031791us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2023-01-010000031791us-gaap:SubsequentEventMembercountry:US2023-01-022023-04-020000031791us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2023-01-010000031791us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-01-020000031791us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-01-032023-01-010000031791us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2021-01-042022-01-020000031791us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2019-12-302021-01-030000031791us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-010000031791us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-020000031791us-gaap:EquitySecuritiesMemberus-gaap:ForeignPlanMembersrt:ScenarioForecastMembersrt:MinimumMember2023-01-022023-12-310000031791srt:MaximumMemberus-gaap:EquitySecuritiesMemberus-gaap:ForeignPlanMembersrt:ScenarioForecastMember2023-01-022023-12-310000031791country:USus-gaap:EquitySecuritiesMembersrt:ScenarioForecastMembersrt:MinimumMember2023-01-022023-12-310000031791srt:MaximumMembercountry:USus-gaap:EquitySecuritiesMembersrt:ScenarioForecastMember2023-01-022023-12-310000031791us-gaap:ForeignPlanMemberus-gaap:DebtSecuritiesMembersrt:ScenarioForecastMembersrt:MinimumMember2023-01-022023-12-310000031791srt:MaximumMemberus-gaap:ForeignPlanMemberus-gaap:DebtSecuritiesMembersrt:ScenarioForecastMember2023-01-022023-12-310000031791country:USus-gaap:DebtSecuritiesMembersrt:ScenarioForecastMembersrt:MinimumMember2023-01-022023-12-310000031791srt:MaximumMembercountry:USus-gaap:DebtSecuritiesMembersrt:ScenarioForecastMember2023-01-022023-12-310000031791us-gaap:ForeignPlanMemberus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMembersrt:ScenarioForecastMembersrt:MinimumMember2023-01-022023-12-310000031791srt:MaximumMemberus-gaap:ForeignPlanMemberus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMembersrt:ScenarioForecastMember2023-01-022023-12-310000031791country:USus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMembersrt:ScenarioForecastMembersrt:MinimumMember2023-01-022023-12-310000031791srt:MaximumMembercountry:USus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMembersrt:ScenarioForecastMember2023-01-022023-12-31pki:years0000031791pki:A2019IncentivePlanMember2021-01-030000031791us-gaap:CostOfSalesMember2022-01-032023-01-010000031791us-gaap:CostOfSalesMember2021-01-042022-01-020000031791us-gaap:CostOfSalesMember2019-12-302021-01-030000031791us-gaap:ResearchAndDevelopmentExpenseMember2022-01-032023-01-010000031791us-gaap:ResearchAndDevelopmentExpenseMember2021-01-042022-01-020000031791us-gaap:ResearchAndDevelopmentExpenseMember2019-12-302021-01-030000031791us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-032023-01-010000031791us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-042022-01-020000031791us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-12-302021-01-030000031791us-gaap:EmployeeStockOptionMember2022-01-032023-01-010000031791us-gaap:EmployeeStockOptionMember2021-01-042022-01-020000031791us-gaap:EmployeeStockOptionMember2019-12-302021-01-030000031791us-gaap:EmployeeStockOptionMember2023-01-010000031791pki:RestrictedStockAwardsMember2022-01-032023-01-010000031791pki:RestrictedStockAwardsMember2022-01-020000031791pki:RestrictedStockAwardsMember2023-01-010000031791pki:RestrictedStockAwardsMember2021-01-042022-01-020000031791pki:RestrictedStockAwardsMember2019-12-302021-01-030000031791us-gaap:EmployeeStockMember2022-01-032023-01-010000031791us-gaap:EmployeeStockMember2023-01-010000031791us-gaap:EmployeeStockMember2021-01-042022-01-020000031791us-gaap:EmployeeStockMember2019-12-302021-01-030000031791pki:RepurchaseProgram07312020Member2020-07-310000031791pki:RepurchaseProgram07222022Member2022-07-220000031791pki:RepurchaseProgram07312020Member2022-01-032023-01-010000031791pki:RepurchaseProgram07222022Member2022-01-032023-01-010000031791pki:RepurchaseProgram07222022Member2023-01-0100000317912022-10-032023-01-010000031791us-gaap:SubsequentEventMember2023-01-022023-04-0200000317912022-07-042022-10-0200000317912022-04-042022-07-0300000317912022-01-032022-04-0300000317912021-07-052021-10-0300000317912021-04-052021-07-0400000317912021-01-042021-04-040000031791pki:EuropeanAndAsianCurrenciesMember2022-01-032023-01-010000031791us-gaap:FairValueHedgingMember2023-01-010000031791us-gaap:FairValueHedgingMember2022-01-020000031791us-gaap:FairValueHedgingMember2021-01-030000031791pki:NotionalAmountofUSDollarDerivativesMemberus-gaap:CashFlowHedgingMember2022-01-020000031791pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberus-gaap:NetInvestmentHedgingMember2022-01-032023-01-010000031791pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberus-gaap:NetInvestmentHedgingMember2021-01-042022-01-020000031791pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberus-gaap:NetInvestmentHedgingMember2019-12-302021-01-030000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-01-010000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-01-010000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-01-010000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-01-010000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-01-020000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-01-020000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-01-020000031791us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-020000031791pki:SeniorUnsecuredNotesMember2023-01-010000031791us-gaap:FairValueInputsLevel2Memberpki:SeniorUnsecuredNotesMember2023-01-010000031791pki:SeniorUnsecuredNotesMember2022-01-020000031791us-gaap:FairValueInputsLevel2Memberpki:SeniorUnsecuredNotesMember2022-01-020000031791pki:OtherDebtFacilitiesIncludingTheSeniorRevolvingCreditFacilityMemberus-gaap:FairValueInputsLevel2Member2023-01-01iso4217:EUR0000031791pki:OtherDebtFacilitiesIncludingTheSeniorRevolvingCreditFacilityMemberus-gaap:FairValueInputsLevel2Member2022-01-020000031791us-gaap:OtherCurrentLiabilitiesMember2023-01-010000031791us-gaap:OtherCurrentLiabilitiesMember2022-01-020000031791us-gaap:OtherNoncurrentLiabilitiesMember2023-01-010000031791us-gaap:OtherNoncurrentLiabilitiesMember2022-01-02pki:segments0000031791pki:DiscoveryAnalyticalSolutionsMemberpki:ReportableSegmentRevenueMember2022-01-032023-01-010000031791pki:DiscoveryAnalyticalSolutionsMemberpki:ReportableSegmentRevenueMember2021-01-042022-01-020000031791pki:DiscoveryAnalyticalSolutionsMemberpki:ReportableSegmentRevenueMember2019-12-302021-01-030000031791pki:DiagnosticsMemberpki:ReportableSegmentRevenueMember2022-01-032023-01-010000031791pki:DiagnosticsMemberpki:ReportableSegmentRevenueMember2021-01-042022-01-020000031791pki:DiagnosticsMemberpki:ReportableSegmentRevenueMember2019-12-302021-01-030000031791pki:RevenuePurchaseAccountingAdjustmentsMemberpki:ReportableSegmentRevenueMember2022-01-032023-01-010000031791pki:RevenuePurchaseAccountingAdjustmentsMemberpki:ReportableSegmentRevenueMember2021-01-042022-01-020000031791pki:RevenuePurchaseAccountingAdjustmentsMemberpki:ReportableSegmentRevenueMember2019-12-302021-01-030000031791pki:ReportableSegmentRevenueMember2022-01-032023-01-010000031791pki:ReportableSegmentRevenueMember2021-01-042022-01-020000031791pki:ReportableSegmentRevenueMember2019-12-302021-01-030000031791us-gaap:CorporateMember2022-01-032023-01-010000031791us-gaap:CorporateMember2021-01-042022-01-020000031791us-gaap:CorporateMember2019-12-302021-01-030000031791pki:SegmentOperatingIncomeMember2022-01-032023-01-010000031791pki:SegmentOperatingIncomeMember2021-01-042022-01-020000031791pki:SegmentOperatingIncomeMember2019-12-302021-01-030000031791pki:AllSegmentsMember2022-01-032023-01-010000031791pki:AllSegmentsMember2021-01-042022-01-020000031791pki:AllSegmentsMember2019-12-302021-01-030000031791us-gaap:CorporateMember2023-01-010000031791us-gaap:CorporateMember2022-01-020000031791country:US2022-01-032023-01-010000031791country:US2021-01-042022-01-020000031791country:US2019-12-302021-01-030000031791country:CN2022-01-032023-01-010000031791country:CN2021-01-042022-01-020000031791country:CN2019-12-302021-01-030000031791country:GB2022-01-032023-01-010000031791country:GB2021-01-042022-01-020000031791country:GB2019-12-302021-01-030000031791pki:OtherInternationalMember2022-01-032023-01-010000031791pki:OtherInternationalMember2021-01-042022-01-020000031791pki:OtherInternationalMember2019-12-302021-01-030000031791pki:TotalInternationalMember2022-01-032023-01-010000031791pki:TotalInternationalMember2021-01-042022-01-020000031791pki:TotalInternationalMember2019-12-302021-01-030000031791country:US2023-01-010000031791country:US2022-01-020000031791country:DE2023-01-010000031791country:DE2022-01-020000031791country:CN2023-01-010000031791country:CN2022-01-020000031791pki:OtherInternationalMember2023-01-010000031791pki:OtherInternationalMember2022-01-020000031791pki:TotalInternationalMember2023-01-010000031791pki:TotalInternationalMember2022-01-0200000317912021-10-042022-01-02
Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_____________________________________
Form 10-K
(Mark One)
☑ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended January 1, 2023
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ________
Commission file number 001-5075
_____________________________________ 
PerkinElmer, Inc.
(Exact name of registrant as specified in its charter)
Massachusetts04-2052042
(State or other jurisdiction of
incorporation or organization)		(I.R.S. Employer
Identification No.)
940 Winter Street, Waltham,Massachusetts02451
(Address of Principal Executive Offices)(Zip Code)
(781) 663-6900
(Registrant’s telephone number, including area code)
____________________________________________________

Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol (s)Name of Each Exchange on Which Registered
Common Stock, $1 Par ValuePKIThe New York Stock Exchange
1.875% Notes due 2026PKI 21AThe New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ    No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No þ
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.        Yes þ        No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).        Yes þ        No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
þ
Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark whether the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.   ☑

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. □
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). □
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No þ
The aggregate market value of the common stock, $1 par value per share, held by non-affiliates of the registrant on July 1, 2022, the last business day of the registrant’s most recently completed second fiscal quarter, was $18,089,645,853 based upon the last reported sale of $144.07 per share of common stock on July 1, 2022.
As of February 24, 2023, there were outstanding 126,411,985 shares of common stock, $1 par value per share.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 25, 2023 are incorporated by reference into Part III of this Form 10-K.

Table of Contents

TABLE OF CONTENTS
 
  Page
PART I
Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.
PART II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
PART III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
PART IV
Item 15.
Item 16.

 

Table of Contents

PART I

Item 1.    Business
Overview
We are a leading provider of products, services and solutions for the diagnostics, life sciences and applied markets. Through our advanced technologies and differentiated solutions, we address critical issues that help to improve lives and the world around us.
Our headquarters are in Waltham, Massachusetts, and we market our products and services in more than 190 countries. As of January 1, 2023, we employed approximately 16,700 employees. Our common stock is listed on the New York Stock Exchange under the symbol “PKI” and we are a component of the S&P 500 Index.
We maintain a website with the address http://www.perkinelmer.com. We are not including the information contained in our website as part of, or incorporating it by reference into, this annual report on Form 10-K. We make available free of charge through our website our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to these reports, as soon as reasonably practicable after we electronically file these materials with, or otherwise furnish them to, the Securities and Exchange Commission.
Our Strategy
Our strategy is to develop and deliver innovative products, services and solutions in high-growth markets that utilize our knowledge and expertise to address customers’ critical needs and drive scientific breakthroughs. To execute on our strategy and accelerate revenue growth, we focus on broadening our offerings through both the investment in research and development and the acquisition of innovative technology. Our strategy includes:
•Strengthening our position within key markets by expanding our global product and service offerings, maintaining superior product quality and driving an enhanced customer experience;
•Attracting, retaining and developing talented and engaged employees;
•Accelerating transformational innovation through both internal research and development and third-party collaborations and alliances;
•Augmenting growth in both of our core business segments, Discovery & Analytical Solutions and Diagnostics, through strategic acquisitions and licensing;
•Engraining focused operational excellence to improve organizational efficiency and agility; and
•Opportunistically utilizing our share repurchase programs to help drive shareholder value.
Recent Developments
As part of our strategy to grow our core businesses and transform our portfolio, we have recently taken the following actions:
Discontinued Operations in Fiscal Year 2022:
3
Table of Contents

In August 2022, we entered into a Master Purchase and Sale Agreement (the “Purchase Agreement”) with Polaris Purchaser, L.P. (the “Purchaser”), a Delaware limited partnership owned by funds managed by affiliates of New Mountain Capital L.L.C. (the “Sponsor”), under which we agreed to sell to the Purchaser certain assets and the equity interests of certain entities constituting our Analytical, Food and Enterprise Services businesses (the “Business”) (as further defined in the Purchase Agreement), for cash consideration of up to approximately $2.45 billion and the Purchaser’s assumption of certain liabilities relating to the Business (collectively, the “Transaction”). Approximately $2.30 billion of the purchase price will be payable at closing, subject to certain customary adjustments, which includes $75.0 million in deferred payments tied to the transfer of the PerkinElmer brand and related trademarks to the Purchaser (which may be completed within 24 months following the date of the closing at our election). The Purchase Agreement also provides for potential post-closing payments totaling up to $150.0 million, which are contingent on the exit valuation the Sponsor and its affiliated funds receive on a sale or other capital events related to the Business. The Transaction is expected to close in the first quarter of fiscal year 2023, subject to regulatory approvals and other customary closing conditions.

Business Segments and Products
We report our business in two segments: Discovery & Analytical Solutions and Diagnostics.

Discovery & Analytical Solutions Segment
Our comprehensive portfolio of technologies helps life sciences researchers better understand diseases and develop treatments. In addition, we enable scientists to detect, monitor and manage contaminants and toxic chemicals that impact our environment and food supply as well as enable manufacturers to verify product quality and safety. Our Discovery & Analytical Solutions segment serves the life sciences and applied markets.

Life Sciences:
In the life sciences market, we provide a broad suite of products, solutions and services that facilitate optimized workflows, increase productivity, and accelerate every stage of the drug discovery and development pipeline. Our offerings span the areas of cell, gene, and protein research, enabling scientists to work smarter, make research breakthroughs, and transform those breakthroughs into real-world outcomes. We partner with global pharmaceutical, biotech and contract research organizations, as well as academic institutions, to enable them to discover and develop better treatments and therapeutics to fight disease faster and more efficiently.
Applied Markets:
The applied markets consist of environmental, food and industrial markets.
For the environmental market, we develop and provide analytical technologies, solutions and services that enable our customers to understand and characterize the health and quality of our environment, including air, water and soil. Our solutions are used to detect and help reduce the impact commercial products and industrial processes have on our environment. For example, our solutions help ensure compliance with regulatory standards that protect the purity of the world’s water supply by detecting harmful substances, including trace metals such as lead, organic pollutants such as pesticides and benzene, and emerging contaminants such as microplastics and polyfluoroalkyl substances (PFAS). We provide the tools needed to meet rigorous regulatory requirements for environmental testing, meet quality specifications and safety standards, and innovate for next generation analytical products.
We also offer a variety of solutions that help farmers and food producers provide a growing population with food that is safe, nutritious and appealing, and assist manufacturers with ensuring product consistency and maximizing production yield. Our solutions confirm food quality, including the level of moisture in grain or the level of fat in butter and nutritional elements, as well as detect the presence of potentially dangerous contaminants, such as veterinary drug residues in milk and harmful microbiological pathogens in foods. Our workflows can also be used to identify the origin of food products such as olive oil, which helps prevent counterfeiting. Our methods and analyses are transferable throughout the supply chain to enable customers to keep pace with industry standards as well as governmental regulations and certifications.
We also provide analytical instrumentation for industrial markets, which include the chemical, semiconductor, mining, energy, lubricant, petrochemical and polymer industries. Our solutions are used to meet the testing needs for quality assurance standards and in on-going product research and development. By providing material and chemical identification, characterization and quantification techniques, we help organizations drive the advancement and innovation of new products,
4
Table of Contents

with a focus on sustainability to increase the recyclability and biodegradability of materials as well as improving renewable energy solutions and energy storage.
We also provide services designed to help customers in the laboratory services market increase efficiencies and production time while reducing laboratory maintenance costs. Our OneSource® laboratory service business is aligned with customers’ needs, enabling them to accelerate scientific progress and commercial opportunities.

Principal Products:
Our principal products and services for Discovery & Analytical Solutions applications include the following:

Life Sciences Market:
•Radiometric detection solutions, including over 750 radiochemicals and instrumentation such as the Tri-Carb® and Quantulus™ GCT families of liquid scintillation analyzers, Wizard2® Gamma counters and MicroBeta2® plate based LSA, which are used for beta, gamma and luminescence counting in microplate and vial formats utilized in research, environmental and drug discovery applications.
•The Opera Phenix® Plus high-content screening system, which is used for sensitive and high-speed phenotypic drug screening of complex cellular models.
•The Operetta® CLS™ high-content analysis system, which enables scientists to reveal fine sub-cellular details from everyday assays as well as more complex studies, for example using live cells, 3D and stem cells.
•Reagents and solutions for microscopy and imaging applications. These include PhenoVue™ cellular imaging reagents and cell painting kits, PhenoPlate (formerly CellCarrier Ultra™) cellular imaging microplates and GrowDex® hydrogels, fluorophore-conjugated and enzyme-conjugated antibodies, as well as buffers and solutions, such as our Ce3D™ collection of buffers for 3D tissue imaging.
•The MuviCyte™ live-cell imaging system, designed to operate inside a cell-culture incubator, enabling researchers to study cellular behaviors and pathways in living cells to gain a deeper understanding of functions, disease mechanisms and responses to treatments.
•The Signals Image Artist™ next-generation image analysis and management platform for drug discovery research, to help scientists process and analyze high-content screening (HCS) and cellular imaging data in a matter of hours versus days or weeks, so they can make more informed decisions faster.
•The VICTOR Nivo® multimode plate reader benchtop system, which is designed for assay development and academic labs, including those using HTRF® and AlphaLISA® assay technologies.
•The EnSight® multimode plate reader benchtop system, which offers well plate imaging alongside labeled detection technologies for target-based and phenotypic assays.
•The EnVision® multimode plate reader, which is designed for high-throughput screening laboratories, including those using HTRF®, AlphaScreen® and AlphaLISA® assay technologies.
•A wide range of homogeneous biochemical and cell-based reagents using HTRF®, LANCE® Ultra™, DELFIA®, AlphaLISA®, AlphaLISA ® SureFire® Ultra, AlphaScreen®, AlphaPlex® and luminescence assay technologies.
•A broad portfolio of recombinant GPCR and ion channel cell lines, including over 300 products and 120 ready-to-use frozen cell lines for a wide range of disease areas.
•BioLegend® ELISA MAX™ Standard Sets, ELISA MAX™ Deluxe Sets, LEGEND MAX™ ELISA Kits and RAPID MAX™ ELISA Kits as well as complementary solutions and buffers for immunoassays to cover more than 200 targets for human, mouse, and rat samples, many of which are designed to assess the immune environment and its inflammatory state for vaccine, infectious disease and autoimmune disease research.
•LEGENDplex™ bead-based reagents, which, in contrast to single analyte assays such as enzyme-linked immunosorbent assays (“ELISAs”), can quantitate up to 14 targets, from one small sample volume in a flow cytometry assay, and include both desktop and cloud-based analysis software.
•In vivo imaging technologies and reagents for preclinical research, comprised of the IVIS® Spectrum™ series for 2D and 3D optical imaging and optionally integrated low-dose CT imaging and the IVIS® Lumina™ series for benchtop 2D imaging, along with IVISbrite™ bioluminescent and IVISense™ fluorescent imaging agents, cell lines and dyes.
5
Table of Contents

•The QuantumTM GX2 system, which enables low-dose in vivo CT imaging of multiple species and areas of anatomical interest across multiple disease areas by way of high-resolution, tomographic imaging.
•GoInVivo™ as well as Ultra-LEAF™ and LEAF™ functional antibodies, which provide an affordable solution for researchers performing in vivo and ex vivo studies.
•Nexcelom BioScience high-throughput, microwell Celigo® image cytometry system, Cellaca™ MX high-throughput cell counter, the new Cellaca™ PLX image cytometry system, and Cellometer® automated cell counters, complemented by consumables and reagents, including reagents and kits for cell counting assays and cell viability, microplates, slides, and counting beads.
•Horizon Discovery tools and services that support drug discovery and development for greater understanding of gene function, identify genetic drivers behind human disease, develop and validate diagnostic workflows, and help deliver biotherapeutics, cellular and gene therapies for precision medicine with a portfolio of cell engineering tools, including Dharmacon™ Reagents, gene modulation technologies such as RNAi, and the Pin-point™ base editing technology.
•Sirion Biotech consultancy services and technologies to design and manufacture viral vectors for cell and gene therapy research and preclinical development.
•BioLegend best-in-class antibodies, recombinant proteins and related reagents, which are used across multiple applications and research areas, including proteogenomics, tissue, cell and protein analysis, cancer research, immunology, cell and gene therapy, stem cell therapy and neuroscience.
•Fluorophore-conjugated antibodies, which are used in flow cytometers to characterize protein expression on the surface and in internal compartments of cells. The large collection of dyes and antibodies allows for an increasing number of conjugate options, facilitating the use of bigger and better flow cytometry panels using conventional and spectral flow cytometers. Notable products are Brilliant Violet™ and the Spark™ and Fire dye series, among others.
•TotalSeq™ reagents, which are oligonucleotide-barcoded antibodies that enable protein detection by sequencing that can be combined with traditional RNA or DNA sequencing experiments with high-parameter protein detection, including comprehensive cloud-based analysis software.
•Cell culture and biofunctional assay reagents, including bioactive recombinant proteins, as well as other specialized reagents such as Cell-Vive™ T-NK Xeno-Free Serum Substitute (compliant with Good Manufacturing Practice requirements (“GMP”)), and other GMP-produced recombinant proteins and reagents. These products serve several markets, notably cell and gene therapy applications.
•MojoSort™ and Lymphopure™ reagents for cell separation that complement our fluorophore-antibody conjugates, used for FACS (Fluorescence-activated Cell Sorting), thus covering most cell separation and cell sorting technologies and applications.
•Flex-T™ reagents that utilize peptide-loaded major histocompatibility molecules assembled into tetramers for the identification of antigen-specific T cells. Our Flex-T products can be used to screen the efficacy of antigen peptides for vaccine and drug trials, as well as characterize the dominance of cancer-specific self-peptides, and more recently, SARS-CoV2 peptides for COVID-19 research.
•Antibodies and solutions for Western blotting. A large collection of validated antibodies, as well as supporting buffers and substrates, which provide a convenient set of tools to characterize protein size and relative expression levels in cell or tissue lysates.
•OneSource® laboratory services, a comprehensive portfolio of multivendor instrument management, QA/QC, lab relocation, scientific, laboratory Information Technology and regulatory compliance services. OneSource® services programs are tailored to the specific needs and goals of individual customers and offer a series of informatics-based consulting, planning and management offerings to assist in laboratory productivity and the optimization of complex Information Technology platforms.
•OneSource® Dashboard software, a TIBCO® Spotfire® technology-driven interactive graphical platform, which provides visibility to a customer’s global asset population, service event and downtime distribution, as well as key performance indicators to assist in asset operation.
•OneSource® Insights as a ServiceTM offerings which leverage comprehensive OneSource® analytics and industry data to develop and deliver customer-need-driven recommendations to optimize, integrate and accelerate lab operations.
6
Table of Contents

•PerkinElmer Signals Medical ReviewTM software, which empowers medical monitors to detect safety signals faster and reduce overall time to submission by combining innovative medical review workflows with advanced analytics.
•PerkinElmer Signals Lead DiscoveryTM software, which enables researchers to quickly gain new insights into chemical and biomolecular research data, featuring guided search and analysis workflows and dynamic data visualizations for on-the-fly exploration.
•PerkinElmer SignalsTM electronic notebook, a scientific research data management solution, which allows researchers to record research data and experiments in digital notebooks, drag and drop, store, organize, share, find and filter data easily.
•PerkinElmer Signals TranslationalTM data management, aggregation and analysis platform, which offers out-of-the-box support for the complete precision medicine workflow from data acquisition to biomarker discovery and validation.
•ChemDraw® 18 platform, a chemical structure drawing and visualization application for scientists and researchers.
•Lead DiscoveryTM Premium software, which allows scientists to import, filter by, analyze and interpret chemical structures and biosequences alongside other related data in a highly visual and interactive environment for faster insights and better decisions.
•OneSource® Asset Genius™ monitoring solution, part of the Asset Genius family, which offers a 360-degree view of laboratory instruments regardless of the manufacturer, correlating instrument usage, age and service data, allowing customers to visually pinpoint under-performing, ideally-performing and over-burdened assets, and to make informed decisions.
•Horizon CHOSOURCE™ platform, which was expanded to include CHO-K1 ADCC+ expression cell line for development of therapeutic antibodies in oncology, infectious disease and autoimmune conditions.
•A catalog of more than 20,000 SKUs from our recent acquisition of BioLegend, incorporating antibodies as well as a large collection of antibody conjugates and modifications. Other products include recombinant proteins, immunoassays and other supportive reagents and solutions for cell and molecular analysis.
•The T-SPOT® Discovery SARS-CoV-2 research use only assay to investigate cell-mediated immunity related to COVID-19.

Applied Markets:
•The series of Clarus® gas chromatographs and gas chromatographs/mass spectrometers, and the family of TurboMatrix™ sample-handling equipment, which are used to identify and quantify compounds in the environmental, forensics, food and beverage, hydrocarbon processing/biofuels, materials testing, pharmaceutical and semiconductor industries.
•A comprehensive gas chromatography (“GC”) column portfolio spanning many popular and application-specific phases that cover the vast majority of the GC market’s separation requirements.
•The LC 300™ ultra-high performance liquid chromatography (“UHPLC”) and LC 300 high performance liquid chromatography (“HPLC”) systems, which provide high throughput along with superior performance and sensitivity.
•The SimplicityChrom™ ™ Chromatography Data System (“CDS”) Software, an easy-to-learn, modern and intuitive CDS software platform that enables efficient control of PerkinElmer HPLC, UHPLC, GC and gas chromatography/mass spectrometry (“GC/MS”) solutions while integrating the overall chromatographic workflow. For labs requiring compliance, SimplicityChrom CDS Software supports 21 CFR Part 11.
•A comprehensive Liquid Chromatography (“LC”) Column portfolio of innovative and highly efficient HPLC/ UHPLC and supercritical fluid chromatography chemistries.
•The NexSAR™ HPLC, which is a speciation analysis ready system engineered with a completely inert and metal-free fluid path, enabling laboratories to meet low chromatographic background requirements on the most challenging speciation applications in food, water or consumer products such as children's toys.
•The Flexar™ UHPLC and Flexar advanced LC systems, which provide high throughput and resolution chromatographic separations.
•The QSight® Triple Quadrupole LC/MS/MS, a flow-based mass spectrometry system that enables high levels of efficiency and productivity to meet both standard and regulatory requirements for food, cannabis and environmental testing laboratories.
7
Table of Contents

•The Torion® T-9 portable GC/MS, a fast person-portable GC/MS system, enabling rapid detection and actionable results to potentially hazardous and emergency environmental conditions.
•Atomic spectroscopy portfolio of instruments, including the families of PinAAcle® atomic absorption spectrometers, Avio® Max inductively coupled plasma (“ICP”) optical emission spectrometers and NexION® ICP mass spectrometers, all of which are used in the environmental, food, pharmaceutical and chemical industries, among others, to determine the elemental content of a sample.
•The LPC 500™ liquid particle counter featuring single particle optical sizing technology. Coupled with the Avio® 550 Max ICP-OES oils system, particle counting and sizing as well as wear metals analysis of in-service oils and lubricants are performed in one run with results delivered in less than a minute.
•Our infrared (“IR”) spectroscopy family of instruments, the Spectrum Two™ IR & NIR spectrometers, which are compact and portable and used for advanced infrared analysis for unknown substance identification, material qualification or concentration determination in fuel and lubricant analysis, polymer analysis and pharmaceutical and environmental applications.
•The OilExpress™ 4 systems, which deliver highly automated, rapid, reliable oil condition monitoring results using recognized industry standard protocols such as ASTM®, JOAP and Caterpillar® S•O•S℠.
•The series of LAMBDA® UV/Vis spectrophotometers that provide sampling flexibility to enable measurement of a wide range of sample types, including liquids, powders and solid materials, both in regulated industries as well as QC/QA and research applications.
•The FL 6500TM and FL 8500TM fluorescence spectrophotometers, which address the challenges of bioscience, industrial, chemical, environmental, pharmaceutical, agricultural and academic application.
•The 2400 Series II CHNS/O elemental analyzer, one of the leading organic elemental analyzers, which is ideal for the rapid determination of carbon, hydrogen, nitrogen, sulfur and oxygen content in organic and other types of materials.
•Our thermal analysis family, which includes our series of Differential Scanning Calorimetry (DSC) instruments that offer exclusive HyperDSC™ capability for unparalleled sensitivity and new insights into material processes, our Thermogravimetric and Simultaneous Thermal Analysis instruments that can be coupled with Fourier Transform Infrared (“FT-IR”), mass spectrometry (“MS”), or GC/MS technologies to provide a complete and advanced line of Evolved Gas Analysis (EGA) platforms for greater analysis power and knowledge with materials characterization in polymers, pharmaceuticals, chemicals, petroleum, rubber, food and other areas.
•Perten® Falling Number®, which is the world standard method for measuring sprout damage. This is an important factor affecting the price of wheat and, ultimately, bread, baked goods, and pasta/noodle quality.
•RVA™ performance analyzer, which provides a screening tool for both producers and users of food ingredients and can be used to test the viscous properties of starch, grain, dairy products and other foods.
•The Bioo Scientific® and Meizheng Group test kits for detection of toxins, veterinary drug residues and contaminants, which enable rapid and easy testing at different steps in the food value chain.
•AuroFlow® AQ Mycotoxin platform that includes strip test versions for total Aflatoxin, Deoxynivalenol (DON), Fumonisin, Ochratoxin A, Zearalenone and T-2/HT-2.
•The PerkinElmer FT 9700™ compact, high-performance and full-wavelength-range FT Near Infrared (“NIR”) spectrometer, which helps food and feed laboratories perform quick analyses for quality assurance of food and feed materials and reduces variations in production.
•The DA 7250 diode-array based NIR lab and at-line system, which simultaneously measures multiple constituents (moisture, protein, fat fiber, etc.) in 10 seconds.
•The IM 9500 Whole Grain NIR, which measures moisture, protein, oil, and more in less than 40 seconds.
•The AM 5200 grain moisture meter, which is based on the latest moisture meter technology, including the use of the Unified Grain Moisture Algorithm (UGMA) and 149MHz.
•The QSight® SP50 online solid phase extraction (SPE) system, which facilitates sample clean-up, enrichment and concentration, obviating the need for elaborate and time-consuming sample preparation procedures.
•MaxSignal HTS™ mycotoxin kits featuring automated and easy-to-use testing workflows for the six most commonly tested mycotoxins.
8
Table of Contents

•PerkinElmer Solus One™ Listeria monocytogenes ELISA Assay. This offering is designed to help high throughput food processors and contract labs focus on L. mono testing for food and environmental surface samples.
•DA 7350™ and DA 7440™ in-line and on-line NIR instruments – combined with Process Plus™ cloud-based software – provide continuous quality control of food and food ingredient manufacturing processes.
•Perten® Glutomatic® 2000 system for gluten quantity and quality testing of wheat, durum, semolina and flour.
•LactoScope™ FT- instruments, which deliver quick and accurate full spectrum in-lab component testing and adulterant screening for liquid dairy products such as whey, raw and skim milk, shelf stable milk and cream with under 40% fat content.
•Lactoscope Wine LQA 300 FT-IR, which is a fit-for-purpose wine analyzer for the analysis of finished wine, grape must, and must under fermentation for a number of key quality parameters, including acidity, brix, pH, glucose and fructose, in less than 45 seconds.
•The Indiscope, a simple FT-IR milk analyzer designed for analysis by novice users at animal milk collection stations that can provide results for fat, protein, and solids-non-fat, as well as targeted and untargeted adulterants screening in 30 seconds.
•MappIR™ accessory for Spectrum™ 3 FT-IR, which helps ensure quality of incoming raw materials and final product quality for better outcomes in semiconductor wafer manufacturing.
•The Polymer ID analyzer, which provides accurate verification of identity, quality and composition of polymers and their blends used in industries such as food packaging, construction and automotive.
•The Tablet Analyzer™ and portable Silica Analyzer™ platform, which are dedicated analyzers launched to address customer needs for quick and accurate characterization of pharmaceutical tablet testing and respirable crystalline silica in mining environments, respectively.
•PureView™ Certified and PureView MS Certified vials, manufactured from Type 1 borosilicate glass which meets all USP, JP and EP requirements. The low-expansion, coefficient glass exhibits excellent thermal conductivity and provides an inert surface with a low free ion content, giving accurate and repeatable results every time.

New Products:
New products introduced or acquired for Discovery & Analytical Solutions applications in fiscal year 2022 include the following:

Life Sciences Market:
•Vega® ultrasound imaging system, which is a hands-free, automated, high-throughput preclinical ultrasound imaging system that delivers high-resolution 2D and 3D ultrasound images in just a few minutes and was originally developed by SonoVol Inc., which was acquired by PerkinElmer in early 2022. The system is complemented by VesselVue® microbubble contrast agents which can be used to study tissue perfusion and blood flow characteristics.
•New assay kits for Adeno-associated Virus Vectors (AAVs) and gene therapy applications in our range of HTRF® and AlphaLISA® reagents, for detecting and quantifying CHO HCP impurities in biotherapeutics development, as well as kits across oncology, neuroscience, and targeted protein degradation applications.
•Cellaca PLX™ image cytometry system, which combines best-in-class image cytometer hardware, software, validated consumables and optimized reagent kits with validated antibodies from our BioLegend business, and trackable data reporting to enable the simultaneous detection of multiple markers and to streamline cell and gene therapy workflows.
•New fluorescent stains, reagents and secondary antibodies in our PhenoVueTM cellular imaging reagents portfolio for the detection and analysis of cellular components.
•The latest version of the Signals Image Artist™ next-generation image analysis and management platform, which provides improved 3D cell segmentation and analysis, an AWS S3 cloud deployment option and enhanced cloud security, and compatibility with a broader range of systems, including the Nexcelom from PerkinElmer Celigo® image cytometer.
•An updated VICTOR® Nivo™ multimode plate reader with a new software version for streamlined data analysis.
•OptiScint™ NPE-free scintillation cocktails and quench standards, providing a more environmentally friendly alternative without compromising performance.
•Expansion of our Western blotting reagents with the addition of the Western Lightning™ One range, which has a pre-mixed one component chemiluminescent HRP substrate for more consistent results.
•Additional Spark™ and Fire dye-conjugated antibodies, enabling higher-parameter flow cytometry. Notable products are the Spark UV™ 387 and Spark Red™ 718 conjugates.
9
Table of Contents

•For the TotalSeq reagent portfolio, more large panels of pre-titrated oligo-conjugated antibodies released in Universal Panels for the analysis of human and mouse samples.
•Software solutions for LEGENDplex™ assays, multiomics analysis with TotalSeq reagents, and flow cytometry-based cell analysis software (Ryvett) that are now part of BioLegend’s data integration offerings.
•OneSource Laboratory Services: Instrument Concierge™ Flow Cytometry, which helps labs streamline the entire flow cytometry workflow by providing a range of support-based services for each lab’s unique needs, including expert onsite flow cytometry specialists to help manage instruments and processes more efficiently and effectively, facilitating reduced downtime, increased productivity as well as better data integrity and reproducibility.
•OneSource Laboratory Services: Instrument Concierge™ Purification, which offloads the complex and time-consuming process of prepping, purifying and analyzing to provide high quality data output for scientific discovery.
•OneSource Laboratory Services: MES (Manufacturing Execution Systems) IT support, which drives production and minimizes downtime in pharmaceutical manufacturing environments by providing customized IT infrastructure support and maintenance, onsite or remotely.
•OneSource Laboratory Services: LabIT per PC Delivery Model, which eliminates the complexity of other pricing models for customers by providing a flat rate for each PC being serviced that includes maintenance and repair as well as a network of IT expertise in benchtop support and scientific applications.
•OneSource Laboratory Services: Food Service Offering, which provides support in various food quality and safety activities such as QA/QC lab testing, on-site troubleshooting and repair of instruments and coordinating vendor visits.

Applied Markets:
◦The MPS 320™, a microwave digestion system for PerkinElmer’s AA, ICP-OES, and ICP-MS instruments, which accommodates a wide range of sample matrices and elemental analysis applications across environmental, food, cannabis, pharmaceutical or manufacturing QA/QC applications and more.
◦GC 2400TM Gas Chromatography Platform with Detachable Touchscreen, featuring GC system, Liquid and Headspace Autosampler, FID and MS Detectors, offering innovative technology that enables access to real-time information on the go. With easy-to-learn SimplicityChrom Software, labs in all markets can take advantage of integrated workflows, and benefit from lab efficiency through the smart, simplified, and sustainable GC 2400 Platform.
◦LAMBDA® 365+ double-beam UV/V is a spectrometer, which delivers the performance researchers and analysts need to measure high absorbance liquids and unravel chemical kinetics. The large sample compartment and wide range of accessories fully integrated with software provide sampling flexibility and simplified workflows to meet all throughput needs without requiring extensive training.

Brand Names:
Our Discovery & Analytical Solutions segment offers additional products under various brand names:
Life Sciences Market:
Accell™, AdenoBOOST™, AlphaLISA®, AlphaPlex™, AlphaScreen®, Alpha™ SureFire®, Brilliant Violet™, Ce3D™, CellCarrier®, Cellaca™, Celigo®™, Cellometer®™, cell::explorer™, Cell-Vive™, Chalice™, Chem3D®, ChemDraw®, ChemOffice®, CHOSOURCE™, Dharmacon™, DharmaFECT™, Edit-R™, ELISA MAX™, EnSight®, EnVision®, Flex-T™, FMT®, FolateRSense™, GoInVivo™, HTRF®, IVIS®, IVISbrite™, IVISense™, LANCE®, LANCE ® Ultra ™, LEAF™, LEGEND MAX™, LEGENDplex™, LentiBOOST™, Lincode™, Living Image®, Lumina™, Lymphopure™, MicroBeta2®, Mini ELISA Plate Reader™, miRIDIAN™, MojoSort™, MuviCyte™, OneSource®, ON-TARGET™, ON-TARGETplus™, Opera Phenix® Plus, Operetta® CLS™, OptiScint™, PerkinElmer Signals for Translational™, PhenoPlate™, PhenoVue™, Pin-point™, Quantulus™ GCT, RAPID MAX™, RediJect™, RNAiONE™, Signals Image Artist™, SMARTpools™, SMARTvector™, Spark™, Spectrum™, TotalSeq™, Tri-Carb®, T-SPOT®, Ultra-LEAF™, Vega®, VesselVue®, ViaStain™, VICTOR Nivo™ Western Lightning™, and Wizard2®.

Applied Markets:
Aquamatic™, AuroFlow®, Clarus®, DairyGuard™, DoughLab™, Falling Number®, FL 6500TM, FL 8500TM, FlexarTM, Frontier™, GC 2400™ , Glutomatic®, Honigs Regression™, HyperDSC®, Inframatic™, LAMBDA®, LPC 500™, MaxSignal™, NexION®, NexSAR™, OilExpress™, OilPrep™, Optima®, Perten®, Perten Instruments®, PinAAcle®, PureViewTM, QSight®, SimplicityChrom™, Spectrum™, Spectrum Two™, Spotlight™, Supra-clean®, Supra-d™, Supra-poly®, Syngistix™, Torion®, TruQ™, TurboMatrix™ and Ultraspray®.

Diagnostics Segment
We offer instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families. Our Diagnostics segment is especially focused on reproductive health, immunodiagnostics, emerging market diagnostics and applied genomics.
We provide early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. Our screening products are designed to provide early and accurate insights into the health of expectant
10
Table of Contents

mothers during pregnancy and into the health of their babies. Diagnostic labs use our instruments, reagents and software for testing and screening genetic abnormalities and certain disorders and diseases, including Down syndrome, hypothyroidism, muscular dystrophy, infertility and various metabolic conditions. We also develop technologies that enable and support genomic workflows using PCR and next-generation DNA sequencing for applications in oncology, immunodiagnostics and drug discovery.
Principal Products:
Our principal products and services for Diagnostics applications include the following:
•The DELFIA® Xpress screening platform, a complete solution for prenatal and maternal health screening, which includes a fast continuous loading system. It is supported by kits for first, second and third trimester analyses for prenatal screening and clinically validated LifeCycle™ software.
•The DELFIA® Xpress sFlt-1 kit, which enables short term prediction of pre-eclampsia and aids in diagnosis in the second and third trimesters of pregnancy together with the previously launched DELFIA® Xpress PlGF 1-2-3™ assay. The NeoBase™ non-derivatized MS/MS AAAC kits, which are used to support detection of metabolic disorders in newborns through tandem mass spectrometry. The kits analyze newborn dry blood spot samples for measurement of amino acids and other metabolic analytes for specific diseases.
•The GSP® Neonatal hTSH, T4 17á-OHP, GALT IRT, BTD, PKU, Total Galactose, CK-MM and G6PD kits, used for screening congenital neonatal conditions from a drop of blood.
•The Specimen Gate® informatics data management solution, designed specifically for newborn screening laboratories.
•The NeoLSDTM MS/MS kit, the first commercial IVD kit for screening of Pompe, MPS-I, Fabry, Gaucher, Niemann-Pick A/B and Krabbe disorders from a single dried blood spot sample.
•QSight® 210MD and 225MD UHPLC MS/MS instruments, which are used for newborn screening.
•ViaCord® umbilical cord blood banking services for the banking of stem cells harvested from umbilical cord blood and cord tissue, for potential therapeutic application in transplant and regenerative medicine.
•An expanded portfolio of molecular-based infectious disease screening technologies for blood bank and clinical laboratory settings in China. The tools include a qualitative 3-in-1 assay for the detection of hepatitis B, hepatitis C and HIV, as well as assays for other communicable diseases.
•TRF-based Anti HBs/HCV/TP kits for infectious disease testing.
•Chitas® instrument and HBV/HCV/HIV 3-in-1 PCR reagents for blood screening, and Hi Sensitivity HBV DNA and HCV RNA assays for clinical infectious disease testing.
•The Bead Ruptor™ Elite Bead Mill Homogenizer, which enables grinding, lysing, and homogenizing of biological samples prior to molecular extraction delivering repeatable sample disassociation.
•The chemagic™ Prime™ instrument, a fully automated, LIMS-compatible solution for primary sample transfer, DNA and RNA isolation, optional normalization and the setup of PCR and Next Generation Sequencing (“NGS”) applications.
•Automated liquid handling platforms (JANUS®, Sciclone®, Zephyr® and FlexDrop™) that offer a choice of robotic solutions in genomics, biotherapeutics, high throughput screening and high content analysis to assist life science research from bench to clinic.
•JANUS® BioTx™ and PreNAT IITM workstations for automated small-scale purification, offering column, tip and plate-based chromatography on a single platform.
•HIVE™ scRNAseq Solution, which integrates sample storage and single cell profiling into a complete workflow, solving the issues that limit single cell RNA analysis.The LabChip® GXII Touch™ protein characterization system, which provides a means of characterizing multiple protein product attributes for research labs through QC.
•The explorer™ automated workstation, which allows integration of multiple laboratory instrumentation using a centralized robotic interface, allowing high throughput and turnkey-application focused solutions.
•Vanadis® NIPT, a non-PCR non-sequencing fully automated cfDNA technology for use in any laboratory for screening common trisomies in the pregnant population.
•PerkinElmer Genomics, a global laboratory network offering services for testing in cytogenetics, biochemical genetics (prenatal and postnatal), molecular genetics and immunodiagnostics. The laboratory network includes testing laboratories in the United States, Sweden, India, China and the United Kingdom.
•The EONISTM assay, a CE marked and United States Food and Drug Administration (“FDA”) authorized system utilizing real-time PCR technology, which allows for simultaneous screening of SMA, SCID and XLA in newborns from a single DBS punch.
•Immune fluorescence testing (“IFT”), ELISAs, chemiluminescence-based immunotesting, immunoblots, molecular microarrays, PCR for infectious disease, autoimmune and allergy diagnostics as well as liquid handlers and software solutions for automated processing of those test systems.
11
Table of Contents

•Chemiluminescence immunoassays covering endocrinology, autoimmunity, infectious diseases, allergy and therapeutic drug monitoring.
•ELISAs covering endocrinology, autoimmunity, diabetes monitoring, steroids, thyroid monitoring, animal research and tumor markers.
•Radioactive immunoassays in calcium metabolism.
•Autoimmune testing covering rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility.
•Allergy testing covering allergen-specific immunoglobin E (IgE), measuring the level of different IgE antibodies in blood using ELISA and EUROLINETM assays.
•Infectious disease testing covering bacteria, viruses, fungi and parasites.
•IFT, ELISA and EUROLINETM assays for veterinary diagnostics.
•EUROIMMUN SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein.
•EURORealTime SARS-CoV-2 Fast: real-time PCR test for direct detection of SARS-CoV-2.
•EURORealTime SARS-CoV-2/Influenza A/B real-time PCR test for direct detection of SARS-CoV-2, influenza virus type A and influenza virus type B.
•Immunoassays for detection of antibodies and T-cells against SARS-CoV-2.
•Anti-SARS-CoV-2 QuantiVacTM ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1 antigen.
•SARS-CoV-2 NeutraLISA to identify neutralizing antibodies against SARS-CoV-2 (CE-marked).
•EUROLabPolaris, which provides the secure transfer of indirect immunofluorescence data to several locations enabling central evaluation within the software (CE-marked).
•MyFoodProfile immunoblots for the determination of IgG and IgE reactivity against more than 200 foods (CE-marked).
•Prenatal and Postnatal testing utilizing PerkinElmer Genomics Next Generation Sequencing products including gene panels, exomes and genomes.
•PerkinElmer Genomics Whole Genome Sequencing test, which detects single nucleotide and copy number variants and includes screening for Spinal Muscular Atrophy and more than 30 short tandem repeat disorders.
•PerkinElmer Genomics Digital Genome test for Facioscapularhumeral dystrophy (FSHD) Genome Optical Mapping technology.
•Oxford Immunotec T-SPOT® Technology platform, a modified ELISPOT used to detect a T cell immune response to infection. Tests available using the platform include:
▪The T-SPOT®.TB test, an FDA-approved and CE-marked test to aid the diagnosis of Tuberculosis infection.
•The T-Cell Select™ reagent kit, which is intended for use with the T-SPOT®.TB test for the isolation of peripheral blood mononuclear cells from whole blood using positive selection via a magnetic bead-based cell separation system.
•The T-Cell Xtend® reagent kit, which is intended for use with the T-SPOT®.TB test for the pretreatment of whole blood prior to lymphocyte separation. The reagent aids in the removal of selected white blood cells from whole blood.
▪The T-SPOT®.COVID test, a CE marked test to detect a T cell immune response to SARS-CoV-2 infection and vaccination.
▪The T-SPOT®.CMV test, a CE marked test to assess anti-CMV T cell mediated immunity.

New Products:
New products or services introduced or acquired for Diagnostics applications in fiscal year 2022 include the following:
•EONIS™ Q for Research Use Only (RUO), which is a novel ‘dry-chemistry’ qPCR reader.
•GAMT RUO assay for Mass Spectrometry that detects the Guanidinoacetate methyltransferase molecule in dried blood spots.
•RONIA™ Platform for Research Use Only, which is a novel point of care device for quantitative determination of Placental Growth Factor.
•The BioQule™ NGS System combines automation, reagents, consumables, and scripts, enabling walkaway automation to simplify low throughput NGS library prep and quantitation.
•PKamp™ Monkeypox Virus Real-time PCR RUO Kit V1 which specifically targets the Monkeypox virus’ F3L gene and offers seamless integration with PerkinElmer’s sample prep workflow.
•HDPCR™ Tick-Borne Pathogen Research Use Only Panel and HDPCR™ Multi-Drug Resistance Panel for Research Use Only.
•NeoMDx™ cCMV Real-time PCR assay to amplify and detect cCMV DNA.
•OMNI Prep 96 Automated Homogenizer Workstation, which is a fully automated homogenization workstation, enabling true walk-away processing.
12
Table of Contents

•chemagic™ 360-D instrument (IVDR) and chemagic™ Prime™ Junior-D instrument (IVDR) for automated nucleic acid isolation, and related kits such as CE-IVD chemagic™ Nucleic Acid Purification Kits and chemagic™ miRNA 200 Kit.
•NEXTFLEX® Small RNA-Seq Kit v4 enables gel-free miRNA library prep while delivering exceptional miRNA discovery.
•NEXTFLEX® Rapid XP V2 DNA-Seq Kit incorporates normalization beads shortening the time needed for quantification and pooling preparation for sequencing and library prep costs.
•NEXTFLEX® Variant-Seq™ SARS-CoV-2 V2 Kit, which reduces the costs and time of SARS-CoV-2 variant detection by incorporating normalization beads into an NGS workflow.
•The PG-Seq™ Rapid Kit v2 analyzes picogram quantities of DNA from an embryo biopsy for preimplantation genetic research with enhanced whole genome coverage and accuracy.
•DOPlify® WGA V2 Kit performs fast whole genome amplification on single cells or limited template DNA samples, allowing cell chromosome copy number status to be determined.
•PerkinElmer® COVID-19 Antigen Self-Test is a CE marked in vitro diagnostic device for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal swab specimen in a non-professional setting by non-professional users.
•PerkinElmer Genomics WholePanel test, which is an enhanced panel testing (WholeCancer, WholeAtaxia, WholeCardiology and WholeMuscularDystrophy panels) using genome sequencing as a backbone and provides full intrinsic coverage and short tandem repeat screening in on test.
•PerkinElmer Genomics UltraRapid Whole Genome Sequencing with StepOne, which provides the sickest babies in NICU multiomic testing results in five days or less.
•EURORealTime SARS-CoV-2 Fast, which is real-time PCR test for direct detection of SARS-CoV-2 (CE-marked)
•Microwell Imager (CE-marked).
•EUROMicroblot Anti-Borrelia (IgG, IgM) (CE-marked) Miniaturised immunoblots for borrelia diagnostics in microplate format where processing can be carried out on automated ELISA systems and evaluation is done fully automatically by the Microwell Imager device and the EUROLineScan software.
•EUROLINE Autoimmune Inflammatory Myopathies 20 Ag (IgG) (CE-marked), in which the immunoblot profile combines 20 target antigens – including the exclusive cN-1A – in one test strip, allowing parallel and monospecific detection of antibodies for the diagnostics of idiopahtic inflammatory myopathies, e.g. myositis.
•Neurology: Complete portfolio of chemiluminescence immunoassays (ChLIA) for precise Alzheimer’s disease diagnostics, which provides reliable analysis of the established CSF biomarkers beta-amyloid (1-40), beta-amyloid (1-42), total tau and pTau(181) and high degree of standardisation due to fully automated processing:
◦Beta-Amyloid (1-40) ChLIA (CE-marked). Chemiluminescence immunoassay (ChLIA) for quantitative in vitro determination of beta-amyloid (1-40) in human cerebrospinal fluid. Supports the diagnosis of amyloid pathology (Alzheimer’s disease). Fully automated processing on the random-access devices IDS-iSYS Multi-Discipline Automated System and IDS-i10.
◦Beta-Amyloid (1-42) ChLIA (CE-marked). Chemiluminescence immunoassay (ChLIA) for quantitative determination of beta-amyloid (1-40) in human cerebrospinal fluid. Supports the diagnosis of amyloid pathology (Alzheimer’s disease). Calibrated against certified reference material. Fully automated processing on the random-access devices IDS-iSYS Multi-Discipline Automated System and IDS-i10.
◦Total-Tau ChLIA (CE-marked). Chemiluminescence immunoassay (ChLIA) for quantitative determination of total tau in human cerebrospinal fluid. Supports the diagnosis of Alzheimer’s disease. Fully automated processing on the random-access devices IDS-iSYS Multi-Discipline Automated System and IDS-i10.
◦pTau(181) ChLIA (CE-marked). Chemiluminescence immunoassay (ChLIA) for quantitative determination of total tau in human cerebrospinal fluid. Supports the diagnosis Supports the diagnosis of Alzheimer’s disease. Fully automated processing on the random-access devices IDS-iSYS Multi-Discipline Automated System and IDS-i10.
•EUROArray PneuVir (CE-marked). PCR-based multiplex test (Microarray) to detect 17 respiratory viruses including SARS-CoV-2 in just one analysis. The differential diagnostic approach for quick virus identification may thus help to rule out a bacterial infection and avoid unnecessary antibiotic treatment.
•Anti-Herpes simplex Virus 1 ChLIA (IgG) (CE-marked). Chemiluminescence immunoassay (ChLIA) for the quantitative determination of human IgG antibodies against herpes simplex virus 1 (HSV-1) High reliability of the HSV type-specific IgG determination due to the use of glycoprotein G1 (gG1). ). Fully automated processing on the random-access devices IDS-iSYS Multi-Discipline Automated System and IDS-i10.
•Anti-Herpes simplex Virus 2 ChLIA (IgG) (CE-marked). Chemiluminescence immunoassay (ChLIA) for quantitative determination of human IgG antibodies against herpes simplex virus 2 (HSV-2). High reliability of the HSV type-specific IgG determination due to the use of glycoprotein G2 (gG2). Fully automated processing on the random-access devices IDS-iSYS Multi-Discipline Automated System and IDS-i10.
13
Table of Contents

•Anti-SARS-CoV-2 RBD ChLIA (IgG) (CE-marked). Chemiluminescence immunoassay (ChLIA) for quantitative determination of human IgG antibodies against the receptor binding domain (RBD) of SARS-CoV-2 with the possibility of conversion into standardised units (BAU/ml). Fully automated processing on the random-access devices IDS-iSYS Multi-Discipline Automated System and IDS-i10.

Brand Names:
Our Diagnostics segment offers additional products under various brand names, including AutoDELFIA®, BACS-on-Beads®, BIOCHIPs, Bioo Scientific®, BoBs®, chemagic™, Chitas®, Datalytix™, DELFIA®, DELFIA® Xpress, DOPlify®, EONISTM, EUROArrayTM, EUROIMMUN®, EUROLabWorkstationTM, EUROLINETM, EUROPatternTM, Evolution™, Evoya®, explorer™, Genoglyphix®, GSP®, HaoyuanTM, IDS® Immunodiagnosticsystems, IDS-i10®, IDS-i10T®, IDS-iSYS®, iLab™, JANUS®, LabChip®, LifeCycle™, LimsLink™, Migele™, MultiPROBE®, NEXTFLEX®, NextPrep™, Pannoramic™, Panthera Puncher™, PG-SeqTM, PG-FindTM, PKampTM, PreNAT IITM, Protein ClearTM, ProteinEXactTM, QSight®, QuantiVacTM, RONIA™, Sciclone®, SimplicityChrom™, Specimen Gate®, SuperflexTM, SymbioTM, T-SPOT®, Twister®, Vanadis®, VariSpec™, ViaCord®, VICTOR 2™ D, and Zephyr®.


Marketing
All of our businesses market their products and services primarily through their own specialized sales forces. As of January 1, 2023, we employed approximately 6,300 sales and service representatives operating in approximately 40 countries and marketing products and services in more than 190 countries. In geographic regions where we do not have a sales and service presence, we utilize distributors to sell our products.


Raw Materials, Key Components and Supplies
Each of our businesses uses a wide variety of raw materials, key components and supplies that are generally available from alternate sources of supply and in adequate quantities from domestic and foreign sources. We generally have multi-year contracts, with no minimum purchase requirements, with our suppliers. For certain critical raw materials, key components and supplies required for the production of some of our principal products, we have qualified only a limited or a single source of supply. We periodically purchase quantities of some of these critical raw materials in excess of current requirements, in anticipation of future manufacturing needs. With sufficient lead times, we believe we would be able to qualify alternative suppliers for each of these raw materials and key components. See the applicable risk factor in “Item 1A. Risk Factors” for an additional description of this risk.


Intellectual Property
We own numerous United States and foreign patents and have patent applications pending in the United States and abroad. We also license intellectual property rights to and from third parties, some of which bear royalties and are terminable in specified circumstances. In addition to our patent portfolio, we possess a wide array of unpatented proprietary technology and know-how. We also own numerous United States and foreign trademarks and trade names for a variety of our product names, and have applications for the registration of trademarks and trade names pending in the United States and abroad. We believe that patents and other proprietary rights are important to the development of both of our reporting segments, but we also rely upon trade secrets, know-how, continuing technological innovations and licensing opportunities to develop and maintain the competitive position of both of our reporting segments. We do not believe that the loss of any one patent or other proprietary right would have a material adverse effect on our overall business or on any of our reporting segments.
 
In some cases, we may participate in litigation or other proceedings to defend against or assert claims of infringement, to enforce our patents or our licensors’ patents, to protect our trade secrets, know-how or other intellectual property rights, or to determine the scope and validity of our or third parties’ intellectual property rights. Litigation of this type could result in substantial cost to us and diversion of our resources. An adverse outcome in any litigation or proceeding could subject us to significant liabilities or expenses, require us to cease using disputed intellectual property or cease the sale of a product, or require us to license the disputed intellectual property from third parties.
 

Competition
Due to the range and diversity of our products and services, we face many different types of competition and competitors. Our competitors range from foreign and domestic organizations, which produce a comprehensive array of goods
14
Table of Contents

and services and that may have greater financial and other resources than we do, to more narrowly focused firms producing a limited number of goods or services for specialized market segments.
We compete on the basis of service level, price, technological innovation, operational efficiency, product differentiation, product availability, quality and reliability. Competitors range from multinational organizations with a wide range of products to specialized firms that in some cases have well-established market positions. We expect the proportion of large competitors to increase through the continued consolidation of competitors.
 

Regulatory Affairs
Our operations are subject to regulation by different state and federal government agencies in the United States and other countries, as well as to the standards established by international standards bodies. Some of our products are subject to regulation by the FDA and similar foreign agencies. These regulations govern a wide variety of our product activities, and if we fail to comply with those regulations or standards, we may face, among other things, warning letters; adverse publicity; investigations or notices of non-compliance, fines, injunctions, and civil penalties; import or export restrictions; partial suspensions or total shutdown of production facilities or the imposition of operating restrictions; increased difficulty in obtaining required FDA clearances or approvals or foreign equivalents; seizures or recalls of our products or those of our customers; or the inability to sell our products.
We have agreements relating to the sale of our products and services to government entities and, as a result, we are subject to various statutes and regulations that apply to companies doing business with the government. We are also subject to investigation for compliance with the regulations governing government contracts. A failure to comply with these regulations could result in suspension of these contracts, as well as other penalties.
We are also subject to a variety of laws, regulations and standards that govern, among other things, the importation and exportation of products, and our business practices in the United States and abroad such as anti-bribery, anti-corruption and competition laws. In addition, changes in governmental regulations may reduce demand for our products or increase our expenses. The healthcare industry, including the genetic screening market, is subject to extensive and frequently changing international and United States federal, state and local laws and regulations. This requires that we devote substantial resources to maintaining our compliance with those laws, regulations and standards.
If we fail to comply with applicable laws and regulations, we could suffer civil and criminal damages, fines and penalties, exclusion from participation in governmental healthcare programs, and the loss of various licenses, certificates and authorizations necessary to operate our business, as well as incur liabilities from third-party claims, all of which could have a significant adverse effect on our business.


Environmental Matters
Our operations are subject to various foreign, federal, state and local environmental and safety laws and regulations. These requirements include the handling, transportation, manufacture and disposal of toxic or hazardous substances, the remediation of contaminated soil and groundwater, the regulation of radioactive materials, and the health and safety of our employees.
We may have liability under the Comprehensive Environmental Response Compensation and Liability Act and comparable state statutes that impose liability for investigation and remediation of contamination without regard to fault, in connection with materials that we or our former businesses sent to various third-party sites. We have incurred, and expect to incur, costs pursuant to these statutes.
We are conducting a number of environmental investigations and remedial actions at our current and former locations and, along with other companies, have been named a potentially responsible party (“PRP”) for certain waste disposal sites. We accrue for environmental issues in the accounting period that our responsibility is established and when the cost can be reasonably estimated. We have accrued $12.2 million and $11.9 million as of January 1, 2023 and January 2, 2022, respectively, which represents our management’s estimate of the cost of the remediation of known environmental matters, and does not include any potential liability for related personal injury or property damage claims. Our environmental accrual is not discounted and does not reflect the recovery of any material amounts through insurance or indemnification arrangements. The cost estimates are subject to a number of variables, including the stage of the environmental investigations, the magnitude of the possible contamination, the nature of the potential remedies, possible joint and several liability, the time period over which remediation may occur, and the possible effects of changing laws and regulations. For sites where we have been named a PRP, our management does not currently anticipate any additional liability to result from the inability of other significant named parties to contribute. We expect that the majority of such accrued amounts could be paid out over a period of up to ten years. As
15
Table of Contents

assessment and remediation activities progress at each individual site, these liabilities are reviewed and adjusted to reflect additional information as it becomes available. There have been no environmental problems to date that have had, or are expected to have, a material adverse effect on our consolidated financial statements. While it is possible that a loss exceeding the amounts recorded in the consolidated financial statements may be incurred, the potential exposure is not expected to be materially different from those amounts recorded.
We may become subject to new or unforeseen environmental costs or liabilities. Compliance with new or more stringent laws or regulations, stricter interpretations of existing laws, or the discovery of new contamination could cause us to incur additional costs.


Human Capital Management
As of January 1, 2023, we employed approximately 16,700 employees on a worldwide basis. Roughly 80% of our workforce is based outside of the United States. Several of our subsidiaries outside the United States have employment contracts with our employees where the terms and conditions are influenced by labor unions and workers’ councils’ agreements that involve approximately 5,000 of our employees. During fiscal year 2022, our voluntary turnover rate was 14%. We believe that management of our human capital resources is vital to the continued growth and success of our company, and we endeavor to create an environment that encourages productivity, rewards performance and values diversity. There are several ways in which we attempt to attract, develop and retain highly qualified employees, as set forth below.
Our human capital objectives include, as applicable, identifying, recruiting, developing, retaining, incentivizing, and integrating our existing and new employees. We strive to meet this objective by offering competitive compensation and benefits, in a diverse, inclusive and safe workplace, with opportunities for our employees to grow and develop in their careers. We hold our employees to high performance standards and our compensation plans are designed to deliver competitive base pay and attractive incentive opportunities. Our benefits programs are specifically tailored to the various countries in which we operate and maintain a significant workforce. We benchmark for market practices and adjust our compensation and benefits programs to ensure they remain both equitable and competitive.
Diversity and Inclusion
We believe in an inclusive workforce, where employees from a number of cultures and countries are engaged and encouraged to leverage their collective talents. We have employees in roughly 40 countries around the world. As of the date of filing of this annual report on Form 10-K, women comprised roughly 34% of our leadership positions on a global basis, which we define as director level and above. We have provided further information regarding our diversity demographics in our Environmental, Social, and Governance (ESG) Report and elsewhere on our website at esg.perkinelmer.com, including summarized data from our EEO-1 form.
esg.perkinelmer.com is a home for information related to ESG policies and initiatives at PerkinElmer. The site provides information for our employees, customers and investors on our environmental and social metrics and policies, our global efforts to preserve our environment and our global efforts to promote social equality. It helps our employees and stakeholders know and understand of our commitment to make positive impacts on our employees, customers, local communities and the environment, while engaging others in our efforts.
Our EEO-1 form is a report filed with the United States Equal Employment Opportunity Commission describing the racial, ethnic and gender composition of our U.S.-based workforce. Information on our website, including the ESG Report, shall not be deemed incorporated by reference into this annual report.
We understand that our ability to operate in a multicultural world is critical to our long-term value creation. By maintaining a culture of diversity and inclusion, we believe that we can innovate more effectively. To that end, we seek to promote diverse perspectives throughout our organization and are an equal opportunity employer committed to making employment decisions without regard to race, religion, national or ethnic origin, sex, sexual orientation, gender identity or expression, age, disability, protected veteran status or other characteristics protected by law.
Our commitment to diversity is evidenced by the establishment of our internal Inclusion and Diversity Committee, formed in fiscal year 2020, which is comprised of a wide cross-section of leaders across all regions and backgrounds. The committee focuses on driving increased diversity within our workforce, as well as creating a safe and engaging platform for dialogue on these issues for all of our employees. Our commitment to creating a diverse and inclusive work environment is further validated by our employees, as reflected in the results of our 2021 PerkinElmer People Experience Engagement Survey, where we received high scores in the areas of Diversity & Inclusion, Inclusiveness, and Non-Discrimination. Among other comments, employees shared that they are proud of the emphasis we place on diversity and inclusion, and on making our company a place
16
Table of Contents

where everyone is valued and respected. We furthered our journey to maintain a diverse and inclusive workplace in 2022 through the launch of three additional employee resource groups offering our Hispanic and Veteran communities enhanced opportunities and visibility as well our Able group highlighting the power of individuals with disabilities. Focusing also on engagement and belonging, we launched four new Employees Networking Groups during fiscal year 2022 to allow our employees to regroup and connect over their passions or common areas of interest.
Training and Development
We are committed to the continued development and training of our employees and we seek to provide them with meaningful learning opportunities to help grow their capabilities and careers. We provide such opportunities across all levels of our organization, covering a variety of professional, technical and leadership topics. We do so through a variety of channels and formats, including formal (classroom-based, blended learning solutions, digital learning) and informal, on-the-job learning.
A pivotal component of our annual performance review and goal-setting process focuses on providing employees with constructive and actionable feedback, as well as management engagement in the creation and completion of development goals. In addition, employees have access to confidential, anonymous feedback through a process that is used as a development tool to help raise awareness on how they are perceived. Lastly, we recognize that professional development requires support of the whole person, and we therefore offer virtual coaching to help eligible employees meet their unique development goals, whether such goals are leadership or well-being focused.
With regards to career growth, we regularly fill open vacancies with internal candidates. Our internal mobility program empowers employees to explore many different career options available to them.
Lastly, management periodically assesses succession planning for certain key positions and reviews our workforce to identify high potential employees for future growth and development.
Health and Safety
Our success depends on the well-being of our employees, and one of our top priorities is to protect the health and safety of our employees. We maintain a culture focused on safety and strive to identify, eliminate and control risk in the workplace to prevent injury and illness. Our employees have access to a global safety management system and are encouraged to report incidents, near misses, or other observations in the system. The system has been widely adopted in our manufacturing locations across the globe, and management uses the information generated by it to set safety-related policies and to establish goals for future performance. Further, we provide our employees with a comprehensive benefits package that includes health insurance and other resources that support their physical and mental well-being. In relation to the COVID-19 pandemic, we have continued to take actions to protect the health and safety of our employees, customers, partners and suppliers. In particular, during fiscal year 2022, we have followed rigorous safety measures in China, during the country’s various lockdowns and subsequent re-openings, and provided well-being support activities for our employees and their families.
Community
At PerkinElmer, we have long held the view that responsible global citizenship along with good governance principles and ethical business practices are essential tenets for sustainability and success. We encourage our employees to support the communities in which they live and where we operate, and to assist in that effort, we fund a long-term charitable matching program for our employees. In addition, we have established a group comprised of management and subject matter experts at our company to focus on developing and delivering on measurable advancements in the areas of reducing waste, reducing carbon emissions and improving employee engagement and diversity.

Item 1A.    Risk Factors
The following important factors affect our business and operations generally or affect multiple segments of our business and operations:
Risks Related to our Business Operations and Industry
If the markets into which we sell our products decline or do not grow as anticipated due to a decline in general economic conditions, or there are uncertainties surrounding the approval of government or industrial funding proposals, or there are unfavorable changes in government regulations, we may see an adverse effect on the results of our business operations.
Our customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors and government agencies. Our quarterly revenue and results
17
Table of Contents

of operations are highly dependent on the volume and timing of orders received during the quarter. In addition, our revenues and earnings forecasts for future quarters are often based on the expected trends in our markets. However, the markets we serve do not always experience the trends that we may expect. Negative fluctuations in our customers’ markets, the inability of our customers to secure credit or funding, restrictions in capital expenditures, general economic conditions, cuts in government funding or unfavorable changes in government regulations would likely result in a reduction in demand for our products and services. In addition, government funding is subject to economic conditions and the political process, which is inherently fluid and unpredictable. Our revenues may be adversely affected if our customers delay or reduce purchases as a result of uncertainties surrounding the approval of government or industrial funding proposals. Such declines could harm our consolidated financial position, results of operations, cash flows and trading price of our common stock, and could limit our ability to sustain profitability.
    The pandemic caused by COVID-19 has had, and may continue to have, a negative effect on the demand for certain of our products and our global operations including our manufacturing capabilities, logistics and supply chain that may materially and adversely impact our business, financial conditions, results of operations and cash flows.
We face risks related to public health crises and pandemics, including the COVID-19 pandemic. The global impact of COVID-19 resulted in an adverse impact on our operations, supply chains and distribution systems, due to significant global mitigation measures, including government-directed quarantines, social distancing and shelter-in-place mandates, and travel restrictions and/or bans. Continued uncertainty with respect to the severity and duration of the COVID-19 pandemic has contributed to the volatility of financial markets. The COVID-19 pandemic has caused extended global economic disruption, and a global recession is possible.
We have experienced significant reductions in demand for certain of our products due to the COVID-19 pandemic and although the severity and duration of the COVID-19 pandemic cannot be reasonably estimated at this time, additional impacts that we may experience include, but are not limited to: fluctuations in our stock price due to market volatility; further decreases in demand for certain of our products; reduced profitability; large-scale supply chain disruptions impeding our ability to ship and/or receive product; potential interruptions of, or limitations on manufacturing operations imposed by local, state or federal governments; shortages of key raw materials or components; workforce absenteeism and distraction; labor shortages including those resulting from unwillingness to comply with vaccination or other requirements; customer credit concerns; cybersecurity risks and data accessibility disruptions due to remote working arrangements; reduced sources of liquidity; increased borrowing costs; fluctuations in foreign currency markets; potential impairment in the carrying value of goodwill; other asset impairment charges; increased obligations related to our pension and other postretirement benefit plans; and deferred tax valuation allowances.
Substantial uncertainty remains regarding the further development of the COVID-19 pandemic, however, we currently anticipate that business disruptions and market volatility resulting from the COVID-19 pandemic will continue to have a material adverse impact on the growth rate of certain of our businesses, and may also have a material adverse impact on our overall financial condition, results of operations and cash flows.
Our Diagnostics segment experienced an increase in revenue resulting from increased demand for our immunodiagnostics and applied genomics COVID-19 product offerings during fiscal years 2020 and 2021, as well as from the COVID-19 testing laboratory facilities we developed to service the State of California and the United Kingdom. The laboratory in the United Kingdom closed earlier in 2022 and the laboratory in the State of California closed in the second quarter of 2022. As a result of these closures, and the general reduction in COVID-19 testing spending by our customers, the demand for these products and services declined in fiscal year 2022 and we expect it will continue to decline in fiscal year 2023, with revenue largely contingent upon consumer demand for COVID-19 testing as well as our ability to develop, produce and market COVID-19 products.
Our growth and profitability is subject to global economic and political conditions, and operational disruptions at our facilities.
Our business is affected by global economic and political conditions as well as the state of the financial markets, particularly as the United States and other countries balance concerns around debt, inflation, growth and budget allocations in their policy initiatives. There can be no assurance that global economic conditions and financial markets will not worsen and that we will not experience any adverse effects that may be material to our consolidated cash flows, results of operations, financial position or our ability to access capital, such as the adverse effects resulting from a prolonged shutdown in government operations both in the United States and internationally. Our business is also affected by local economic environments, including inflation, recession, financial liquidity and currency volatility or devaluation. Political changes, including war or other conflicts, such as the current conflict in Ukraine, some of which may be disruptive, could interfere with our supply chain, our customers and all of our activities in a particular location.
18
Table of Contents

While we take precautions to prevent production or service interruptions at our global facilities, a major earthquake, fire, flood, power loss or other catastrophic event that results in the destruction or delay of any of our critical business operations could result in our incurring significant liability to customers or other third parties, cause significant reputational damage or have a material adverse effect on our business, operating results or financial condition.
Certain of these risks can be hedged to a limited degree using financial instruments, or other measures, and some of these risks are insurable, but any such mitigation efforts are costly and may not always be fully successful. Our ability to engage in such mitigation efforts has decreased or become even more costly as a result of recent market developments.
If we do not introduce new products in a timely manner, we may lose market share and be unable to achieve revenue growth targets.
We sell many of our products in industries characterized by rapid technological change, frequent new product and service introductions, and evolving customer needs and industry standards. Many of the businesses competing with us in these industries have significant financial and other resources to invest in new technologies, substantial intellectual property portfolios, substantial experience in new product development, regulatory expertise, manufacturing capabilities, and established distribution channels to deliver products to customers. Our products could become technologically obsolete over time, or we may invest in technology that does not lead to revenue growth or continue to sell products for which the demand from our customers is declining, in which case we may lose market share or not achieve our revenue growth targets. The success of our new product offerings will depend upon several factors, including our ability to:
•accurately anticipate customer needs,
•innovate and develop new reliable technologies and applications,
•receive regulatory approvals in a timely manner,
•successfully commercialize new technologies in a timely manner,
•price our products competitively, and manufacture and deliver our products in sufficient volumes and on time, and
•differentiate our offerings from our competitors’ offerings.
Many of our products are used by our customers to develop, test and manufacture their products. We must anticipate industry trends and consistently develop new products to meet our customers’ expectations. In developing new products, we may be required to make significant investments before we can determine the commercial viability of the new product. If we fail to accurately foresee our customers’ needs and future activities, we may invest heavily in research and development of products that do not lead to significant revenue. We may also suffer a loss in market share and potential revenue if we are unable to commercialize our technology in a timely and efficient manner.
In addition, some of our licensed technology is subject to contractual restrictions, which may limit our ability to develop or commercialize products for some applications.
We may not be able to successfully execute acquisitions or divestitures, such as the divestiture of the Analytical, Food and Enterprise Services businesses, license technologies, integrate acquired businesses or licensed technologies into our existing businesses, or make acquired businesses or licensed technologies profitable.
We have in the past supplemented, and may in the future supplement, our internal growth by acquiring businesses and licensing technologies that complement or augment our existing product lines. However, we may be unable to identify or complete promising acquisitions or license transactions for many reasons, such as:
•competition among buyers and licensees,
•the high valuations of businesses and technologies,
•the need for regulatory and other approval, and
•our inability to raise capital to fund these acquisitions.
Some of the businesses we acquire may be unprofitable or marginally profitable, or may increase the variability of our revenue recognition. If, for example, we are unable to successfully commercialize products and services related to significant in-process research and development that we have capitalized, we may have to impair the value of such assets. Accordingly, the earnings or losses of acquired businesses may dilute our earnings. For these acquired businesses to achieve acceptable levels of profitability, we would have to improve their management, operations, products and market penetration. We may not be successful in this regard and may encounter other difficulties in integrating acquired businesses into our existing operations, such as incompatible management, information or other systems, cultural differences, loss of key personnel, unforeseen
19
Table of Contents

regulatory requirements, previously undisclosed liabilities or difficulties in predicting financial results. To finance our acquisitions, we may have to raise additional funds, either through public or private financings. We may be unable to obtain such funds or may be able to do so only on terms unacceptable to us. We may also incur expenses related to completing acquisitions or licensing technologies, or in evaluating potential acquisitions or technologies, which may adversely impact our profitability.
Additionally, if we are not successful in selling businesses we seek to divest, such as our recent agreement to divest our Analytical, Food and Enterprise Service businesses to New Mountain Capital L.L.C., the activity of such businesses may dilute our earnings and we may not be able to achieve the expected benefits of such divestitures. Divestitures could involve difficulties in the separation of operations, services, products and personnel, the diversion of management’s attention, the disruption of our business and the potential loss of key employees. The transaction may be subject to the satisfaction of pre-closing conditions, including obtaining necessary regulatory and government approvals as well as establishing operational segregations, which, if not satisfied or obtained, may prevent us from completing the transaction. Divestitures may also involve continued financial involvement in or liability with respect to the divested assets and businesses, such as indemnities or other financial obligations, in which the performance of the divested assets or businesses could impact our results of operations. Our ability to provide transition services and support to assist the buyer in the transition to certain functions, including, but not limited to, information technology, accounting and human resources, for a certain period of time may cause us to incur unanticipated costs and liabilities and could adversely affect our financial condition and results of operations.
If we do not compete effectively, our business will be harmed.
We encounter aggressive competition from numerous competitors in many areas of our business. We may not be able to compete effectively with all of these competitors. To remain competitive, we must develop new products and periodically enhance our existing products. We anticipate that we may also have to adjust the prices of many of our products to stay competitive. In addition, new competitors, technologies or market trends may emerge to threaten or reduce the value of entire product lines.
Our quarterly operating results could be subject to significant fluctuation, and we may not be able to adjust our operations to effectively address changes we do not anticipate, which could increase the volatility of our stock price and potentially cause losses to our shareholders.
Given the nature of the markets in which we participate, we cannot reliably predict future revenue and profitability. Changes in competitive, market and economic conditions may require us to adjust our operations, and we may not be able to make those adjustments or make them quickly enough to adapt to changing conditions. A high proportion of our costs are fixed in the short term, due in part to our research and development and manufacturing costs. As a result, small declines in sales could disproportionately affect our operating results in a quarter. Factors that may affect our quarterly operating results include:
•demand for and market acceptance of our products,
•competitive pressures resulting in lower selling prices,
•changes in the level of economic activity in regions in which we do business, including as a result of the COVID-19 pandemic and other global health crises or pandemics,
•changes in general economic conditions or government funding,
•settlements of income tax audits,
•expenses incurred in connection with claims related to environmental conditions at locations where we conduct or formerly conducted operations,
•contract termination and litigation costs,
•differing tax laws and changes in those laws, or changes in the countries in which we are subject to taxation,
•changes in our effective tax rate,
•changes in industries, such as pharmaceutical and biomedical,
•changes in the portions of our revenue represented by our various products and customers,
•our ability to introduce new products,
•our competitors’ announcement or introduction of new products, services or technological innovations,
•costs of raw materials, labor, energy, supplies, transportation or other indirect costs,
20
Table of Contents

•changes in healthcare or other reimbursement rates paid by government agencies and other third parties for certain of our products and services,
•our ability to realize the benefit of ongoing productivity initiatives,
•changes in the volume or timing of product orders,
•fluctuation in the expense related to the mark-to-market adjustment on postretirement benefit plans,
•changes in our assumptions underlying future funding of pension obligations,
•changes in assumptions used to determine contingent consideration in acquisitions, and
•changes in foreign currency exchange rates.
A significant disruption in third-party package delivery and import/export services, or significant increases in prices for those services, could interfere with our ability to ship products, increase our costs and lower our profitability.
We ship a significant portion of our products to our customers through independent package delivery and import/export companies, including UPS and Federal Express in the United States; TNT, UPS and DHL in Europe; and UPS in Asia. We also ship our products through other carriers, including commercial airlines, freight carriers, national trucking firms, overnight carrier services and the United States Postal Service. If one or more of the package delivery or import/export providers experiences a significant disruption in services or institutes a significant price increase, we may have to seek alternative providers and the delivery of our products could be prevented or delayed. Such events could cause us to incur increased shipping costs that could not be passed on to our customers, negatively impacting our profitability and our relationships with certain of our customers.
Disruptions in the supply of raw materials, certain key components and other goods from our limited or single source suppliers could have an adverse effect on the results of our business operations, and could damage our relationships with customers.
The production of our products requires a wide variety of raw materials, key components and other goods that are generally available from alternate sources of supply. However, certain critical raw materials, key components and other goods required for the production and sale of some of our principal products are available from limited or single sources of supply. We generally have multi-year contracts with no minimum purchase requirements with these suppliers, but those contracts may not fully protect us from a failure by certain suppliers to supply critical materials or from the delays inherent in being required to change suppliers and, in some cases, validate new raw materials. Such raw materials, key components and other goods can usually be obtained from alternative sources with the potential for an increase in price, decline in quality or delay in delivery. A prolonged inability to obtain certain raw materials, key components or other goods is possible and could have an adverse effect on our business operations, and could damage our relationships with customers. In addition, a global health crisis or pandemic such as the COVID-19 pandemic, wars, conflicts, or other changes in a country’s or region’s political or economic conditions, could have a significant adverse effect on our supply chain.
We are subject to the rules of the Securities and Exchange Commission requiring disclosure as to whether certain materials known as conflict minerals (tantalum, tin, gold, tungsten and their derivatives) that may be contained in our products are mined from the Democratic Republic of the Congo and adjoining countries. As a result of these rules, we may incur additional costs in complying with the disclosure requirements and in satisfying those customers who require that the components used in our products be certified as conflict-free, and the potential lack of availability of these materials at competitive prices could increase our production costs.
If we do not retain our key personnel, our ability to execute our business strategy will be limited.
Our success depends to a significant extent upon the continued service of our executive officers and key management and technical personnel, particularly our experienced engineers and scientists, and on our ability to continue to attract, retain, and motivate qualified personnel. The competition for these employees is intense. The loss of the services of key personnel could have a material adverse effect on our operating results. In addition, there could be a material adverse effect on us should the turnover rates for key personnel increase significantly or if we are unable to continue to attract qualified personnel. We do not maintain any key person life insurance policies on any of our officers or employees.
Our success also depends on our ability to execute leadership succession plans. The inability to successfully transition key management roles could have a material adverse effect on our operating results.
If we experience a significant disruption in, or breach in security of, our information technology systems or those of our customers, suppliers or other third parties, or cybercrime, resulting in inappropriate access to or inadvertent transfer of
21
Table of Contents

information or assets, or if we fail to implement new systems, software and technologies successfully, our business could be adversely affected.
We rely on several centralized information technology systems throughout our company to develop, manufacture and provide products and services, keep financial records, process orders, manage inventory, process shipments to customers and operate other critical functions. Our and our third-party service providers' information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, computer viruses, attacks by computer hackers, telecommunication failures, user errors, catastrophes or other unforeseen events. If we were to experience a prolonged system disruption in the information technology systems that involve our interactions with customers, suppliers or other third parties, it could result in the loss of sales and customers and significant incremental costs, which could adversely affect our business. In addition, security breaches of our information technology systems or cybercrime, resulting in inappropriate access to or inadvertent transfer of information or assets, could result in losses or misappropriation of assets or unauthorized disclosure of confidential information belonging to us or to our employees, partners, customers or suppliers, which could result in our suffering significant financial or reputational damage.
Our results of operations will be adversely affected if we fail to realize the full value of our intangible assets.
As of January 1, 2023, our total assets included $9.9 billion of net intangible assets. Net intangible assets consist principally of goodwill associated with acquisitions and costs associated with securing patent rights, trademark rights, customer relationships, core technology and technology licenses and in-process research and development, net of accumulated amortization. We test certain of these items—specifically all of those that are considered “indefinite-lived”—at least annually for potential impairment by comparing the carrying value to the fair market value of the reporting unit to which they are assigned. All of our amortizing intangible assets are also evaluated for impairment should events occur that call into question the value of the intangible assets.
Adverse changes in our business, adverse changes in the assumptions used to determine the fair value of our reporting units, or the failure to grow our Discovery & Analytical Solutions and Diagnostics segments may result in impairment of our intangible assets, which could adversely affect our results of operations.
Risks Related to our Intellectual Property
We may not be successful in adequately protecting our intellectual property.
Patent and trade secret protection is important to us because developing new products, processes and technologies gives us a competitive advantage, although it is time-consuming and expensive. We own many United States and foreign patents and intend to apply for additional patents. Patent applications we file, however, may not result in issued patents or, if they do, the claims allowed in the patents may be narrower than what is needed to protect fully our products, processes and technologies. The expiration of our previously issued patents may cause us to lose a competitive advantage in certain of the products and services we provide. Similarly, applications to register our trademarks may not be granted in all countries in which they are filed. For our intellectual property that is protected by keeping it secret, such as trade secrets and know-how, we may not use adequate measures to protect this intellectual property.
Third parties have in the past and may in the future also challenge the validity of our issued patents, may circumvent or “design around” our patents and patent applications, or claim that our products, processes or technologies infringe their patents. In addition, third parties may assert that our product names infringe their trademarks. We may incur significant expense in legal proceedings to protect our intellectual property against infringement by third parties or to defend against claims of infringement by third parties. Claims by third parties in pending or future lawsuits could result in awards of substantial damages against us or court orders that could effectively prevent us from manufacturing, using, importing or selling our products in the United States or other countries.
If we are unable to renew our licenses or otherwise lose our licensed rights, we may have to stop selling products or we may lose competitive advantage.
We may not be able to renew our existing licenses, or licenses we may obtain in the future, on terms acceptable to us, or at all. If we lose the rights to a patented or other proprietary technology, we may need to stop selling products incorporating that technology and possibly other products, redesign our products or lose a competitive advantage. Potential competitors could in-license technologies that we fail to license and potentially erode our market share.
Our licenses typically subject us to various economic and commercialization obligations. If we fail to comply with these obligations, we could lose important rights under a license, such as the right to exclusivity in a market, or incur losses for failing to comply with our contractual obligations. In some cases, we could lose all rights under the license. In addition, rights
22
Table of Contents

granted under the license could be lost for reasons out of our control. For example, the licensor could lose patent protection for a number of reasons, including invalidity of the licensed patent, or a third-party could obtain a patent that curtails our freedom to operate under one or more licenses.
Risks Related to Legal, Government and Regulatory Matters
The manufacture and sale of products and services may expose us to product and other liability claims for which we could have substantial liability.
We face an inherent business risk of exposure to product and other liability claims if our products, services or product candidates are alleged or found to have caused injury, damage or loss. We may be unable to obtain insurance with adequate levels of coverage for potential liability on acceptable terms or claims of this nature may be excluded from coverage under the terms of any insurance policy that we obtain. If we are unable to obtain such insurance or the amounts of any claims successfully brought against us substantially exceed our coverage, then our business could be adversely impacted.
If we fail to maintain satisfactory compliance with the regulations of the United States Food and Drug Administration and other governmental agencies in the United States and abroad, we may be forced to recall products and cease their manufacture and distribution, and we could be subject to civil, criminal or monetary penalties.
Our operations are subject to regulation by different state and federal government agencies in the United States and other countries, as well as to the standards established by international standards bodies. If we fail to comply with those regulations or standards, we could be subject to fines, penalties, criminal prosecution or other sanctions. Some of our products are subject to regulation by the United States Food and Drug Administration and similar foreign and domestic agencies. These regulations govern a wide variety of product activities, from design and development to labeling, manufacturing, promotion, sales and distribution. If we fail to comply with those regulations or standards, we may have to recall products, cease their manufacture and distribution, and may be subject to fines or criminal prosecution.
We are also subject to a variety of laws, regulations and standards that govern, among other things, the importation and exportation of products, the handling, transportation and manufacture of toxic or hazardous substances, the collection, storage, transfer, use, disclosure, retention and other processing of personal data, and our business practices in the United States and abroad such as anti-bribery, anti-corruption and competition laws. This requires that we devote substantial resources to maintaining our compliance with those laws, regulations and standards. A failure to do so could result in the imposition of civil, criminal or monetary penalties having a material adverse effect on our operations.
Changes in governmental regulations may reduce demand for our products or increase our expenses.
We compete in markets in which we or our customers must comply with federal, state, local and foreign regulations, such as environmental, health and safety, data privacy and food and drug regulations. We develop, configure and market our products to meet customer needs created by these regulations. Any significant change in these regulations could reduce demand for our products or increase our costs of producing these products.
The healthcare industry is highly regulated and if we fail to comply with its extensive system of laws and regulations, we could suffer fines and penalties or be required to make significant changes to our operations which could have a significant adverse effect on the results of our business operations.
The healthcare industry, including the genetic screening market, is subject to extensive and frequently changing international and United States federal, state and local laws and regulations. In addition, legislative provisions relating to healthcare fraud and abuse, patient privacy violations and misconduct involving government insurance programs provide federal enforcement personnel with substantial powers and remedies to pursue suspected violations. We believe that our business will continue to be subject to increasing regulation as the federal government continues to strengthen its position on healthcare matters, the scope and effect of which we cannot predict. If we fail to comply with applicable laws and regulations, we could suffer civil and criminal damages, fines and penalties, exclusion from participation in governmental healthcare programs, and the loss of various licenses, certificates and authorizations necessary to operate our business, as well as incur liabilities from third-party claims, all of which could have a significant adverse effect on our business.
Risks Related to our Foreign Operations
    Economic, political and other risks associated with foreign operations could adversely affect our international sales and profitability.
23
Table of Contents

Because we sell our products worldwide, our businesses are subject to risks associated with doing business internationally. Our sales originating outside the United States represented the majority of our total revenue in fiscal year 2022. We anticipate that sales from international operations will continue to represent a substantial portion of our total revenue. In addition, many of our manufacturing facilities, employees and suppliers are located outside the United States. Accordingly, our future results of operations could be harmed by a variety of factors, including:
•changes in actual, or from projected, foreign currency exchange rates,
•a global health crisis of unknown duration, such as the COVID-19 pandemic,
•wars, conflicts, or other changes in a country’s or region’s political or economic conditions, particularly in developing or emerging markets,
•longer payment cycles of foreign customers and timing of collections in foreign jurisdictions,
•trade protection measures including embargoes, sanctions and tariffs, such as the sanctions and other restrictions implemented by the United States and other governments on the Russian Federation and related parties in connection with the conflict in Ukraine,
•import or export licensing requirements and the associated potential for delays or restrictions in the shipment of our products or the receipt of products from our suppliers,
•policies in foreign countries benefiting domestic manufacturers or other policies detrimental to companies headquartered in the United States,
•differing tax laws and changes in those laws, or changes in the countries in which we are subject to tax,
•adverse income tax audit settlements or loss of previously negotiated tax incentives,
•differing business practices associated with foreign operations,
•difficulty in transferring cash between international operations and the United States,
•difficulty in staffing and managing widespread operations,
•differing labor laws and changes in those laws,
•differing protection of intellectual property and changes in that protection,
•expanded enforcement of laws related to data protection and personal privacy,
•increasing global enforcement of anti-bribery and anti-corruption laws, and
•differing regulatory requirements and changes in those requirements.
Risks Related to our Debt
We have a substantial amount of outstanding debt, which could impact our ability to obtain future financing and limit our ability to make other expenditures in the conduct of our business.
    
We have a substantial amount of debt and other financial obligations. Our debt level and related debt service obligations could have negative consequences, including:
•requiring us to dedicate significant cash flow from operations to the payment of principal and interest on our debt, which reduces the funds we have available for other purposes, such as acquisitions and stock repurchases;
•reducing our flexibility in planning for or reacting to changes in our business and market conditions;
•exposing us to interest rate risk as a portion of our debt obligations are at variable rates;
•increasing our foreign currency risk as a portion of our debt obligations are in denominations other than the U.S. dollar; and
•increasing the chances of a downgrade of our debt ratings due to the amount or intended purpose of our debt obligations.
We may incur additional indebtedness in the future to meet future financing needs. If we add new debt, the risks described above could increase. In addition, the market for both public and private debt offerings could experience liquidity concerns and increased volatility as a result of the COVID-19 pandemic, which could ultimately increase our borrowing costs and limit our ability to obtain future financing.
24
Table of Contents

Restrictions in our senior unsecured revolving credit facility and other debt instruments may limit our activities.
Our senior unsecured revolving credit facility, senior unsecured notes due in 2023 (“2023 Notes”), senior unsecured notes due in 2024 (“2024 Notes”), senior unsecured notes due in 2026 (“2026 Notes”), senior unsecured notes due in 2028 (“2028 Notes”), senior unsecured notes due in 2029 (“2029 Notes”), senior unsecured notes due in 2031 (“March 2031 Notes”), senior unsecured notes due in 2031 (“September 2031 Notes”) and senior unsecured notes due in 2051 (“2051 Notes”) include restrictive covenants that limit our ability to engage in activities that could otherwise benefit our company. These include restrictions on our ability and the ability of our subsidiaries to:
•pay dividends on, redeem or repurchase our capital stock,
•sell assets,
•incur obligations that restrict our subsidiaries’ ability to make dividend or other payments to us,
•guarantee or secure indebtedness,
•enter into transactions with affiliates, and
•consolidate, merge or transfer all, or substantially all, of our assets and the assets of our subsidiaries on a consolidated basis.
We are also required to meet specified financial ratios under the terms of certain of our existing debt instruments. Our ability to comply with these financial restrictions and covenants is dependent on our future performance, which is subject to prevailing economic conditions and other factors, including factors that are beyond our control, such as foreign exchange rates, interest rates, changes in technology and changes in the level of competition. In addition, if we are unable to maintain our investment grade credit rating, our borrowing costs would increase and we would be subject to different and potentially more restrictive financial covenants under some of our existing debt instruments.
Any future indebtedness that we incur may include similar or more restrictive covenants. Our failure to comply with any of the restrictions in our senior unsecured revolving credit facility, the 2023 Notes, the 2024 Notes, the 2026 Notes, the 2028 Notes, the 2029 Notes, the March 2031 Notes, the September 2031 Notes, the 2051 Notes or any future indebtedness may result in an event of default under those debt instruments, which could permit acceleration of the debt under those debt instruments, and require us to prepay that debt before its scheduled due date under certain circumstances.
Discontinuation or replacement of LIBOR may adversely affect our variable rate debt.
Our indebtedness under our senior unsecured revolving credit facility bears interest at fluctuating interest rates, primarily based on the London Interbank Offered Rate (“LIBOR”) for deposits of U.S. dollars. In July 2017, the United Kingdom Financial Conduct Authority (the authority that regulates LIBOR) announced that it intends to stop compelling banks to submit rates for the calculation of LIBOR after 2021. The discontinuation date for submission and publication of rates for certain tenors of U.S. dollar LIBOR (1-month, 3-month, 6-month, and 12-month) was subsequently extended by the ICE Benchmark Administration (the administrator of LIBOR) until June 30, 2023. The Alternative Reference Rates Committee in the United States has proposed that the Secured Overnight Financing Rate (“SOFR”), calculated using short-term repurchase agreements backed by U.S. Treasury securities, is the rate that represents best practice as the alternative to U.S. dollar LIBOR for use in derivatives and other financial contracts that are currently indexed to LIBOR. No later than June 30, 2023, our indebtedness under our senior unsecured revolving credit facility will be indexed to a replacement benchmark based on SOFR in accordance with the terms of that facility. This change could cause the effective interest rate under our senior unsecured revolving credit facility and our overall interest expense to increase, in which event we may have difficulties making interest payments and funding our other fixed costs, and our available cash flow for general corporate requirements may be adversely affected.
Risks Related to Ownership of our Common Stock
Our share price will fluctuate.
Over the last several years, stock markets in general and our common stock in particular have experienced significant price and volume volatility. Both the market price and the daily trading volume of our common stock may continue to be subject to significant fluctuations due not only to general stock market conditions but also to a change in sentiment in the market regarding our operations and business prospects. In addition to the risk factors discussed above, the price and volume volatility of our common stock may be affected by:
•operating results that vary from our financial guidance or the expectations of securities analysts and investors,
•the financial performance of the major end markets that we target,
•the operating and securities price performance of companies that investors consider to be comparable to us,
25
Table of Contents

•announcements of strategic developments, acquisitions and other material events by us or our competitors,
•changes in global financial markets and global economies and general market conditions, such as interest or foreign exchange rates, inflation, freight costs, commodity and equity prices and the value of financial assets, and
•changes to economic conditions arising from global health crises such as the COVID-19 pandemic or from wars or conflicts.
Dividends on our common stock could be reduced or eliminated in the future.
On October 26, 2022, we announced that our Board of Directors (our “Board”) had declared a quarterly dividend of $0.07 per share for the fourth quarter of fiscal year 2022 that was paid in February 2023. On January 26, 2023, we announced that our Board had declared a quarterly dividend of $0.07 per share for the first quarter of fiscal year 2023 that will be payable in May 2023. In the future, our Board may determine to reduce or eliminate our common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.

 
Item 1B.    Unresolved Staff Comments
 
Not applicable.
 
Item 2.    Properties
 
We conduct operations for both our Discovery & Analytical Solutions and Diagnostics segments in manufacturing and assembly plants, research laboratories, administrative offices and other facilities. A majority of all such facilities utilized are leased from third parties. Our real property leases are both short-term and long-term. See Note 21, Leases, in the Notes to Consolidated Financial Statements for further discussion of our leases.
 

Item 3.    Legal Proceedings
 
We are subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of our business activities. Although we have established accruals for potential losses that we believe are probable and reasonably estimable, in the opinion of our management, based on its review of the information available at this time, the total cost of resolving these contingencies at January 1, 2023 should not have a material adverse effect on our consolidated financial statements included in this annual report on Form 10-K. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to us.

Item 4.    Mine Safety Disclosures
 
Not applicable.
 
26
Table of Contents

INFORMATION ABOUT OUR EXECUTIVE OFFICERS
 
Listed below are our executive officers as of March 1, 2023. No family relationship exists between any one of these executive officers and any of the other executive officers or directors. 
NamePositionAge
Prahlad SinghPresident and Chief Executive Officer58
Maxwell KrakowiakSenior Vice President and Chief Financial Officer33
Joel S. GoldbergSenior Vice President, Administration, General Counsel and Secretary54
Daniel R. TereauSenior Vice President, Strategy and Business Development56
Miriame VictorSenior Vice President, Chief Commercial Officer42
Tajinder VohraSenior Vice President, Global Operations57
Andrew OkunVice President, Chief Accounting Officer and Treasurer53
 Prahlad Singh, 58. Dr. Singh currently serves as President and Chief Executive Officer of PerkinElmer, having previously served as President and Chief Operating Officer of PerkinElmer from January 2019 through December 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals.

Maxwell Krakowiak, 33. Mr. Krakowiak was appointed Senior Vice President and Chief Financial Officer of PerkinElmer in August 2022 after having most recently served as our Vice President, Corporate Finance, focusing on driving global finance transformation through people, process and automation. Mr. Krakowiak joined PerkinElmer in October 2018, and prior to being appointed as our Senior Vice President and Chief Financial Officer held several financial leadership positions of increasing scope and responsibilities, including oversight of financial planning and analysis, commercial finance and business development. Prior to joining PerkinElmer, Mr. Krakowiak worked for General Electric Company (“GE”) for seven years, most recently as Executive Audit Manager (from January 2018 to October 2018), working globally across GE’s businesses on financial audits and operational excellence projects. During his tenure at GE, he served in a number of progressively responsible leadership roles across GE’s Corporate Audit Staff and Financial Management leadership programs. Mr. Krakowiak holds a Bachelor of Science degree in finance from Fordham University.
 
Joel S. Goldberg, 54. Mr. Goldberg currently serves as our Senior Vice President, Administration, General Counsel and Secretary, having joined as our Senior Vice President, General Counsel and Secretary in July 2008. Prior to joining us, Mr. Goldberg spent seven years at Millennium Pharmaceuticals, Inc., where he most recently served as Vice President, Chief Compliance Officer and Secretary. During his seven years with Millennium, he focused in the areas of mergers and acquisitions, strategic alliances, investment and financing transactions, securities and healthcare related compliance, and employment law. Previously, he was an associate of the law firm Edwards & Angell, LLP. Mr. Goldberg graduated from the Northeastern University School of Law and also holds a Master of Business Administration from Northeastern University. He completed his undergraduate degree at the University of Wisconsin-Madison.
Daniel R. Tereau, 56. Mr. Tereau was appointed Senior Vice President, Strategy and Business Development in January 2016, having joined PerkinElmer in April 2014 as Vice President, Strategy and Business Development. He is responsible for leading PerkinElmer’s overall strategic planning and business development activities. Prior to joining PerkinElmer, Mr. Tereau served on Novartis’ leadership team as Senior Vice President and Global Head of Strategy, Business Development and Licensing from 2011 to 2014, where he was responsible for global strategy and business development for the Consumer Health division. Prior to 2011, Mr. Tereau held similar roles at Thermo Fisher Scientific and GE Healthcare. Mr. Tereau holds a Bachelor of Science degree in finance from Ferris State University, a Juris Doctorate from Wayne State University, and earned his Master of Business Administration from Yale University.
Miriame Victor, 42. Ms. Victor joined PerkinElmer in October 2014 as Sales Leader for the Diagnostics business in Europe and most recently served as Vice President and General Manager for EMEAI, prior to being appointed Senior Vice President and Chief Commercial Officer in January 2021. In that role, she oversees PerkinElmer’s product commercialization
27
Table of Contents

efforts across all businesses, having previously completed the successful consolidation of the Diagnostics and Discovery & Analytical Solutions businesses into one unified commercial organization. Prior to joining PerkinElmer, Ms. Victor held various commercial leadership positions in the pharmaceutical industry with MSD and Novartis, and in the medical device industry with GE Healthcare. Ms. Victor holds a Bachelor of Science degree in pharmacy and pharmaceutical sciences from Cairo University and earned her Master of Business Administration from Arab Academy for Science, Technology and Maritime Transport.
Tajinder Vohra, 57. Mr. Vohra joined PerkinElmer in October 2015 as Vice President of Global Operations and was appointed Senior Vice President Global Operations in January 2018. He oversees all of PerkinElmer’s global operations, including manufacturing, supply chain, customer care and distribution. Prior to joining PerkinElmer, Mr. Vohra served at ABB as a Country Operations Leader from 2011 to 2015, where he was responsible for India-wide operations and Supply Chains for India, Middle East and Africa. Prior to 2011, Mr. Vohra was a Senior Vice President with Genpact, managing Supply Chain and IT businesses, and held a number of global management operational positions with GE Healthcare. Mr. Vohra received his Bachelor’s degree in Mechanical Engineering from the University of Delhi, Master’s degree in Industrial Engineering from the University of Alabama and Master’s degree in Manufacturing Engineering from Lehigh University. Mr. Vohra is a certified Six Sigma Black Belt, and was trained in lean manufacturing at the Shingijitsu Training Institute in Japan.

Andrew Okun, 53. Mr. Okun serves as our Vice President, Chief Accounting Officer and Treasurer. Mr. Okun has served as Vice President and Chief Accounting Officer since April 2011 and was appointed Treasurer in February 2021. Mr. Okun joined us in 2001 and has served in financial and controllership positions of increasing responsibility, including Director of Finance for the Optoelectronics business from 2001 through 2005, Vice President of Finance from 2005 through 2009 and Vice President and Corporate Controller from 2009 through 2011. Prior to joining us, Mr. Okun most recently worked for Honeywell International as a Site Controller as well as for Coopers & Lybrand. Mr. Okun is a Certified Public Accountant and earned his Master of Business Administration from the University of Virginia. He completed his undergraduate degree at the University of California, Santa Barbara.


28
Table of Contents

PART II

Item 5.    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Common Equity
We only have one class of common stock. Our common stock is listed on the New York Stock Exchange under the symbol “PKI”. As of February 24, 2023, we had approximately 3,056 holders of record of our common stock.
Stock Repurchases
The following table provides information with respect to the shares of common stock repurchased by us for the periods indicated.
 Issuer Repurchases of Equity Securities
Period
Total Number
of Shares
Purchased(1)
Average Price
Paid Per
Share
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs(2)
Maximum Aggregate Number (or Approximate Dollar Value) of Shares that May Yet
Be Purchased
Under the Plans or
Programs
October 3, 2022 - October 30, 2022
44,266 $120.12 — $300,000,000 
October 31, 2022 - November 27, 2022
138,174 138.65 138,025 280,862,780 
November 28, 2022 - January 1, 2023
179 142.98 — 280,862,780 
Activity for quarter ended January 1, 2023182,619 $134.16 138,025 $280,862,780 
________________
(1)Our Board of Directors (our “Board”) has authorized us to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to our equity incentive plans. During the fourth quarter of fiscal year 2022, we repurchased 44,594 shares of common stock for this purpose at an aggregate cost of $5.4 million. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value.
(2)On July 31, 2020, our Board authorized us to repurchase shares of common stock for an aggregate amount up to $250.0 million under a stock repurchase program (the “Repurchase Program”). On July 22, 2022, the Repurchase Program was terminated by our Board and our Board authorized us to repurchase shares of common stock for an aggregate amount up to $300.0 million under a new stock repurchase program (the “New Repurchase Program”). No shares remain available for repurchase under the Repurchase Program due to its termination. The New Repurchase Program will expire on July 22, 2024 unless terminated earlier by our Board and may be suspended or discontinued at any time. During the fourth quarter of fiscal year 2022, we repurchased 138,025 shares of common stock under the New Repurchase Program for an aggregate cost of $19.1 million. As of January 1, 2023, $280.9 million remained available for aggregate repurchases of shares under the New Repurchase Program.
 

29
Table of Contents

Stock Performance Graph
Set forth below is a line graph comparing the cumulative total shareholder return on our common stock against the cumulative total return of the S&P Composite-500 Index, the S&P 500 Life Sciences Tools & Services Industry Index and a Peer Group Index for the five fiscal years from December 31, 2017 to January 1, 2023. Our Peer Group Index consists of Agilent Technologies Inc., Thermo Fisher Scientific Inc., and Waters Corporation. The peer group is the same as the peer group used in the stock performance graph in our Annual Report on Form 10-K for the fiscal year ended January 2, 2022.

Comparison of Five-Year Cumulative Total Return
Among PerkinElmer, Inc. Common Stock, S&P Composite-500,
S&P 500 Life Sciences Tools & Services Industry Index and Peer Group Index

TOTAL RETURN TO SHAREHOLDERS
(Includes reinvestment of dividends)

pki-20230101_g1.jpg
31-Dec-1730-Dec-1829-Dec-193-Jan-212-Jan-221-Jan-23
PerkinElmer, Inc.$100.00 $106.07 $133.61 $198.11 $278.09 $194.30 
S&P 500 Index$100.00 $95.62 $125.72 $148.85 $191.58 $156.89 
S&P 500 Life Sciences Tools & Services Industry Index$100.00 $115.18 $152.65 $203.04 $281.69 $217.15 
Peer Group Index$100.00 $111.08 $157.75 $219.67 $313.61 $266.70 


Item 6.    [Reserved]
 
Reserved.

30
Table of Contents

Item 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
This annual report on Form 10-K, including the following management’s discussion and analysis, contains forward-looking information that you should read in conjunction with the consolidated financial statements and notes to consolidated financial statements that we have included elsewhere in this annual report on Form 10-K. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “believes,” “plans,” “anticipates,” “expects,” “will” and similar expressions are intended to identify forward-looking statements. Our actual results may differ materially from the plans, intentions or expectations we disclose in the forward-looking statements we make. We have included important factors above under the heading “Risk Factors” in Item 1A above that we believe could cause actual results to differ materially from the forward-looking statements we make. We are not obligated to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
 
Accounting Period
Our fiscal year ends on the Sunday nearest December 31. We report fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. Each of the fiscal years ended January 1, 2023 (“fiscal year 2022”) and January 2, 2022 (“fiscal year 2021”) included 52 weeks. The fiscal year ended January 3, 2021 (“fiscal year 2020”) included 53 weeks. The fiscal year ending December 31, 2023 (“fiscal year 2023”) will include 52 weeks.
 
Overview of Fiscal Year 2022
During fiscal year 2022, we continued to see strong returns from our acquisitions as well as our organic investments across technology, marketing and people. Our overall revenue in fiscal year 2022 decreased by $516.0 million, or 13%, as compared to fiscal year 2021, reflecting a decrease of $913.0 million, or 31%, in our Diagnostics segment revenue, partially offset by an increase of $395.2 million, or 44%, in our Discovery & Analytical Solutions segment revenue. Revenue from our 2021 acquisitions contributed $366.9 million to our overall revenue during fiscal year 2022. The decrease in our Diagnostics segment revenue during fiscal year 2022 was primarily driven by decreased demand for our COVID-19 product offerings, partially offset by an increase in our core product offerings resulting in a decrease of $689.0 million in our immunodiagnostics revenue and a decrease of $225.8 million in our applied genomics revenue. Revenue from our 2021 acquisitions contributed $58.1 million to our Diagnostics segment revenue during fiscal year 2022. The increase in our Discovery & Analytical Solutions segment revenue during fiscal year 2022 was driven by an increase of $395.2 million in our life sciences market revenue. Revenue from our 2021 acquisitions contributed $308.7 million to the increase in our Discovery & Analytical Solutions segment revenue during fiscal year 2022.
In our Diagnostics segment, we experienced a global decline in demand for our COVID-19 product offerings due to the cancellation of our service contracts for the State of California and the United Kingdom, and lower COVID-19 testing volumes compared to fiscal year 2021. We saw strong growth in our core immunodiagnostics business in the Americas and Europe, partially offset by the impact of extensive shutdowns in China. In our reproductive health business, an expanded range of product offerings and increased geographic reach more than offset the impact of declining birthrates.
In our Discovery & Analytical Solutions segment, the increase in our life sciences market revenue was the result of an increase in revenue in our pharmaceutical and biotechnology markets across all regions. Instruments, reagents and software experienced strong growth and we saw a positive impact from pricing actions we took in early 2022.
Our consolidated gross margins decreased 350 basis points in fiscal year 2022, as compared to fiscal year 2021, primarily due to increased amortization of acquired intangible assets and lower revenue from our COVID-19 product offerings, partially offset by a favorable shift in product mix and service productivity. Our consolidated operating margin decreased 1,045 basis points in fiscal year 2022, as compared to fiscal year 2021, primarily due to lower revenue from our COVID-19 product offerings, increased costs related to amortization of acquired intangible assets, and investments in new product development and growth initiatives. During fiscal year 2022, supply chain disruptions and inflation did not materially impact our results of operations as compared to fiscal year 2021 as the effects of our initiatives to reduce transportation costs more than offset the impact of inflation on our raw materials purchases. During fiscal year 2022, supply chain disruptions and inflation increased our cost of goods sold by less than $10.0 million as compared to fiscal year 2021.
Overall, we believe that our strategic priorities and recent portfolio transformations, coupled with our expanded range of product offerings, leading market positions, global scale and financial strength provides us with a foundation for continued revenue growth, strong margins and cash flows, and long-term earnings per share growth.

31
Table of Contents

Consolidated Results of Operations
 Fiscal Year 2022 Compared to Fiscal Year 2021
Revenue
Revenue for fiscal year 2022 was $3.3 billion, as compared to $3.8 billion for fiscal year 2021, a decrease of $0.5 billion, or 13%, which includes an approximate 4% decrease in revenue attributable to unfavorable changes in foreign exchange rates, partially offset by an approximate 9% increase in revenue attributable to acquisitions. Revenue from our 2021 acquisitions contributed $366.9 million to our overall revenue during fiscal year 2022. The analysis in the remainder of this paragraph compares segment revenue for fiscal year 2022 as compared to fiscal year 2021 and includes the effect of foreign exchange rate fluctuations, and acquisitions and divestitures. The decrease in total revenue reflects a decrease in our Diagnostics segment revenue of $913.0 million, or 31%, due to decreased demand for our COVID-19 product offerings, partially offset by an increase in our core product offerings resulting in a decrease of $689.0 million in our immunodiagnostics revenue and a decrease of $225.8 million in our applied genomics revenue. Our Discovery & Analytical Solutions segment revenue increased by $395.2 million, or 44%, due to increase in revenue in our life sciences market, particularly in the pharmaceutical and biotechnology markets. As a result of adjustments to deferred revenue related to certain acquisitions required by business combination rules, we did not recognize $0.8 million and $2.6 million of revenue for fiscal years 2022 and 2021, respectively, that otherwise would have been recorded by the acquired businesses during each of the respective periods.
Cost of Revenue
Cost of revenue for fiscal year 2022 was $1.3 billion, as compared to $1.4 billion for fiscal year 2021, a decrease of approximately $71.8 million, or 5%. As a percentage of revenue, cost of revenue increased to 40% in fiscal year 2022 from 36% in fiscal year 2021, resulting in a decrease in gross margin of approximately 350 basis points to 60% in fiscal year 2022 from 64% in fiscal year 2021. Amortization of intangible assets increased to $141.6 million for fiscal year 2022, as compared to $100.7 million for fiscal year 2021. Amortization of intangible assets from our 2021 acquisitions amounted to $88.5 million for fiscal year 2022. The amortization of purchase accounting adjustments to record the inventory from certain acquisitions added an incremental expense of $45.3 million for fiscal year 2022, as compared to $35.2 million for fiscal year 2021. Other purchase accounting adjustments added an incremental expense of $6.2 million for fiscal year 2022, of which $5.6 million was acquisition-related stock compensation and $0.6 million was increased depreciation on property, plant and equipment. The overall decrease in gross margin was partially offset by a favorable shift in product mix, pricing actions and service productivity.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for fiscal year 2022 were $1,025.5 million, as compared to $975.2 million for fiscal year 2021, an increase of approximately $50.3 million, or 5%. As a percentage of revenue, selling, general and administrative expenses increased to 31% in fiscal year 2022 from 25% in fiscal year 2021. Amortization of intangible assets increased to $229.1 million for fiscal year 2022, as compared to $155.9 million for fiscal year 2021. Amortization of intangible assets from our 2021 acquisitions amounted to $135.3 million for fiscal year 2022. Acquisition and divestiture-related expenses added an incremental expense of $28.9 million for fiscal year 2022, of which $15.6 million was acquisition-related stock compensation, as compared to acquisition and divestiture-related expenses increasing expenses by $59.7 million for fiscal year 2021, of which $3.9 million was acquisition-related stock compensation. Purchase accounting adjustments decreased expenses by $1.2 million for fiscal year 2022, resulting from a $1.4 million change in contingent consideration, partially offset by $0.2 million in increased depreciation on property, plant and equipment, as compared to purchase accounting adjustments increasing expenses by $2.9 million for fiscal year 2021, which was attributable to change in contingent consideration. Asset impairment costs added an incremental expense of $3.9 million for fiscal year 2021. Legal costs for significant litigation matters and settlements, net of reversals, decreased expenses by $0.6 million for fiscal year 2022. In addition to the above items, the increase in selling, general and administrative expenses was primarily the result of costs related to investments in people, digital capabilities, innovation, and recent acquisitions.
Research and Development Expenses
Research and development expenses for fiscal year 2022 were $221.6 million, as compared to $200.3 million for fiscal year 2021, an increase of $21.3 million, or 11%. As a percentage of revenue, research and development expenses increased to 7% in fiscal year 2022 from 5% in fiscal year 2021. Stock compensation related to our acquisitions added an incremental expense of $5.4 million in fiscal year 2022, as compared to $1.4 million for fiscal year 2021. Purchase accounting adjustments for depreciation on property, plant and equipment added an incremental expense of $0.2 million in fiscal year 2022, as compared to $0.1 million for fiscal year 2021. Excluding the factors above, the net increase in research and development
32
Table of Contents

expenses was due to timing of investments in new non-COVID-19 product development, partially offset by a decrease in COVID-19 related research and development expenses.
Interest and Other Expense, Net
Interest and other expense, net, consisted of the following for the fiscal years ended:
 
January 1,
2023		January 2,
2022
 (in thousands)
Interest income$(3,589)$(2,241)
Interest expense including costs of bridge financing103,955 102,128 
Change in fair value of financial securities
15,754 (10,985)
Other components of net periodic pension credit
(33,158)(37,385)
Other expense, net7,900 3,358 
Total interest and other expense, net$90,862 $54,875 
The increase of $36.0 million in interest and other expense, net, in fiscal year 2022 as compared to fiscal year 2021 was largely due to a change in fair value of financial securities of $15.8 million in fiscal year 2022 as compared to $(11.0) million in fiscal year 2021, an increase of $1.8 million in interest expense and $4.5 million in other expense, net in fiscal year 2022 and a lower net pension credit of $33.2 million in fiscal year 2022 as compared to $37.4 million in fiscal year 2021. A more complete discussion of our liquidity is set forth below under the heading “Liquidity and Capital Resources.”
Provision for Income Taxes
The effective tax rates on continuing operations were 21.3% and 26.1% for fiscal years 2022 and 2021, respectively. Certain of our subsidiaries have, at various times, been granted tax relief in their respective countries, resulting in lower income taxes than would otherwise be the case under statutory tax rates. A reconciliation of income tax expense at the U.S. federal statutory income tax rate to the recorded tax provision is as follows for the fiscal years ended:
January 1,
2023		January 2,
2022
(In thousands)
Tax at statutory rate$136,886 $252,752 
Non-U.S. rate differential, net(5,221)(33,847)
U.S. taxation of multinational operations22,102 7,964 
State income taxes, net7,820 36,832 
Prior year tax matters(10,160)1,850 
Effect of stock compensation845 (2,187)
General business tax credits(7,132)(2,715)
Change in valuation allowance4,964 (179)
Rate change on long term intangibles— 14,031 
Effect of foreign repatriations(4,940)37,147 
Other, net(6,003)2,498 
Total$139,161 $314,146 
 The variation in our effective tax rate for fiscal year 2022 is primarily affected by the accrual of $20.5 million related to a change in tax status of a certain foreign subsidiary. During fiscal year 2021, we also recognized $37.1 million in U.S. federal, U.S. state and non-U.S. taxes related to foreign earnings that we no longer considered indefinitely reinvested. During fiscal year 2022, we adjusted these estimates and recognized a net benefit of $4.9 million relative to our position to permanently reinvest those foreign earnings. We also recognized $1.1 million of benefit in fiscal year 2022 derived from the tax holiday in Singapore. We recognized $18.2 million in fiscal year 2021 of benefits derived from tax holidays in China and Singapore. The effect of these benefits, derived from tax holidays, on basic and diluted earnings per share for fiscal year 2022 was $0.01 and $0.01, respectively, and for fiscal year 2021 was $0.16 and $0.16, respectively. The tax holiday in China is renewed every three years. We expect to renew the tax holiday for one of our subsidiaries in China that is set to expire in fiscal year 2023.

33
Table of Contents

Fiscal Year 2021 Compared to Fiscal Year 2020
Revenue
Revenue for fiscal year 2021 was $3.8 billion, as compared to $2.7 billion for fiscal year 2020, an increase of $1.2 billion, or 44%, which includes an approximate 11% increase in revenue attributable to acquisitions, and a 1% increase in revenue attributable to favorable changes in foreign exchange rates. The analysis in the remainder of this paragraph compares segment revenue for fiscal year 2021 as compared to fiscal year 2020 and includes the effect of foreign exchange rate fluctuations, and acquisitions and divestitures. The total increase in revenue reflects an increase in our Diagnostics segment revenue of $865.0 million, or 42%, due to increased demand for our COVID-19 product offerings resulting in an increase of $748.0 million in our immunodiagnostics revenue. Our Diagnostics segment revenue also increased during fiscal year 2021 due to growth in our core product offerings resulting in an increase of $58.0 million in our reproductive health revenue and an increase of $59.0 million in our applied genomics revenue. Our Discovery & Analytical Solutions segment revenue increased by $301.1 million, or 50%, due to an increase in revenue in our life sciences market, particularly in the pharmaceutical and biotechnology markets. As a result of adjustments to deferred revenue related to certain acquisitions required by business combination rules, we did not recognize $2.6 million and $1.1 million of revenue for fiscal years 2021 and 2020, respectively, that otherwise would have been recorded by the acquired businesses during each of the respective periods.
Cost of Revenue
Cost of revenue for fiscal year 2021 was $1.4 billion, as compared to $933.1 million for fiscal year 2020, an increase of approximately $460.8 million, or 49%. As a percentage of revenue, cost of revenue increased to 36% in fiscal year 2021 from 35% in fiscal year 2020, resulting in a decrease in gross margin of approximately 138 basis points to 64% in fiscal year 2021 from 65% in fiscal year 2020. Amortization of intangible assets increased and was $100.7 million for fiscal year 2021, as compared to $51.4 million for fiscal year 2020. Amortization of intangible assets from our 2021 acquisitions amounted to $34.0 million for fiscal year 2021. The amortization of purchase accounting adjustments to record the inventory from certain acquisitions added an incremental expense of $35.2 million for fiscal year 2021, as compared to $1.8 million for fiscal year 2020. Other purchase accounting adjustments added an incremental expense of $1.8 million in fiscal year 2021, of which $1.6 million was acquisition-related stock compensation and $0.2 million was increased depreciation on property, plant and equipment. Asset impairment was $7.9 million for fiscal year 2020. The overall decrease in gross margin was partially offset by a favorable shift in product mix and service productivity.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for fiscal year 2021 were $975.2 million, as compared to $716.5 million for fiscal year 2020, an increase of approximately $258.7 million, or 36%. As a percentage of revenue, selling, general and administrative expenses decreased to 25% in fiscal year 2021 from 27% in fiscal year 2020. Amortization of intangible assets increased to $155.9 million for fiscal year 2021, as compared to $109.6 million for fiscal year 2020. Amortization of intangible assets from our 2021 acquisitions amounted to $37.2 million for fiscal year 2021. Acquisition and divestiture-related expenses added an incremental expense of $59.7 million for fiscal year 2021, of which $3.9 million was acquisition-related stock compensation, as compared to acquisition and divestiture-related expenses increasing expenses by $4.3 million for fiscal year 2020. Purchase accounting adjustments added an incremental expense of $2.9 million for fiscal year 2021, of which $2.8 million was change in contingent consideration and $0.1 million was increased depreciation on property, plant and equipment, as compared to purchase accounting adjustments increasing expenses by $3.5 million for fiscal year 2020, which was attributable to change in contingent consideration. Asset impairment costs added an incremental expense of $3.9 million for fiscal year 2021. Legal costs for significant litigation matters and settlements were $5.9 million for fiscal year 2020. Costs for significant environmental matters were $5.2 million for fiscal year 2020. In addition to the above items, the increase in selling, general and administrative expenses was primarily the result of costs related to investments in people, digital capabilities and innovation, and recent acquisitions amplified by pandemic-related cost controls and disruptions in the prior year.
Research and Development Expenses
Research and development expenses for fiscal year 2021 were $200.3 million, as compared to $146.4 million for fiscal year 2020, an increase of $53.9 million, or 36.8%. Research and development expenses from our 2021 acquisitions were $24.0 million. As a percentage of revenue, research and development expenses decreased and were 5.2% for fiscal year 2021, as compared to 5.5% for fiscal year 2020. Stock compensation related to our acquisitions added an incremental expense of $1.4 million in fiscal year 2021. Purchase accounting adjustments for depreciation on property, plant and equipment added an incremental expense of $0.1 million in fiscal year 2021. The increase in research and development expenses was driven by our investments in new product development.
34
Table of Contents

Interest and Other Expense, Net
Interest and other expense, net, consisted of the following for the fiscal years ended:
 
January 2,
2022		January 3,
2021
 (in thousands)
Interest income$(2,241)$(1,010)
Interest expense including costs of bridge financing102,128 49,712 
Change in fair value of financial securities
(10,985)(35)
Other components of net periodic pension (credit) cost
(37,385)13,819 
Other expense, net3,358 4,715 
Total interest and other expense, net$54,875 $67,201 
The decrease of $12.3 million in interest and other expense, net, in fiscal year 2021 as compared to fiscal year 2020 was largely due to a net pension credit of $37.4 million in fiscal year 2021 as compared to a net pension cost of $13.8 million in fiscal year 2020, a decrease in other expense, net of $1.4 million and a change in fair value of financial securities of $11.0 million, partially offset by an increase of $52.4 million in interest expense in fiscal year 2021. The increase of $52.4 million in interest expense in fiscal year 2021 was the result of $23.4 million of costs of bridge financing and debt pre-issuance hedges that were recognized in fiscal year 2021 and interest expense from new debt in fiscal year 2021. A more complete discussion of our liquidity is set forth below under the heading “Liquidity and Capital Resources.”
Provision for Income Taxes
The effective tax rates on continuing operations were 26.1% and 21.2% for fiscal years 2021 and 2020, respectively. Certain of our subsidiaries have, at various times, been granted tax relief in their respective countries, resulting in lower income taxes than would otherwise be the case under statutory tax rates. A reconciliation of income tax expense at the U.S. federal statutory income tax rate to the recorded tax provision is as follows for the fiscal years ended:
January 2,
2022		January 3,
2021
(In thousands)
Tax at statutory rate$252,752 $168,015 
Non-U.S. rate differential, net(33,847)(29,155)
U.S. taxation of multinational operations7,964 11,468 
State income taxes, net36,832 13,249 
Prior year tax matters1,850 5,532 
Effect of stock compensation(2,187)(8,148)
General business tax credits(2,715)(2,145)
Change in valuation allowance(179)(369)
Rate change on long term intangibles14,031 — 
Effect of foreign operations37,147 — 
Foreign consolidations— 15,222 
Other, net2,498 (4,157)
Total$314,146 $169,512 
 The variation in our effective tax rate for fiscal year 2021 is primarily affected by the recognition of $37.1 million in U.S. federal, U.S. state and non-U.S. taxes related to foreign earnings that we no longer considered indefinitely reinvested. We also recognized $18.2 million in fiscal year 2021 and $12.7 million in fiscal year 2020 of benefits derived from tax holidays in China and Singapore. The effect of these benefits, derived from tax holidays, on basic and diluted earnings per share for fiscal year 2021 was $0.16 and $0.16, respectively, and for fiscal year 2020 was $0.11 and $0.11, respectively.
35
Table of Contents

Business Combinations
Acquisitions in fiscal year 2022
During fiscal year 2022, we completed the acquisition of two businesses for aggregate consideration of $13.3 million. Identifiable definite-lived intangible assets, such as core technology, acquired as part of these acquisitions had a weighted average amortization period of 5 years.
Acquisitions in fiscal year 2021
Acquisition of BioLegend, Inc. In fiscal year 2021, we completed the acquisition of BioLegend, Inc. (“BioLegend”) for an aggregate consideration of $5.7 billion. BioLegend’s revenue and net loss for the period from the acquisition date to January 2, 2022 were $91.7 million and $25.8 million, respectively.
Other acquisitions in 2021. During fiscal year 2021, we also completed the acquisition of seven other businesses for aggregate consideration of $1.2 billion. The acquired businesses include Oxford Immunotec Global PLC for a total consideration of $590.9 million and Nexcelom Bioscience Holdings, LLC for a total consideration of $267.3 million, and five other businesses, which were acquired for a total consideration of $318.6 million.
See Note 3, Business Combinations, in the Notes to Consolidated Financial Statements for a detailed discussion of our acquisitions.

Reporting Segment Results of Continuing Operations
Discovery & Analytical Solutions
 Fiscal Year 2022 Compared to Fiscal Year 2021
Revenue for fiscal year 2022 was $1,292.9 million, as compared to $897.7 million for fiscal year 2021, an increase of $395.2 million, or 44%, which includes an approximate 32% increase in revenue attributable to acquisitions and a 4% decrease in revenue attributable to unfavorable changes in foreign exchange rates. Revenue from our 2021 acquisitions contributed $308.7 million to the Discovery & Analytical Solutions segment revenue during fiscal year 2022. The increase in revenue in our Discovery & Analytical Solutions segment was a result of an increase in revenue in our life sciences market, particularly in the pharmaceutical and biotechnology markets.
Segment operating income for fiscal year 2022 was $503.2 million, as compared to $281.6 million for fiscal year 2021, an increase of $221.6 million, or 79%. Segment operating margin increased 750 basis points in fiscal year 2022, as compared to fiscal year 2021, primarily due to pricing actions, product mix and higher sales volume.
Fiscal Year 2021 Compared to Fiscal Year 2020
Revenue for fiscal year 2021 was $897.7 million, as compared to $596.6 million for fiscal year 2020, an increase of $301.1 million, or 50%, which includes an approximate 33% increase in revenue attributable to acquisitions and a 1% increase in revenue attributable to favorable changes in foreign exchange rates. The increase in revenue in our Discovery & Analytical Solutions segment was a result of an increase in revenue in our life sciences market, particularly in the pharmaceutical and biotechnology markets.
Segment operating income for fiscal year 2021 was $281.6 million, as compared to $129.2 million for fiscal year 2020, an increase of $152.4 million, or 118%. Segment operating margin increased 970 basis points in fiscal year 2021, as compared to fiscal year 2020, primarily due to higher sales volume, partially offset by investments in new product development and growth initiatives.

36
Table of Contents

Diagnostics
 Fiscal Year 2022 Compared to Fiscal Year 2021
Revenue for fiscal year 2022 was $2,019.7 million, as compared to $2,932.7 million for fiscal year 2021, a decrease of $913.0 million, or 31%, which includes an approximate 2% increase in revenue attributable to acquisitions and a 4% decrease in revenue attributable to unfavorable changes in foreign exchange rates. Revenue from our 2021 acquisitions contributed $58.1 million to our Diagnostics segment revenue during fiscal year 2022. The decrease in our Diagnostics segment revenue during fiscal year 2022 was primarily driven by decreased demand for our COVID-19 product offerings, partially offset by an increase in our core product offerings resulting in a decrease of $689.0 million in our immunodiagnostics revenue, a decrease of $225.8 million in our applied genomics revenue, and an increase of $1.7 million in our reproductive health revenue.
Segment operating income from continuing operations for fiscal year 2022 was $782.0 million, as compared to $1,432.8 million for fiscal year 2021, a decrease of $650.8 million, or 45%. Segment operating margin decreased 1,020 basis points in fiscal year 2022, as compared to fiscal year 2021, primarily due to lower sales volume and product mix, partially offset by cost controls.
Fiscal Year 2021 Compared to Fiscal Year 2020
Revenue for fiscal year 2021 was $2,932.7 million, as compared to $2,067.7 million for fiscal year 2020, an increase of $865.0 million, or 42%, which includes an approximate 5% increase in revenue attributable to acquisitions and a 2% increase in revenue attributable to favorable changes in foreign exchange rates. The increase in our Diagnostics segment revenue during fiscal year 2021 was primarily driven by increased demand for our COVID-19 product offerings resulting in an increase of $748.0 million in our immunodiagnostics revenue. Our Diagnostics segment revenue also increased during fiscal year 2021 due to growth in our core product offerings resulting in an increase of $58.0 million in our reproductive health revenue and an increase of $59.0 million in our applied genomics revenue.
Segment operating income for fiscal year 2021 was $1,432.8 million, as compared to $1,010.4 million for fiscal year 2020, an increase of $422.4 million, or 42%. Segment operating margin was flat in fiscal year 2021, as compared to fiscal year 2020, primarily due to higher sales volume and favorable product mix, offset by increased investments in new product development and growth initiatives.
Discontinued Operations
In August 2022, we entered into a Master Purchase and Sale Agreement (the “Purchase Agreement”) with Polaris Purchaser, L.P. (the “Purchaser”), a Delaware limited partnership owned by funds managed by affiliates of New Mountain Capital L.L.C. (the “Sponsor”), under which we agreed to sell to the Purchaser certain assets and the equity interests of certain entities constituting our Analytical, Food and Enterprise Services businesses (the “Business”) (as further defined in the Purchase Agreement), for cash consideration of up to approximately $2.45 billion and the Purchaser’s assumption of certain liabilities relating to the Business (collectively, the “Transaction”). Approximately $2.30 billion of the purchase price will be payable at closing, subject to certain customary adjustments, which includes $75.0 million in deferred payments tied to the transfer of the PerkinElmer brand and related trademarks to the Purchaser (which may be completed within 24 months following the date of the closing at our election). The Purchase Agreement also provides for potential post-closing payments totaling up to $150.0 million, which are contingent on the exit valuation the Sponsor and its affiliated funds receive on a sale or other capital events related to the Business. The Transaction is expected to close in the first quarter of fiscal year 2023, subject to regulatory approvals and other customary closing conditions.
The Business had been recorded in the Discovery & Analytical Solutions segment. The sale of the Business represents a strategic shift that will have a major effect on our operations and financial statements. Accordingly, we have classified the assets and liabilities related to the Business as assets and liabilities of discontinued operations in our consolidated balance sheets and its results of operations are classified as income from discontinued operations in our consolidated statements of operations. Financial information in this report relating to the fiscal years ended January 2, 2022 and January 3, 2021 has been retrospectively adjusted to reflect this discontinued operation.
The summary pre-tax operating results of the discontinued operations, were as follows:
37
Table of Contents

 January 1, 2023January 2, 2022January 3, 2021
 (In thousands)
Revenue$1,298,376 $1,239,361 $1,119,515 
Cost of revenue859,330 822,048 739,817 
Selling, general and administrative expenses306,032 268,760 209,442 
Research and development expenses64,605 74,632 58,948 
Operating income68,409 73,921 111,308 
Other expense (income), net(5,195)(2,383)5,016 
Income from discontinued operations before income taxes$73,604 $76,304 $106,292 

During fiscal year 2022, we recognized $69.4 million of divestiture-related costs in selling, general and administrative expenses in discontinued operations, as compared to $7.5 million during fiscal year 2021, an increase of $61.9 million. The increase in selling, general and administrative expenses was partially offset by decreased amortization expense and acquisition-related costs. During fiscal year 2022, we recognized $8.2 million of amortization expense in selling, general and administrative expenses in discontinued operations, as compared to $19.3 million during fiscal year 2021, a decrease of $11.1 million, as we suspended the amortization of the intangible assets related to the Business during fiscal year 2022 when it was reclassified into discontinued operations. During fiscal year 2022, we recognized $6.4 million of incentive award associated with one of the Company’s acquisitions in discontinued operations, as compared to $14.3 million during fiscal year 2021, a decrease of $7.8 million.
During fiscal year 2021, divestiture-related costs in selling, general and administrative expenses in discontinued operations increased by $7.5 million as compared to fiscal year 2020. In addition, payroll and employee benefits and acquisition-related costs pertaining to an incentive award associated with one of the Company’s acquisitions increased by $20.4 million and $9.6 million, respectively, as compared to fiscal year 2020.

Liquidity and Capital Resources
We require cash to pay our operating expenses, make capital expenditures, make strategic acquisitions, service our debt and other long-term liabilities, repurchase shares of our common stock and pay dividends on our common stock. Our principal sources of funds are cash flows from our operations, borrowing capacity available under our senior unsecured credit facility and access to the debt markets. We anticipate that our internal operations will generate sufficient cash to fund our operating expenses, capital expenditures, smaller acquisitions, interest payments on our debt and dividends on our common stock. However, we expect to use external sources to satisfy the balance of our debt when due, any larger acquisitions and other long-term liabilities, such as contributions to our postretirement benefit plans. The proposed sale of the Business classified as discontinued operations is expected to close in the first quarter of fiscal year 2023, which we expect will generate approximately $2.2 billion of proceeds to us. We expect to use these proceeds for funding upcoming debt maturities, opportunistic share repurchases and continued strategic and value-creating acquisitions.
We and our subsidiaries and affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt securities (including any publicly issued debt securities), in privately negotiated or open market transactions, by tender offer or otherwise, or extend or refinance any of our outstanding indebtedness.
Principal factors that could affect the availability of our internally generated funds include:
•changes in sales due to weakness in markets in which we sell our products and services, and
•changes in our working capital requirements.
Principal factors that could affect our ability to obtain cash from external sources include:
•financial covenants contained in the financial instruments controlling our borrowings that limit our total borrowing capacity,
•increases in interest rates applicable to our outstanding variable rate debt,
•a ratings downgrade that could limit the amount we can borrow under our senior unsecured revolving credit facility and our overall access to the corporate debt market,
38
Table of Contents

•increases in interest rates or credit spreads, as well as limitations on the availability of credit, that affect our ability to borrow under future potential facilities on a secured or unsecured basis,
•a decrease in the market price for our common stock, and
•volatility in the public debt and equity markets.
Cash Flows
Fiscal Year 2022 Compared to Fiscal Year 2021
Operating Activities. Net cash provided by continuing operations was $672.5 million for fiscal year 2022, as compared to $1,330.2 million for fiscal year 2021, a decrease of $657.7 million. The cash provided by operating activities for fiscal year 2022 was principally a result of income from continuing operations of $512.7 million, adjustments for non-cash charges aggregating to $422.8 million, including depreciation and amortization of $427.0 million, and a net cash decrease in working capital of $263.0 million. During fiscal year 2022, we contributed $6.6 million, in the aggregate, to pension plans outside of the United States.
Investing Activities. Net cash used in the investing activities of our continuing operations was $116.9 million for fiscal year 2022, as compared to $4,089.8 million for fiscal year 2021, a decrease of $3,972.9 million. For fiscal year 2022, we used $7.5 million of net cash for acquisitions, as compared to $3,982.2 million used in fiscal year 2021. Capital expenditures for fiscal year 2022 were $85.6 million, primarily for manufacturing equipment and other capital equipment purchases, as compared to $86.0 million for fiscal year 2021. During fiscal year 2022, we purchased investments amounting to $47.2 million as compared to $23.1 million in fiscal year 2021. These items were partially offset by $14.5 million in proceeds from disposition of businesses and assets in fiscal year 2022, as compared to $1.5 million in fiscal year 2021. In addition, proceeds from notes receivable were $8.9 million in fiscal year 2022. Proceeds from surrender of life insurance policies were $0.1 million in fiscal year 2021.
Financing Activities. Net cash used in the financing activities of our continuing operations was $661.8 million for fiscal year 2022, as compared to net cash provided by the financing activities of our continuing operations of $2,941.7 million for fiscal year 2021, an increase of $3,603.5 million in net cash used in financing activities. The cash used in financing activities during fiscal year 2022 was primarily a result of payments of borrowings, repurchases of our common stock, payments of dividends and settlement of cash flow hedges. During fiscal year 2022, we made net payments on our borrowings of $559.2 million, as compared to net proceeds from borrowings of $3,043.0 million during fiscal year 2021. The changes reflect financing transactions in fiscal year 2021 to finance acquisitions and to refinance borrowings as compared to paying down debt in fiscal year 2022, which we expect to continue throughout fiscal year 2023. During fiscal year 2022, we repurchased shares of our common stock for a total cost of $80.6 million, as compared to $73.1 million in fiscal year 2021. During fiscal year 2022, we paid $35.3 million in dividends as compared to $32.4 million for fiscal year 2021. We paid $0.8 million in settlement of hedges during fiscal year 2022 as compared to $4.5 million for fiscal year 2021. In addition, we paid $14.3 million for settlement of a swap and $2.2 million for acquisition-related contingent consideration in fiscal year 2021. The cash used in financing activities during fiscal year 2022 was partially offset by proceeds from the issuance of common stock under our stock plans of $14.1 million during fiscal year 2022, as compared to $25.1 million for fiscal year 2021.
Fiscal Year 2021 Compared to Fiscal Year 2020
    Operating Activities. Net cash provided by continuing operations was $1,330.2 million for fiscal year 2021, as compared to $704.7 million for fiscal year 2020, an increase of $625.5 million. The cash provided by operating activities for fiscal year 2021 was principally a result of income from continuing operations of $889.4 million, adjustments for non-cash charges aggregating to $307.8 million, including depreciation and amortization of $311.4 million, and a net cash increase in working capital of $133.0 million. During fiscal year 2021, $1.7 million of contingent consideration payments were included in operating activities. During fiscal year 2021, we contributed $6.9 million, in the aggregate, to pension plans outside of the United States and $20.0 million to our defined benefit pension plan in the United States.
Investing Activities. Net cash used in the investing activities of our continuing operations was $4,089.8 million for fiscal year 2021, as compared to $490.6 million for fiscal year 2020, an increase of $3,599.2 million. For fiscal year 2021, we used $3,982.2 million of net cash for acquisitions, as compared to $411.5 million used in fiscal year 2020. Capital expenditures for fiscal year 2021 were $86.0 million, primarily for manufacturing equipment and other capital equipment purchases, as compared to $63.6 million for fiscal year 2020. During fiscal year 2021, we purchased investments amounting to $23.1 million as compared to $20.1 million in fiscal year 2020. These items were partially offset by $1.5 million in proceeds from disposition of businesses and assets in fiscal year 2021, as compared to $4.3 million in fiscal year 2020, and by proceeds from surrender of life insurance policies of $0.1 million in fiscal year 2021, as compared to $0.3 million in fiscal year 2020.
39
Table of Contents

Financing Activities. Net cash provided by the financing activities of our continuing operations was $2,941.7 million for fiscal year 2021, as compared to net cash used in the financing activities of our continuing operations of $202.9 million for fiscal year 2020, an increase of $3,144.5 million in net cash provided by financing activities. The cash provided by financing activities during fiscal year 2021 was primarily a result of net proceeds from borrowings and proceeds from the issuance of common stock under stock plans. During fiscal year 2021, we had net proceeds from borrowings of $3,043.0 million, as compared to net payments on borrowings of $187.5 million during fiscal year 2020. The changes reflect financing transactions in fiscal year 2021 to finance acquisitions and to refinance borrowings as compared to paying down debt in fiscal year 2020. Proceeds from the issuance of common stock under our stock plans were $25.1 million during fiscal year 2021, as compared to $37.7 million for fiscal year 2020. The cash provided by financing activities during fiscal year 2021 was partially offset by repurchases of our common stock, payments of dividends, settlement of swaps, settlement of cash flow hedges and payments for acquisition-related contingent consideration. During fiscal year 2021, we repurchased shares of common stock for a total cost of $73.1 million, as compared to $6.9 million in fiscal year 2020. During fiscal year 2021, we paid $32.4 million in dividends as compared to $31.2 million for fiscal year 2020. During fiscal year 2021, we paid $14.3 million for settlement of a swap. We paid $4.5 million in settlement of hedges during fiscal year 2021 as compared to $4.6 million for fiscal year 2020. During fiscal year 2021, we paid $2.2 million for acquisition-related contingent consideration as compared to $10.4 million in fiscal year 2020.
Borrowing Arrangements
During fiscal year 2022, we repaid the full $500.0 million principal amount of the term loan facility. Since the beginning of the third quarter of fiscal year 2022, we have repurchased $32.9 million and $78.8 million in aggregate principal amount of our 0.550% senior unsecured notes due in September 2023 (the “2023 Notes”) and 0.850% senior unsecured notes due in September 2024 (the “2024 Notes”), respectively, in open market transactions. We expect to complete the repayment of the $467.1 million in outstanding 2023 Notes in fiscal year 2023. We expect to continue repurchasing outstanding 2024 Notes from time to time, subject to market conditions. See Note 13, Debt, in the Notes to Consolidated Financial Statements for a detailed discussion of our borrowing arrangements.
Dividends
Our Board of Directors (our “Board”) declared a regular quarterly cash dividend of $0.07 per share in each quarter of fiscal years 2022, 2021 and 2020, resulting in an annual dividend rate of $0.28 per share. At January 1, 2023, we had accrued $8.8 million for a dividend declared in October 2022 for the fourth quarter of fiscal year 2022 that was paid in February 2023. On January 26, 2023, we announced that our Board had declared a quarterly dividend of $0.07 per share for the first quarter of fiscal year 2023 that will be payable in May 2023. In the future, our Board may determine to reduce or eliminate our common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.
Capital Expenditures
During fiscal year 2023, we expect to invest an amount for capital expenditures similar to that in fiscal year 2022, primarily to introduce new products, to improve our operating processes, to shift the production capacity to lower cost locations, and to develop information technology. We expect to use our available cash and internally generated funds to fund these expenditures.
Other Potential Liquidity Considerations
At January 1, 2023, we had cash and cash equivalents of $454.4 million, of which $385.4 million was held by our non-U.S. subsidiaries, and we had $1.5 billion of additional borrowing capacity available under a senior unsecured revolving credit facility. We had no other liquid investments at January 1, 2023.
We utilize a variety of tax planning and financing strategies to ensure that our worldwide cash is available in the locations in which it is needed. We use our non-U.S. cash for needs outside of the United States including foreign operations,
capital investments, acquisitions and repayment of debt. In addition, we transfer cash to the United States using nontaxable returns of capital, distributions of previously taxed income, as well as dividends, where the related income tax cost is managed efficiently. We have accrued tax expense on the unremitted earnings of foreign subsidiaries as required by the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) and where the foreign earnings are not considered permanently reinvested. In accordance with the Tax Act, we are making scheduled annual cash payments on our accrued transition tax.
As of January 1, 2023, we evaluated our undistributed foreign earnings and identified approximately $879.0 million in earnings that we do not consider to be permanently reinvested. We have recorded a provision of approximately $15.8 million for taxes that would fall due when such earnings are repatriated. We began repatriating foreign earnings to the United States in the first quarter of fiscal year 2022 and expect to continue the repatriation in fiscal year 2023. There are no other undistributed
40
Table of Contents

foreign earnings and outside basis differences for which we have not provided for any taxes as these amounts continue to be indefinitely reinvested, and it is not practicable to estimate the amount of deferred tax liability that would be incurred.
On July 31, 2020, our Board authorized us to repurchase shares of common stock for an aggregate amount up to $250.0 million under a stock repurchase program (the “Repurchase Program”). On July 22, 2022, the Repurchase Program was terminated by our Board and the Board authorized us to repurchase shares of common stock for an aggregate amount up to $300.0 million under a new stock repurchase program (the “New Repurchase Program”). No shares remain available for repurchase under the Repurchase Program due to its termination. The New Repurchase Program will expire on July 22, 2024 unless terminated earlier by our Board and may be suspended or discontinued at any time. During fiscal year 2022, we repurchased 240,000 shares of common stock under the Repurchase Program for an aggregate cost of $43.4 million. During fiscal year 2022, we repurchased 138,025 shares of common stock under the New Repurchase Program for an aggregate cost of $19.1 million. As of January 1, 2023, $280.9 million remained available for aggregate repurchases of shares under the New Repurchase Program.
In addition, our Board has authorized us to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to our equity incentive plans. During fiscal year 2022, we repurchased 115,247 shares of common stock for this purpose at an aggregate cost of $18.1 million. During fiscal year 2021, we repurchased 71,248 shares of common stock for this purpose at an aggregate cost of $10.5 million.
The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value. Any repurchased shares will be available for use in connection with corporate programs. If we continue to repurchase shares, the New Repurchase Program will be funded using our existing financial resources, including cash and cash equivalents, and our existing senior unsecured revolving credit facility.
As of January 1, 2023, we may have to pay contingent consideration, related to acquisitions with open contingency periods, of up to $106.2 million. As of January 1, 2023, we have recorded contingent consideration obligations of $46.6 million, of which $3.6 million was recorded in accrued expenses and other current liabilities, and $43.0 million was recorded in long-term liabilities. The expected maximum earnout period for acquisitions with open contingency periods is 5.9 years from January 1, 2023, and the remaining weighted average expected earnout period at January 1, 2023 was 4.9 years.
Distressed global financial markets could adversely impact general economic conditions by reducing liquidity and credit availability, creating increased volatility in security prices, widening credit spreads and decreasing valuations of certain investments. The widening of credit spreads may create a less favorable environment for certain of our businesses and may affect the fair value of financial instruments that we issue or hold. Increases in credit spreads, as well as limitations on the availability of credit at rates we consider to be reasonable, could affect our ability to borrow under future potential facilities on a secured or unsecured basis, which may adversely affect our liquidity and results of operations. In difficult global financial markets, we may be forced to fund our operations at a higher cost, or we may be unable to raise as much funding as we need to support our business activities.
Our pension plans have not experienced a material impact on liquidity or counterparty exposure due to the volatility and uncertainty in the credit markets. With respect to plans outside of the United States, we expect to contribute $6.8 million in the aggregate during fiscal year 2023. During fiscal year 2023, we contributed $10.0 million to our defined benefit pension plan in the United States for the plan year 2022. During fiscal years 2022, 2021 and 2020, we contributed $6.6 million, $6.9 million and $7.5 million in the aggregate, respectively, to pension plans outside of the United States. During fiscal year 2021, we contributed $20.0 million to our defined benefit pension plan in the United States. We could potentially have to make additional funding payments in future periods for all pension plans. We expect to use existing cash and external sources to satisfy future contributions to our pension plans.
We are conducting a number of environmental investigations and remedial actions at our current and former locations, and are subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of our business activities. Although we have established accruals for potential losses that we believe are probable and reasonably estimable, in our opinion, based on our review of the information available at this time, the total cost of resolving these contingencies at January 1, 2023 should not have a material adverse effect on our consolidated financial statements included in this annual report on Form 10-K. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to us. See “Business—Environmental Matters” above and Note 16, Contingencies, in the Notes to Consolidated Financial Statements for a discussion of these matters and proceedings.
41
Table of Contents

Effects of Recently Issued and Adopted Accounting Pronouncements
See Note 1, Nature of Operations and Accounting Policies, in the Notes to Consolidated Financial Statements for a summary of recently issued accounting pronouncements. We did not adopt any new accounting pronouncements during the fiscal year 2022. We do not believe that any recently issued accounting pronouncements that have not yet been adopted will have a material impact on our consolidated financial statements.
Application of Critical Accounting Policies and Estimates
The preparation of consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to accounting for business combinations, long-lived assets, including goodwill and other intangibles and employee compensation and benefits. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
We believe the following critical accounting policies affect our more significant judgments and estimates used in preparation of our consolidated financial statements.
Business combinations. Business combinations are accounted for at fair value. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses; restructuring costs associated with a business combination are expensed subsequent to the acquisition date; and changes in deferred tax asset valuation allowances and income tax uncertainties after the acquisition date affect income tax expense. Measurement period adjustments are made in the period in which the amounts are determined and the current period income effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition date. All changes that do not qualify as measurement period adjustments are also included in current period earnings. The accounting for business combinations requires estimates and judgment as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. For intangible assets, we normally utilize the “income method” which incorporates the forecast of all the expected future net cash flows attributable to the subject intangible asset, adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Depending on the asset valued, the key assumptions included one or more of the following: (1) future revenue growth rates, (2) future gross margin, (3) future selling, general and administrative expenses, (4) royalty rates, (5) customer attrition rates, and (6) discount rates. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of finite-lived intangible assets, or the recognition of additional consideration which would be expensed. The fair value of contingent consideration is remeasured each period based on relevant information and changes to the fair value are included in the operating results for the period.
Value of long-lived assets, including goodwill and other intangibles. We carry a variety of long-lived assets on our consolidated balance sheets including property and equipment, operating lease right of use assets, investments, identifiable intangible assets, and goodwill. We periodically review the carrying value of all of these assets based, in part, upon current estimates of fair values and our projections of anticipated future cash flows. We undertake this review (i) on an annual basis for assets such as goodwill and non-amortizing intangible assets and (ii) on a periodic basis for other long-lived assets when facts and circumstances suggest that cash flows related to those assets may be diminished. Any impairment charge that we record reduces our earnings.
For goodwill, the test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. We perform the annual impairment assessment on the later of January 1 or the first day of each fiscal year. This same impairment test will be performed at other times during the course of the year should an event occur which suggests that the recoverability of goodwill should be reconsidered. We completed the annual goodwill impairment test using a measurement date of January 3, 2022, and concluded that there was no goodwill impairment. At January 3, 2022, the fair value exceeded the carrying value by more than 20.0% for each reporting unit. The range of the long-term terminal growth rates for the reporting units was 2.0% to 5.0% for the fiscal year 2022 impairment analysis. The range for the discount rates for the reporting units was 7.0% to 11.5%. Keeping all other variables
42
Table of Contents

constant, a 10.0% change in any one of these input assumptions for the various reporting units would still allow us to conclude that there was no impairment of goodwill.
In connection with the fiscal year 2023 impairment test performed as of January 2, 2023, the Tulip and EUROIMMUN reporting units, which had goodwill balances of $74.4 million and $572.0 million, respectively, at January 1, 2023, had fair values that exceeded their carrying values by less than 20%. These reporting units are at increased risk of an impairment charge given the higher discount rates, competition and, to some extent, the recent impacts of the COVID-19 pandemic. Despite the increased impairment risk associated with these reporting units, we do not believe there will be a significant change in the key estimates or assumptions driving the fair value of these reporting units that would lead to a material impairment charge.
We consistently employ the income approach to estimate the current fair value when testing for impairment of goodwill. A number of significant assumptions and estimates are involved in the application of the income approach to forecast operating cash flows, including markets and market share, sales volumes and prices, costs to produce, tax rates, capital spending, discount rates and working capital changes. Cash flow forecasts are based on approved business unit operating plans for the early years’ cash flows and historical relationships in later years. The income approach is sensitive to changes in long-term terminal growth rates and the discount rates. The long-term terminal growth rates are consistent with our historical long-term terminal growth rates, as the current economic trends are not expected to affect our long-term terminal growth rates. We corroborate the income approach with a market approach. While we believe that our estimates of current value are reasonable, if actual results differ from the estimates and judgments used including such items as future cash flows and the volatility inherent in markets which we serve, impairment charges against the carrying value of those assets could be required in the future.
Employee compensation and benefits. We sponsor both funded and unfunded U.S. and non-U.S. defined benefit pension plans and other postretirement benefits. Retirement and postretirement benefit plans are a significant cost of doing business, and represent obligations that will be ultimately settled far in the future, and therefore are subject to estimation. Retirement and postretirement benefit plan expenses are allocated to cost of revenue, research and development, and selling, general and administrative expenses, in our consolidated statements of operations. We immediately recognize actuarial gains and losses in operating results in the year in which the gains and losses occur. Actuarial gains and losses are measured annually as of the calendar month-end that is closest to our fiscal year end and accordingly will be recorded in the fourth quarter, unless we are required to perform an interim remeasurement.
We recognized gains of $28.3 million and $30.9 million in fiscal years 2022 and 2021, respectively, for our retirement and postretirement benefit plans, which include the gains from the immediate recognition of the actuarial gains and losses for the benefit plans, which were recorded in the fourth quarter of each fiscal year. The loss or income related to the immediate recognition of the actuarial gains and losses on benefit plans were pre-tax gains of $28.9 million and $24.7 million fiscal years 2022 and 2021, respectively. We expect an expense of approximately $13.3 million in fiscal year 2023 for our retirement and postretirement benefit plans, excluding any actuarial gains and losses. It is difficult to reliably calculate and predict the amount of any actuarial gains and losses in fiscal year 2023 as these gains and losses are primarily driven by events and circumstances beyond our control, including changes in interest rates, the performance of the financial markets and mortality assumptions. To the extent the discount rates decrease or the value of our pension and postretirement investments decrease, actuarial losses will impact our operating results. Conversely, to the extent the discount rates increase or the value of our pension and postretirement investments increase more than expected, actuarial gains will favorably impact our operating results. Pension accounting is intended to reflect the recognition of future benefit costs over the employee’s approximate service period based on the terms of the plans and the investment and funding decisions made. We are required to make assumptions regarding such variables as the expected long-term rate of return on assets, the discount rate applied and mortality assumptions, to determine service cost and interest cost, in order to arrive at expected pension income or expense for the year. We use discount rates for each individual plan based upon the expected cash flows using the applicable spot rates derived from a yield curve over the projected cash flow period.
If any of our assumptions were to change as of January 1, 2023, our pension plan expenses would also change as follows:
Increase (Decrease) at
January 1, 2023
Percentage Point ChangeNon-U.S.U.S.
Pension plans discount rate+0.25$(6,847)$(4,763)
-0.257,229 4,946 

43
Table of Contents

Item 7A.    Quantitative and Qualitative Disclosures About Market Risk
 
Quantitative and Qualitative Disclosures about Market Risk
Financial Instruments
Financial instruments that potentially subject us to concentrations of credit risk consist principally of temporary cash investments, derivatives, marketable securities and accounts receivable. We believe we had no significant concentrations of credit risk as of January 1, 2023.
We use derivative instruments as part of our risk management strategy only, and includes derivatives utilized as economic hedges that are not designated as hedging instruments. By nature, all financial instruments involve market and credit risks. We enter into derivative instruments with major investment grade financial institutions and have policies to monitor the credit risk of those counterparties. We do not enter into derivative contracts for trading or other speculative purposes, nor do we use leveraged financial instruments.
In the ordinary course of business, we enter into foreign exchange contracts for periods consistent with its committed exposures to mitigate the effect of foreign currency movements on transactions denominated in foreign currencies. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures from these currencies, with gains and losses resulting from the forward currency contracts that hedge these exposures. Transactions covered by hedge contracts include intercompany and third-party receivables and payables. The contracts are primarily in European and Asian currencies, have maturities that do not exceed 12 months, have no cash requirements until maturity, and are recorded at fair value on our consolidated balance sheets. The unrealized gains and losses on these foreign currency contracts are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from operating activities within our consolidated statements of cash flows.
Principal hedged currencies include the Australian Dollar, British Pound, Euro, Indian Rupee, Singapore Dollar and Swedish Krona. We held forward foreign exchange contracts, designated as economic hedges, with U.S. dollar equivalent notional amounts totaling $476.9 million at January 1, 2023, $371.9 million at January 2, 2022, and $808.0 million at January 3, 2021, and the fair value of these foreign currency derivative contracts was insignificant. The gains and losses realized on these foreign currency derivative contracts are not material. The duration of these contracts was generally 30 days or less during each of fiscal years 2022, 2021 and 2020.
In addition, in connection with certain intercompany loan agreements utilized to finance our acquisitions and stock repurchase program, we enter into forward foreign exchange contracts intended to hedge movements in foreign exchange rates prior to settlement of such intercompany loans denominated in foreign currencies. We record these hedges at fair value on our consolidated balance sheets. The unrealized gains and losses on these hedges, as well as the gains and losses associated with the remeasurement of the intercompany loans, are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from financing activities within our consolidated statements of cash flows.
The outstanding forward exchange contracts designated as economic hedges, which were intended to hedge movements in foreign exchange rates prior to the settlement of certain intercompany loan agreements, included combined U.S. Dollar notional amounts of $360.2 million as of January 2, 2022. The net gains and losses on these derivatives, combined with the gains and losses on the remeasurement of the hedged intercompany loans were not material.
During fiscal year 2018, we designated a portion of the 2026 Notes to hedge our investments in certain foreign subsidiaries. Unrealized translation adjustments from a portion of the 2026 Notes were included in the foreign currency translation component of accumulated other comprehensive income (“AOCI”), which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of January 1, 2023, the total notional amount of the 2026 Notes that was designated to hedge investments in foreign subsidiaries was €497.2 million. The unrealized foreign exchange (gains) losses recorded in AOCI related to the net investment hedge were $(34.5) million, $33.2 million and $49.6 million during the fiscal years 2022, 2021 and 2020, respectively.
We do not expect any material net pre-tax gains or losses to be reclassified from accumulated other comprehensive (loss) income into interest and other expense, net within the next twelve months.
See Note 19, Derivatives and Hedging Activities, in the Notes to Consolidated Financial Statements for a detailed discussion of our derivative instruments and hedging activities.
44
Table of Contents

Market Risk
Market Risk. We are exposed to market risk, including changes in interest rates and currency exchange rates. To manage the volatility relating to these exposures, we enter into various derivative transactions pursuant to our policies to hedge against known or forecasted market exposures.
Foreign Exchange Risk. The potential change in foreign currency exchange rates offers a substantial risk to us, as approximately 55% of our business is conducted outside of the United States, generally in foreign currencies. Our risk management strategy currently uses forward contracts to mitigate certain balance sheet foreign currency transaction exposures. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures, with gains and losses resulting from the forward contracts that hedge these exposures. Moreover, we are able to partially mitigate the impact that fluctuations in currencies have on our net income as a result of our manufacturing facilities located in countries outside the United States, material sourcing and other spending which occur in countries outside the United States, resulting in natural hedges.
Although we attempt to manage our foreign currency exchange risk through the above activities, when the U.S. dollar weakens against other currencies in which we transact business, sales and net income will in general be positively but not proportionately impacted. Conversely, when the U.S. dollar strengthens against other currencies in which we transact business, sales and net income will in general be negatively but not proportionately impacted.
Foreign Currency Risk—Value-at-Risk Disclosure. We utilize a Value-at-Risk model to determine the potential earning/fair value exposures presented by our foreign currency related financial instruments. As discussed above, we seek to minimize this exposure through our hedging program. Our Value-at-Risk computation is based on the Monte Carlo simulation, utilizing a 95% confidence interval and a holding period of 30 days. As of January 1, 2023, this computation estimated that there is a 5% chance that the market value of the underlying exposures and the corresponding derivative instruments either increase or decrease due to foreign currency fluctuations by more than $3.1 million. This Value-At-Risk measure is consistent with our financial statement disclosures relative to our foreign currency hedging program. Specifically, during each of the four quarters ended in fiscal year 2022, the Value-At-Risk ranged between $1.3 million and $3.1 million, with an average of approximately $2.1 million.
Interest Rate Risk. As of January 1, 2023, we had no outstanding borrowings under our senior unsecured revolving credit facility. Amounts drawn under our senior unsecured revolving credit facility bear interest at variable rates; all of our other debt bear interest at fixed rates. Our cash and cash equivalents from continuing operations, for which we receive interest at variable rates, were $454.4 million at January 1, 2023. Fluctuations in interest rates can therefore have a direct impact on both our short-term cash flows, as they relate to interest, and our earnings. To manage the volatility relating to these exposures, we periodically enter into various derivative transactions pursuant to our policies to hedge against known or forecasted interest rate exposures. However, no such instruments are outstanding at January 1, 2023.

Interest Rate Risk—Sensitivity. Our current earnings exposure for changes in interest rates can be summarized as follows:
(i) Changes in interest rates can cause our interest expense and cash flows to fluctuate to the extent we have borrowing outstanding on our revolving credit facility.
(ii) Changes in interest rates can cause our interest income and cash flows to fluctuate.
We believe that we do not have any material exposure of interest rate risk.
45
Table of Contents

Item 8.    Financial Statements and Supplemental Data
 
TABLE OF CONTENTS
 

46
Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Stockholders and the Board of Directors of PerkinElmer, Inc.

Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of PerkinElmer, Inc. and subsidiaries (the “Company”) as of January 1, 2023 and January 2, 2022 and the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period ended January 1, 2023 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of January 1, 2023 and January 2, 2022, and the results of its operations and its cash flows for each of the three years in the period ended January 1, 2023, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s internal control over financial reporting as of January 1, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March 1, 2023 expressed an unqualified opinion on the Company’s internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Discontinued Operations - Refer to Notes 1 and 4 to the financial statements
Critical Audit Matter Description
In August 2022, the Company entered into a definitive agreement to sell certain assets and the equity interests of certain entities constituting the Analytical, Food and Enterprise Services businesses (the “Business”). At that time, management determined that the proposed sale met the criteria for the Business to be classified as held-for-sale and the results of operations and cashflows of the Business was presented as discontinued operations for all periods presented in accordance with Accounting Standard Codification 205-20, Discontinued Operations (“ASC 205-20”).
The net assets of the Business were $1.42 billion and $1.40 billion as of January 1, 2023 and January 2, 2022, respectively.

Given the level of operational and financial integration between the Business and the continuing operations of the Company, auditing the segregation of assets and liabilities of the Business and the identification of the results of operation and cashflows of the Business required both extensive audit effort and a high degree of auditor judgment.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to the identification and measurement of the net assets of the Business and the related results of operations and cashflows presented as discontinued operations included the following, among others:
•We tested the effectiveness of controls over the identification of the net assets, results of operations and cash flows included in the Company’s discontinued operations presentation.
•We obtained and read the purchase and sale agreement for the proposed sale and compared the terms of that agreement to the identification of the assets and liabilities included in the disposal group.
•We assessed the Company’s identification of assets and liabilities and the related operations and cash flows of the Business by testing the completeness and accuracy of the Company’s accounting data and schedules that segregate the Business from the continuing operations of the Company.
•We assessed the presentation and disclosures related to the discontinued operations to ensure proper application of ASC 205-20.


/s / DELOITTE & TOUCHE LLP

Boston, Massachusetts
March 1, 2023

We have served as the Company’s auditor since 2002.



47
Table of Contents

CONSOLIDATED STATEMENTS OF OPERATIONS
 


January 1,
2023		January 2,
2022		January 3,
2021
(In thousands, except per share data)
Revenue
Product revenue$2,634,582 $2,735,068 $2,280,853 
Service revenue677,240 1,092,740 382,377 
Total revenue3,311,822 3,827,808 2,663,230 
Cost of product revenue1,150,402 1,129,223 794,405 
Cost of service revenue171,590 264,598 138,646 
Selling, general and administrative expenses1,025,514 975,193 716,465 
Research and development expenses221,617 200,337 146,441 
Operating income from continuing operations742,699 1,258,457 867,273 
Interest and other expense, net90,862 54,875 67,201 
Income from continuing operations before income taxes651,837 1,203,582 800,072 
Provision for income taxes139,161 314,146 169,512 
Income from continuing operations512,676 889,436 630,560 
Income from discontinued operations before income taxes73,604 76,304 106,292 
Loss on disposition of discontinued operations before income taxes— — (76)
Provision for income taxes on discontinued operations17,101 22,583 8,889 
Income from discontinued operations56,503 53,721 97,327 
Net income$569,179 $943,157 $727,887 
Basic earnings per share:
Income from continuing operations$4.06 $7.66 $5.65 
Income from discontinued operations0.45 0.46 0.87 
Net income$4.51 $8.12 $6.52 
Diluted earnings per share:
Income from continuing operations$4.06 $7.62 $5.63 
Income from discontinued operations0.45 0.46 0.87 
Net income$4.50 $8.08 $6.49 

The accompanying notes are an integral part of these consolidated financial statements.
48
Table of Contents

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 

 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Net income$569,179 $943,157 $727,887 
Other comprehensive (loss) income
Foreign currency translation adjustments, net of tax(284,854)(130,873)169,500 
Unrecognized prior service credit (cost), net of tax44 (95)(1,799)
Unrealized gains (losses) on securities, net of tax5 237 (16)
Other comprehensive (loss) income (284,805)(130,731)167,685 
Comprehensive income$284,374 $812,426 $895,572 
 







































The accompanying notes are an integral part of these consolidated financial statements.


49
Table of Contents

CONSOLIDATED BALANCE SHEETS
 

 
January 1,
2023		January 2,
2022
(In thousands, except share
and per share data)
Current assets:
Cash and cash equivalents$454,358 $603,320 
Accounts receivable, net612,780 707,941 
Inventories405,462 425,890 
Other current assets122,254 148,255 
Current assets of discontinued operations1,693,704 555,374 
Total current assets3,288,558 2,440,780 
Property, plant and equipment, net482,950 485,531 
Operating lease right-of-use assets188,351 164,040 
Intangible assets, net3,377,174 3,821,847 
Goodwill6,481,768 6,627,119 
Other assets, net311,054 317,069 
Long-term assets of discontinued operations— 1,144,168 
Total assets$14,129,855 $15,000,554 
Current liabilities:
Current portion of long-term debt$470,929 $4,240 
Accounts payable272,826 324,811 
Accrued expenses and other current liabilities527,863 679,099 
Current liabilities of discontinued operations272,865 205,594 
Total current liabilities1,544,483 1,213,744 
Long-term debt3,923,347 4,979,737 
Deferred taxes and other long-term liabilities1,109,181 1,426,731 
Operating lease liabilities169,968 147,395 
Long-term liabilities of discontinued operations— 91,702 
Total liabilities6,746,979 7,859,309 
Commitments and contingencies (see Note 16)
Stockholders’ equity:
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding— — 
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 126,300,000 and 126,241,000 shares at January 1, 2023 and January 2, 2022, respectively126,300 126,241 
Capital in excess of par value2,753,055 2,760,522 
Retained earnings4,951,018 4,417,174 
Accumulated other comprehensive loss(447,497)(162,692)
Total stockholders’ equity7,382,876 7,141,245 
Total liabilities and stockholders’ equity$14,129,855 $15,000,554 
 
The accompanying notes are an integral part of these consolidated financial statements.
50
Table of Contents

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Common
Stock
Shares		Common
Stock
Amount		Capital in
Excess of
Par Value		Retained
Earnings		Accumulated
Other
Comprehensive
Income (Loss)		Total
Stockholders’
Equity
(In thousands)
Balance, December 30, 2019111,140 $111,140 $90,357 $2,811,973 $(199,646)$2,813,824 
Impact of adopting ASU 2016-13— — — (1,328)— (1,328)
Net income— — — 727,887 — 727,887 
Other comprehensive income— — — — 167,685 167,685 
Dividends— — — (31,270)— (31,270)
Exercise of employee stock options764 764 36,907 — — 37,671 
Issuance of common stock for employee stock purchase plans39 39 4,062 — — 4,101 
Purchases of common stock(72)(72)(6,872)— — (6,944)
Issuance of common stock for long-term incentive program219 219 19,985 — — 20,204 
Stock-based compensation— — 3,662 — — 3,662 
Balance, January 3, 2021112,090 $112,090 $148,101 $3,507,262 $(31,961)$3,735,492 
Net income— — — 943,157 — 943,157 
Other comprehensive loss— — — — (130,731)(130,731)
Dividends— — — (33,245)— (33,245)
Issuance of common stock for business combination, net of issuance costs14,067 14,067 2,624,077 — — 2,638,144 
Exercise of employee stock options 358 358 24,762 — — 25,120 
Issuance of common stock for employee benefit plans21 21 3,607 — — 3,628 
Purchases of common stock(504)(504)(72,568)— — (73,072)
Issuance of common stock for long-term incentive program209 209 26,292 — — 26,501 
Stock compensation— — 6,251 — — 6,251 
Balance, January 2, 2022126,241 $126,241 $2,760,522 $4,417,174 $(162,692)$7,141,245 
Net income— — — 569,179 — 569,179 
Other comprehensive loss— — — — (284,805)(284,805)
Dividends— — — (35,335)— (35,335)
Exercise of employee stock options195 195 13,919 — — 14,114 
Issuance of common stock for employee stock purchase plans31 31 4,141 — — 4,172 
Purchases of common stock(493)(493)(80,145)— — (80,638)
Issuance of common stock for long-term incentive program326 326 44,235 — — 44,561 
Stock-based compensation— — 10,383 — — 10,383 
Balance, January 1, 2023126,300 $126,300 $2,753,055 $4,951,018 $(447,497)$7,382,876 
 The accompanying notes are an integral part of these consolidated financial statements.
51
Table of Contents

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Fiscal Years Ended


January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Operating activities:
Net income$569,179 $943,157 $727,887 
Income from discontinued operations(56,503)(53,721)(97,327)
Income from continuing operations512,676 889,436 630,560 
Adjustments to reconcile income from continuing operations to net cash provided by continuing operations:
Restructuring and other costs, net13,580 14,358 7,661 
Depreciation and amortization427,000 311,443 201,648 
Stock-based compensation51,518 29,675 26,904 
Pension and other post-retirement (income) expense(23,104)(28,509)14,904 
Change in fair value of contingent consideration(1,377)3,119 (8,827)
Deferred taxes(105,923)(55,328)(35,338)
Contingencies and non-cash tax matters(1,488)1,924 4,518 
Amortization of deferred debt issuance costs and accretion of discounts7,310 4,962 3,391 
(Gain) loss on disposition of businesses and assets, net(2,887)(1,970)886 
Amortization of acquired inventory revaluation45,289 35,201 1,831 
Asset impairment— 3,868 7,937 
Change in fair value of financial securities15,754 (10,985)(35)
Debt extinguishment gain(2,880)— — 
Changes in assets and liabilities which provided (used) cash, excluding effects from companies acquired:
Accounts receivable, net66,093 165,590 (398,853)
Inventories(48,634)32,280 (127,357)
Accounts payable(43,804)(7,577)63,231 
Accrued expenses and other(236,623)(57,303)311,659 
Net cash provided by operating activities of continuing operations672,500 1,330,184 704,720 
Net cash provided by operating activities of discontinued operations7,310 80,566 187,457 
Net cash provided by operating activities679,810 1,410,750 892,177 
Investing activities:
Capital expenditures(85,632)(86,020)(63,634)
Purchases of investments(47,181)(23,130)(20,059)
Proceeds from notes receivables8,890 — — 
Proceeds from disposition of businesses and assets14,505 1,460 4,280 
Proceeds from surrender of life insurance policies— 109 282 
Cash paid for acquisitions, net of cash acquired(7,518)(3,982,216)(411,495)
Net cash used in investing activities of continuing operations(116,936)(4,089,797)(490,626)
Net cash used in investing activities of discontinued operations(15,915)(22,961)(13,872)
52
Table of Contents

January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Net cash used in investing activities(132,851)(4,112,758)(504,498)
Financing activities:
Payments on borrowings(240,000)(1,559,133)(897,674)
Proceeds from borrowings240,000 1,400,282 714,698 
Proceeds from term loan— 500,000 — 
Payments of term loan(500,000)— — 
Payments of senior unsecured notes(57,876)(339,605)— 
Proceeds from sale of senior unsecured notes— 3,086,095 — 
Payments of debt financing and equity issuance costs— (30,983)— 
Payments on other credit facilities(1,292)(13,670)(4,494)
Settlement of cash flow hedges(762)(4,482)(4,554)
Settlement of swaps— (14,314)— 
Payments for acquisition-related contingent consideration(5)(2,208)(10,363)
Proceeds from issuance of common stock under stock plans14,114 25,120 37,671 
Purchases of common stock(80,638)(73,072)(6,944)
Dividends paid(35,344)(32,373)(31,212)
Net cash (used in) provided by financing activities(661,803)2,941,657 (202,872)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(33,747)(22,926)25,913 
Net (decrease) increase in cash, cash equivalents and restricted cash(148,591)216,723 210,720 
Cash, cash equivalents and restricted cash at beginning of year619,337 402,614 191,894 
Cash, cash equivalents and restricted cash at end of year$470,746 $619,337 $402,614 
Supplemental disclosures of cash flow information
Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total shown in the consolidated statements of cash flows:
Cash and cash equivalents$454,358 $603,320 $387,054 
Restricted cash included in other current assets1,040 1,018 578 
Restricted cash included in other assets349 — — 
Cash and cash equivalents included in current assets of discontinued operations14,999 14,999 14,982 
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows$470,746 $619,337 $402,614 
Cash paid during the year for:
Interest$97,934 $54,120 $42,142 
Income taxes323,077 364,565 162,454 
Supplemental disclosures of non-cash investing and financing activities:
Equity issued for business combination, net of issuance costs$— $2,638,144 $— 


The accompanying notes are an integral part of these consolidated financial statements.
53
Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
Note 1:    Nature of Operations and Accounting Policies
Nature of Operations:    PerkinElmer, Inc. is a leading provider of products, services and solutions to the diagnostics and life sciences and applied markets. The Company has two operating segments: Discovery & Analytical Solutions and Diagnostics. The Company’s Discovery & Analytical Solutions segment focuses on service and innovating for customers spanning the life sciences and applied markets. The Company’s Diagnostics segment is targeted towards meeting the needs of clinically-oriented customers, especially within the growing areas of reproductive health, emerging market diagnostics and applied genomics.
The consolidated financial statements include the accounts of PerkinElmer, Inc. and its subsidiaries (the “Company”). All intercompany balances and transactions have been eliminated in consolidation. In August 2022, the Company announced the proposed sale of certain assets and the equity interests of certain entities constituting the Company’s Analytical, Food and Enterprise Services businesses (the “Business”). The 2021 and 2020 consolidated financial statements presented herein have been retrospectively adjusted to present the Business as discontinued operations for all periods presented.
The Company’s fiscal year ends on the Sunday nearest December 31. The Company reports fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. Each of the fiscal years ended January 1, 2023 (“fiscal year 2022”) and January 2, 2022 (“fiscal year 2021”) included 52 weeks. The fiscal year ended January 3, 2021 (“fiscal year 2020”) included 53 weeks. The fiscal year ending December 31, 2023 (“fiscal year 2023”) will include 52 weeks.
Accounting Policies and Estimates: The preparation of consolidated financial statements in accordance with United States (“U.S.”) Generally Accepted Accounting Principles (“GAAP”) requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
Revenue Recognition: The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for the promised products or services when a performance obligation is satisfied by transferring control of those products or services to customers.
Taxes that are collected by the Company from a customer and assessed by a governmental authority, that are both imposed on and concurrent with a specific revenue-producing transaction, are excluded from revenue.
The Company reports shipping and handling revenue in revenue, to the extent it is billed to customers, and the associated costs in cost of product revenue.
Inventories: Inventories, which include material, labor and manufacturing overhead, are valued at the lower of cost or market. Inventories are accounted for using the first-in, first-out method of determining inventory costs. Inventory quantities on-hand are regularly reviewed, and where necessary, provisions for excess and obsolete inventory are recorded based primarily on the Company’s estimated forecast of product demand and production requirements.
Income Taxes: The Company uses the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. This method also requires the recognition of future tax benefits such as net operating loss carryforwards, to the extent that realization of such benefits is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established for any deferred tax asset for which realization is not more likely than not.
The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions and other issues. These reserves are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. Potential interest and penalties associated with such uncertain tax positions is recorded as a component of income tax expense.
54
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Property, Plant and Equipment: The Company depreciates property, plant and equipment using the straight-line method over its estimated useful lives, which generally fall within the following ranges: buildings- 10 to 40 years; leasehold improvements - estimated useful life or remaining term of lease, whichever is shorter; and machinery and equipment- 3 to 8 years. Certain tooling costs are capitalized and amortized over a 3-year life, while repairs and maintenance costs are expensed.
Pension and Other Postretirement Benefits: The Company sponsors both funded and unfunded U.S. and non-U.S. defined benefit pension plans and other postretirement benefits. The Company immediately recognizes actuarial gains and losses in operating results in the year in which the gains and losses occur. Actuarial gains and losses are measured annually as of the calendar month-end that is closest to the Company's fiscal year end and accordingly will be recorded in the fourth quarter, unless the Company is required to perform an interim remeasurement. The remaining components of pension expense, primarily service and interest costs and assumed return on plan assets, are recorded on a quarterly basis. The Company’s funding policy provides that payments to the U.S. pension trusts shall at least be equal to the minimum funding requirements of the Employee Retirement Income Security Act of 1974. Non-U.S. plans are accrued for, but generally not fully funded, and benefits are paid from operating funds.
Translation of Foreign Currencies: For foreign operations, asset and liability accounts are translated at current exchange rates; income and expenses are translated using weighted average exchange rates for the reporting period. Resulting translation adjustments, as well as translation gains and losses from certain intercompany transactions considered permanent in nature, are reported in accumulated other comprehensive income (“AOCI”), a separate component of stockholders’ equity. Gains and losses arising from transactions and translation of period-end balances denominated in currencies other than the functional currency are included in other expense, net.
Business Combinations: Business combinations are accounted for at fair value. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses. Measurement period adjustments are made in the period in which the amounts are determined and the current period income effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition date. All changes that do not qualify as measurement period adjustments are also included in current period earnings. The accounting for business combinations requires estimates and judgment as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of finite-lived intangible assets, or the recognition of additional consideration which would be expensed.
Goodwill and Other Intangible Assets:  The Company’s intangible assets consist of (i) goodwill, which is not being amortized; (ii) indefinite lived intangibles, which consist of a trade name that is not subject to amortization; and (iii) amortizing intangibles, which consist of patents, trade names and trademarks, licenses, customer relationships and purchased technologies, which are being amortized over their estimated useful lives.
The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. This annual impairment assessment is performed by the Company on the later of January 1 or the first day of each fiscal year. Indefinite-lived intangibles are also subject to an annual impairment test. The impairment test consists of a comparison of the fair value of the indefinite-lived intangible asset with its carrying amount. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of the amortizing intangible asset. Amortizing intangible assets are reviewed for impairment when indicators of impairment are present. When a potential impairment has been identified, forecasted undiscounted net cash flows of the operations to which the asset relates are compared to the current carrying value of the long-lived assets present in that operation. If such cash flows are less than such carrying amounts, long-lived assets, including such intangibles, are written down to their respective fair values.
Stock-Based Compensation: The Company accounts for stock-based compensation expense based on estimated grant date fair value, generally using the Black-Scholes option-pricing model. The fair value is recognized as expense in the consolidated financial statements over the requisite service period. The determination of fair value and the timing of expense using option pricing models such as the Black-Scholes model require the input of subjective assumptions, including the expected term and the expected price volatility of the underlying stock. The Company estimates the expected term assumption based on historical
55
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
experience. In determining the Company’s expected stock price volatility assumption, the Company reviews both the historical and implied volatility of the Company’s common stock.
 Marketable Securities and Investments:  Investments in debt securities that are classified as available for sale are recorded at fair value with unrealized gains and losses included in AOCI until realized. Investments in equity securities are recorded at their fair values with unrealized holding gains and losses included in earnings. Investments in equity securities without a readily determinable fair value are carried at cost minus impairment, if any. When an observable price change in orderly transactions for the identical or a similar investment of the same issuer has occurred, the Company elects to carry those equity investments at fair value as of the date that the observable transaction occurred.
Cash and Cash Equivalents: The Company considers all highly liquid, unrestricted instruments with a purchased maturity of three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value due to the short maturities of these instruments.
Environmental Matters: The Company accrues for costs associated with the remediation of environmental pollution when it is probable that a liability has been incurred and the Company’s proportionate share of the amount can be reasonably estimated. The recorded liabilities have not been discounted.
 Research and Development: Research and development costs are expensed as incurred. In-process research and development (“IPRD”) costs acquired in a business combination are recorded at fair value as an intangible asset at the acquisition date and amortized once the product is ready for sale or expensed if abandoned.
Restructuring and Other Costs: Generally, costs associated with an exit or disposal activity are recognized when the liability is incurred. Prior to recording restructuring charges for employee separation agreements, the Company notifies all employees of termination. Costs related to employee separation arrangements requiring future service beyond a specified minimum retention period are recognized over the service period.
Comprehensive Income:  Comprehensive income is defined as net income or loss and other changes in stockholders’ equity from transactions and other events from sources other than stockholders. Comprehensive income is reflected in the consolidated statements of comprehensive income.
Derivative Instruments and Hedging: Derivatives are recorded on the consolidated balance sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.
For a cash flow hedge, the effective portion of the derivative’s gain or loss is initially reported as a component of other comprehensive income and subsequently amortized into net earnings when the hedged exposure affects net earnings. Cash flow hedges related to anticipated transactions are designated and documented at the inception of each hedge by matching the terms of the contract to the underlying transaction. The Company classifies the cash flows from hedging transactions in the same categories as the cash flows from the respective hedged items. Once established, cash flow hedges are generally recorded in other comprehensive income, unless an anticipated transaction is no longer likely to occur, and subsequently amortized into net earnings when the hedged exposure affects net earnings. Discontinued or dedesignated cash flow hedges are immediately settled with counterparties, and the related accumulated derivative gains or losses are recognized into net earnings on the consolidated financial statements. Settled cash flow hedges related to forecasted transactions that remain probable are recorded as a component of other comprehensive (loss) income and are subsequently amortized into net earnings when the hedged exposure affects net earnings. Forward contract effectiveness for cash flow hedges is calculated by comparing the fair value of the contract to the change in value of the anticipated transaction using forward rates on a monthly basis. The Company also has entered into other foreign currency forward contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into interest and other expense, net on the consolidated financial statements.
The Company also uses foreign currency denominated debt to hedge its investments in certain foreign subsidiaries. Realized and unrealized translation adjustments from these hedges are included in the foreign currency translation component of AOCI, as well as the offset translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold.
Leases: Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities, and operating lease liabilities in the Company's consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining lease payments over the lease term. When the Company’s lease did not provide an implicit rate, the Company used its incremental
56
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
borrowing rate in determining the present value of lease payments. The Company used the implicit rate when readily determinable. The operating lease ROU asset excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as cars, the Company accounts for the lease and non-lease components as a single lease component.
The Company has made an accounting policy election not to recognize ROU assets and lease liabilities that arise from short-term leases for facilities and equipment. Instead, the Company recognizes the lease payments in the consolidated statements of operations on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred.
As a lessor, the Company applies the practical expedient to not separate non-lease components from the associated lease component and instead accounts for those components as a single component if the non-lease components otherwise would be accounted for under Accounting Standards Codification 606, Revenue From Contracts With Customers (“ASC 606”), and both of the following criteria are met: 1) the timing and pattern of transfer of the non-lease component or components and associated lease component are the same; and 2) the lease component, if accounted for separately, would be classified as an operating lease. If the non-lease component or components associated with the lease component are the predominant component of the combined component, the Company accounts for the combined component in accordance with ASC 606. Otherwise, the Company accounts for the combined component as an operating lease in accordance with Accounting Standards Codification 842, Leases (“ASC 842”).
Recently Issued Accounting Pronouncements: From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the “FASB”) and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations.
In October 2021, the FASB issued Accounting Standards Update 2021-08, Accounting for Contract Assets and Contract Liabilities From Contracts With Customers (“ASU 2021-08”). ASU 2021-08 amends Accounting Standards Codification 805, Business Combinations (“ASC 805”), to require acquiring entities to apply ASC 606 to recognize and measure contract assets and contract liabilities in a business combination. Under ASC 805, an acquirer generally recognizes such items at fair value on the acquisition date. The Company adopted the guidance beginning on January 2, 2023 and will apply the guidance on business combinations beginning in fiscal year 2023.

Note 2:        Revenue
For arrangements with multiple performance obligations, the Company accounts for individual products and services separately if they are distinct - i.e., if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their stand-alone selling prices. The stand-alone selling prices are determined based on the prices at which the Company separately sells the products, extended warranties, and services. For items that are not sold separately, the Company estimates stand-alone selling prices by reference to the amount charged for similar items on a stand-alone basis.
The Company sells products and services predominantly through its direct sales force. As a result, the use of distributors is generally limited to geographic regions where the Company has no direct sales force. The Company does not offer product return or exchange rights (other than those relating to defective goods under warranty) or price protection allowances to its customers, including distributors. Payment terms granted to distributors are the same as those granted to end-customers and payments are not dependent upon the distributor's receipt of payment from their end-user customers.
In instances where the timing of revenue recognition differs from the timing of invoicing, the Company determined that the contracts generally do not include a significant financing component. The primary purpose of its invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, rather than to receive financing from the customers or to provide customers with financing. Examples include invoicing at the beginning of a subscription term with revenue recognized ratably over the contract period, and multi-year software licenses or software subscriptions that are invoiced annually with revenue recognized upfront. In limited circumstances where the Company provides the customer with a
57
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
significant benefit of financing, the Company uses the practical expedient and only adjusts the transaction price for the effects of the time value of money and only on contracts where the duration of financing is more than one year.
Nature of goods and services
The Discovery & Analytical Solutions segment of the Company principally generates revenue from sales of instruments, reagents, informatics, software, subscriptions, detection and imaging technologies, extended warranties, training and services in the life sciences market and instruments, consumables and services in the applied markets. The Diagnostics segment of the Company principally generates revenue from sales of instruments, solutions, consumables, reagents, extended warranties and services in the diagnostics market. Products and services may be sold separately or in bundled packages. The typical length of a contract for service is 12 to 36 months.
The revenue generated from the sale of instruments, consumables, reagents, and certain software is recognized at a point in time. The Company recognizes revenue in these arrangements at the point in time when control of the products has been transferred to customers, which is typically at delivery. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. When the Company places the instrument at the customer's site and sells the reagents to a customer, the instrument and reagents are accounted for together as one performance obligation. The Company does not charge a fee for the use of the instrument and retains ownership of the placed instrument. The Company has a right to remove the instrument and replace it with another instrument at the customer’s site at any time throughout the contract term. The Company recognizes revenue upon delivery of reagents, which is the point in time where the Company has performed its obligation to provide a screening solution to the customer. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
The revenue generated from the sale of licenses for software as a service, cloud services, subscriptions, extended warranties, and laboratory services and training is recognized over time. Term licenses, subscriptions and cloud services, are generally recognized ratably over the contract period or based upon consumption. The Company sells its software subscriptions and cloud services with maintenance services and, in some cases, with consulting services. The Company recognizes revenue for the software commencing when the service is made available to the customer. For maintenance and consulting services, revenue is recognized ratably over the period in which the services are provided. Revenue for laboratory services is recognized over the contract period or when the service is billable, based on time and materials. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
Product revenue is recognized at a point in time and all service revenue is recognized over time.
Disaggregation of revenue
In the following tables, revenue is disaggregated by primary geographical market, end-markets and timing of revenue recognition.
Reportable Segments
For the fiscal year ended
January 1, 2023January 2, 2022January 3, 2021
Discovery & Analytical SolutionsDiagnosticsTotalDiscovery & Analytical SolutionsDiagnosticsTotalDiscovery & Analytical SolutionsDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$683,170 $979,473 $1,662,643 $444,459 $1,362,213 $1,806,672 $286,354 $750,641 $1,036,995 
Europe297,468 534,343 831,811 234,334 982,476 1,216,810 157,277 864,687 1,021,964 
Asia312,271 505,097 817,368 217,076 587,250 804,326 152,657 451,614 604,271 
$1,292,909 $2,018,913 $3,311,822 $895,869 $2,931,939 $3,827,808 $596,288 $2,066,942 $2,663,230 
Primary end-markets
Diagnostics$— $2,018,913 $2,018,913 $— $2,931,939 $2,931,939 $— $2,066,942 $2,066,942 
Life sciences1,292,909 — 1,292,909 895,869 — 895,869 596,288 — 596,288 
$1,292,909 $2,018,913 $3,311,822 $895,869 $2,931,939 $3,827,808 $596,288 $2,066,942 $2,663,230 
58
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Major Customer Concentration
Revenues from one customer in the Company’s Diagnostics segment represent approximately $330.7 million, $638.6 million and $97.8 million of the Company’s total revenue during the fiscal years 2022, 2021 and 2020, respectively.
Contract Balances
Contract assets: The unbilled receivables (contract assets) primarily relate to the Company’s right to consideration for work completed but not billed at the reporting date. The unbilled receivables are transferred to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in “Accounts receivable, net” in the consolidated balance sheets.
Contract liabilities: The contract liabilities primarily relate to the advance consideration received from customers for products and related services for which transfer of control has not occurred at the balance sheet date. Contract liabilities are classified as either current in “Accounts payable” or “Accrued expenses and other current liabilities” or as long-term in “Long-term liabilities” in the consolidated balance sheets based on the timing of when the Company expects to recognize revenue. The contract liability balances at the beginning of each period presented were generally fully recognized in the subsequent three month period.
Contract balances were as follows:
January 1, 2023January 2, 2022
(In thousands)
Contract assets$56,631 $61,999 
Contract liabilities$(30,133)$(184,897)

Note 3:        Business Combinations
Acquisitions in fiscal year 2022
During fiscal year 2022, the Company completed the acquisition of two businesses for aggregate consideration of $13.3 million. Identifiable definite-lived intangible assets, such as core technology, acquired as part of these acquisitions had a weighted average amortization period of 5 years.
Acquisitions in fiscal year 2021
Acquisition of BioLegend, Inc. In fiscal year 2021, the Company completed the acquisition of BioLegend, Inc. (“BioLegend”) and paid an aggregate consideration of $5.7 billion, net of cash acquired of $292.4 million, reflecting working capital and other adjustments (the “Aggregate Consideration”). The Aggregate Consideration was paid in a combination of $3.3 billion in cash and shares of the Company’s common stock having a fair value of approximately $2.6 billion based on the $187.56 per share closing price of the Company's common stock on the New York Stock Exchange on September 17, 2021 (the “Stock Consideration”). The Stock Consideration consisted of 14,066,799 shares of the Company’s common stock. BioLegend is recognized as a leading, global provider of life science antibodies and reagents headquartered in San Diego, California, with approximately 700 employees. The operations for this acquisition is reported within the results of the Company’s Discovery & Analytical Solutions segment from the acquisition date. The excess of the purchase price over the fair value of the acquired net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforce acquired, and is not tax deductible. Identifiable definite-lived intangible assets, such as core technology, trade names, customer relationships and clone library, acquired as part of this acquisition had a weighted-average amortization period of 16.3 years.
BioLegend’s revenue and net loss for the period from the acquisition date to January 2, 2022 were $91.7 million and $25.8 million, respectively. The net loss includes $47.0 million of amortization of acquired intangible assets. The following unaudited pro forma information presents the combined financial results for the Company and BioLegend as if the acquisition of BioLegend had been completed at the beginning of fiscal year 2020:
59
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
January 2,
2022		January 3,
2021
(In thousands, except per share data)
Pro Forma Statement of Operations Information:
Revenue$4,056,122 $2,905,116 
Income from continuing operations947,387 454,034 
Basic earnings per share:
Income from continuing operations$7.27 $3.62 
Diluted earnings per share:
Income from continuing operations$7.25 $3.60 
The unaudited pro forma information for fiscal year 2021 has been calculated after applying the Company’s accounting policies and the impact of acquisition date fair value adjustments. The fiscal year 2021 unaudited pro forma income from continuing operations was adjusted to exclude approximately $43.2 million of acquisition-related transaction costs and $23.3 million of costs of bridge financing and debt pre-issuance hedges that were recognized in expense during fiscal year 2021. The fiscal year 2020 unaudited pro forma income from continuing operations was adjusted to include these acquisition-related transaction costs and the nonrecurring expenses related to the bridge financing and debt pre-issuance hedging costs and fair value adjustments as if those expenses were incurred in fiscal year 2020. These pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments, such as fair value adjustment to inventory, increased interest expense on debt obtained to finance the transaction, and increased amortization for the fair value of acquired intangible assets.
The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of each period presented, or of future results of the consolidated entities. The actual results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors.
Other acquisitions in 2021. During fiscal year 2021, the Company also completed the acquisition of seven other businesses for aggregate consideration of $1.2 billion. The acquired businesses include Oxford Immunotec Global PLC, a company based in Abingdon, UK with approximately 275 employees, for total consideration of $590.9 million and Nexcelom Bioscience Holdings, LLC, a company based in Lawrence, Massachusetts with approximately 130 employees, for total consideration of $267.3 million, and five other businesses, which were acquired for total consideration of $318.6 million. The excess of the purchase prices over the fair values of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as employee workforces acquired, and has been allocated to goodwill, which is not tax deductible. Identifiable definite-lived intangible assets, such as core technology, trade names, and customer relationships, acquired as part of these acquisitions had a weighted-average amortization period of 12.4 years.
60
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The total purchase price for the acquisitions in fiscal year 2021 has been allocated to the estimated fair value of assets acquired and liabilities assumed as follows:
Final
BioLegendOther
(In thousands)
Fair value of business combinations:
Cash payments$3,336,115 $1,128,584 
Common stock issued2,638,369 — 
Other liability6,857 2,910 
Contingent consideration— 45,031 
Working capital and other adjustments— 183 
Less: cash acquired(292,377)(195,010)
Total$5,688,964 $981,698 
Identifiable assets acquired and liabilities assumed:
Current assets$184,704 $71,840 
Property, plant and equipment147,200 26,507 
Other assets9,330 15,527 
Identifiable intangible assets:
Core technology and clone library782,400 290,089 
Trade names and patents38,000 39,476 
Licenses8,979 — 
Customer relationships and backlog1,714,800 141,670 
Goodwill3,509,931 545,262 
Deferred taxes(668,919)(80,923)
Deferred revenue— (1,197)
Debt assumed— (4,628)
Liabilities assumed(37,461)(61,925)
Total$5,688,964 $981,698 
The Company does not consider the other acquisitions completed during fiscal year 2021 to be material to its consolidated results of operations; therefore, the Company is only presenting pro forma financial information of operations for the BioLegend acquisition. The aggregate revenue and results of operations for the other acquisitions completed during fiscal year 2021 for the period from their respective acquisition dates to January 2, 2022 were not material.
Acquisitions in fiscal year 2020
During fiscal year 2020, the Company completed the acquisition of four businesses for aggregate consideration of $438.9 million. The acquired businesses were Horizon Discovery Group plc, a company based in Cambridge, UK with approximately 400 employees, which was acquired on December 23, 2020 for a total consideration of $399.8 million (£296.0 million), and three other businesses which were acquired for a total consideration of $39.1 million. The excess of the purchase prices over the fair values of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforces acquired, and has been allocated to goodwill, which is not tax deductible. Identifiable definite-lived intangible assets, such as core technology, trade names, customer relationships and in-process research and development, acquired as part of these acquisitions had a weighted average amortization period of 11 years.
61
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The total purchase price for the acquisitions in fiscal year 2020 has been allocated to the estimated fair value of assets acquired and liabilities assumed as follows:
Final
(In thousands)
Fair value of business combinations:
Cash payments$437,661 
Other liability1,660 
Working capital and other adjustments(384)
Less: cash acquired(26,840)
Total$412,097 
Identifiable assets acquired and liabilities assumed:
Current assets$35,532 
Property, plant and equipment20,302 
Other assets18,114 
Identifiable intangible assets:
Core technology65,730 
Trade names5,580 
Customer relationships and backlog108,523 
IPRD10,700 
Goodwill221,751 
Deferred taxes(25,674)
Deferred revenue(2,031)
Liabilities assumed(46,430)
Total$412,097 
The Company does not consider the acquisitions completed during fiscal year 2020 to be material to its consolidated results of operations. The aggregate revenue and results of operations for the acquisitions completed during fiscal year 2020 for the period from their respective acquisition dates to January 3, 2021 were not material.
As of January 1, 2023, the allocations of purchase prices for all acquisitions completed in fiscal years 2021 and 2020 were considered final.
During fiscal year 2022, the Company obtained information relevant to determining the fair values of certain tangible and intangible assets acquired, and liabilities assumed, related to recent acquisitions and adjusted its purchase price allocations. The adjustments to the preliminary measurements were not material.
The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair values for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash. Increases or decreases in the fair value of contingent consideration liabilities primarily result from changes in the estimated probabilities of achieving revenue thresholds or product development milestones during the earnout period.
As of January 1, 2023, the Company may have to pay contingent consideration, related to acquisitions with open contingency periods, of up to $106.2 million. As of January 1, 2023, the Company has recorded contingent consideration obligations of $46.6 million, of which $3.6 million was recorded in accrued expenses and other current liabilities, and $43.0 million was recorded in long-term liabilities. As of January 2, 2022, the Company had recorded contingent consideration obligations with an estimated fair value of $58.0 million, of which $1.3 million was recorded in accrued expenses and other current liabilities, and $56.7 million was recorded in long-term liabilities. The expected maximum earnout period for acquisitions with open contingency periods is 5.9 years from January 1, 2023, and the remaining weighted average expected
62
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
earnout period at January 1, 2023 was 4.9 years. If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the consolidated financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of definite-lived intangible assets or the recognition of additional contingent consideration which would be recognized as a component of operating expenses from continuing operations.
Total acquisition and divestiture-related costs were $39.8 million, $80.8 million and $4.9 million for fiscal years 2022, 2021 and 2020. These amounts included $26.5 million and $6.9 million of stock compensation expense related to awards given to BioLegend employees in fiscal years 2022 and 2021, respectively, $5.4 million of net foreign exchange gain and $23.4 million of costs of bridge financing and debt pre-issuance hedges related to the BioLegend acquisition in fiscal year 2021, and $0.5 million of acquisition-related interest expenses in fiscal year 2020. These acquisition and divestiture-related costs were expensed as incurred and recorded in selling, general and administrative expenses and interest and other expense, net in the Company’s consolidated statements of operations.

Note 4:        Discontinued Operations
As part of the Company’s continuing efforts to focus on higher growth opportunities, the Company has discontinued certain businesses. When the discontinued operations represented a strategic shift that will have a major effect on the Company’s operations and financial statements, the Company has accounted for these businesses as discontinued operations and accordingly, has presented the results of operations and related cash flows as discontinued operations.
In August 2022, the Company entered into a Master Purchase and Sale Agreement (the “Purchase Agreement”) with Polaris Purchaser, L.P. (the “Purchaser”), a Delaware limited partnership owned by funds managed by affiliates of New Mountain Capital L.L.C. (the “Sponsor”), under which the Company agreed to sell to the Purchaser certain assets and the equity interests of certain entities constituting the Company’s Analytical, Food and Enterprise Services businesses (the “Business”) (as further defined in the Purchase Agreement), for cash consideration of up to approximately $2.45 billion and the Purchaser’s assumption of certain liabilities relating to the Business (collectively, the “Transaction”). Approximately $2.30 billion of the purchase price will be payable at closing, subject to certain customary adjustments, which includes $75.0 million in deferred payments tied to the transfer of the PerkinElmer brand and related trademarks to the Purchaser (which may be completed within 24 months following the date of the closing at the Company’s election). The Purchase Agreement also provides for potential post-closing payments totaling up to $150.0 million, which are contingent on the exit valuation the Sponsor and its affiliated funds receive on a sale or other capital events related to the Business. The Transaction is expected to close in the first quarter of fiscal year 2023, subject to regulatory approvals and other customary closing conditions.
The Business had been recorded in the Discovery & Analytical Solutions segment. The sale of the Business represents a strategic shift that will have a major effect on the Company’s operations and financial statements. Accordingly, the Company has classified the assets and liabilities related to the Business as assets and liabilities of discontinued operations in the Company’s consolidated balance sheets and its results of operations are classified as income from discontinued operations in the Company’s consolidated statements of operations. Financial information in this report relating to fiscal years 2021 and 2020 has been retrospectively adjusted to reflect this discontinued operation.
The summary pre-tax operating results of the discontinued operations, were as follows:
 January 1, 2023January 2, 2022January 3, 2021
 (In thousands)
Revenue$1,298,376 $1,239,361 $1,119,515 
Cost of revenue859,330 822,048 739,817 
Selling, general and administrative expenses306,032 268,760 209,442 
Research and development expenses64,605 74,632 58,948 
Operating income68,409 73,921 111,308 
Other (income) expense, net(5,195)(2,383)5,016 
Income from discontinued operations before income taxes$73,604 $76,304 $106,292 
The carrying amounts of the major classes of assets and liabilities included in discontinued operations related to the Business consisted of the following:
63
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
January 1, 2023January 2, 2022
 (In thousands)
Cash and cash equivalents$14,999 $14,999 
Accounts receivable343,064 315,851 
Inventories210,367 198,824 
Other current assets32,063 25,700 
Total current assets555,374 
Property, plant and equipment, net60,983 60,074 
Operating lease right-of-use assets41,487 43,735 
Intangible assets, net202,850 241,257 
Goodwill772,812 789,465 
Other assets, net15,079 9,637 
    Total long-term assets
1,144,168 
Total assets of discontinued operations
$1,693,704 $1,699,542 
Accounts payable29,912 30,647 
Accrued expenses and other current liabilities161,260 174,947 
    Total current liabilities205,594 
Deferred taxes and long-term liabilities46,046 53,738 
Operating lease liabilities35,647 37,964 
    Total long-term liabilities91,702 
Total liabilities of discontinued operations$272,865 $297,296 
The following operating and investing non-cash items from discontinued operations were as follows for the fiscal years ended:
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Depreciation
$8,011 $12,897 $13,299 
Amortization
16,984 33,664 31,560 
Capital expenditures10,670 13,868 13,872 

Note 5:        Interest and Other Expense, Net
Interest and other expense, net, consisted of the following for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Interest income$(3,589)$(2,241)$(1,010)
Interest expense including costs of bridge financing103,955 102,128 49,712 
Change in fair value of financial securities15,754 (10,985)(35)
Other components of net periodic pension (credit) cost(33,158)(37,385)13,819 
Other expense, net7,900 3,358 4,715 
Total interest and other expense, net$90,862 $54,875 $67,201 


64
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Note 6:        Income Taxes
The components of income from continuing operations before income taxes were as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
U.S.$326,438 $547,705 $210,130 
Non-U.S.325,399 655,877 589,942 
Total$651,837 $1,203,582 $800,072 
The components of the provision for income taxes on continuing operations were as follows:
 
Current
Expense		Deferred 
Expense
(Benefit)		Total
(In thousands)
Fiscal year ended January 1, 2023
Federal$115,436 $(45,246)$70,190 
State27,757 (16,139)11,618 
Non-U.S.101,891 (44,538)57,353 
Total$245,084 $(105,923)$139,161 
Fiscal year ended January 2, 2022
Federal$154,905 $(37,858)$117,047 
State53,961 3,602 57,563 
Non-U.S.160,608 (21,072)139,536 
Total$369,474 $(55,328)$314,146 
Fiscal year ended January 3, 2021
Federal$39,878 $4,875 $44,753 
State15,469 (1,240)14,229 
Non-U.S.149,503 (38,973)110,530 
Total$204,850 $(35,338)$169,512 
The total provision for income taxes included in the consolidated financial statements is as follows for the fiscal years ended: 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Continuing operations$139,161 $314,146 $169,512 
Discontinued operations17,101 22,583 8,889 
Total$156,262 $336,729 $178,401 
 A reconciliation of income tax expense at the U.S. federal statutory income tax rate to the recorded tax provision is as follows for the fiscal years ended:
65
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Tax at statutory rate$136,886 $252,752 $168,015 
Non-U.S. rate differential, net(5,221)(33,847)(29,155)
U.S. taxation of multinational operations22,102 7,964 11,468 
State income taxes, net7,820 36,832 13,249 
Prior year tax matters(10,160)1,850 5,532 
Effect of stock compensation845 (2,187)(8,148)
General business tax credits(7,132)(2,715)(2,145)
Change in valuation allowance4,964 (179)(369)
Rate change on long term intangibles— 14,031 — 
Effect of foreign repatriations(4,940)37,147 — 
Foreign consolidations— — 15,222 
Other, net(6,003)2,498 (4,157)
Total$139,161 $314,146 $169,512 
The variation in the Company’s effective tax rate for fiscal year 2021 is primarily affected by the recognition of $37.1 million in U.S. federal, U.S. state and non-U.S. taxes related to foreign earnings that the Company no longer considered indefinitely reinvested. During fiscal year 2022, the Company adjusted these estimates and recognized a net benefit of $4.9 million relative to its position to permanently reinvest those foreign earnings.
The Company also recognized $1.1 million of benefit in fiscal year 2022 derived from the tax holiday in Singapore. The Company recognized $18.2 million in fiscal year 2021 and $12.7 million in fiscal year 2020 of benefits derived from tax holidays in China and Singapore. The effect of these benefits, derived from tax holidays, on basic and diluted earnings per share for fiscal year 2022 was $0.01 and $0.01, respectively, for fiscal year 2021 was $0.16 and $0.16, respectively, and for fiscal year 2020 was $0.11 and $0.11, respectively. The tax holiday in China is renewed every three years. The Company expects to renew the tax holiday for one of the Company’s subsidiaries in China that is set to expire in fiscal year 2023.
The Company regularly reviews its tax positions in each significant taxing jurisdiction in the process of evaluating its unrecognized tax benefits. The Company makes adjustments to its unrecognized tax benefits when: (i) facts and circumstances regarding a tax position change, causing a change in management’s judgment regarding that tax position; (ii) a tax position is effectively settled with a tax authority at a differing amount; and/or (iii) the statute of limitations expires regarding a tax position.
The tabular reconciliation of the total amounts of unrecognized tax benefits is as follows for the fiscal years ended:
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Unrecognized tax benefits, beginning of year$61,658 $38,773 $35,547 
Gross increases—tax positions in prior periods1,489 2,877 4,974 
Gross decreases—tax positions in prior periods(2,519)— (2,471)
Gross increases—current-period tax positions7,187 149 151 
Gross increases related to acquisitions— 22,697 158 
Settlements— (2,252)— 
Lapse of statute of limitations(8,625)(563)— 
Foreign currency translation adjustments(1,242)(23)414 
Unrecognized tax benefits, end of year$57,948 $61,658 $38,773 
The Company classifies interest and penalties as a component of income tax expense. At January 1, 2023 and January 2, 2022, the Company had accrued interest and penalties of $7.2 million and $7.6 million, respectively. During fiscal years 2022, 2021 and 2020, the Company recognized a net (benefit) expense of $(0.5) million, $1.8 million and $1.8 million, respectively,
66
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
for interest and penalties in its total tax provision. At January 1, 2023, substantially all of the unrecognized tax benefits, if recognized, would affect the effective tax rate.
The Company believes that it is reasonably possible that approximately $17.8 million of its uncertain tax positions at January 1, 2023, including accrued interest and penalties, and net of tax benefits, may be resolved over the next twelve months as a result of lapses in applicable statutes of limitations and potential settlements. Various tax years after 2010 remain open to examination by certain jurisdictions in which the Company has significant business operations, such as China, Finland, Germany, Luxembourg, The Netherlands, Singapore, the United Kingdom and the United States. The tax years under examination vary by jurisdiction.
The tax effects of temporary differences and attributes that gave rise to deferred income tax assets and liabilities were as follows:
 
January 1,
2023		January 2,
2022
(In thousands)
Deferred tax assets:
Inventory$17,920 $2,388 
Reserves and accruals70,912 53,403 
Accrued compensation23,868 29,960 
Net operating loss and credit carryforwards117,953 110,149 
Accrued pension11,653 23,714 
Restructuring reserve1,640 1,442 
Deferred revenue22,644 49,207 
Capitalized research and development expenses44,922 12,114 
Operating lease liabilities43,547 37,299 
Unrealized foreign exchange loss
11,158 14,594 
All other, net841 583 
Total deferred tax assets367,058 334,853 
Deferred tax liabilities:
Postretirement health benefits(4,379)(5,303)
Depreciation and amortization(916,581)(1,021,487)
Operating lease right-of-use assets(39,281)(33,607)
Prepaid expenses(3,515)(3,265)
Deferred tax liability on foreign earnings(15,782)(31,239)
Total deferred tax liabilities(979,538)(1,094,901)
Valuation allowance(96,681)(89,523)
Net deferred tax liabilities$(709,161)$(849,571)

The components of net deferred tax liabilities were recognized in the consolidated balance sheets as follows:

January 1,
2023		January 2,
2022
(In thousands)
Other assets, net$18,527 $18,534 
Deferred taxes and other long-term liabilities(727,688)(868,105)
Total$(709,161)$(849,571)

At January 1, 2023, for income tax return purposes, the Company had U.S. federal net operating loss carryforwards of $67.5 million, state net operating loss carryforwards of $4.9 million, foreign net operating loss carryforwards of $458.0 million, state tax credit carryforwards of $13.8 million and general business tax credit carryforwards of $0.1 million. Certain net operating loss carryforwards and state credit carryforwards do not expire, while other losses begin to expire in 2023.
67
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Valuation allowances take into consideration limitations imposed upon the use of the tax attributes and reduce the value of such items to the likely net realizable amount. The Company regularly evaluates positive and negative evidence available to determine if valuation allowances are required or if existing valuation allowances are no longer required. Valuation allowances have been provided on state net operating loss and state tax credit carryforwards and on certain foreign tax attributes that the Company has determined are not more likely than not to be realized. The increase in the valuation allowance of $7.2 million in fiscal year 2022 is primarily due to net operating losses incurred for which the benefit is not expected to be realized.
As of January 1, 2023, the Company evaluated its undistributed foreign earnings and identified approximately $879.0 million in earnings that it does not consider to be permanently reinvested. The Company has recorded a provision of approximately $15.8 million for the taxes that would fall due when such earnings are repatriated. The Company began repatriating such foreign earnings to the United States in the first quarter of fiscal year 2022 and expects to continue the repatriation in fiscal year 2023. There are other undistributed foreign earnings and outside basis differences for which the Company has not provided for any taxes as these amounts continue to be indefinitely reinvested, and it is not practicable to estimate the amount of deferred tax liability that would be incurred.

Note 7:    Earnings Per Share
Basic earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding during the period less restricted unvested shares. Diluted earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding plus all potentially dilutive common stock equivalents, primarily shares issuable upon the exercise of stock options using the treasury stock method. The following table reconciles the number of shares utilized in the earnings per share calculations for the fiscal years ended:

January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Number of common shares—basic126,155 116,165 111,514 
Effect of dilutive securities:
Stock options249 391 466 
Restricted stock awards22 118 105 
Number of common shares—diluted126,426 116,674 112,085 
Number of potentially dilutive securities excluded from calculation due to antidilutive impact611 487 220 
Antidilutive securities include outstanding stock options with exercise prices and average unrecognized compensation cost in excess of the average fair market value of common stock for the related period. Antidilutive options were excluded from the calculation of diluted net income per share and could become dilutive in the future.


Note 8:     Accounts Receivable, Net
Accounts receivable, net consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Accounts receivable, net$612,780 $707,941 
Long-term accounts receivable, net, included in Other assets, net34,040 29,958 
Total accounts receivable, net$646,820 $737,899 
Reserves for credit losses consisted of the following:

68
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Balance at
Beginning of
Year		ProvisionsCharges/
Write-
offs
Other(1)
Balance
at End
of Year
  (In thousands)
Year ended January 3, 2021$23,574 $10,294 $(1,895)$1,524 $33,497 
Year ended January 2, 202233,497 6,854 (2,198)101 38,254 
Year ended January 1, 202338,254 9,857 (9,672)(896)37,543 
(1) Other amounts primarily relate to the impact of acquisitions, discontinued operations and foreign exchange movements.

Note 9:    Inventories
Inventories consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Raw materials$190,640 $166,486 
Work in progress68,206 63,580 
Finished goods146,616 195,824 
Total inventories$405,462 $425,890 

Note 10:    Property, Plant and Equipment, Net
Property, plant and equipment consisted of the following:
January 1,
2023		January 2,
2022
(In thousands)
At cost:
Land$28,340 $28,540 
Building and leasehold improvements346,164 351,084 
Machinery and equipment482,639 464,856 
Total property, plant and equipment857,143 844,480 
Accumulated depreciation(374,193)(358,949)
Total property, plant and equipment, net$482,950 $485,531 
Depreciation expense on property, plant and equipment for the fiscal years ended January 1, 2023, January 2, 2022 and January 3, 2021 was $56.4 million, $54.9 million and $40.7 million, respectively.

69
Table of Contents

Note 11:    Marketable Securities and Investments
 Investments, which are classified in Other assets, net, consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Marketable securities$11,083 $33,683 
Equity investments54,503 33,801 
Investments in debt securities42,500 13,500 
$108,086 $80,984 
Marketable securities. Marketable securities include equity and fixed-income securities. The net unrealized holding gain and loss on marketable securities, net of deferred income taxes, reported as a component of other comprehensive income (loss) in the consolidated statements of stockholders’ equity, was not material in fiscal years 2022 and 2021. The proceeds from the sales of securities and the related gains and losses are not material for any period presented.
Marketable securities classified as available for sale consisted of the following:
 
 Market ValueGross Unrealized Holding
CostGains(Losses)
(In thousands)
January 1, 2023
Equity securities$6,775 $6,775 $— $— 
Other4,308 4,308 — — 
$11,083 $11,083 $— $— 
January 2, 2022
Equity securities$29,768 $29,768 $— $— 
Fixed-income securities7 7 — — 
Other3,908 3,971 — (63)
$33,683 $33,746 $— $(63)
Equity Investments. The Company has equity interests in privately-held entities over which the Company neither has significant influence nor control. Equity investments as of January 1, 2023 and January 2, 2022 consisted of the following:
January 1,
2023		January 2,
2022
(In thousands)
Equity investments, carried at cost minus impairment, if any$50,654 $29,738 
Equity investments, carried at fair value3,849 4,063 
$54,503 $33,801 
The amount of upward adjustments during fiscal years 2022 and 2021 were $2.9 million and $19.6 million, respectively. The cumulative amount of upward adjustments as of January 1, 2023 and January 2, 2022 was $30.7 million and $27.8 million, respectively. The amount of impairments and downward adjustments during fiscal year 2020 was $4.9 million. The cumulative amount of impairments and downward adjustments as of each of January 1, 2023 and January 2, 2022 was $5.0 million.
Investments in debt securities. The Company has investments in debt securities that are classified as available for sale. The amortized cost of these investments are not materially different to their fair value. Investments with total carrying value of $25.5 million have contractual maturities of one year through five years. Investments with a carrying value of $17.0 million are convertible into equity securities or are due and payable upon event of default (as defined in the applicable agreement).

Note 12:    Goodwill and Intangible Assets, Net
The Company tests goodwill and indefinite-lived intangible assets at least annually for possible impairment. The Company completes the annual testing of impairment for goodwill and indefinite-lived intangible assets on the later of
70
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

January 1 or the first day of each fiscal year. In addition to its annual test, the Company regularly evaluates whether events or circumstances have occurred that may indicate a potential impairment of goodwill or indefinite-lived intangible assets.
The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. The Company performed its annual impairment testing for its reporting units as of January 3, 2022, its annual impairment testing date for fiscal year 2022. There were no impairments measured in the periods presented. While the Company believes that its estimates of current value are reasonable, if actual results differ from the estimates and judgments used, including such items as future cash flows and the volatility inherent in markets which the Company serves, impairment charges against the carrying value of those assets could be required in the future.
The changes in the carrying amount of goodwill for fiscal years 2022 and 2021 are as follows:
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Balance at January 3, 2021$948,360 $1,691,227 $2,639,587 
Foreign currency translation(33,901)(40,557)(74,458)
Acquisitions, earnouts and measurement period adjustments3,742,310 319,680 4,061,990 
Balance at January 2, 20224,656,769 1,970,350 6,627,119 
Foreign currency translation(98,268)(41,617)(139,885)
Acquisitions, earnouts and measurement period adjustments(6,926)1,460 (5,466)
Balance at January 1, 2023$4,551,575 $1,930,193 $6,481,768 

71
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Identifiable intangible asset balances at January 1, 2023 by category and segment were as follows:
 
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Patents$25,312 $2,708 $28,020 
Less: Accumulated amortization(25,099)(956)(26,055)
Net patents213 1,752 1,965 
Trade names and trademarks76,521 72,932 149,453 
Less: Accumulated amortization(36,945)(26,645)(63,590)
Net trade names and trademarks39,576 46,287 85,863 
Licenses54,478 8,136 62,614 
Less: Accumulated amortization(49,582)(4,672)(54,254)
Net licenses4,896 3,464 8,360 
Core technology1,080,611 476,129 1,556,740 
Less: Accumulated amortization(209,247)(240,442)(449,689)
Net core technology871,364 235,687 1,107,051 
Customer relationships2,123,266 820,495 2,943,761 
Less: Accumulated amortization(358,402)(416,702)(775,104)
Net customer relationships1,764,864 403,793 2,168,657 
IPRD5,278 — 5,278 
Net amortizable intangible assets$2,686,191 $690,983 $3,377,174 

Identifiable intangible asset balances at January 2, 2022 by category and segment were as follows:
 
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Patents$25,524 $2,709 $28,233 
Less: Accumulated amortization(25,161)(732)(25,893)
Net patents363 1,977 2,340 
Trade names and trademarks77,181 79,683 156,864 
Less: Accumulated amortization(32,005)(21,969)(53,974)
Net trade names and trademarks45,176 57,714 102,890 
Licenses54,217 8,410 62,627 
Less: Accumulated amortization(48,670)(3,968)(52,638)
Net licenses5,547 4,442 9,989 
Core technology1,072,700 519,864 1,592,564 
Less: Accumulated amortization(126,374)(208,833)(335,207)
Net core technology946,326 311,031 1,257,357 
Customer relationships2,149,765 884,105 3,033,870 
Less: Accumulated amortization(224,461)(366,058)(590,519)
Net customer relationships1,925,304 518,047 2,443,351 
IPRD5,920 — 5,920 
Net amortizable intangible assets$2,928,636 $893,211 $3,821,847 
Total amortization expense related to definite-lived intangible assets was $370.6 million in fiscal year 2022, $256.6 million in fiscal year 2021 and $161.0 million in fiscal year 2020. Estimated amortization expense related to definite-lived intangible assets for each of the next five years is $363.8 million in fiscal year 2023, $355.2 million in fiscal year 2024, $334.0 million in fiscal year 2025, $327.0 million in fiscal year 2026, and $299.6 million in fiscal year 2027.
72
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


Note 13:    Debt
 The Company’s debt consisted of the following:

January 1,
2023
Outstanding Principal
Unamortized Debt Discount
Unamortized Debt Issuance Costs
Net Carrying Amount
(In thousands)
Long-Term Debt:
Senior Unsecured Revolving Credit Facility$— $— $(2,641)$(2,641)
0.850% Senior Unsecured Notes due in 2024 (“2024 Notes”)
771,659 (283)(3,136)768,240 
€500,000 Principal 1.875% Senior Unsecured Notes due in 2026 (“2026 Notes”)533,950 (1,902)(1,779)530,269 
1.900% Senior Unsecured Notes due in 2028 (“2028 Notes”)
500,000 (301)(3,631)496,068 
3.3% Senior Unsecured Notes due in 2029 (“2029 Notes”)850,000 (2,000)(5,537)842,463 
2.55% Senior Unsecured Notes due in March 2031 (“March 2031 Notes”)400,000 (114)(2,978)396,908 
2.250% Senior Unsecured Notes due in September 2031 (“September 2031 Notes”)
500,000 (1,353)(3,991)494,656 
3.625% Senior Unsecured Notes due in 2051 (“2051 Notes”)400,000 (4)(4,260)395,736 
Other Debt Facilities, non-current1,648 — — 1,648 
Total Long-Term Debt3,957,257 (5,957)(27,953)3,923,347 
Current Portion of Long-term Debt:
0.550% Senior Unsecured Notes due in 2023 (“2023 Notes”)
467,138 (63)(867)466,208 
Other Debt Facilities, current4,721 — — 4,721 
Total Current Portion of Long-Term Debt471,859 (63)(867)470,929 
Total Debt$4,429,116 $(6,020)$(28,820)$4,394,276 
73
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

January 2,
2022
Outstanding Principal
Unamortized Debt Discount
Unamortized Debt Issuance Costs
Net Carrying Amount
(In thousands)
Long-Term Debt:
Senior Unsecured Revolving Credit Facility$— $— $(3,362)$(3,362)
Unsecured Term Loan Credit Facility500,000 (14)(658)499,328 
2023 Notes500,000 (152)(2,093)497,755 
2024 Notes800,000 (447)(4,945)794,608 
2026 Notes568,600 (2,538)(2,280)563,782 
2028 Notes500,000 (348)(4,200)495,452 
2029 Notes850,000 (2,252)(6,234)841,514 
March 2031 Notes400,000 (126)(3,294)396,580 
September 2031 Notes500,000 (1,485)(4,380)494,135 
2051 Notes400,000 (4)(4,335)395,661 
Other Debt Facilities, non-current4,284 — — 4,284 
Total Long-Term Debt5,022,884 (7,366)(35,781)4,979,737 
Current Portion of Long-term Debt:
Other Debt Facilities, current4,240 — — 4,240 
Total Debt$5,027,124 $(7,366)$(35,781)$4,983,977 

Senior Unsecured Revolving Credit Facility. On August 24, 2021, the Company terminated its previous senior unsecured revolving credit facility and entered into a new senior unsecured revolving credit facility with a five-year term and a borrowing capacity of $1.5 billion available through August 24, 2026. As of January 1, 2023, undrawn letters of credit in the aggregate amount of $7.1 million were treated as issued and outstanding when calculating the borrowing availability under the facility. As of January 1, 2023, the Company had $1.49 billion available for additional borrowing under the facility. Borrowings will bear interest, payable quarterly or, if earlier, at the end of any interest period, at the Company’s option at either (a) the base rate (as defined in the credit agreement), or (b) the eurocurrency rate (a publicly published rate), in each case plus a percentage spread based on the credit rating of the Company's debt. The base rate is the highest of (a) the Federal Funds Rate (as defined in the credit agreement) plus 0.50%, (b) the rate of interest in effect for such day as publicly announced from time to time by Bank of America as its “prime rate”, and (c) the Eurocurrency Rate plus 1.00%. The credit agreement for the new facility contains customary affirmative, negative and financial covenants and events of default. The financial covenants include a debt-to-capital ratio that remains applicable for so long as the Company’s debt is rated as investment grade. In the event that the Company’s debt is not rated as investment grade, the debt-to-capital ratio covenant is replaced with leverage ratio and interest coverage ratio covenants.
During the fiscal year 2022, the Company repurchased $32.9 million and $28.3 million in aggregate principal amount of the 2023 Notes and 2024 Notes, respectively, in open market transactions.
Subsequent to fiscal year 2022, the Company repurchased $50.5 million in aggregate principal amount of the 2024 Notes in open market transactions.
74
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The following table summarizes the maturities of the Company’s indebtedness as of January 1, 2023: 
202320242025202620272028 and thereafterTotal before unamortized discount and debt issuance costsUnamortized discount and issuance costTotal
(In thousands)
Senior Unsecured Revolving Credit Facility$— $— $— $— $— $— $— $(2,641)$(2,641)
2023 Notes467,138 — — — — — 467,138 (930)466,208 
2024 Notes— 771,659 — — — — 771,659 (3,419)768,240 
2026 Notes— — — 533,950 — — 533,950 (3,681)530,269 
2028 Notes— — — — — 500,000 500,000 (3,932)496,068 
2029 Notes— — — — — 850,000 850,000 (7,537)842,463 
March 2031 Notes— — — — — 400,000 400,000 (3,092)396,908 
September 2031 Notes— — — — — 500,000 500,000 (5,344)494,656 
2051 Notes— — — — — 400,000 400,000 (4,264)395,736 
Other Debt Facilities4,721 1,200 201 115 89 43 6,369 — 6,369 
Total$471,859 $772,859 $201 $534,065 $89 $2,650,043 $4,429,116 $(34,840)$4,394,276 

Note 14:    Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Payroll and incentives$52,331 $52,116 
Employee benefits51,983 52,199 
Deferred revenue135,531 138,052 
Federal, non-U.S. and state income taxes45,625 88,285 
Operating lease liabilities
31,217 29,313 
Other accrued operating expenses211,176 319,134 
Total accrued expenses and other current liabilities$527,863 $679,099 

Note 15:    Employee Benefit Plans
 Savings Plan:    The Company has a 401(k) Savings Plan for the benefit of all qualified U.S. employees, with such employees receiving matching contributions in the amount equal to 100.0% of the first 5.0% of eligible compensation up to applicable Internal Revenue Service limits. Savings plan expense was $20.0 million in fiscal year 2022, $16.5 million in fiscal year 2021, and $14.1 million in fiscal year 2020.
Pension Plans:    The Company has a defined benefit pension plan covering certain U.S. employees and non-U.S. pension plans for certain non-U.S. employees. The principal U.S. defined benefit pension plan is closed to new hires and plan benefits have been frozen. The plans provide benefits that are based on an employee’s years of service and compensation near retirement.
 Net periodic pension cost for U.S. and non-U.S. plans included the following components for fiscal years ended:
75
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Service and administrative costs$6,331 $5,174 $7,414 
Interest cost10,751 9,440 12,876 
Expected return on plan assets(22,056)(24,417)(21,786)
Actuarial (gain) loss(23,706)(19,514)20,291 
Net periodic pension (credit) cost$(28,680)$(29,317)$18,795 
The Company recognizes actuarial gains and losses, unless an interim remeasurement is required, in the fourth quarter of the year in which the gains and losses occur. Such adjustments for gains and losses are primarily driven by events and circumstances beyond the Company’s control, including changes in interest rates, the performance of the financial markets and mortality assumptions. Actuarial gains and losses, including other components of periodic pension cost, are recognized in the line item “Interest and other expense, net” in the consolidated statements of operations.


76
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table sets forth the changes in the funded status of the principal U.S. pension plan and the principal non-U.S. pension plans and the amounts recognized in the Company’s consolidated balance sheets as of January 1, 2023 and January 2, 2022. The pension liability of the Business at the end of fiscal year 2022 that will transfer upon sale was reclassified to discontinued operations, while the prior year was not restated.
 
 January 1, 2023January 2, 2022
Non-U.S.U.S.Non-U.S.U.S.
(In thousands)
Actuarial present value of benefit obligations:
Accumulated benefit obligations$207,503 $231,492 $337,454 $299,826 
Change in benefit obligations:
Projected benefit obligations at beginning of year$339,390 $299,826 $395,339 $317,679 
Service and administrative costs4,956 1,375 4,924 250 
Interest cost3,671 7,080 2,632 6,808 
Benefits paid and plan expenses(14,978)(19,870)(15,299)(18,693)
Benefit obligation classified in discontinued operations(8,261)— — — 
Actuarial gains(88,724)(56,919)(30,705)(6,218)
Effect of exchange rate changes(28,099)— (17,501)— 
Projected benefit obligations at end of year$207,955 $231,492 $339,390 $299,826 
Change in plan assets:
Fair value of plan assets at beginning of year$181,189 $290,116 $204,744 $268,686 
Actual return on plan assets(46,383)(53,498)(13,115)20,123 
Benefits paid and plan expenses(14,978)(19,870)(15,299)(18,693)
Employer’s contributions6,572 — 6,851 20,000 
Effect of exchange rate changes(19,659)— (1,992)— 
Fair value of plan assets at end of year$106,741 $216,748 $181,189 $290,116 
Net liabilities recognized in the consolidated balance sheets$(101,214)$(14,744)$(158,201)$(9,710)
Net amounts recognized in the consolidated balance sheets consist of:
Other assets$19,521 $— $33,084 $— 
Current liabilities(6,568)— (6,966)— 
Long-term liabilities(114,167)(14,744)(184,319)(9,710)
Net liabilities recognized in the consolidated balance sheets$(101,214)$(14,744)$(158,201)$(9,710)
Actuarial assumptions as of the year-end measurement date:
Discount rate4.12 %4.84 %1.41 %2.44 %
Rate of compensation increase3.16 %None2.78 %None
Actuarial assumptions used to determine net periodic pension cost during the year were as follows:
January 1, 2023January 2, 2022January 3, 2021
Non-U.S.U.S.Non-U.S.U.S.Non-U.S.U.S.
Discount rate1.41 %2.44 %0.92 %2.21 %1.34 %3.01 %
Rate of compensation increase2.78 %None2.78 %None3.36 %None
Expected rate of return on assets1.11 %7.25 %2.10 %7.25 %2.20 %7.25 %
 
77
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The Company’s expected rate of return on assets assumptions are derived from management’s estimates, as well as other information compiled by management, including studies that utilize customary procedures and techniques. The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings expected on the funds invested to provide for the pension plans benefits. While the study gives appropriate consideration to recent fund performance and historical returns, the assumption is primarily a long-term, prospective rate.
The Company’s discount rate assumptions are derived from a range of factors, including a yield curve for certain plans, composed of the rates of return on high-quality fixed-income corporate bonds available at the measurement date and the related expected duration for the obligations, and a bond matching approach for certain plans.
The following table provides a breakdown of the non-U.S. benefit obligations and fair value of assets for pension plans that have benefit obligations in excess of plan assets:
January 1,
2023		January 2,
2022
(In thousands)
Pension Plans with Projected Benefit Obligations in Excess of Plan Assets
Projected benefit obligations$120,736 $191,285 
Fair value of plan assets— — 
Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets
Accumulated benefit obligations$120,283 $189,349 
Fair value of plan assets— — 
 Assets of the defined benefit pension plans are primarily equity and debt securities. Asset allocations as of January 1, 2023 and January 2, 2022, and target asset allocations for fiscal year 2023 are as follows:
 Target AllocationPercentage of Plan Assets at
December 31, 2023January 1, 2023January 2, 2022
Asset CategoryNon-U.S.U.S.Non-U.S.U.S.Non-U.S.U.S.
Equity securities0-5%0-10%— %44 %— %46 %
Debt securities0-5%90-100%— %56 %— %54 %
Other95-100%0-10%100 %— %100 %— %
Total100 %100 %100 %100 %100 %100 %
The Company maintains target allocation percentages among various asset classes based on investment policies established for the pension plans which are designed to maximize the total rate of return (income and appreciation) after inflation within the limits of prudent risk taking, while providing for adequate near-term liquidity for benefit payments.
The target allocations for plan assets are listed in the above table. Equity securities primarily include investments in large-cap and mid-cap companies located in the United States and abroad, and equity index funds. Debt securities include corporate bonds of companies from diversified industries, high-yield bonds, and U.S. government securities. Other types of investments include investments in non-U.S. government index linked bonds, multi-strategy hedge funds and venture capital funds that follow several different strategies.
78
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The fair value of the Company’s pension plan assets as of January 1, 2023 and January 2, 2022 by asset category, classified in the three levels of inputs described in Note 20 to the consolidated financial statements are as follows:
 
 Fair Value Measurements at January 1, 2023 Using:
Total Carrying
Value at
January 1, 2023		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
(In thousands)
Cash$14,483 $14,483 $— $— 
Equity securities:
U.S. large-cap61,680 61,680 — — 
International large-cap value20,148 20,148 — — 
Emerging markets growth9,902 9,902 — — 
Fixed income securities:
Corporate and U.S. debt instruments105,126 36,346 68,780 — 
Short-term corporate bonds17,088 — 17,088 — 
Other types of investments:
Foreign liability driven instrument95,062 — — 95,062 
Total assets measured at fair value$323,489 $142,559 $85,868 $95,062 
 Fair Value Measurements at January 2, 2022 Using:
Total Carrying
Value at
January 2, 2022		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
(In thousands)
Cash$22,241 $22,241 $— $— 
Equity Securities:
U.S. large-cap91,601 91,601 — — 
International large-cap value29,803 29,803 — — 
Emerging markets growth12,603 12,603 — — 
Fixed income securities:
Corporate and U.S. debt instruments133,727 41,725 92,002 — 
Corporate bonds15,650 — 15,650 — 
Other types of investments:
Foreign liability driven instrument165,680 — — 165,680 
Total assets measured at fair value$471,305 $197,973 $107,652 $165,680 

Valuation Techniques:    Valuation techniques utilized need to maximize the use of observable inputs and minimize the use of unobservable inputs. There have been no changes in the methodologies utilized at January 1, 2023 compared to January 2, 2022. The following is a description of the valuation techniques utilized to measure the fair value of the assets shown in the table above.

Equity Securities:    Shares of registered investment companies that are publicly traded are categorized as Level 1 assets; they are valued at quoted market prices that represent the net asset value of the fund. These instruments have active markets.

Equity index funds are mutual funds that are not publicly traded and are comprised primarily of underlying equity securities that are publicly traded on exchanges. Price quotes for the assets held by these funds are readily observable and available. Equity index funds are categorized as Level 2 assets.

Fixed Income Securities:    Fixed income mutual funds that are publicly traded are valued at quoted market prices that represent the net asset value of securities held by the fund and are categorized as Level 1 assets.

79
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Fixed income index funds that are not publicly traded are stated at net asset value as determined by the issuer of the fund based on the fair value of the underlying investments and are categorized as Level 2 assets.

Individual fixed income bonds are categorized as Level 2 assets except where sufficient quoted prices exist in active markets, in which case such securities are categorized as Level 1 assets. These securities are valued using third-party pricing services. These services may use, for example, model-based pricing methods that utilize observable market data as inputs. Broker dealer bids or quotes of securities with similar characteristics may also be used.
Other Types of Investments:    Hedge funds, private equity funds, foreign real estate funds and venture capital funds are valued at fair value by using the net asset values provided by the investment managers and are updated, if necessary, using analytical procedures, appraisals, public market data and/or inquiry of the investment managers. The net asset values are determined based upon the fair values of the underlying investments in the funds. These other investments invest primarily in readily available marketable securities and allocate gains, losses, and expense to the investor based on the ownership percentage as described in the fund agreements. They are categorized as Level 3 assets.
In September 2021, the Company’s UK pension scheme executed a buy-in contract with Phoenix Life LTD (“Phoenix”), under which the Company made an upfront payment to Phoenix in exchange for Phoenix agreeing to make the benefit payments under the Company’s UK pension scheme due to specified participants and their beneficiaries, thus transferring most of the investment and longevity risk associated with the covered participants and beneficiaries from the Company to Phoenix. This buy-in contract can be considered a liability-driven investment (“LDI”) solution that hedges not only the investment risk but also the longevity risk under the Company’s UK pension scheme. Like other LDI solutions, it does not eliminate ongoing administrative costs.

The Company’s policy is to recognize significant transfers between levels at the actual date of the event.

A reconciliation of the beginning and ending Level 3 assets for fiscal years 2022, 2021 and 2020 is as follows:
 
 Fair Value Measurements Using
Significant Unobservable Inputs
(Level 3):
Foreign liability driven investmentForeign
Real Estate
Funds		Multi-strategy
Hedge
Funds		Total
(In thousands)
Balance at December 30, 2019$— $22,688 $1,721 $24,409 
Sales— — (1,721)(1,721)
Unrealized gains— 571 — 571 
Balance at January 3, 2021— 23,259 — 23,259 
Sales— (23,115)— (23,115)
Purchases165,680 — — 165,680 
Realized losses— (226)— (226)
Realized gains— 82 — 82 
Balance at January 2, 2022165,680 — — 165,680 
Pension benefits paid(6,639)— — (6,639)
Foreign exchange losses(18,411)— — (18,411)
Return on plan assets(45,568)— — (45,568)
Balance at January 1, 2023$95,062 $— $— $95,062 
 
With respect to plans outside of the United States, the Company expects to contribute $6.8 million in the aggregate during fiscal year 2023. During fiscal year 2023, the Company contributed $10.0 million to its defined benefit pension plan in the United States for the plan year 2022.
80
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid as follows:
 
Non-U.S.U.S.
(In thousands)
2023$11,907 $19,311 
202412,371 19,267 
202512,442 19,218 
202612,835 19,094 
202712,450 18,906 
2028-203264,237 87,807 
 
The Company also sponsors a supplemental executive retirement plan to provide senior management with benefits in excess of normal pension benefits. Effective July 31, 2000, this plan was closed to new entrants. At January 1, 2023 and January 2, 2022, the projected benefit obligations were $18.9 million and $24.1 million, respectively. Assets with a fair value of $0.9 million and $1.6 million, segregated in a trust (which is included in marketable securities and investments on the consolidated balance sheets), were available to meet this obligation as of January 1, 2023 and January 2, 2022, respectively. Pension expenses and income for this plan netted to income of $3.2 million in fiscal year 2022, expense of $0.2 million in fiscal year 2021 and expense of $2.1 million in fiscal year 2020.
 
Postretirement Medical Plans:    The Company provides healthcare benefits for eligible retired U.S. employees under a comprehensive major medical plan or under health maintenance organizations where available. Eligible U.S. employees qualify for retiree health benefits if they retire directly from the Company and have at least ten years of service. Generally, the major medical plan pays stated percentages of covered expenses after a deductible is met and takes into consideration payments by other group coverage and by Medicare. The plan requires retiree contributions under most circumstances and has provisions for cost-sharing charges. Effective January 1, 2000, this plan was closed to new hires. For employees retiring after 1991, the Company has capped its medical premium contribution based on employees’ years of service. The Company funds the amount allowable under a 401(h) provision in the Company’s defined benefit pension plan. Assets of the plan are primarily equity and debt securities and are available only to pay retiree health benefits. The costs of these plans are not material and the net assets in the plans totaled $17.1 million and $20.7 million at January 1, 2023 and January 2, 2022, respectively.
 


Note 16:    Contingencies

The Company is conducting a number of environmental investigations and remedial actions at current and former locations of the Company and, along with other companies, has been named a potentially responsible party (“PRP”) for certain waste disposal sites. The Company accrues for environmental issues in the accounting period that the Company’s responsibility is established and when the cost can be reasonably estimated. The Company has accrued $12.2 million and $11.9 million as of January 1, 2023 and January 2, 2022, respectively, in accrued expenses and other current liabilities, which represents its management’s estimate of the cost of the remediation of known environmental matters, and does not include any potential liability for related personal injury or property damage claims. The Company’s environmental accrual is not discounted and does not reflect the recovery of any material amounts through insurance or indemnification arrangements. The cost estimates are subject to a number of variables, including the stage of the environmental investigations, the magnitude of the possible contamination, the nature of the potential remedies, possible joint and several liability, the time period over which remediation may occur, and the possible effects of changing laws and regulations. For sites where the Company has been named a PRP, management does not currently anticipate any additional liability to result from the inability of other significant named parties to contribute. The Company expects that the majority of such accrued amounts could be paid out over a period of up to ten years. As assessment and remediation activities progress at each individual site, these liabilities are reviewed and adjusted to reflect additional information as it becomes available. There have been no environmental problems to date that have had, or are expected to have, a material adverse effect on the Company’s consolidated financial statements. While it is possible that a loss exceeding the amounts recorded in the consolidated financial statements may be incurred, the potential exposure is not expected to be materially different from those amounts recorded.
The Company is subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of its business activities. Although the Company has established accruals for potential losses that it believes are probable and reasonably estimable, in the opinion of the Company’s management, based on its review of the information available at this time, the total cost of resolving these contingencies at January 1, 2023 should not have a material
81
Table of Contents

adverse effect on the Company’s consolidated financial statements. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to the Company.


Note 17:    Stock Plans

Stock-Based Compensation:
 
The Company’s 2019 Incentive Plan (the “2019 Plan”) authorizes the issuance of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock-based awards and cash awards as part of the Company’s compensation programs. The 2019 Plan replaced the Company’s 2009 Incentive Plan (the “2009 Plan”). Upon shareholder approval of the 2019 Plan, 6.25 million shares of the Company’s common stock, as well as shares of the Company’s common stock previously granted under the 2009 Plan that expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased by the Company at their original issuance price subject to a contractual repurchase right, became available for grant under the 2019 Plan. Awards granted under the 2009 Plan prior to its expiration remain outstanding. As part of the Company’s compensation programs, the Company also offers shares of its common stock under its Employee Stock Purchase Plan.
 
The following table summarizes total pre-tax compensation expense recognized related to the Company’s stock options, restricted stock, restricted stock units, performance restricted stock units, performance units and stock grants, included in the Company’s consolidated statements of operations for fiscal years 2022, 2021 and 2020:
 
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Cost of product and service revenue$7,459 $3,193 $1,106 
Research and development expenses6,799 2,393 944 
Selling, general and administrative expenses37,260 24,089 24,854 
Total stock-based compensation expense$51,518 $29,675 $26,904 
The total income tax benefit recognized in the consolidated statements of operations for stock-based compensation was $12.8 million in fiscal year 2022, $12.2 million in fiscal year 2021 and $18.0 million in fiscal year 2020. Stock-based compensation costs capitalized as part of inventory were immaterial in all periods presented.

Stock Options:    The Company has granted options to purchase common shares at prices equal to the market price of the common shares on the date the option is granted. Conditions of vesting are determined at the time of grant. Options are generally exercisable in equal annual installments over a period of three years, and will generally expire seven years after the date of grant. Options replaced in association with business combination transactions are generally issued with the same terms of the respective plans under which they were originally issued.
 
The fair value of each option grant is estimated using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. Expected volatility was calculated based on the historical and implied volatility of the Company’s stock. The average expected life was based on the contractual term of the option and historic exercise experience. The risk-free interest rate is based on United States Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant. The Company’s weighted-average assumptions used in the Black-Scholes option pricing model were as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
Risk-free interest rate2.3 %0.9 %0.9 %
Expected dividend yield0.2 %0.2 %0.3 %
Expected lives5 years5 years5 years
Expected stock volatility28.5 %27.3 %23.8 %

82
Table of Contents

The following table summarizes stock option activity for the fiscal year ended January 1, 2023:
 
 Number
of
Shares		Weighted-
Average Exercise
Price
 (Shares in thousands)
Outstanding at beginning of year1,192 $119.33 
Granted184 167.58 
Exercised(195)72.41 
Canceled(4)143.62 
Forfeited(129)152.90 
Outstanding at end of year1,048 $132.32 
Exercisable at end of year461 $102.72 
 
The aggregate intrinsic value for stock options outstanding at January 1, 2023 was $24.4 million with a weighted-average remaining contractual term of 4.7 years. The aggregate intrinsic value for stock options exercisable at January 1, 2023 was $20.1 million with a weighted-average remaining contractual term of 3.6 years. At January 1, 2023, there were 0.6 million stock options that were expected to vest in the future, with an aggregate intrinsic value of $4.3 million and a weighted-average remaining contractual term of 5.6 years.
 
The weighted-average grant-date fair value of options granted during fiscal years 2022, 2021 and 2020 was $48.09, $40.00, and $18.98 per share, respectively. The total intrinsic value of options exercised during fiscal years 2022, 2021 and 2020 was $13.9 million, $32.4 million, and $51.1 million, respectively. Cash received from option exercises for fiscal years 2022, 2021 and 2020 was $14.1 million, $25.1 million, and $37.7 million, respectively. The total compensation expense recognized related to the Company’s outstanding options was $9.5 million in fiscal year 2022, $5.6 million in fiscal year 2021 and $3.1 million in fiscal year 2020.
There was $15.3 million of total unrecognized compensation cost related to nonvested stock options granted as of January 1, 2023. This cost is expected to be recognized over a weighted-average period of 1.9 years.
Restricted Stock Awards:    The Company has awarded shares of restricted stock and restricted stock units to certain employees and non-employee directors at no cost to them, which cannot be sold, assigned, transferred or pledged during the restriction period. The restricted stock and restricted stock units vest through the passage of time, assuming continued employment. The fair value of the award at the time of the grant is expensed on a straight line basis primarily in selling, general and administrative expenses over the vesting period, which is generally 3 years. Recipients of the restricted stock have the right to vote such shares and receive dividends.
 
The following table summarizes restricted stock award activity for the fiscal year ended January 1, 2023:
 
Number
of
Shares		Weighted-
Average
Grant-
Date Fair
Value
 (Shares in thousands)
Nonvested at beginning of year637 $144.62 
Granted134 164.65 
Vested(238)137.90 
Forfeited(80)151.75 
Nonvested at end of year453 $152.79 
 
The fair value of restricted stock awards vested during fiscal years 2022, 2021 and 2020 was $32.8 million, $11.6 million, and $14.0 million, respectively. The total compensation expense recognized related to the restricted stock awards was $34.2 million in fiscal year 2022, $16.3 million in fiscal year 2021 and $8.7 million in fiscal year 2020.
 
As of January 1, 2023, there was $43.5 million of total unrecognized compensation cost, related to nonvested restricted stock awards. That cost is expected to be recognized over a weighted-average period of 1.3 years.
83
Table of Contents

Employee Stock Purchase Plan:
In April 1999, the Company’s shareholders approved the 1998 Employee Stock Purchase Plan. In April 2005, the Compensation and Benefits Committee of the Company's Board of Directors (the “Board”) voted to amend the Employee Stock Purchase Plan, effective July 1, 2005, whereby participating employees have the right to purchase common stock at a price equal to 95% of the closing price on the last day of each six-month offering period. The number of shares which an employee may purchase, subject to certain aggregate limits, is determined by the employee’s voluntary contribution, which may not exceed 10% of the employee’s base compensation. During fiscal year 2022, the Company issued 30,818 shares of common stock under the Company’s Employee Stock Purchase Plan at a weighted-average price of $134.05 per share. During fiscal year 2021, the Company issued 21,578 shares under this plan at a weighted-average price of $168.11 per share. During fiscal year 2020, the Company issued 38,727 shares under this plan at a weighted-average price of $105.23 per share. At January 1, 2023 there remains available for sale to employees an aggregate of 0.7 million shares of the Company’s common stock out of the 5.0 million shares authorized by shareholders for issuance under this plan.

Note 18:    Stockholders’ Equity
Comprehensive Income:
The components of accumulated other comprehensive (loss) income consisted of the following:
 
Foreign
Currency
Translation
Adjustment,
net of tax		Unrecognized
Prior Service
Costs, net of
tax		Unrealized
(Losses)
Gains on
Securities,
net of tax		Accumulated
Other
Comprehensive
Income (Loss)
 (In thousands)
Balance, December 30, 2019$(200,437)$1,052 $(261)$(199,646)
Current year change169,500 (1,799)(16)167,685 
Balance, January 3, 2021(30,937)(747)(277)(31,961)
Current year change(130,873)(95)237 (130,731)
Balance, January 2, 2022(161,810)(842)(40)(162,692)
Current year change(284,854)44 5 (284,805)
Balance, January 1, 2023$(446,664)$(798)$(35)$(447,497)

Stock Repurchases:
On July 31, 2020, the Company’s Board of Directors (the “Board”) authorized the Company to repurchase shares of common stock for an aggregate amount up to $250.0 million under a stock repurchase program (the “Repurchase Program”). On July 22, 2022, the Repurchase Program was terminated by the Board and the Board authorized the Company to repurchase shares of common stock for an aggregate amount up to $300.0 million under a new stock repurchase program (the “New Repurchase Program”). No shares remain available for repurchase under the Repurchase Program due to its termination. The New Repurchase Program will expire on July 22, 2024 unless terminated earlier by the Board and may be suspended or discontinued at any time. During fiscal year 2022, the Company repurchased 240,000 shares of common stock under the Repurchase Program for an aggregate cost of $43.4 million. During fiscal year 2022, the Company repurchased 138,025 shares of common stock under the New Repurchase Program for an aggregate cost of $19.1 million. As of January 1, 2023, $280.9 million remained available for aggregate repurchases of shares under the New Repurchase Program.
In addition, the Board has authorized the Company to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to the Company’s equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to the Company’s equity incentive plans. During fiscal year 2022, the Company repurchased 115,247 shares of common stock for this purpose at an aggregate cost of $18.1 million. During fiscal year 2021, the Company repurchased 71,248 shares of common stock for this purpose at an aggregate cost of $10.5 million. During fiscal year 2020, the Company repurchased 72,251 shares of common stock for this purpose at an aggregate cost of $6.9 million. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value.
 
84
Table of Contents

Dividends:
The Board declared a regular quarterly cash dividend of $0.07 per share in each quarter of fiscal years 2022, 2021 and 2020. At January 1, 2023, the Company had accrued $8.8 million for a dividend declared in October 2022 for the fourth quarter of fiscal year 2022 that was paid in February 2023. On January 26, 2023, the Company announced that the Board had declared a quarterly dividend of $0.07 per share for the first quarter of fiscal year 2023 that will be payable in May 2023. In the future, the Board may determine to reduce or eliminate the Company’s common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.


Note 19:    Derivatives and Hedging Activities
 
The Company uses derivative instruments as part of its risk management strategy only, and includes derivatives utilized as economic hedges that are not designated as hedging instruments. By nature, all financial instruments involve market and credit risks. The Company enters into derivative instruments with major investment grade financial institutions and has policies to monitor the credit risk of those counterparties. The Company does not enter into derivative contracts for trading or other speculative purposes, nor does the Company use leveraged financial instruments. Approximately 55% of the Company’s business is conducted outside of the United States, generally in foreign currencies. As a result, fluctuations in foreign currency exchange rates can increase the costs of financing, investing and operating the business.
In the ordinary course of business, the Company enters into foreign exchange contracts for periods consistent with its committed exposures to mitigate the effect of foreign currency movements on transactions denominated in foreign currencies. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures from these currencies, with gains and losses resulting from the forward currency contracts that hedge these exposures. Transactions covered by hedge contracts include intercompany and third-party receivables and payables. The contracts are primarily in European and Asian currencies, have maturities that do not exceed 12 months, have no cash requirements until maturity, and are recorded at fair value on the Company’s consolidated balance sheets. The unrealized gains and losses on the Company’s foreign currency contracts are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from operating activities within the Company’s consolidated statements of cash flows.
Principal hedged currencies include the Australian Dollar, British Pound, Euro, Indian Rupee, Singapore Dollar and Swedish Krona. The Company held forward foreign exchange contracts, designated as economic hedges, with U.S. dollar equivalent notional amounts totaling $476.9 million at January 1, 2023 $371.9 million at January 2, 2022, and $808.0 million at January 3, 2021, and the fair value of these foreign currency derivative contracts was insignificant. The gains and losses realized on these foreign currency derivative contracts are not material. The duration of these contracts was generally 30 days or less during each of fiscal years 2022, 2021 and 2020.
In addition, in connection with certain intercompany loan agreements utilized to finance its acquisitions and stock repurchase program, the Company enters into forward foreign exchange contracts intended to hedge movements in foreign exchange rates prior to settlement of such intercompany loans denominated in foreign currencies. The Company records these hedges at fair value on the Company’s consolidated balance sheets. The unrealized gains and losses on these hedges, as well as the gains and losses associated with the remeasurement of the intercompany loans, are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from financing activities within the Company’s consolidated statements of cash flows.
The outstanding forward exchange contracts designated as economic hedges, which were intended to hedge movements in foreign exchange rates prior to the settlement of certain intercompany loan agreements, included combined U.S. Dollar notional amounts of $360.2 million as of January 2, 2022. The net gains and losses on these derivatives, combined with the gains and losses on the remeasurement of the hedged intercompany loans were not material.
During fiscal year 2018, the Company designated a portion of the 2026 Notes to hedge its investments in certain foreign subsidiaries. Unrealized translation adjustments from a portion of the 2026 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of January 1, 2023, the total notional amount of the 2026 Notes that was designated to hedge investments in foreign subsidiaries was €497.2 million. The unrealized foreign exchange (gains) losses recorded in AOCI related to the net investment hedge were $(34.5) million, $(33.2) million and $49.6 million during the fiscal years 2022, 2021 and 2020, respectively.
The Company does not expect any material net pre-tax gains or losses to be reclassified from accumulated other comprehensive (loss) income into interest and other expense, net within the next twelve months.

85
Table of Contents


Note 20:    Fair Value Measurements
 Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash equivalents, derivatives, marketable securities and accounts receivable. The Company believes it had no significant concentrations of credit risk as of January 1, 2023.
 The Company’s financial assets and liabilities carried at fair value are primarily comprised of marketable securities, derivative contracts used to hedge the Company’s currency risk, and acquisition related contingent consideration. The Company has not elected to measure any additional financial instruments or other items at fair value.
 Valuation Hierarchy: The following summarizes the three levels of inputs required to measure fair value. For Level 1 inputs, the Company utilizes quoted market prices as these instruments have active markets. For Level 2 inputs, the Company utilizes quoted market prices in markets that are not active, broker or dealer quotations, or utilizes alternative pricing sources with reasonable levels of price transparency. For Level 3 inputs, the Company utilizes unobservable inputs based on the best information available, including estimates by management primarily based on information provided by third-party fund managers, independent brokerage firms and insurance companies. A financial asset’s or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible.
 The following tables show the assets and liabilities carried at fair value measured on a recurring basis as of January 1, 2023 and January 2, 2022 classified in one of the three classifications described above:
 
 Fair Value Measurements at January 1, 2023 Using:
 Total Carrying
Value at January 1, 2023		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable Inputs
(Level 3)
 (In thousands)
Marketable securities$11,083 $11,083 $— $— 
Foreign exchange derivative assets2,142 — 2,142 — 
Foreign exchange derivative liabilities(1,549)— (1,549)— 
Contingent consideration(46,618)— — (46,618)
 Fair Value Measurements at January 2, 2022 Using:
 Total Carrying
Value at January 2, 2022		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable Inputs
(Level 3)
 (In thousands)
Marketable securities$33,683 $33,683 $— $— 
Foreign exchange derivative assets3,765 — 3,765 — 
Foreign exchange derivative liabilities(3,463)— (3,463)— 
Contingent consideration(57,996)— — (57,996)
 
Level 1 and Level 2 Valuation Techniques: The Company’s Level 1 and Level 2 assets and liabilities are comprised of investments in equity and fixed-income securities as well as derivative contracts. For financial assets and liabilities that utilize Level 1 and Level 2 inputs, the Company utilizes both direct and indirect observable price quotes, including common stock price quotes, foreign exchange forward prices and bank price quotes. Below is a summary of valuation techniques for Level 1 and Level 2 financial assets and liabilities.

Marketable securities: Include equity and fixed-income securities measured at fair value using the quoted market prices in active markets at the reporting date.

Foreign exchange derivative assets and liabilities: Include foreign exchange derivative contracts that are valued using quoted forward foreign exchange prices at the reporting date. The Company’s foreign exchange derivative contracts are subject to master netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company’s consolidated balance sheet on a net basis and are recorded in other assets. As of both January 1, 2023 and January 2, 2022, none of the master netting arrangements involved collateral.
86
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


Level 3 Valuation Techniques:    The Company’s Level 3 liabilities are comprised of contingent consideration related to acquisitions. For liabilities that utilize Level 3 inputs, the Company uses significant unobservable inputs. Below is a summary of valuation techniques for Level 3 liabilities.

Contingent consideration:    Contingent consideration is measured at fair value at the acquisition date using projected milestone dates, discount rates, probabilities of success and projected revenues (for revenue-based considerations). Projected risk-adjusted contingent payments are discounted back to the current period using a discounted cash flow model.
The fair values of contingent consideration are calculated on a quarterly basis based on a collaborative effort of the Company’s regulatory, research and development, operations, finance and accounting groups, as appropriate. Potential valuation adjustments are made as additional information becomes available, including the progress towards achieving proof of concept, regulatory approvals and revenue targets as compared to initial projections, the impact of market competition and market landscape shifts from non-invasive prenatal testing products, with the impact of such adjustments being recorded in the consolidated statements of operations.

As of January 1, 2023, the Company may have to pay contingent consideration, related to acquisitions with open contingency periods that are substantially all revenue-based consideration, of up to $106.2 million. The expected maximum earnout period for acquisitions with open contingency period is 5.9 years from January 1, 2023, and the remaining weighted average expected earnout period at January 1, 2023 was 4.9 years.

A reconciliation of the beginning and ending Level 3 net liabilities for contingent consideration is as follows:
 
 (In thousands)
Balance at December 29, 2019$(35,481)
Amounts paid and foreign currency translation23,701 
Change in fair value (included within selling, general and administrative expenses)8,827 
Balance at January 3, 2021(2,953)
Additions(57,431)
Amounts paid and foreign currency translation5,507 
Change in fair value (included within selling, general and administrative expenses)(3,119)
Balance at January 2, 2022(57,996)
Additions(4,961)
Amounts paid and foreign currency translation2,562 
Adjustments recognized in goodwill12,400 
Change in fair value (included within selling, general and administrative expenses)1,377 
Balance at January 1, 2023$(46,618)


Assets and Liabilities Not Carried at Fair Value
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to the short-term maturities of these assets and liabilities. If measured at fair value, cash and cash equivalents would be classified as Level 1.
The Company’s outstanding senior unsecured notes had an aggregate fair value of $3,812.3 million and aggregate carrying value of $4,390.5 million as of January 1, 2023. The Company's outstanding senior unsecured notes had an aggregate fair value of $4,612.8 million and aggregate carrying value of $4,479.5 million as of January 2, 2022. The fair values of the outstanding senior unsecured notes were estimated using market quotes from brokers and were based on current rates offered for similar debt, which are Level 2 measurements.
The Company’s other debt facilities, including the Company's senior revolving credit facility and term loan facility, had an aggregate carrying value of $3.7 million and $504.5 million as of January 1, 2023 and January 2, 2022, respectively. The carrying value approximates fair value and were classified as Level 2.

87
Table of Contents

Note 21:    Leases
Lessee Disclosures
The Company leases certain property and equipment under operating and finance leases. The Company’s leases have remaining lease terms of less than 1 year to 30 years, some of which include options to extend the lease for up to 5 years, and some of which include options to terminate the lease within 1 year. Finance leases are not material to the Company.
The components of lease expense were as follows:
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Lease Cost:
Operating lease cost$39,989 $39,516 37,613 
Supplemental cash flow information related to leases was as follows:
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$37,488 $38,970 $34,373 
Right-of-use assets obtained in exchange for new lease obligations:
   Operating leases$55,016 $12,345 $2,605 
Supplemental balance sheet information related to leases was as follows:
 January 1,
2023		January 2,
2022
 (In thousands, except lease term and discount rate)
Operating Leases:
Operating lease right-of-use assets$188,351 $164,040 
Operating lease liabilities included in Accrued expenses and other current liabilities$31,217 $29,313 
Operating lease liabilities169,968 147,395 
Total operating lease liabilities$201,185 $176,708 
Weighted Average Remaining Lease Term in Years
Operating leases6.15.8
Weighted Average Remaining Discount Rate
Operating leases2.6%1.8%
Lease costs from finance leases, short-term leases, variable lease costs and sub-lease income are not material.
88
Table of Contents

Future payments of operating lease liabilities as of January 1, 2023 were as follows:
 (In thousands)
2023$38,452 
202435,361 
202532,080 
202627,064 
202723,983 
2028 and thereafter65,308 
Total lease payments222,248 
Less imputed interest(21,063)
    Total $201,185 

Note 22:    Industry Segment and Geographic Area Information
The Company discloses information about its operating segments based on the way that management organizes the segments within the Company for making operating decisions and assessing financial performance. The Company evaluates the performance of its operating segments based on revenue and operating income. Intersegment revenue and transfers are not significant. The accounting policies of the operating segments are the same as those described in Note 1.
The principal products and services of the Company’s two operating segments are:
•Discovery & Analytical Solutions. Provides products and services targeted towards the life sciences and applied markets.
•Diagnostics. Develops diagnostics, tools and applications focused on clinically-oriented customers, especially within the reproductive health, emerging market diagnostics and applied genomics markets. The Diagnostics segment serves the diagnostics market.
The Company has included the expenses for its corporate headquarters, such as legal, tax, audit, human resources, information technology, and other management and compliance costs, as well as the activity related to the mark-to-market adjustment on postretirement benefit plans, as “Corporate” below. The Company has a process to allocate and recharge expenses to the reportable segments when these costs are administered or paid by the corporate headquarters based on the extent to which the segment benefited from the expenses. These amounts have been calculated in a consistent manner and are included in the Company’s calculations of segment results to internally plan and assess the performance of each segment for all purposes, including determining the compensation of the business leaders for each of the Company’s operating segments.
The primary financial measure by which the Company evaluates the performance of its segments is adjusted operating income, which consists of operating income plus amortization of intangible assets, adjustments to operations arising from purchase accounting (primarily adjustments to the fair value of acquired inventory that are subsequently recognized), acquisition and divestiture-related costs, and other costs that are not expected to recur or are of a non-cash nature, including primarily restructuring actions.

89
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Revenues
Discovery & Analytical Solutions$1,292,909 $897,718 $596,585 
Diagnostics2,019,727 2,932,738 2,067,728 
Revenue purchase accounting adjustments(814)(2,648)(1,083)
Total revenues$3,311,822 $3,827,808 $2,663,230 
Segment Operating Income
Discovery & Analytical Solutions$503,243 $281,602 $129,174 
Diagnostics781,985 1,432,769 1,010,361 
Corporate(73,431)(77,364)(73,854)
Subtotal reportable segments1,211,797 1,637,007 1,065,681 
Amortization of intangible assets(370,638)(256,569)(160,991)
Purchase accounting adjustments(45,681)(40,993)(6,382)
Acquisition and divestiture-related costs(39,826)(62,760)(4,335)
Restructuring and other(12,953)(18,228)(26,700)
Operating income from continuing operations742,699 1,258,457 867,273 
Interest and other expense, net90,862 54,875 67,201 
Income from continuing operations before income taxes$651,837 $1,203,582 $800,072 

Additional information relating to the Company’s reporting segments is as follows for the three fiscal years ended January 1, 2023:
 Depreciation and Amortization ExpenseCapital Expenditures
 January 1,
2023		January 2,
2022		January 3,
2021		January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)(In thousands)
Discovery & Analytical Solutions$263,698 $94,700 $48,657 $41,532 $27,818 $6,345 
Diagnostics161,394 214,178 149,738 40,671 57,206 55,236 
Corporate1,908 2,565 3,253 3,429 996 2,053 
Continuing operations$427,000 $311,443 $201,648 $85,632 $86,020 $63,634 

 Total Assets
 January 1,
2023		January 2,
2022
 (In thousands)
Discovery & Analytical Solutions$8,330,045 $8,478,292 
Diagnostics3,991,659 4,692,816 
Corporate114,447 129,904 
Current and long-term assets of discontinued operations1,693,704 1,699,542 
Total assets$14,129,855 $15,000,554 
The following geographic area information for continuing operations includes revenue based on location of external customers for the three fiscal years ended January 1, 2023 and net long-lived assets based on physical location as of January 1, 2023 and January 2, 2022:
90
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 Revenue
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
U.S.$1,546,520 $1,682,294 $921,574 
International:
China476,366 449,588 305,660 
United Kingdom136,017 357,911 323,837 
Other international1,152,919 1,338,015 1,112,159 
Total international1,765,302 2,145,514 1,741,656 
Total revenue$3,311,822 $3,827,808 $2,663,230 
 
 
Net Long-Lived Assets(1)
 January 1,
2023		January 2,
2022
 (In thousands)
U.S.$311,661 $295,397 
International:
Germany147,766 146,633 
China68,072 59,851 
Other international216,235 222,190 
Total international432,073 428,674 
Total net long-lived assets$743,734 $724,071 
(1) Long-lived assets consist of property and equipment, net, operating lease right-of-use assets, rental equipment, software and other long-term assets.


91
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 23:    Quarterly Financial Information (Unaudited)

Selected quarterly financial information is as follows for the fiscal years ended:

First
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter		Year
 (In thousands, except per share data)
January 1, 2023
Revenue$963,163 $895,642 $711,803 $741,214 $3,311,822 
Gross profit594,740 551,717 407,044 436,329 1,989,830 
Operating income from continuing operations261,967 232,486 110,780 137,466 742,699 
Income from continuing operations before income taxes224,904 206,344 82,142 138,447 651,837 
Income from continuing operations184,070 161,601 69,508 97,497 512,676 
(Loss) income from discontinued operations(7,108)17,611 15,839 30,161 56,503 
Net income176,962 179,212 85,347 127,658 569,179 
Basic earnings per share:
Income from continuing operations$1.46 $1.28 $0.55 $0.77 $4.06 
(Loss) income from discontinued operations(0.06)0.14 0.13 0.24 0.45 
Net income1.40 1.42 0.68 1.01 4.51 
Diluted earnings per share:
Income from continuing operations$1.45 $1.28 $0.55 $0.77 $4.06 
(Loss) income from discontinued operations(0.06)0.14 0.13 0.24 0.45 
Net income1.39 1.42 0.67 1.01 4.50 
January 2, 2022
Revenue$1,027,836 $910,747 $861,315 $1,027,910 $3,827,808 
Gross profit693,187 574,143 522,860 643,797 2,433,987 
Operating income from continuing operations455,010 307,999 195,554 299,894 1,258,457 
Income from continuing operations before income taxes467,537 301,329 135,012 299,704 1,203,582 
Income from continuing operations369,859 227,857 107,631 184,089 889,436 
Income from discontinued operations9,446 18,073 20,107 6,095 53,721 
Net income379,305 245,930 127,738 190,184 943,157 
Basic earnings per share:
Income from continuing operations$3.30 $2.03 $0.94 $1.46 $7.66 
Income from discontinued operations0.08 0.16 0.18 0.05 0.46 
Net income3.38 2.19 1.12 1.51 8.12 
Diluted earnings per share:
Income continuing operations$3.29 $2.03 $0.94 $1.45 $7.62 
Income from discontinued operations0.08 0.16 0.17 0.05 0.46 
Net income3.37 2.19 1.11 1.50 8.08 


Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Not applicable.

Item 9A.    Controls and Procedures
Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
92
Table of Contents

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of January 1, 2023. The term “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of January 1, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Management’s Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:
•Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;

•Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and

•Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Our management assessed the effectiveness of our internal control over financial reporting as of January 1, 2023. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013).
Based on this assessment, our management concluded that, as of January 1, 2023, our internal control over financial reporting was effective based on those criteria.
Our registered public accounting firm has issued an attestation report on our internal control over financial reporting. This report appears below.

Changes in Internal Control Over Financial Reporting
No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended January 1, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. We have not experienced any material impact to our internal controls over financial reporting despite the fact that many of our employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the effect of the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.
93
Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of PerkinElmer, Inc.

Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of PerkinElmer, Inc. and subsidiaries (the “Company”) as of January 1, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of January 1, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended January 1, 2023 of the Company and our report dated March 1, 2023 expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.

/s / DELOITTE & TOUCHE LLP
Boston, Massachusetts
March 1, 2023
94
Table of Contents



Item 9B.    Other Information
 
Not applicable.

 
Item 9C.    Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
 
Not applicable.


 
95
Table of Contents

PART III

Item 10.    Directors, Executive Officers and Corporate Governance
 
The information required to be disclosed by this Item pursuant to Item 401 of Regulation S-K with respect to our executive officers is contained in Part I of this annual report on Form 10-K under the caption, “Information About Our Executive Officers”. The remaining information required to be disclosed by the Item pursuant to Item 401 and Item 407 of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 25, 2023 under the captions “Proposal No. 1 Election of Directors” and “Information Relating to Our Board of Directors and Its Committees” and is incorporated in this annual report on Form 10-K by reference.
We have adopted a code of ethics, our Standards of Business Conduct, that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions. Our Standards of Business Conduct, as well as our corporate governance guidelines and the charters for the audit, compensation and benefits, nominating and corporate governance, executive and finance committees of our Board of Directors, are each accessible under the “Corporate Governance” heading of the “Investors” section of our website, http://www.perkinelmer.com. This information is also available in print to any stockholder who requests it, by writing to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations. We also intend to disclose in the same location on our website, any amendments to, or waivers from, our Standards of Business Conduct that are required to be disclosed pursuant to the disclosure requirements of Item 5.05 of Form 8-K.

Item 11.    Executive Compensation
     The information required to be disclosed by this Item pursuant to Item 402 and Item 407(e) of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 25, 2023 under the captions “Director Compensation,” “Information Relating to Our Board of Directors and Its Committees—Compensation Committee Interlocks and Insider Participation,” and “Executive Compensation,” and is incorporated in this annual report on Form 10-K by reference.

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
     The information required to be disclosed by this Item pursuant to Item 403 of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 25, 2023 under the caption “Beneficial Ownership of Common Stock,” and is incorporated in this annual report on Form 10-K by reference.
     The information required to be disclosed by this Item pursuant to Item 201(d) of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 25, 2023 under the caption “Executive Compensation—Equity Compensation Plan Information,” and is incorporated in this annual report on Form 10-K by reference.

Item 13.    Certain Relationships and Related Transactions, and Director Independence
     The information required to be disclosed by this Item pursuant to Item 404 of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 25, 2023 under the caption “Information Relating to Our Board of Directors and Its Committees—Certain Relationships and Policies on Related Party Transactions,” and is incorporated in this annual report on Form 10-K by reference.
The information required to be disclosed by this Item pursuant to Item 407(a) of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 25, 2023 under the caption “Information Relating to Our Board of Directors and Its Committees—Determination of Independence,” and is incorporated in this annual report on Form 10-K by reference.

Item 14.    Principal Accountant Fees and Services
     The information required to be disclosed by this Item pursuant to Item 9(e) of Schedule 14A is contained in the proxy statement for our annual meeting of stockholders to be held on April 25, 2023 under the caption “Information Relating to Our Board of Directors and Its Committees—Independent Registered Public Accounting Firm Fees and Other Matters”, and is incorporated in this annual report on Form 10-K by reference.
96
Table of Contents

PART IV

Item 15.    Exhibits and Financial Statement Schedules
 
(a) DOCUMENTS FILED AS PART OF THIS REPORT:
 
1. FINANCIAL STATEMENTS
 
Included in Part II, Item 8:
 
Report of Independent Registered Public Accounting Firm
 
Consolidated Statements of Operations for Each of the Three Fiscal Years in the Period Ended January 1, 2023
 
Consolidated Statements of Comprehensive Income for Each of the Three Fiscal Years in the Period Ended January 1, 2023
Consolidated Balance Sheets as of January 1, 2023 and January 2, 2022
 
Consolidated Statements of Stockholders’ Equity for Each of the Three Fiscal Years in the Period Ended January 1, 2023
 
Consolidated Statements of Cash Flows for Each of the Three Fiscal Years in the Period Ended January 1, 2023
 
Notes to Consolidated Financial Statements

2. FINANCIAL STATEMENT SCHEDULE
 
We have omitted financial statement schedules because of the absence of conditions under which they are required, or because the required information is given in the financial statements or notes thereto.
 
3. EXHIBITS
 
Exhibit No.Exhibit Title
2.1(1)
2.2(1)
3.1
3.2
4.1
4.2
4.3
4.4
97
Table of Contents

Exhibit No.Exhibit Title
4.5
4.6
4.7
4.8
10.1
10.2*Employment Contracts:
 
10.3*
10.4*
98
Table of Contents

Exhibit No.Exhibit Title
10.5*
10.6*
10.7*
10.8*
10.9*
10.10*
10.11*
10.12*
10.13*
10.14*
10.15*
10.16*
10.17*
10.18*
10.19*
10.20*
99
Table of Contents

Exhibit No.Exhibit Title
10.21*
10.22*

10.23*
10.24*
10.25*
21
23
31.1
31.2
32.1
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Calculation Linkbase Document.
101.DEFInline XBRL Definition Linkbase Document.
101.LABInline XBRL Labels Linkbase Document.
101.PREInline XBRL Presentation Linkbase Document.
104Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).
____________________________
(1)    The exhibits and schedules to this agreement have been omitted from this filing pursuant to Item 601(b)(2) of Regulation S-K. The registrant agrees to furnish copies of any of such exhibits or schedules to the SEC upon request.
*    Management contract or compensation plan or arrangement required to be filed as an exhibit pursuant to Item 15(b) of Form 10-K.
 
Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language):
 
(i) Consolidated Statements of Operations for each of the three years in the period ended January 1, 2023, (ii) Consolidated Balance Sheets as of January 1, 2023 and January 2, 2022, (iii) Consolidated Statements of Comprehensive Income for each of the three years in the period ended January 1, 2023, (iv) Consolidated Statements of Stockholders' Equity for each of the three years in the period ended January 1, 2023, (v) Consolidated Statements of Cash Flows for each of the three years in the period ended January 1, 2023, and (vi) Notes to Consolidated Financial Statements.

100
Table of Contents

Item 16.    Form 10-K Summary
 
Not applicable.

SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
SignaturePERKINELMER, INC.
Title		Date
By:
/s/   PRAHLAD SINGH, PhD
President and Chief Executive OfficerMarch 1, 2023
Prahlad Singh, PhD
(Principal Executive Officer)
By:
/S/     MAXWELL KRAKOWIAK
Sr. Vice President andMarch 1, 2023
Maxwell Krakowiak
Chief Financial Officer
(Principal Financial Officer)
By:
/S/     ANDREW OKUN
Vice President, March 1, 2023
Andrew Okun
Chief Accounting Officer and Treasurer
(Principal Accounting Officer)
 
101
Table of Contents

POWER OF ATTORNEY AND SIGNATURES
 
We, the undersigned officers and directors of PerkinElmer, Inc., hereby severally constitute Prahlad Singh and Maxwell Krakowiak, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names, in the capacities indicated below, this Annual Report on Form 10-K and any and all amendments to said Annual Report on Form 10-K, and generally to do all such things in our name and behalf in our capacities as officers and directors to enable PerkinElmer, Inc. to comply with the provisions of the Securities Exchange Act of 1934, and all requirements of the Securities and Exchange Commission, hereby rectifying and confirming signed by our said attorneys, and any and all amendments thereto.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
 
 SignatureTitleDate
By:/s/     PRAHLAD SINGH, PhDPresident, Chief Executive Officer and March 1, 2023
Prahlad Singh, PhD
Director
(Principal Executive Officer)
By:/s/     MAXWELL KRAKOWIAKSr. Vice President andMarch 1, 2023
Maxwell Krakowiak
Chief Financial Officer
(Principal Financial Officer)
By:/s/     ANDREW OKUNVice President, Chief Accounting Officer March 1, 2023
Andrew Okun
and Treasurer
(Principal Accounting Officer)
By:/s/     PETER BARRETT, PhDDirectorMarch 1, 2023
Peter Barrett, PhD
By:/s/     SAMUEL R. CHAPINDirectorMarch 1, 2023
Samuel R. Chapin
By:/s/     SYLVIE GRÉGOIRE, PharmDDirectorMarch 1, 2023
Sylvie Grégoire, PharmD
By:/s/MICHELLE MCMURRY-HEATH, MD PhDDirectorMarch 1, 2023
Michelle McMurry-Heath, MD PhD
By:/s/     ALEXIS P. MICHASDirectorMarch 1, 2023
Alexis P. Michas
By:/s     MICHEL VOUNATSOSDirectorMarch 1, 2023
Michel Vounatsos
By:/s/     FRANK WITNEY, PhDDirectorMarch 1, 2023
Frank Witney, PhD
By:/s/     PASCALE WITZDirectorMarch 1, 2023
Pascale Witz
102


EXHIBIT 21

Subsidiaries of the Registrant

As of March 1, 2023, the following is a list of the parent (Registrant) and its active subsidiaries, together with their subsidiaries. Except as noted, all voting securities of the listed subsidiaries are 100% beneficially owned by the Registrant or a subsidiary thereof. The subsidiaries are arranged alphabetically by state and then country of incorporation or organization.






Name of Company

State or Country
of Incorporation
or Organization



Name of Parent
1.    
PerkinElmer, Inc.MassachusettsN/A
2.    
2Cure, LLCCaliforniaBioLegend, Inc.
3.    
BioLegend CNS, Inc.CaliforniaBioLegend, Inc.
4.    
BioLegend Ventures, LLCCaliforniaBioLegend, Inc.
5.    
BioLegend, Inc.CaliforniaPerkinElmer, Inc.
6.    
Caliper Life Sciences, Inc.DelawarePerkinElmer Holdings, Inc.
7.    
Cambridge Research & Instrumentation, Inc.DelawareCaliper Life Sciences, Inc.
8.    
Dharmacon, Inc.DelawarePerkinElmer Holdings, Inc.
9.    
Horizon Discovery, Inc.DelawareHorizon Discovery Limited
10.    
Immunodiagnostic Systems Inc.DelawarePerkinElmer Holdings, Inc.
11.    
Nexcelom Bioscience Holdings, LLCDelawarePerkinElmer Health Sciences, Inc.
12.    
Oxford Immunotec USA, Inc.DelawareOxford Immunotec Limited
13.    
PerkinElmer Argentina Holdings, LLCDelawarePerkinElmer Holdings, Inc.
14.    
PerkinElmer CV Holdings, LLCDelawarePerkinElmer Global Holdings S.à r.l.
15.    
PerkinElmer Diagnostics Holdings, Inc.DelawarePerkinElmer Holdings, Inc.
16.    
PerkinElmer Health Sciences, Inc.DelawarePerkinElmer Holdings, Inc.
17.    
PerkinElmer Informatics, Inc.DelawarePerkinElmer Holdings, Inc.
18.    
Qognit, Inc.DelawareBioLegend, Inc
19.    
Sage Labs, LLCDelawareDharmacon, Inc.
20.    
SonoVol, Inc.DelawarePerkinElmer Holdings, Inc.
21.    
ViaCord, LLCDelawarePerkinElmer Diagnostics Holdings, Inc.
22.    
VisEn Medical Inc.DelawarePerkinElmer Health Sciences, Inc.
23.    
Xenogen CorporationDelawareCaliper Life Sciences, Inc.
24.    
Omni International, Inc.GeorgiaPerkinElmer Holdings, Inc.
25.    
NovaScreen Biosciences CorporationMarylandCaliper Life Sciences, Inc.
26.    
Immunetics, Inc.MassachusettsOxford Immunotec USA, Inc.
27.    
Nexcelom Bioscience, LLCMassachusettsNexcelom Bioscience Holdings, LLC
28.    
PerkinElmer Holdings, Inc.MassachusettsPerkinElmer, Inc.
29.    
SIRION Biotech International, Inc.MassachusettsPerkinElmer Holdings, Inc.
30.    
OZ Systems USA, LLCNevadaOptimization Zorn Corporation
31.    
EUROIMMUN US, Inc.New JerseyPerkinElmer Diagnostics Holdings, Inc.
32.    
EUROIMMUN US Real Estate LLCNew JerseyEUROIMMUN US, Inc.
33.    
PerkinElmer Genetics, Inc.PennsylvaniaPerkinElmer Diagnostics Holdings, Inc.
34.    
PerkinElmer Health Sciences Puerto Rico, LLCPuerto RicoPerkinElmer Holdings, Inc.
35.    
Bioo Scientific CorporationTexasPerkinElmer Holdings, Inc.
36.    
Optimization Zorn CorporationTexasPerkinElmer Diagnostics Holdings, Inc.
37.    
PerkinElmer Automotive Research, Inc.TexasPerkinElmer Holdings, Inc.
38.    
Perkin-Elmer Argentina S.R.L.ArgentinaPerkinElmer Holdings, Inc. (98%) 1
39.    
PerkinElmer Pty. Ltd.AustraliaPerkinElmer Holdings, Inc.
40.    
Perten Instruments of Australia Pty Ltd.AustraliaPerten Instruments AB
41.    
Horizon Genomics GmbHAustriaHorizon Discovery Group Ltd.
42.    
PerkinElmer VertriebsgmbHAustriaWellesley B.V.
43.    
Immunodiagnostic Systems SABelgiumImmunodiagnostic Systems Holdings Limited
1     PerkinElmer Health Sciences, Inc. owns 2%.
1 of 5






Name of Company

State or Country
of Incorporation
or Organization



Name of Parent
44.    
PerkinElmer BVBelgiumPerkinElmer Life Sciences International Holdings 2
45.    
EUROIMMUN Brasil Medicina Diagnostica Ltda.BrazilEUROIMMUN Medizinische Labordiagnostika AG 3
46.    
IDS Brasil Diagnósticos Ltda.BrazilImmunodiagnostic Systems Limited (99%) 4
47.    
PerkinElmer do Brasil Ltda.BrazilPerkinElmer Diagnostics Global Holdings S.à r.l. (99%) 5
48.    
EUROIMMUN Medical Diagnostics Canada Inc.CanadaEUROIMMUN Medizinische Labordiagnostika AG
49.    
PerkinElmer Health Sciences Canada, Inc.CanadaPerkinElmer Life Sciences International Holdings (97%) 6
50.    
Perkin Elmer Chile Ltda.ChilePerkinElmer Health Sciences, Inc. (68%) 7
51.    
Beijing Huaan Magnech Bio-Tech Co., Ltd.ChinaShandong Meizheng Bio-Tech Co., Ltd.
52.    
Beijing Meizheng Bio-Tech Co., Ltd.ChinaShandong Meizheng Bio-Tech Co., Ltd.
53.    
Beijing Meizheng Testing Lab Co., Ltd.ChinaShandong Meizheng Bio-Tech Co., Ltd.
54.    
Beijing OUMENG Biotechnology Co., Ltd.ChinaEUROIMMUN Medizinische Labordiagnostika AG
55.    
BioLegend China (Beijing) Ltd.ChinaBioLegend, Inc.
56.    
BioLegend (Shenzhen) Ltd.ChinaBioLegend China (Beijing) Ltd.
57.    
Chengdu PerkinElmer Medical Laboratory Co., Ltd.ChinaSuzhou PerkinElmer Medical Laboratory Co., Ltd.
58.    
Cisbio China, Ltd.ChinaCisbio Asia Pacific Ltd
59.    
EUROIMMUN (Hangzhou) Medical Laboratory Diagnostics Co., Ltd.ChinaEUROIMMUN Medical Diagnostics (China) Co., Ltd.
60.    
EUROIMMUN Medical Diagnostics (China) Co., Ltd.ChinaEUROIMMUN Medizinische Labordiagnostika AG
61.    
EUROIMMUN (Tianjin) Medical Diagnostic Technology Co., Ltd.ChinaEUROIMMUN Medical Diagnostics (China) Co., Ltd.
62.    
Guangzhou EUROIMMUN Medical Diagnostic Products Co., Ltd.ChinaEUROIMMUN Medical Diagnostics (China) Co., Ltd.
63.    
Hangzhou EUROIMMUN Medical Diagnostic Products Co., Ltd.ChinaEUROIMMUN Medical Diagnostics (China) Co., Ltd.
64.    
Jiangsu Meizheng Bio-Tech Co., Ltd.ChinaShandong Meizheng Bio-Tech Co., Ltd.
65.    
Nexcelom Bioscience Instruments (Shanghai) Co. Ltd.ChinaNexcelom Bioscience, LLC
66.    
Oxford Immunotec (Shanghai) Medical Device Co. Ltd.ChinaOxford Immunotec Asia Ltd.
67.    
PerkinElmer Healthcare Diagnostics (Shanghai) Co., Ltd. ChinaPerkinElmer IVD Pte Ltd.
68.    
PerkinElmer Instruments (Suzhou) Co., Ltd.ChinaWellesley B.V.
69.    
PerkinElmer Management (Chengdu) Co., Ltd.ChinaPerkinElmer Management (Shanghai) Co., Ltd.
70.    
PerkinElmer Management (Shanghai) Co., Ltd.ChinaPerkinElmer Singapore Pte Ltd.
71.    
PerkinElmer (Shanghai) Equity Investment Fund, L.P.ChinaPerkinElmer Singapore Pte Ltd. (98%) 8
72.    
PerkinElmer (Shanghai) Equity Investment Fund Management Co., Ltd.ChinaPerkinElmer Singapore Pte Ltd.
73.    
Shandong Meizheng Bio-Tech Co., Ltd. ChinaPerkinElmer Health Sciences B.V.
74.    
Shanghai Haoyuan Biotech Co., Ltd.ChinaPerkinElmer Holding Luxembourg S.à r.l.
75.    
Shanghai Spectrum Instruments Co., Ltd.ChinaWellesley B.V.
76.    
Suzhou PerkinElmer Medical Laboratory Co., Ltd.ChinaSuzhou Sym-Bio Lifescience Co., Ltd. (70%) 9
77.    
Suzhou Sym-Bio Lifescience Co., Ltd.ChinaPerkinElmer Healthcare Diagnostics (Shanghai) Co., Ltd. (75%) 10
78.    
PerkinElmer Danmark A/SDenmarkWallac Oy
79.    
PerkinElmer Finland OyFinlandWallac Oy
2 PerkinElmer Holdings, Inc. owns a de minimus share.
3    PerkinElmer Holdings, Inc. owns a de minimus share.
4    Immunodiagnostic Systems Holdings Limited owns a de minimus share.
5     PerkinElmer Holdings, Inc. owns 1%; PerkinElmer Health Sciences, Inc. owns a de minimus share.
6     Perten Instruments AB owns 3%.
7     PerkinElmer Holdings, Inc. owns 32%.
8 PerkinElmer (Shanghai) Equity Investment Fund Management Co., Ltd. owns 2%.
9     Shanghai Sai Ke Si Medical Technology L.P. owns 30%.
10     Wallac Oy owns 25%.
2 of 5






Name of Company

State or Country
of Incorporation
or Organization



Name of Parent
80.    
PerkinElmer Investments KyFinlandPerkinElmer Finance Luxembourg S.à r.l. 11
81.    
PerkinElmer OyFinlandWellesley B.V.
82.    
Suomen Bioanalytiikka OyFinlandImmunodiagnostic Systems Limited
83.    
Wallac OyFinlandPerkinElmer Oy
84.    
Bio Evolution SASFranceEUROIMMUN France SAS
85.    
BioLegend France SASFranceBioLegend, Inc.
86.    
Cisbio Bioassays SASFrancePerkinElmer SAS
87.    
EUROIMMUN France SASFranceEUROIMMUN Medizinische Labordiagnostika AG
88.    
Immunodiagnostic Systems France SASFranceImmunodiagnostic Systems Holdings Limited
89.    
PerkinElmer SAS FrancePerkinElmer Nederland B.V.
90.    
SIRION Biotech SASFranceSIRION Biotech GmbH
      91.
ZeLab SASFrancePerkinElmer SAS
92.    
BioLegend GmbHGermanyBioLegend, Inc.
93.    
Boulder Diagnostics Europe GmbHGermanyOxford Immunotec Limited
94.    
EUROIMMUN Medizinische Labordiagnostika AGGermanyPerkinElmer Germany Diagnostics GmbH
95.    
Immunodiagnostic Systems Deutschland GmbHGermanyImmunodiagnostic Systems Limited
96.    
PerkinElmer Cellular Technologies Germany GmbHGermanyPerkinElmer LAS (Germany) GmbH
97.    
PerkinElmer chemagen Technologie GmbHGermanyPerkinElmer Cellular Technologies Germany GmbH
98.    
PerkinElmer Germany Diagnostics GmbHGermanyPerkinElmer Global Diagnostics S.C.A.
99.    
PerkinElmer LAS (Germany) GmbHGermanyPerkinElmer Germany Diagnostics GmbH
100.    
Perten Instruments GmbHGermanyPerten Instruments AB
101.    
SIRION Biotech GmbHGermanyPerkinElmer Germany Diagnostics GmbH
102.    
Cisbio Asia Pacific Ltd.Hong KongCisbio Bioassays SAS
103.    
Oxford Immunotec Asia Ltd.Hong KongOxford Immunotec Limited
104.    
PerkinElmer (Hong Kong) Ltd.Hong KongPerkinElmer Holdings, Inc.
105.    
Biosense Technologies Pvt Ltd.IndiaTulip Diagnostics Pvt Ltd. 12
106.    
Orchid Biomedical Systems Pvt Ltd.IndiaTulip Diagnostics Pvt Ltd.
107.    
PerkinElmer Health Sciences Pvt Ltd.IndiaPerkinElmer IVD Pte Ltd. (91%) 13
108.    
PerkinElmer (India) Pvt Ltd.IndiaPerkinElmer Singapore Pte Ltd. 14
109.    
Prisms India Private Ltd.IndiaTulip Diagnostics Pvt Ltd. (97%) 15
110.    
Tulip Diagnostics Pvt Ltd.IndiaPerkinElmer Holding Luxembourg S.à r.l. (99%) 16
111.    
PT Tulip Diagnostics IndonesiaIndonesiaTulip Diagnostics Pvt Ltd.
112.    
Oxford Immunotec (Ireland) LimitedIrelandOxford Immunotec Limited
113.    
PerkinElmer (Ireland) Ltd.IrelandWellesley B.V.
114.    
PerkinElmer Scientific (Ireland) Ltd.IrelandWellesley B.V.
115.    
PerkinElmer Israel Ltd. IsraelPerkinElmer Holding Luxembourg S.à r.l.
116.    
DIA.Metra S.R.L.ItalyImmunodiagnostic Systems Limited
117.    
EUROIMMUN Italia Diagnostica Medica S.r.l.ItalyEUROIMMUN Medizinische Labordiagnostika AG
118.    
Perkin Elmer Italia SpAItalyWellesley B.V.
119.    
PerkinElmer Scientifica Italia S.r.l.ItalyPerkin Elmer Italia SpA
120.    
BioLegend Japan, KKJapanBioLegend, Inc.
121.    
EUROIMMUN Japan Co. Ltd.JapanEUROIMMUN Medizinische Labordiagnostika AG
122.    
Horizon Discovery KKJapanHorizon Discovery Group Ltd.
123.    
Oxford Immunotec KKJapanOxford Immunotec Limited
11     PerkinElmer Holding Luxembourg S.à r.l. owns a de minimus share.
12 Individual shareholder own 1%.
13     Surendra Genetic Laboratory & Research Centre Pvt Ltd. owns 9%.
14 Wellesley B.V. owns a de minimus share.
15 Individual shareholders own 1%.
16 Individual shareholders own 1%.
3 of 5






Name of Company

State or Country
of Incorporation
or Organization



Name of Parent
124.    
PerkinElmer Japan Co. Ltd.JapanPerkinElmer Life Sciences International Holdings (97%) 17
125.    
Perkin Elmer Yuhan HoesaKoreaPerkinElmer Diagnostics Global Holdings S.à r.l.
126.    
PerkinElmer Diagnostics Global Holdings S.à r.l.LuxembourgPerkinElmer Global Holdings S.à r.l.
127.    
PerkinElmer Finance Luxembourg S.à r.l.LuxembourgPerkinElmer Holding Luxembourg S.à r.l.
128.    
PerkinElmer Global Diagnostics S.C.A.LuxembourgPerkinElmer Global Financing S.à r.l. 18
129.    
PerkinElmer Global Financing S.à r.l.LuxembourgPerkinElmer Global Holdings S.à r.l.
130.    
PerkinElmer Global Holdings S.à r.l.LuxembourgPerkinElmer Holdings, Inc.
131.    
PerkinElmer Holding Luxembourg S.à r.l.LuxembourgPerkinElmer Diagnostics Global Holdings S.à r.l.
132.    
Perkin Elmer Sdn. Bhd.MalaysiaPerkinElmer Diagnostics Global Holdings S.à r.l.
133.    
Inochem S.A. de C. V.MexicoPerkin Elmer de Mexico, S.A. 19
134.    
Perkin-Elmer de Mexico, S.A.MexicoPerkinElmer Holdings, Inc. 20
135.    
BioLegend Europe B.V.NetherlandsBioLegend, Inc.
136.    
PerkinElmer Health Sciences B.V.NetherlandsPerkinElmer Life Sciences International Holdings
137.    
PerkinElmer International C.V. NetherlandsPerkinElmer Global Holdings S.à r.l. 21
138.    
PerkinElmer Nederland B.V.Netherlands
139.    
Wellesley B.V.NetherlandsPerkinElmer Holding Luxembourg S.à r.l.
140.    
PerkinElmer Norge ASNorwayWallac Oy
141.    
Perkin Elmer Instruments (Philippines) CorporationPhilippinesPerkinElmer Holdings, Inc.
142.    
EUROIMMUN Polska Sp. z o.o.PolandEUROIMMUN Medizinische Labordiagnostika AG
143.    
PerkinElmer Polska Sp. z o.o.PolandWellesley B.V.
143.    
PerkinElmer Shared Services Sp. z o.o.PolandWellesley B.V.
144.    
EUROIMMUN Portugal, Unipessoal Lda.PortugalEUROIMMUN Medizinische Labordiagnostika AG
145.    
EUROIMMUN (South East Asia) Pte Ltd.SingaporeEUROIMMUN Medizinische Labordiagnostika AG
146.    
PerkinElmer Holdings Singapore Pte Ltd.SingaporePerkinElmer Holdings, Inc,
147.    
PerkinElmer IVD Pte Ltd.SingaporeWallac Oy
148.    
PerkinElmer Life Sciences Singapore Pte. Ltd.SingaporePerkinElmer Holdings Singapore Pte Ltd.
149.    
PerkinElmer Singapore Pte Ltd.SingaporePerkinElmer Diagnostics Global Holdings S.à r.l.
150.    
Singapore Biosciences Pte Ltd.SingaporeTulip Diagnostics Pvt Ltd.
151.    
EUROIMMUN Medical Laboratory Diagnostics South Africa (Pty) Ltd.South AfricaEUROIMMUN Medizinische Labordiagnostika AG
152.    
PerkinElmer South Africa (Pty) Ltd.South AfricaWellesley B.V.
153.    
EUROIMMUN Diagnostics España, S.L.SpainEUROIMMUN Medizinische Labordiagnostika AG
154.    
Integromics, S.L.SpainPerkinElmer España, S.L.
155.    
PerkinElmer España, S.L.SpainWellesley B.V.
156.    
PerkinElmer Genomics Sweden ABSwedenPerten Instruments AB
157.    
PerkinElmer Sverige ABSwedenWallac Oy
158.    
Perten Instruments ABSwedenPerkinElmer Holding Luxembourg S.à r.l. (73%) 22
159.    
Vanadis Diagnostics ABSwedenPerten Instruments AB
160.    
EUROIMMUN Schweiz AGSwitzerlandEUROIMMUN Medizinische Labordiagnostika AG
161.    
OZ Systems International SARLSwitzerlandOZ Systems USA, LLC
162.    
PerkinElmer (Schweiz) AGSwitzerlandWellesley B.V.
163.    
BioLegend Taiwan, Ltd.TaiwanBioLegend, Inc.
164.    
PerkinElmer Taiwan CorporationTaiwanPerkinElmer Holding Luxembourg S.à r.l.
17 Wallac Oy owns 3%.
18 PerkinElmer Global Holdings S.à r.l. owns 1%.
19 EUROIMMUN Medizinische Labordiagnostika AG owns 1%.
20 PerkinElmer, Inc. owns a de minimus share.
21 PerkinElmer CV Holdings, LLC owns 1%.
22 PerkinElmer Diagnostics Global Holdings S.à r.l. owns 27%.
4 of 5






Name of Company

State or Country
of Incorporation
or Organization



Name of Parent
165.    
PerkinElmer LimitedThailandPerkinElmer, Inc. 23
166.    
EUROIMMUN Turkey Tibbi Laboratuar Teşhisleri A.Ş.TurkeyEUROIMMUN Medizinische Labordiagnostika AG24
167.    
PerkinElmer Sağlık ve Çevre Bilimleri Ltd.TurkeyPerkinElmer Holding Luxembourg S.à r.l.
168.    
PerkinElmer Health Sciences FZ-LLCUnited Arab EmiratesPerkinElmer Holding Luxembourg S.à r.l.
169.    
BioLegend UK, Ltd.United KingdomBioLegend, Inc.
170.    
EUROIMMUN UK Ltd.United KingdomEUROIMMUN Medizinische Labordiagnostika AG
171.    
Horizon Diagnostics LimitedUnited KingdomHorizon Discovery Limited
172.    
Horizon Discovery Biosciences LimitedUnited KingdomHorizon Discovery Limited
173.    
Horizon Discovery Group Ltd.United KingdomPerkinElmer (UK) Holdings Ltd.
174.    
Horizon Discovery LimitedUnited KingdomHorizon Discovery Group Ltd.
175.    
Immunodiagnostic Systems Holdings LimitedUnited KingdomPerkinElmer (UK) Holdings Ltd.
176.    
Immunodiagnostic Systems LimitedUnited KingdomImmunodiagnostic Systems Holdings Limited
177.    
Nexcelom Bioscience Ltd.United KingdomNexcelom Bioscience, LLC
178.    
Oxford Diagnostic Laboratories (UK) LimitedUnited KingdomOxford Immunotec Limited
179.    
Oxford Immunotec Global LimitedUnited KingdomPerkinElmer (UK) Holdings Ltd.
180.    
Oxford Immunotec LimitedUnited KingdomOxford Immunotec Global Limited
181.    
PerkinElmer LAS (UK) Ltd.United KingdomPerkinElmer (UK) Holdings Ltd.
182.    
PerkinElmer Life Sciences International Holdings United KingdomPerkinElmer Health Sciences, Inc.
183.    
PerkinElmer Ltd.United KingdomPerkinElmer (UK) Holdings Ltd.
184.    
PerkinElmer (UK) Holdings Ltd.United KingdomWellesley B.V.
185.    
RayAl Ltd.United KingdomSolus Scientific Solutions Ltd.
186.
Solus Scientific Solutions Ltd.United KingdomPerkinElmer (UK) Holdings Ltd.
187.
Synthetx LimitedUnited KingdomHorizon Discovery Limited




23 PerkinElmer Holdings, Inc. and PerkinElmer Health Sciences, Inc. each own a de minimus share.
24 Individual shareholders own de minimus shares.
5 of 5


EXHIBIT 23
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-61615, 333-92228, 333-158877, 333-231071 and 333-263860 on Form S-8 and Registration Statement No. 333-263859 on Form S-3 of our reports dated March 1, 2023, relating to the financial statements of PerkinElmer, Inc. and subsidiaries, and the effectiveness of PerkinElmer, Inc. and subsidiaries’ internal control over financial reporting, appearing in this Annual Report on Form 10-K for the year ended January 1, 2023.

/s/ DELOITTE & TOUCHE LLP
Boston, Massachusetts
March 1, 2023



CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302
 
EXHIBIT 31.1
 
CERTIFICATION
 
I, Prahlad Singh, certify that:
 
1.I have reviewed this Annual Report on Form 10-K of PerkinElmer, Inc.;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date:March 1, 2023/S/    PRAHLAD SINGH, PhD   
 Prahlad Singh, PhD
 President and Chief Executive Officer



CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302
 
EXHIBIT 31.2
 
CERTIFICATION
 
I, Maxwell Krakowiak, certify that:
 
1.I have reviewed this Annual Report on Form 10-K of PerkinElmer, Inc.;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date:March 1, 2023/s/    MAXWELL KRAKOWIAK 
 Maxwell Krakowiak
Senior Vice President and Chief Financial Officer





CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906
 
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report on Form 10-K of PerkinElmer, Inc. (the “Company”) for the period ended January 1, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Prahlad Singh, President and Chief Executive Officer of the Company, and Maxwell Krakowiak, Senior Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)Based on my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)Based on my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
  
Date:March 1, 2023/S/    PRAHLAD SINGH, PhD 
 Prahlad Singh, PhD
 President and Chief Executive Officer
 
 
Date:March 1, 2023/s/    MAXWELL KRAKOWIAK        
 Maxwell Krakowiak
Senior Vice President and Chief Financial Officer



v3.22.4
Cover Page - USD ($)
 12 Months Ended
Jan. 01, 2023
Feb. 24, 2023
Jul. 01, 2022
Jan. 02, 2022
Entity Listings [Line Items]        
Document Annual Report true      
Entity Well-known Seasoned Issuer Yes      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Public Float     $ 18,089,645,853  
ICFR Auditor Attestation Flag true      
Entity Shell Company false      
Sale of Stock, Price Per Share     $ 144.07  
Common stock, par value $ 1     $ 1
Document Type 10-K      
Document Period End Date Jan. 01, 2023      
Document Transition Report false      
Entity File Number 001-5075      
Entity Registrant Name PERKINELMER, INC.      
Entity Incorporation, State or Country Code MA      
Entity Tax Identification Number 04-2052042      
Entity Address, Address Line One 940 Winter Street,      
Entity Address, City or Town Waltham,      
Entity Address, State or Province MA      
Entity Address, Postal Zip Code 02451      
City Area Code 781      
Local Phone Number 663-6900      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Large Accelerated Filer      
Entity Small Business false      
Entity Emerging Growth Company false      
Entity Common Stock, Shares Outstanding   126,411,985    
Entity Central Index Key 0000031791      
Document Fiscal Year Focus 2022      
Document Fiscal Period Focus FY      
Amendment Flag false      
Current Fiscal Year End Date --01-01      
PKI [Member]        
Entity Listings [Line Items]        
Trading Symbol PKI      
Trading Symbol PKI      
PKI 21A [Member]        
Entity Listings [Line Items]        
Trading Symbol PKI 21A      
Trading Symbol PKI 21A      
Common stock, $1 par value per share [Member]        
Entity Listings [Line Items]        
Title of 12(b) Security Common Stock, $1 Par Value      
Title of 12(b) Security Common Stock, $1 Par Value      
1.875% Notes due 2026 [Member]        
Entity Listings [Line Items]        
Title of 12(b) Security 1.875% Notes due 2026      
Title of 12(b) Security 1.875% Notes due 2026      
NEW YORK STOCK EXCHANGE, INC. [Member]        
Entity Listings [Line Items]        
Security Exchange Name NYSE      
Security Exchange Name NYSE      

v3.22.4
Audit Information
 12 Months Ended
Jan. 01, 2023
Audit Information [Abstract]  
Auditor Name DELOITTE & TOUCHE LLP
Auditor Location Boston, Massachusetts
Auditor Firm ID 34

v3.22.4
Document and Entity Information - USD ($)
 12 Months Ended
Jan. 01, 2023
Feb. 24, 2023
Jul. 01, 2022
Entity Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 01, 2023    
Document Transition Report false    
Entity File Number 001-5075    
Entity Registrant Name PERKINELMER, INC.    
Entity Central Index Key 0000031791    
Current Fiscal Year End Date --01-01    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Incorporation, State or Country Code MA    
Entity Tax Identification Number 04-2052042    
Entity Address, Address Line One 940 Winter Street,    
Entity Address, City or Town Waltham,    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02451    
City Area Code 781    
Local Phone Number 663-6900    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 18,089,645,853
Entity Common Stock, Shares Outstanding   126,411,985  
Documents Incorporated by Reference Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 25, 2023 are incorporated by reference into Part III of this Form 10-K.    
Common stock, $1 par value per share [Member]      
Entity Information [Line Items]      
Title of 12(b) Security Common Stock, $1 Par Value    
1.875% Notes due 2026 [Member]      
Entity Information [Line Items]      
Title of 12(b) Security 1.875% Notes due 2026    
NEW YORK STOCK EXCHANGE, INC. [Member]      
Entity Information [Line Items]      
Security Exchange Name NYSE    
PKI [Member]      
Entity Information [Line Items]      
Trading Symbol PKI    
PKI 21A [Member]      
Entity Information [Line Items]      
Trading Symbol PKI 21A    

v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Revenue      
Revenue from Contract with Customer, Excluding Assessed Tax $ 3,311,822 $ 3,827,808 $ 2,663,230
Selling, general and administrative expenses 1,025,514 975,193 716,465
Research and development expenses 221,617 200,337 146,441
Restructuring and other costs, net (13,580) 14,358 7,661
Operating income from continuing operations 742,699 1,258,457 867,273
Interest and other expense, net 90,862 54,875 67,201
Income from continuing operations before income taxes 651,837 1,203,582  
Income from continuing operations before income taxes 651,837 1,203,582 800,072
Provision for income taxes 139,161 314,146 169,512
Income from continuing operations 512,676 889,436 630,560
Income from discontinued operations before income taxes 73,604 76,304 106,292
(Loss) gain on disposition of discontinued operations before income taxes 0 0 (76)
(Benefit from) provision for income taxes on discontinued operations and dispositions 17,101 22,583 8,889
Income from discontinued operations and dispositions 56,503 53,721 97,327
Net income $ 569,179 $ 943,157 $ 727,887
Basic earnings per share:      
Income from continuing operations $ 4.06 $ 7.66 $ 5.65
Income from discontinued operations and dispositions 0.45 0.46 0.87
Net income 4.51 8.12 6.52
Diluted earnings per share:      
Income from continuing operations 4.06 7.62 5.63
Income from discontinued operations and dispositions 0.45 0.46 0.87
Net income $ 4.50 $ 8.08 $ 6.49
Product [Member]      
Revenue      
Revenue from Contract with Customer, Excluding Assessed Tax $ 2,634,582 $ 2,735,068 $ 2,280,853
Cost of Goods and Services Sold 1,150,402 1,129,223 794,405
Service [Member]      
Revenue      
Revenue from Contract with Customer, Excluding Assessed Tax 677,240 1,092,740 382,377
Cost of Goods and Services Sold $ 171,590 $ 264,598 $ 138,646

v3.22.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Net income $ 569,179 $ 943,157 $ 727,887
Other comprehensive income (loss)      
Foreign currency translation adjustments, net of tax (284,854) (130,873) 169,500
Unrecognized prior service credit (cost), net of tax 44 (95) (1,799)
Unrealized gains (losses) on securities, net of tax 5 237 (16)
Other comprehensive (loss) income (284,805) (130,731) 167,685
Comprehensive income $ 284,374 $ 812,426 $ 895,572

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Current assets:    
Cash and cash equivalents $ 454,358 $ 603,320
Accounts receivable, net 612,780 707,941
Inventories 405,462 425,890
Other current assets 122,254 148,255
Current assets of discontinued operations 1,693,704 555,374
Total current assets 3,288,558 2,440,780
Property, plant and equipment, net 482,950 485,531
Operating Lease, Right-of-Use Asset 188,351 164,040
Intangible assets, net 3,377,174 3,821,847
Goodwill 6,481,768 6,627,119
Other assets, net 311,054 317,069
Long-term assets of discontinued operations 0 1,144,168
Total assets 14,129,855 15,000,554
Current liabilities:    
Current portion of long-term debt 470,929 4,240
Accounts payable 272,826 324,811
Accrued expenses and other current liabilities 527,863 679,099
Current liabilities of discontinued operations 272,865 205,594
Total current liabilities 1,544,483 1,213,744
Long-term debt 3,923,347 4,979,737
Long-term liabilities 1,109,181 1,426,731
Operating Lease, Liability, Noncurrent 169,968 147,395
Long-term liabilities of discontinued operations 0 91,702
Total liabilities 6,746,979 7,859,309
Commitments and contingencies (see Note 16)
Stockholders' equity:    
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding 0 0
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 126,300,000 and 126,241,000 shares at January 1, 2023 and January 2, 2022, respectively 126,300 126,241
Capital in excess of par value 2,753,055 2,760,522
Retained earnings 4,951,018 4,417,174
Accumulated other comprehensive loss (447,497) (162,692)
Total stockholders' equity 7,382,876 7,141,245
Total liabilities and stockholders' equity $ 14,129,855 $ 15,000,554

v3.22.4
Consolidated Balance Sheet Parenthetical - $ / shares
Jan. 01, 2023
Jan. 02, 2022
Balance Sheet Parenthetical [Abstract]    
Preferred stock, par value $ 1 $ 1
Preferred stock, authorized 1,000,000 1,000,000
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Common stock, par value $ 1 $ 1
Common stock, authorized 300,000,000 300,000,000
Common stock, issued 126,300,000 126,241,000
Common stock, outstanding 126,300,000 126,241,000

v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Amount [Member]
Common Stock Amount [Member]
Net Income [Member]
Common Stock Amount [Member]
Other comprehensive loss [Member]
Common Stock Amount [Member]
Dividends [Member]
Common Stock Amount [Member]
Issuance of common stock for business combination, net of issuance costs [Member]
Common Stock Amount [Member]
Exercise of employee stock options and related income tax benefits [Member]
Common Stock Amount [Member]
Purchases of common stock [Member]
Common Stock Amount [Member]
Issuance of common stock for employee stock purchase plans [Member]
Common Stock Amount [Member]
Issuance of common stock for long-term incentive program [Member]
Common Stock Amount [Member]
Stock compensation [Member]
Capital In Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Common stock, outstanding   111,140,000                        
Beginning Balance at Dec. 29, 2019 $ 2,813,824 $ 111,140                   $ 90,357 $ 2,811,973 $ (199,646)
Net income 727,887                       727,887  
Other comprehensive income (loss) 167,685                          
Dividends (31,270)                       (31,270) 0
Exercise of employee stock options and related income tax benefits 37,671 764                   36,907    
Issuance of common stock for employee benefit plans 4,101 39                   4,062    
Cost of Repurchased Common Shares, Repurchase Plan and Amount for Statutory Tax Withholding Obligations 6,944 72                   6,872    
Issuance of common stock for long-term incentive program 20,204 219                   19,985    
Stock compensation 3,662 0                   3,662 0 0
Ending Balance at Jan. 03, 2021 3,735,492 $ 112,090                   148,101 3,507,262 (31,961)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 167,685                          
Other Comprehensive Income (Loss), after Reclassifications, Net of Tax 167,685                         167,685
Cumulative Effect of New Accounting Pronouncement in Period of Adoption | Accounting Standards Update 2016-02 [Member] (1,328)                     0 (1,328)  
Common stock, outstanding   112,090,000 0 0 0   764,000 (72,000) 39,000 219,000 0      
Common stock, outstanding | Accounting Standards Update 2016-02 [Member]   0                        
Net income 943,157                       943,157  
Other comprehensive income (loss) (130,731)                          
Dividends (33,245)                       (33,245)  
Exercise of employee stock options and related income tax benefits 25,120 $ 358                   24,762    
Issuance of common stock for employee benefit plans 3,628 21                   3,607    
Cost of Repurchased Common Shares, Repurchase Plan and Amount for Statutory Tax Withholding Obligations 73,072 504                   72,568    
Issuance of common stock for long-term incentive program 26,501 209                   26,292    
Stock compensation 6,251 0                   6,251 0 0
Ending Balance at Jan. 02, 2022 7,141,245 126,241                   2,760,522 4,417,174 (162,692)
Other Comprehensive Income (Loss), after Reclassifications, Net of Tax (130,731)                         (130,731)
Stock Issued During Period, Value, Acquisitions $ (2,638,144) $ (14,067)                   (2,624,077)    
Common stock, outstanding 126,241,000 126,241,000 0 0 0 14,067,000 358,000 (504,000) 21,000 209,000 0      
Net income $ 569,179                       569,179  
Other comprehensive income (loss) (284,805)                          
Dividends (35,335)                       (35,335)  
Exercise of employee stock options and related income tax benefits 14,114 $ 195                   13,919    
Issuance of common stock for employee benefit plans 4,172 31                   4,141    
Cost of Repurchased Common Shares, Repurchase Plan and Amount for Statutory Tax Withholding Obligations 80,638 493                   80,145    
Issuance of common stock for long-term incentive program 44,561 326                   44,235    
Stock compensation 10,383 0                   10,383 0 0
Ending Balance at Jan. 01, 2023 7,382,876 $ 126,300                   $ 2,753,055 $ 4,951,018 (447,497)
Other Comprehensive Income (Loss), after Reclassifications, Net of Tax $ (284,805)                         $ (284,805)
Common stock, outstanding 126,300,000 126,300,000 0 0 0   195,000 (493,000) 31,000 326,000 0      

v3.22.4
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Jan. 01, 2023
USD ($)
Jan. 02, 2022
USD ($)
Jan. 03, 2021
USD ($)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 470,746 $ 619,337 $ 402,614
Operating activities:      
Net income 569,179 943,157 727,887
Income (Loss) from discontinued operations and dispositions (56,503) (53,721) (97,327)
Income from continuing operations 512,676 889,436 630,560
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:      
Restructuring and other costs, net 13,580 (14,358) (7,661)
Depreciation and amortization 427,000 311,443 201,648
Stock-based compensation 51,518 29,675 26,904
Pension and other post-retirement (income) expense (23,104) (28,509) 14,904
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (1,377) 3,119 (8,827)
Deferred taxes (105,923) (55,328) (35,338)
Deferred Income Tax Expense (Benefit), Continuing Operations, Discontinuing Operations (105,923) (55,328) (35,338)
Contingencies and Non-Cash Tax Matters (1,488) 1,924 4,518
Amortization of deferred debt issuance costs, interest rate hedge and accretion of discounts 7,310 4,962 3,391
(Gain) loss on disposition of businesses and assets, net (2,887) (1,970) 886
Amortization of acquired inventory revaluation 45,289 35,201 1,831
Asset Impairment Charges 0 3,868 7,937
Change in fair value of financial securities 15,754 (10,985) (35)
Gain (Loss) on Extinguishment of Debt (2,880) 0 0
Changes in assets and liabilities which (used) provided cash, excluding effects from companies purchased and divested:      
Accounts receivable, net 66,093 165,590 (398,853)
Inventories, net (48,634) 32,280 (127,357)
Accounts payable (43,804) (7,577) 63,231
Accrued expenses and other (236,623) (57,303) 311,659
Net cash provided by operating activities of continuing operations 672,500 1,330,184 704,720
Net cash provided by operating activities of discontinued operations 7,310 80,566 187,457
Net cash provided by operating activities 679,810 1,410,750 892,177
Investing activities:      
Capital expenditures (85,632) (86,020) (63,634)
Payments to Acquire Investments (47,181) (23,130) (20,059)
Proceeds from Collection of Notes Receivable 8,890 0 0
Proceeds from Divestiture of Businesses 14,505 1,460 4,280
Proceeds from surrender of life insurance policies 0 109 282
Cash paid for acquisitions, net of cash acquired (7,518) (3,982,216) (411,495)
Net cash used in investing activities of continuing operations (116,936) (4,089,797) (490,626)
Net cash used in investing activities of discontinued operations (15,915) (22,961) (13,872)
Net cash used in investing activities (132,851) (4,112,758) (504,498)
Financing activities:      
Payments on revolving credit facility (240,000) (1,559,133) (897,674)
Proceeds from Long-term Lines of Credit 240,000 1,400,282 714,698
Proceeds from term loan 0 500,000 0
Repayments of Term Loan (500,000) 0 0
Payments of Senior Debt (57,876) (339,605) 0
Proceeds from sale of senior debt 0 3,086,095 0
Payments of debt financing and equity issuance costs 0 (30,983) 0
Proceeds from (Repayments of) Other Debt (1,292) (13,670) (4,494)
Settlement of cash flow hedges (762) (4,482) (4,554)
Settlement of swaps 0 14,314 0
Payments for acquisition-related contingent consideration (5) (2,208) (10,363)
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 14,114 25,120 37,671
Purchases of common stock (80,638) (73,072) (6,944)
Dividends paid (35,344) (32,373) (31,212)
Net cash (used in) provided by financing activities (661,803) 2,941,657 (202,872)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (33,747) (22,926) 25,913
Net (decrease) increase in cash, cash equivalents and restricted cash (148,591) 216,723 210,720
Cash and cash equivalents at beginning of year 603,320 387,054  
Restricted Cash, Current 1,040 1,018 578
Restricted Cash, Noncurrent 349 0 0
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 14,999 14,999 14,982
Cash and cash equivalents at end of year 454,358 603,320 387,054
Supplemental disclosures of cash flow information      
Interest Paid, Excluding Capitalized Interest, Operating Activities 97,934 54,120 42,142
Income taxes 323,077 364,565 162,454
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]      
Equity issued for business combination, net of issuance costs $ 0 $ 2,638,144 $ 0

v3.22.4
Interest and Other Expense (Income), Net
 12 Months Ended
Jan. 01, 2023
Other Income and Expenses [Abstract]  
Interest and Other Expense (Income), Net Interest and Other Expense, Net
Interest and other expense, net, consisted of the following for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Interest income$(3,589)$(2,241)$(1,010)
Interest expense including costs of bridge financing103,955 102,128 49,712 
Change in fair value of financial securities15,754 (10,985)(35)
Other components of net periodic pension (credit) cost(33,158)(37,385)13,819 
Other expense, net7,900 3,358 4,715 
Total interest and other expense, net$90,862 $54,875 $67,201 

v3.22.4
Interest and Other Expense (Income), Net
 12 Months Ended
Jan. 01, 2023
Other Income and Expenses [Abstract]  
Interest and Other Expense (Income), Net
Interest and other expense, net, consisted of the following for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Interest income$(3,589)$(2,241)$(1,010)
Interest expense including costs of bridge financing103,955 102,128 49,712 
Change in fair value of financial securities15,754 (10,985)(35)
Other components of net periodic pension (credit) cost(33,158)(37,385)13,819 
Other expense, net7,900 3,358 4,715 
Total interest and other expense, net$90,862 $54,875 $67,201 

v3.22.4
Interest and Other Expense (Income), Net - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Change in fair value of financial securities $ 15,754 $ (10,985) $ (35)
Interest expense including costs of bridge financing 103,955 102,128 49,712
Interest income (3,589) (2,241) (1,010)
Interest expense including costs of bridge financing 103,955 102,128 49,712
Gain (Loss) on Extinguishment of Debt (2,880) 0 0
Other components of net periodic pension (credit) cost (33,158) (37,385) 13,819
Other expense, net 7,900 3,358 4,715
Total interest and other expense, net $ 90,862 $ 54,875 $ 67,201

v3.22.4
Business Combinations and Asset Purchases
 12 Months Ended
Jan. 01, 2023
Business Combinations [Abstract]  
Business Combinations and Asset Purchases Business Combinations
Acquisitions in fiscal year 2022
During fiscal year 2022, the Company completed the acquisition of two businesses for aggregate consideration of $13.3 million. Identifiable definite-lived intangible assets, such as core technology, acquired as part of these acquisitions had a weighted average amortization period of 5 years.
Acquisitions in fiscal year 2021
Acquisition of BioLegend, Inc. In fiscal year 2021, the Company completed the acquisition of BioLegend, Inc. (“BioLegend”) and paid an aggregate consideration of $5.7 billion, net of cash acquired of $292.4 million, reflecting working capital and other adjustments (the “Aggregate Consideration”). The Aggregate Consideration was paid in a combination of $3.3 billion in cash and shares of the Company’s common stock having a fair value of approximately $2.6 billion based on the $187.56 per share closing price of the Company's common stock on the New York Stock Exchange on September 17, 2021 (the “Stock Consideration”). The Stock Consideration consisted of 14,066,799 shares of the Company’s common stock. BioLegend is recognized as a leading, global provider of life science antibodies and reagents headquartered in San Diego, California, with approximately 700 employees. The operations for this acquisition is reported within the results of the Company’s Discovery & Analytical Solutions segment from the acquisition date. The excess of the purchase price over the fair value of the acquired net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforce acquired, and is not tax deductible. Identifiable definite-lived intangible assets, such as core technology, trade names, customer relationships and clone library, acquired as part of this acquisition had a weighted-average amortization period of 16.3 years.
BioLegend’s revenue and net loss for the period from the acquisition date to January 2, 2022 were $91.7 million and $25.8 million, respectively. The net loss includes $47.0 million of amortization of acquired intangible assets. The following unaudited pro forma information presents the combined financial results for the Company and BioLegend as if the acquisition of BioLegend had been completed at the beginning of fiscal year 2020:
January 2,
2022		January 3,
2021
(In thousands, except per share data)
Pro Forma Statement of Operations Information:
Revenue$4,056,122 $2,905,116 
Income from continuing operations947,387 454,034 
Basic earnings per share:
Income from continuing operations$7.27 $3.62 
Diluted earnings per share:
Income from continuing operations$7.25 $3.60 
The unaudited pro forma information for fiscal year 2021 has been calculated after applying the Company’s accounting policies and the impact of acquisition date fair value adjustments. The fiscal year 2021 unaudited pro forma income from continuing operations was adjusted to exclude approximately $43.2 million of acquisition-related transaction costs and $23.3 million of costs of bridge financing and debt pre-issuance hedges that were recognized in expense during fiscal year 2021. The fiscal year 2020 unaudited pro forma income from continuing operations was adjusted to include these acquisition-related transaction costs and the nonrecurring expenses related to the bridge financing and debt pre-issuance hedging costs and fair value adjustments as if those expenses were incurred in fiscal year 2020. These pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments, such as fair value adjustment to inventory, increased interest expense on debt obtained to finance the transaction, and increased amortization for the fair value of acquired intangible assets.
The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of each period presented, or of future results of the consolidated entities. The actual results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors.
Other acquisitions in 2021. During fiscal year 2021, the Company also completed the acquisition of seven other businesses for aggregate consideration of $1.2 billion. The acquired businesses include Oxford Immunotec Global PLC, a company based in Abingdon, UK with approximately 275 employees, for total consideration of $590.9 million and Nexcelom Bioscience Holdings, LLC, a company based in Lawrence, Massachusetts with approximately 130 employees, for total consideration of $267.3 million, and five other businesses, which were acquired for total consideration of $318.6 million. The excess of the purchase prices over the fair values of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as employee workforces acquired, and has been allocated to goodwill, which is not tax deductible. Identifiable definite-lived intangible assets, such as core technology, trade names, and customer relationships, acquired as part of these acquisitions had a weighted-average amortization period of 12.4 years.
The total purchase price for the acquisitions in fiscal year 2021 has been allocated to the estimated fair value of assets acquired and liabilities assumed as follows:
Final
BioLegendOther
(In thousands)
Fair value of business combinations:
Cash payments$3,336,115 $1,128,584 
Common stock issued2,638,369 — 
Other liability6,857 2,910 
Contingent consideration— 45,031 
Working capital and other adjustments— 183 
Less: cash acquired(292,377)(195,010)
Total$5,688,964 $981,698 
Identifiable assets acquired and liabilities assumed:
Current assets$184,704 $71,840 
Property, plant and equipment147,200 26,507 
Other assets9,330 15,527 
Identifiable intangible assets:
Core technology and clone library782,400 290,089 
Trade names and patents38,000 39,476 
Licenses8,979 — 
Customer relationships and backlog1,714,800 141,670 
Goodwill3,509,931 545,262 
Deferred taxes(668,919)(80,923)
Deferred revenue— (1,197)
Debt assumed— (4,628)
Liabilities assumed(37,461)(61,925)
Total$5,688,964 $981,698 
The Company does not consider the other acquisitions completed during fiscal year 2021 to be material to its consolidated results of operations; therefore, the Company is only presenting pro forma financial information of operations for the BioLegend acquisition. The aggregate revenue and results of operations for the other acquisitions completed during fiscal year 2021 for the period from their respective acquisition dates to January 2, 2022 were not material.
Acquisitions in fiscal year 2020
During fiscal year 2020, the Company completed the acquisition of four businesses for aggregate consideration of $438.9 million. The acquired businesses were Horizon Discovery Group plc, a company based in Cambridge, UK with approximately 400 employees, which was acquired on December 23, 2020 for a total consideration of $399.8 million (£296.0 million), and three other businesses which were acquired for a total consideration of $39.1 million. The excess of the purchase prices over the fair values of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforces acquired, and has been allocated to goodwill, which is not tax deductible. Identifiable definite-lived intangible assets, such as core technology, trade names, customer relationships and in-process research and development, acquired as part of these acquisitions had a weighted average amortization period of 11 years.
The total purchase price for the acquisitions in fiscal year 2020 has been allocated to the estimated fair value of assets acquired and liabilities assumed as follows:
Final
(In thousands)
Fair value of business combinations:
Cash payments$437,661 
Other liability1,660 
Working capital and other adjustments(384)
Less: cash acquired(26,840)
Total$412,097 
Identifiable assets acquired and liabilities assumed:
Current assets$35,532 
Property, plant and equipment20,302 
Other assets18,114 
Identifiable intangible assets:
Core technology65,730 
Trade names5,580 
Customer relationships and backlog108,523 
IPRD10,700 
Goodwill221,751 
Deferred taxes(25,674)
Deferred revenue(2,031)
Liabilities assumed(46,430)
Total$412,097 
The Company does not consider the acquisitions completed during fiscal year 2020 to be material to its consolidated results of operations. The aggregate revenue and results of operations for the acquisitions completed during fiscal year 2020 for the period from their respective acquisition dates to January 3, 2021 were not material.
As of January 1, 2023, the allocations of purchase prices for all acquisitions completed in fiscal years 2021 and 2020 were considered final.
During fiscal year 2022, the Company obtained information relevant to determining the fair values of certain tangible and intangible assets acquired, and liabilities assumed, related to recent acquisitions and adjusted its purchase price allocations. The adjustments to the preliminary measurements were not material.
The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair values for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash. Increases or decreases in the fair value of contingent consideration liabilities primarily result from changes in the estimated probabilities of achieving revenue thresholds or product development milestones during the earnout period.
As of January 1, 2023, the Company may have to pay contingent consideration, related to acquisitions with open contingency periods, of up to $106.2 million. As of January 1, 2023, the Company has recorded contingent consideration obligations of $46.6 million, of which $3.6 million was recorded in accrued expenses and other current liabilities, and $43.0 million was recorded in long-term liabilities. As of January 2, 2022, the Company had recorded contingent consideration obligations with an estimated fair value of $58.0 million, of which $1.3 million was recorded in accrued expenses and other current liabilities, and $56.7 million was recorded in long-term liabilities. The expected maximum earnout period for acquisitions with open contingency periods is 5.9 years from January 1, 2023, and the remaining weighted average expected
earnout period at January 1, 2023 was 4.9 years. If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the consolidated financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of definite-lived intangible assets or the recognition of additional contingent consideration which would be recognized as a component of operating expenses from continuing operations.
Total acquisition and divestiture-related costs were $39.8 million, $80.8 million and $4.9 million for fiscal years 2022, 2021 and 2020. These amounts included $26.5 million and $6.9 million of stock compensation expense related to awards given to BioLegend employees in fiscal years 2022 and 2021, respectively, $5.4 million of net foreign exchange gain and $23.4 million of costs of bridge financing and debt pre-issuance hedges related to the BioLegend acquisition in fiscal year 2021, and $0.5 million of acquisition-related interest expenses in fiscal year 2020. These acquisition and divestiture-related costs were expensed as incurred and recorded in selling, general and administrative expenses and interest and other expense, net in the Company’s consolidated statements of operations.

v3.22.4
Nature of Operations and Accounting Policies
 12 Months Ended
Jan. 01, 2023
Accounting Policies [Abstract]  
Nature of Operations and Accounting Policies Nature of Operations and Accounting Policies
Nature of Operations:    PerkinElmer, Inc. is a leading provider of products, services and solutions to the diagnostics and life sciences and applied markets. The Company has two operating segments: Discovery & Analytical Solutions and Diagnostics. The Company’s Discovery & Analytical Solutions segment focuses on service and innovating for customers spanning the life sciences and applied markets. The Company’s Diagnostics segment is targeted towards meeting the needs of clinically-oriented customers, especially within the growing areas of reproductive health, emerging market diagnostics and applied genomics.
The consolidated financial statements include the accounts of PerkinElmer, Inc. and its subsidiaries (the “Company”). All intercompany balances and transactions have been eliminated in consolidation. In August 2022, the Company announced the proposed sale of certain assets and the equity interests of certain entities constituting the Company’s Analytical, Food and Enterprise Services businesses (the “Business”). The 2021 and 2020 consolidated financial statements presented herein have been retrospectively adjusted to present the Business as discontinued operations for all periods presented.
The Company’s fiscal year ends on the Sunday nearest December 31. The Company reports fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. Each of the fiscal years ended January 1, 2023 (“fiscal year 2022”) and January 2, 2022 (“fiscal year 2021”) included 52 weeks. The fiscal year ended January 3, 2021 (“fiscal year 2020”) included 53 weeks. The fiscal year ending December 31, 2023 (“fiscal year 2023”) will include 52 weeks.
Accounting Policies and Estimates: The preparation of consolidated financial statements in accordance with United States (“U.S.”) Generally Accepted Accounting Principles (“GAAP”) requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
Revenue Recognition: The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for the promised products or services when a performance obligation is satisfied by transferring control of those products or services to customers.
Taxes that are collected by the Company from a customer and assessed by a governmental authority, that are both imposed on and concurrent with a specific revenue-producing transaction, are excluded from revenue.
The Company reports shipping and handling revenue in revenue, to the extent it is billed to customers, and the associated costs in cost of product revenue.
Inventories: Inventories, which include material, labor and manufacturing overhead, are valued at the lower of cost or market. Inventories are accounted for using the first-in, first-out method of determining inventory costs. Inventory quantities on-hand are regularly reviewed, and where necessary, provisions for excess and obsolete inventory are recorded based primarily on the Company’s estimated forecast of product demand and production requirements.
Income Taxes: The Company uses the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. This method also requires the recognition of future tax benefits such as net operating loss carryforwards, to the extent that realization of such benefits is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established for any deferred tax asset for which realization is not more likely than not.
The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions and other issues. These reserves are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. Potential interest and penalties associated with such uncertain tax positions is recorded as a component of income tax expense.
Property, Plant and Equipment: The Company depreciates property, plant and equipment using the straight-line method over its estimated useful lives, which generally fall within the following ranges: buildings- 10 to 40 years; leasehold improvements - estimated useful life or remaining term of lease, whichever is shorter; and machinery and equipment- 3 to 8 years. Certain tooling costs are capitalized and amortized over a 3-year life, while repairs and maintenance costs are expensed.
Pension and Other Postretirement Benefits: The Company sponsors both funded and unfunded U.S. and non-U.S. defined benefit pension plans and other postretirement benefits. The Company immediately recognizes actuarial gains and losses in operating results in the year in which the gains and losses occur. Actuarial gains and losses are measured annually as of the calendar month-end that is closest to the Company's fiscal year end and accordingly will be recorded in the fourth quarter, unless the Company is required to perform an interim remeasurement. The remaining components of pension expense, primarily service and interest costs and assumed return on plan assets, are recorded on a quarterly basis. The Company’s funding policy provides that payments to the U.S. pension trusts shall at least be equal to the minimum funding requirements of the Employee Retirement Income Security Act of 1974. Non-U.S. plans are accrued for, but generally not fully funded, and benefits are paid from operating funds.
Translation of Foreign Currencies: For foreign operations, asset and liability accounts are translated at current exchange rates; income and expenses are translated using weighted average exchange rates for the reporting period. Resulting translation adjustments, as well as translation gains and losses from certain intercompany transactions considered permanent in nature, are reported in accumulated other comprehensive income (“AOCI”), a separate component of stockholders’ equity. Gains and losses arising from transactions and translation of period-end balances denominated in currencies other than the functional currency are included in other expense, net.
Business Combinations: Business combinations are accounted for at fair value. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses. Measurement period adjustments are made in the period in which the amounts are determined and the current period income effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition date. All changes that do not qualify as measurement period adjustments are also included in current period earnings. The accounting for business combinations requires estimates and judgment as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of finite-lived intangible assets, or the recognition of additional consideration which would be expensed.
Goodwill and Other Intangible Assets:  The Company’s intangible assets consist of (i) goodwill, which is not being amortized; (ii) indefinite lived intangibles, which consist of a trade name that is not subject to amortization; and (iii) amortizing intangibles, which consist of patents, trade names and trademarks, licenses, customer relationships and purchased technologies, which are being amortized over their estimated useful lives.
The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. This annual impairment assessment is performed by the Company on the later of January 1 or the first day of each fiscal year. Indefinite-lived intangibles are also subject to an annual impairment test. The impairment test consists of a comparison of the fair value of the indefinite-lived intangible asset with its carrying amount. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of the amortizing intangible asset. Amortizing intangible assets are reviewed for impairment when indicators of impairment are present. When a potential impairment has been identified, forecasted undiscounted net cash flows of the operations to which the asset relates are compared to the current carrying value of the long-lived assets present in that operation. If such cash flows are less than such carrying amounts, long-lived assets, including such intangibles, are written down to their respective fair values.
Stock-Based Compensation: The Company accounts for stock-based compensation expense based on estimated grant date fair value, generally using the Black-Scholes option-pricing model. The fair value is recognized as expense in the consolidated financial statements over the requisite service period. The determination of fair value and the timing of expense using option pricing models such as the Black-Scholes model require the input of subjective assumptions, including the expected term and the expected price volatility of the underlying stock. The Company estimates the expected term assumption based on historical
experience. In determining the Company’s expected stock price volatility assumption, the Company reviews both the historical and implied volatility of the Company’s common stock.
 Marketable Securities and Investments:  Investments in debt securities that are classified as available for sale are recorded at fair value with unrealized gains and losses included in AOCI until realized. Investments in equity securities are recorded at their fair values with unrealized holding gains and losses included in earnings. Investments in equity securities without a readily determinable fair value are carried at cost minus impairment, if any. When an observable price change in orderly transactions for the identical or a similar investment of the same issuer has occurred, the Company elects to carry those equity investments at fair value as of the date that the observable transaction occurred.
Cash and Cash Equivalents: The Company considers all highly liquid, unrestricted instruments with a purchased maturity of three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value due to the short maturities of these instruments.
Environmental Matters: The Company accrues for costs associated with the remediation of environmental pollution when it is probable that a liability has been incurred and the Company’s proportionate share of the amount can be reasonably estimated. The recorded liabilities have not been discounted.
 Research and Development: Research and development costs are expensed as incurred. In-process research and development (“IPRD”) costs acquired in a business combination are recorded at fair value as an intangible asset at the acquisition date and amortized once the product is ready for sale or expensed if abandoned.
Restructuring and Other Costs: Generally, costs associated with an exit or disposal activity are recognized when the liability is incurred. Prior to recording restructuring charges for employee separation agreements, the Company notifies all employees of termination. Costs related to employee separation arrangements requiring future service beyond a specified minimum retention period are recognized over the service period.
Comprehensive Income:  Comprehensive income is defined as net income or loss and other changes in stockholders’ equity from transactions and other events from sources other than stockholders. Comprehensive income is reflected in the consolidated statements of comprehensive income.
Derivative Instruments and Hedging: Derivatives are recorded on the consolidated balance sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.
For a cash flow hedge, the effective portion of the derivative’s gain or loss is initially reported as a component of other comprehensive income and subsequently amortized into net earnings when the hedged exposure affects net earnings. Cash flow hedges related to anticipated transactions are designated and documented at the inception of each hedge by matching the terms of the contract to the underlying transaction. The Company classifies the cash flows from hedging transactions in the same categories as the cash flows from the respective hedged items. Once established, cash flow hedges are generally recorded in other comprehensive income, unless an anticipated transaction is no longer likely to occur, and subsequently amortized into net earnings when the hedged exposure affects net earnings. Discontinued or dedesignated cash flow hedges are immediately settled with counterparties, and the related accumulated derivative gains or losses are recognized into net earnings on the consolidated financial statements. Settled cash flow hedges related to forecasted transactions that remain probable are recorded as a component of other comprehensive (loss) income and are subsequently amortized into net earnings when the hedged exposure affects net earnings. Forward contract effectiveness for cash flow hedges is calculated by comparing the fair value of the contract to the change in value of the anticipated transaction using forward rates on a monthly basis. The Company also has entered into other foreign currency forward contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into interest and other expense, net on the consolidated financial statements.
The Company also uses foreign currency denominated debt to hedge its investments in certain foreign subsidiaries. Realized and unrealized translation adjustments from these hedges are included in the foreign currency translation component of AOCI, as well as the offset translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold.
Leases: Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities, and operating lease liabilities in the Company's consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining lease payments over the lease term. When the Company’s lease did not provide an implicit rate, the Company used its incremental
borrowing rate in determining the present value of lease payments. The Company used the implicit rate when readily determinable. The operating lease ROU asset excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as cars, the Company accounts for the lease and non-lease components as a single lease component.
The Company has made an accounting policy election not to recognize ROU assets and lease liabilities that arise from short-term leases for facilities and equipment. Instead, the Company recognizes the lease payments in the consolidated statements of operations on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred.
As a lessor, the Company applies the practical expedient to not separate non-lease components from the associated lease component and instead accounts for those components as a single component if the non-lease components otherwise would be accounted for under Accounting Standards Codification 606, Revenue From Contracts With Customers (“ASC 606”), and both of the following criteria are met: 1) the timing and pattern of transfer of the non-lease component or components and associated lease component are the same; and 2) the lease component, if accounted for separately, would be classified as an operating lease. If the non-lease component or components associated with the lease component are the predominant component of the combined component, the Company accounts for the combined component in accordance with ASC 606. Otherwise, the Company accounts for the combined component as an operating lease in accordance with Accounting Standards Codification 842, Leases (“ASC 842”).
Recently Issued Accounting Pronouncements: From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the “FASB”) and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations.
In October 2021, t

v3.22.4
Revenue from Contract with Customer
 12 Months Ended
Jan. 01, 2023
Revenue from Contract with Customer [Abstract]  
Revenue from Contract with Customer [Text Block] Revenue
For arrangements with multiple performance obligations, the Company accounts for individual products and services separately if they are distinct - i.e., if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their stand-alone selling prices. The stand-alone selling prices are determined based on the prices at which the Company separately sells the products, extended warranties, and services. For items that are not sold separately, the Company estimates stand-alone selling prices by reference to the amount charged for similar items on a stand-alone basis.
The Company sells products and services predominantly through its direct sales force. As a result, the use of distributors is generally limited to geographic regions where the Company has no direct sales force. The Company does not offer product return or exchange rights (other than those relating to defective goods under warranty) or price protection allowances to its customers, including distributors. Payment terms granted to distributors are the same as those granted to end-customers and payments are not dependent upon the distributor's receipt of payment from their end-user customers.
In instances where the timing of revenue recognition differs from the timing of invoicing, the Company determined that the contracts generally do not include a significant financing component. The primary purpose of its invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, rather than to receive financing from the customers or to provide customers with financing. Examples include invoicing at the beginning of a subscription term with revenue recognized ratably over the contract period, and multi-year software licenses or software subscriptions that are invoiced annually with revenue recognized upfront. In limited circumstances where the Company provides the customer with a
significant benefit of financing, the Company uses the practical expedient and only adjusts the transaction price for the effects of the time value of money and only on contracts where the duration of financing is more than one year.
Nature of goods and services
The Discovery & Analytical Solutions segment of the Company principally generates revenue from sales of instruments, reagents, informatics, software, subscriptions, detection and imaging technologies, extended warranties, training and services in the life sciences market and instruments, consumables and services in the applied markets. The Diagnostics segment of the Company principally generates revenue from sales of instruments, solutions, consumables, reagents, extended warranties and services in the diagnostics market. Products and services may be sold separately or in bundled packages. The typical length of a contract for service is 12 to 36 months.
The revenue generated from the sale of instruments, consumables, reagents, and certain software is recognized at a point in time. The Company recognizes revenue in these arrangements at the point in time when control of the products has been transferred to customers, which is typically at delivery. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. When the Company places the instrument at the customer's site and sells the reagents to a customer, the instrument and reagents are accounted for together as one performance obligation. The Company does not charge a fee for the use of the instrument and retains ownership of the placed instrument. The Company has a right to remove the instrument and replace it with another instrument at the customer’s site at any time throughout the contract term. The Company recognizes revenue upon delivery of reagents, which is the point in time where the Company has performed its obligation to provide a screening solution to the customer. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
The revenue generated from the sale of licenses for software as a service, cloud services, subscriptions, extended warranties, and laboratory services and training is recognized over time. Term licenses, subscriptions and cloud services, are generally recognized ratably over the contract period or based upon consumption. The Company sells its software subscriptions and cloud services with maintenance services and, in some cases, with consulting services. The Company recognizes revenue for the software commencing when the service is made available to the customer. For maintenance and consulting services, revenue is recognized ratably over the period in which the services are provided. Revenue for laboratory services is recognized over the contract period or when the service is billable, based on time and materials. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
Product revenue is recognized at a point in time and all service revenue is recognized over time.
Disaggregation of revenue
In the following tables, revenue is disaggregated by primary geographical market, end-markets and timing of revenue recognition.
Reportable Segments
For the fiscal year ended
January 1, 2023January 2, 2022January 3, 2021
Discovery & Analytical SolutionsDiagnosticsTotalDiscovery & Analytical SolutionsDiagnosticsTotalDiscovery & Analytical SolutionsDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$683,170 $979,473 $1,662,643 $444,459 $1,362,213 $1,806,672 $286,354 $750,641 $1,036,995 
Europe297,468 534,343 831,811 234,334 982,476 1,216,810 157,277 864,687 1,021,964 
Asia312,271 505,097 817,368 217,076 587,250 804,326 152,657 451,614 604,271 
$1,292,909 $2,018,913 $3,311,822 $895,869 $2,931,939 $3,827,808 $596,288 $2,066,942 $2,663,230 
Primary end-markets
Diagnostics$— $2,018,913 $2,018,913 $— $2,931,939 $2,931,939 $— $2,066,942 $2,066,942 
Life sciences1,292,909 — 1,292,909 895,869 — 895,869 596,288 — 596,288 
$1,292,909 $2,018,913 $3,311,822 $895,869 $2,931,939 $3,827,808 $596,288 $2,066,942 $2,663,230 
Major Customer Concentration
Revenues from one customer in the Company’s Diagnostics segment represent approximately $330.7 million, $638.6 million and $97.8 million of the Company’s total revenue during the fiscal years 2022, 2021 and 2020, respectively.
Contract Balances

v3.22.4
Discontinued Operations
 12 Months Ended
Jan. 01, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations Discontinued Operations
As part of the Company’s continuing efforts to focus on higher growth opportunities, the Company has discontinued certain businesses. When the discontinued operations represented a strategic shift that will have a major effect on the Company’s operations and financial statements, the Company has accounted for these businesses as discontinued operations and accordingly, has presented the results of operations and related cash flows as discontinued operations.
In August 2022, the Company entered into a Master Purchase and Sale Agreement (the “Purchase Agreement”) with Polaris Purchaser, L.P. (the “Purchaser”), a Delaware limited partnership owned by funds managed by affiliates of New Mountain Capital L.L.C. (the “Sponsor”), under which the Company agreed to sell to the Purchaser certain assets and the equity interests of certain entities constituting the Company’s Analytical, Food and Enterprise Services businesses (the “Business”) (as further defined in the Purchase Agreement), for cash consideration of up to approximately $2.45 billion and the Purchaser’s assumption of certain liabilities relating to the Business (collectively, the “Transaction”). Approximately $2.30 billion of the purchase price will be payable at closing, subject to certain customary adjustments, which includes $75.0 million in deferred payments tied to the transfer of the PerkinElmer brand and related trademarks to the Purchaser (which may be completed within 24 months following the date of the closing at the Company’s election). The Purchase Agreement also provides for potential post-closing payments totaling up to $150.0 million, which are contingent on the exit valuation the Sponsor and its affiliated funds receive on a sale or other capital events related to the Business. The Transaction is expected to close in the first quarter of fiscal year 2023, subject to regulatory approvals and other customary closing conditions.
The Business had been recorded in the Discovery & Analytical Solutions segment. The sale of the Business represents a strategic shift that will have a major effect on the Company’s operations and financial statements. Accordingly, the Company has classified the assets and liabilities related to the Business as assets and liabilities of discontinued operations in the Company’s consolidated balance sheets and its results of operations are classified as income from discontinued operations in the Company’s consolidated statements of operations. Financial information in this report relating to fiscal years 2021 and 2020 has been retrospectively adjusted to reflect this discontinued operation.
The summary pre-tax operating results of the discontinued operations, were as follows:
 January 1, 2023January 2, 2022January 3, 2021
 (In thousands)
Revenue$1,298,376 $1,239,361 $1,119,515 
Cost of revenue859,330 822,048 739,817 
Selling, general and administrative expenses306,032 268,760 209,442 
Research and development expenses64,605 74,632 58,948 
Operating income68,409 73,921 111,308 
Other (income) expense, net(5,195)(2,383)5,016 
Income from discontinued operations before income taxes$73,604 $76,304 $106,292 
The carrying amounts of the major classes of assets and liabilities included in discontinued operations related to the Business consisted of the following:
January 1, 2023January 2, 2022
 (In thousands)
Cash and cash equivalents$14,999 $14,999 
Accounts receivable343,064 315,851 
Inventories210,367 198,824 
Other current assets32,063 25,700 
Total current assets555,374 
Property, plant and equipment, net60,983 60,074 
Operating lease right-of-use assets41,487 43,735 
Intangible assets, net202,850 241,257 
Goodwill772,812 789,465 
Other assets, net15,079 9,637 
    Total long-term assets
1,144,168 
Total assets of discontinued operations
$1,693,704 $1,699,542 
Accounts payable29,912 30,647 
Accrued expenses and other current liabilities161,260 174,947 
    Total current liabilities205,594 
Deferred taxes and long-term liabilities46,046 53,738 
Operating lease liabilities35,647 37,964 
    Total long-term liabilities91,702 
Total liabilities of discontinued operations$272,865 $297,296 
The following operating and investing non-cash items from discontinued operations were as follows for the fiscal years ended:
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Depreciation
$8,011 $12,897 $13,299 
Amortization
16,984 33,664 31,560 
Capital expenditures10,670 13,868 13,872 

v3.22.4
Income Taxes
 12 Months Ended
Jan. 01, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of income from continuing operations before income taxes were as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
U.S.$326,438 $547,705 $210,130 
Non-U.S.325,399 655,877 589,942 
Total$651,837 $1,203,582 $800,072 
The components of the provision for income taxes on continuing operations were as follows:
 
Current
Expense		Deferred 
Expense
(Benefit)		Total
(In thousands)
Fiscal year ended January 1, 2023
Federal$115,436 $(45,246)$70,190 
State27,757 (16,139)11,618 
Non-U.S.101,891 (44,538)57,353 
Total$245,084 $(105,923)$139,161 
Fiscal year ended January 2, 2022
Federal$154,905 $(37,858)$117,047 
State53,961 3,602 57,563 
Non-U.S.160,608 (21,072)139,536 
Total$369,474 $(55,328)$314,146 
Fiscal year ended January 3, 2021
Federal$39,878 $4,875 $44,753 
State15,469 (1,240)14,229 
Non-U.S.149,503 (38,973)110,530 
Total$204,850 $(35,338)$169,512 
The total provision for income taxes included in the consolidated financial statements is as follows for the fiscal years ended: 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Continuing operations$139,161 $314,146 $169,512 
Discontinued operations17,101 22,583 8,889 
Total$156,262 $336,729 $178,401 
 A reconciliation of income tax expense at the U.S. federal statutory income tax rate to the recorded tax provision is as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Tax at statutory rate$136,886 $252,752 $168,015 
Non-U.S. rate differential, net(5,221)(33,847)(29,155)
U.S. taxation of multinational operations22,102 7,964 11,468 
State income taxes, net7,820 36,832 13,249 
Prior year tax matters(10,160)1,850 5,532 
Effect of stock compensation845 (2,187)(8,148)
General business tax credits(7,132)(2,715)(2,145)
Change in valuation allowance4,964 (179)(369)
Rate change on long term intangibles— 14,031 — 
Effect of foreign repatriations(4,940)37,147 — 
Foreign consolidations— — 15,222 
Other, net(6,003)2,498 (4,157)
Total$139,161 $314,146 $169,512 
The variation in the Company’s effective tax rate for fiscal year 2021 is primarily affected by the recognition of $37.1 million in U.S. federal, U.S. state and non-U.S. taxes related to foreign earnings that the Company no longer considered indefinitely reinvested. During fiscal year 2022, the Company adjusted these estimates and recognized a net benefit of $4.9 million relative to its position to permanently reinvest those foreign earnings.
The Company also recognized $1.1 million of benefit in fiscal year 2022 derived from the tax holiday in Singapore. The Company recognized $18.2 million in fiscal year 2021 and $12.7 million in fiscal year 2020 of benefits derived from tax holidays in China and Singapore. The effect of these benefits, derived from tax holidays, on basic and diluted earnings per share for fiscal year 2022 was $0.01 and $0.01, respectively, for fiscal year 2021 was $0.16 and $0.16, respectively, and for fiscal year 2020 was $0.11 and $0.11, respectively. The tax holiday in China is renewed every three years. The Company expects to renew the tax holiday for one of the Company’s subsidiaries in China that is set to expire in fiscal year 2023.
The Company regularly reviews its tax positions in each significant taxing jurisdiction in the process of evaluating its unrecognized tax benefits. The Company makes adjustments to its unrecognized tax benefits when: (i) facts and circumstances regarding a tax position change, causing a change in management’s judgment regarding that tax position; (ii) a tax position is effectively settled with a tax authority at a differing amount; and/or (iii) the statute of limitations expires regarding a tax position.
The tabular reconciliation of the total amounts of unrecognized tax benefits is as follows for the fiscal years ended:
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Unrecognized tax benefits, beginning of year$61,658 $38,773 $35,547 
Gross increases—tax positions in prior periods1,489 2,877 4,974 
Gross decreases—tax positions in prior periods(2,519)— (2,471)
Gross increases—current-period tax positions7,187 149 151 
Gross increases related to acquisitions— 22,697 158 
Settlements— (2,252)— 
Lapse of statute of limitations(8,625)(563)— 
Foreign currency translation adjustments(1,242)(23)414 
Unrecognized tax benefits, end of year$57,948 $61,658 $38,773 
The Company classifies interest and penalties as a component of income tax expense. At January 1, 2023 and January 2, 2022, the Company had accrued interest and penalties of $7.2 million and $7.6 million, respectively. During fiscal years 2022, 2021 and 2020, the Company recognized a net (benefit) expense of $(0.5) million, $1.8 million and $1.8 million, respectively,
for interest and penalties in its total tax provision. At January 1, 2023, substantially all of the unrecognized tax benefits, if recognized, would affect the effective tax rate.
The Company believes that it is reasonably possible that approximately $17.8 million of its uncertain tax positions at January 1, 2023, including accrued interest and penalties, and net of tax benefits, may be resolved over the next twelve months as a result of lapses in applicable statutes of limitations and potential settlements. Various tax years after 2010 remain open to examination by certain jurisdictions in which the Company has significant business operations, such as China, Finland, Germany, Luxembourg, The Netherlands, Singapore, the United Kingdom and the United States. The tax years under examination vary by jurisdiction.
The tax effects of temporary differences and attributes that gave rise to deferred income tax assets and liabilities were as follows:
 
January 1,
2023		January 2,
2022
(In thousands)
Deferred tax assets:
Inventory$17,920 $2,388 
Reserves and accruals70,912 53,403 
Accrued compensation23,868 29,960 
Net operating loss and credit carryforwards117,953 110,149 
Accrued pension11,653 23,714 
Restructuring reserve1,640 1,442 
Deferred revenue22,644 49,207 
Capitalized research and development expenses44,922 12,114 
Operating lease liabilities43,547 37,299 
Unrealized foreign exchange loss
11,158 14,594 
All other, net841 583 
Total deferred tax assets367,058 334,853 
Deferred tax liabilities:
Postretirement health benefits(4,379)(5,303)
Depreciation and amortization(916,581)(1,021,487)
Operating lease right-of-use assets(39,281)(33,607)
Prepaid expenses(3,515)(3,265)
Deferred tax liability on foreign earnings(15,782)(31,239)
Total deferred tax liabilities(979,538)(1,094,901)
Valuation allowance(96,681)(89,523)
Net deferred tax liabilities$(709,161)$(849,571)

The components of net deferred tax liabilities were recognized in the consolidated balance sheets as follows:

January 1,
2023		January 2,
2022
(In thousands)
Other assets, net$18,527 $18,534 
Deferred taxes and other long-term liabilities(727,688)(868,105)
Total$(709,161)$(849,571)

At January 1, 2023, for income tax return purposes, the Company had U.S. federal net operating loss carryforwards of $67.5 million, state net operating loss carryforwards of $4.9 million, foreign net operating loss carryforwards of $458.0 million, state tax credit carryforwards of $13.8 million and general business tax credit carryforwards of $0.1 million. Certain net operating loss carryforwards and state credit carryforwards do not expire, while other losses begin to expire in 2023.
Valuation allowances take into consideration limitations imposed upon the use of the tax attributes and reduce the value of such items to the likely net realizable amount. The Company regularly evaluates positive and negative evidence available to determine if valuation allowances are required or if existing valuation allowances are no longer required. Valuation allowances have been provided on state net operating loss and state tax credit carryforwards and on certain foreign tax attributes that the Company has determined are not more likely than not to be realized. The increase in the valuation allowance of $7.2 million in fiscal year 2022 is primarily due to net operating losses incurred for which the benefit is not expected to be realized.
As of January 1, 2023, the Company evaluated its undistributed foreign earnings and identified approximately $879.0 million in earnings that it does not consider to be permanently reinvested. The Company has recorded a provision of approximately $15.8 million for the taxes that would fall due when such earnings are repatriated. The Company began repatriating such foreign earnings to the United States in the first quarter of fiscal year 2022 and expects to continue the repatriation in fiscal year 2023. There are other undistributed foreign earnings and outside basis differences for which the Company has not provided for any taxes as these amounts continue to be indefinitely reinvested, and it is not practicable to estimate the amount of deferred tax liability that would be incurred.

v3.22.4
Earnings Per Share
 12 Months Ended
Jan. 01, 2023
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding during the period less restricted unvested shares. Diluted earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding plus all potentially dilutive common stock equivalents, primarily shares issuable upon the exercise of stock options using the treasury stock method. The following table reconciles the number of shares utilized in the earnings per share calculations for the fiscal years ended:

January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Number of common shares—basic126,155 116,165 111,514 
Effect of dilutive securities:
Stock options249 391 466 
Restricted stock awards22 118 105 
Number of common shares—diluted126,426 116,674 112,085 
Number of potentially dilutive securities excluded from calculation due to antidilutive impact611 487 220 
Antidilutive securities include outstanding stock options with exercise prices and average unrecognized compensation cost in excess of the average fair market value of common stock for the related period. Antidilutive options were excluded from the calculation of diluted net income per share and could become dilutive in the future.

v3.22.4
Accounts Receivable, Net
 12 Months Ended
Jan. 01, 2023
Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]  
Accounts Receivable, Net Accounts Receivable, Net
Accounts receivable, net consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Accounts receivable, net$612,780 $707,941 
Long-term accounts receivable, net, included in Other assets, net34,040 29,958 
Total accounts receivable, net$646,820 $737,899 
Reserves for credit losses consisted of the following:
Balance at
Beginning of
Year		ProvisionsCharges/
Write-
offs
Other(1)
Balance
at End
of Year
  (In thousands)
Year ended January 3, 2021$23,574 $10,294 $(1,895)$1,524 $33,497 
Year ended January 2, 202233,497 6,854 (2,198)101 38,254 
Year ended January 1, 202338,254 9,857 (9,672)(896)37,543 
(1) Other amounts primarily relate to the impact of acquisitions, discontinued operations and foreign exchange movements.

v3.22.4
Inventories, Net
 12 Months Ended
Jan. 01, 2023
Inventory Disclosure [Abstract]  
Inventories, Net Inventories
Inventories consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Raw materials$190,640 $166,486 
Work in progress68,206 63,580 
Finished goods146,616 195,824 
Total inventories$405,462 $425,890 

v3.22.4
Property, Plant and Equipment, Net
 12 Months Ended
Jan. 01, 2023
Property, Plant and Equipment, Net [Abstract]  
Property, Plant and Equipment, Net Property, Plant and Equipment, Net
Property, plant and equipment consisted of the following:
January 1,
2023		January 2,
2022
(In thousands)
At cost:
Land$28,340 $28,540 
Building and leasehold improvements346,164 351,084 
Machinery and equipment482,639 464,856 
Total property, plant and equipment857,143 844,480 
Accumulated depreciation(374,193)(358,949)
Total property, plant and equipment, net$482,950 $485,531 
Depreciation expense on property, plant and equipment for the fiscal years ended January 1, 2023, January 2, 2022 and January 3, 2021 was $56.4 million, $54.9 million and $40.7 million, respectively.

v3.22.4
Marketable Securities and Investments
 12 Months Ended
Jan. 01, 2023
Marketable Securities [Abstract]  
Marketable Securities and Investments Marketable Securities and Investments
 Investments, which are classified in Other assets, net, consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Marketable securities$11,083 $33,683 
Equity investments54,503 33,801 
Investments in debt securities42,500 13,500 
$108,086 $80,984 
Marketable securities. Marketable securities include equity and fixed-income securities. The net unrealized holding gain and loss on marketable securities, net of deferred income taxes, reported as a component of other comprehensive income (loss) in the consolidated statements of stockholders’ equity, was not material in fiscal years 2022 and 2021. The proceeds from the sales of securities and the related gains and losses are not material for any period presented.
Marketable securities classified as available for sale consisted of the following:
 
 Market ValueGross Unrealized Holding
CostGains(Losses)
(In thousands)
January 1, 2023
Equity securities$6,775 $6,775 $— $— 
Other4,308 4,308 — — 
$11,083 $11,083 $— $— 
January 2, 2022
Equity securities$29,768 $29,768 $— $— 
Fixed-income securities7 7 — — 
Other3,908 3,971 — (63)
$33,683 $33,746 $— $(63)
Equity Investments. The Company has equity interests in privately-held entities over which the Company neither has significant influence nor control. Equity investments as of January 1, 2023 and January 2, 2022 consisted of the following:
January 1,
2023		January 2,
2022
(In thousands)
Equity investments, carried at cost minus impairment, if any$50,654 $29,738 
Equity investments, carried at fair value3,849 4,063 
$54,503 $33,801 
The amount of upward adjustments during fiscal years 2022 and 2021 were $2.9 million and $19.6 million, respectively. The cumulative amount of upward adjustments as of January 1, 2023 and January 2, 2022 was $30.7 million and $27.8 million, respectively. The amount of impairments and downward adjustments during fiscal year 2020 was $4.9 million. The cumulative amount of impairments and downward adjustments as of each of January 1, 2023 and January 2, 2022 was $5.0 million.
Investments in debt securities. The Company has investments in debt securities that are classified as available for sale. The amortized cost of these investments are not materially different to their fair value. Investments with total carrying value of $25.5 million have contractual maturities of one year through five years. Investments with a carrying value of $17.0 million are convertible into equity securities or are due and payable upon event of default (as defined in the applicable agreement).

v3.22.4
Goodwill and Intangible Assets, Net
 12 Months Ended
Jan. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net Goodwill and Intangible Assets, NetThe Company tests goodwill and indefinite-lived intangible assets at least annually for possible impairment. The Company completes the annual testing of impairment for goodwill and indefinite-lived intangible assets on the later of
January 1 or the first day of each fiscal year. In addition to its annual test, the Company regularly evaluates whether events or circumstances have occurred that may indicate a potential impairment of goodwill or indefinite-lived intangible assets.
The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. The Company performed its annual impairment testing for its reporting units as of January 3, 2022, its annual impairment testing date for fiscal year 2022. There were no impairments measured in the periods presented. While the Company believes that its estimates of current value are reasonable, if actual results differ from the estimates and judgments used, including such items as future cash flows and the volatility inherent in markets which the Company serves, impairment charges against the carrying value of those assets could be required in the future.
The changes in the carrying amount of goodwill for fiscal years 2022 and 2021 are as follows:
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Balance at January 3, 2021$948,360 $1,691,227 $2,639,587 
Foreign currency translation(33,901)(40,557)(74,458)
Acquisitions, earnouts and measurement period adjustments3,742,310 319,680 4,061,990 
Balance at January 2, 20224,656,769 1,970,350 6,627,119 
Foreign currency translation(98,268)(41,617)(139,885)
Acquisitions, earnouts and measurement period adjustments(6,926)1,460 (5,466)
Balance at January 1, 2023$4,551,575 $1,930,193 $6,481,768 
Identifiable intangible asset balances at January 1, 2023 by category and segment were as follows:
 
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Patents$25,312 $2,708 $28,020 
Less: Accumulated amortization(25,099)(956)(26,055)
Net patents213 1,752 1,965 
Trade names and trademarks76,521 72,932 149,453 
Less: Accumulated amortization(36,945)(26,645)(63,590)
Net trade names and trademarks39,576 46,287 85,863 
Licenses54,478 8,136 62,614 
Less: Accumulated amortization(49,582)(4,672)(54,254)
Net licenses4,896 3,464 8,360 
Core technology1,080,611 476,129 1,556,740 
Less: Accumulated amortization(209,247)(240,442)(449,689)
Net core technology871,364 235,687 1,107,051 
Customer relationships2,123,266 820,495 2,943,761 
Less: Accumulated amortization(358,402)(416,702)(775,104)
Net customer relationships1,764,864 403,793 2,168,657 
IPRD5,278 — 5,278 
Net amortizable intangible assets$2,686,191 $690,983 $3,377,174 

Identifiable intangible asset balances at January 2, 2022 by category and segment were as follows:
 
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Patents$25,524 $2,709 $28,233 
Less: Accumulated amortization(25,161)(732)(25,893)
Net patents363 1,977 2,340 
Trade names and trademarks77,181 79,683 156,864 
Less: Accumulated amortization(32,005)(21,969)(53,974)
Net trade names and trademarks45,176 57,714 102,890 
Licenses54,217 8,410 62,627 
Less: Accumulated amortization(48,670)(3,968)(52,638)
Net licenses5,547 4,442 9,989 
Core technology1,072,700 519,864 1,592,564 
Less: Accumulated amortization(126,374)(208,833)(335,207)
Net core technology946,326 311,031 1,257,357 
Customer relationships2,149,765 884,105 3,033,870 
Less: Accumulated amortization(224,461)(366,058)(590,519)
Net customer relationships1,925,304 518,047 2,443,351 
IPRD5,920 — 5,920 
Net amortizable intangible assets$2,928,636 $893,211 $3,821,847 
Total amortization expense related to definite-lived intangible assets was $370.6 million in fiscal year 2022, $256.6 million in fiscal year 2021 and $161.0 million in fiscal year 2020. Estimated amortization expense related to definite-lived intangible assets for each of the next five years is $363.8 million in fiscal year 2023, $355.2 million in fiscal year 2024, $334.0 million in fiscal year 2025, $327.0 million in fiscal year 2026, and $299.6 million in fiscal year 2027.

v3.22.4
Debt
 12 Months Ended
Jan. 01, 2023
Debt Disclosure [Abstract]  
Debt Debt
 The Company’s debt consisted of the following:

January 1,
2023
Outstanding Principal
Unamortized Debt Discount
Unamortized Debt Issuance Costs
Net Carrying Amount
(In thousands)
Long-Term Debt:
Senior Unsecured Revolving Credit Facility$— $— $(2,641)$(2,641)
0.850% Senior Unsecured Notes due in 2024 (“2024 Notes”)
771,659 (283)(3,136)768,240 
€500,000 Principal 1.875% Senior Unsecured Notes due in 2026 (“2026 Notes”)533,950 (1,902)(1,779)530,269 
1.900% Senior Unsecured Notes due in 2028 (“2028 Notes”)
500,000 (301)(3,631)496,068 
3.3% Senior Unsecured Notes due in 2029 (“2029 Notes”)850,000 (2,000)(5,537)842,463 
2.55% Senior Unsecured Notes due in March 2031 (“March 2031 Notes”)400,000 (114)(2,978)396,908 
2.250% Senior Unsecured Notes due in September 2031 (“September 2031 Notes”)
500,000 (1,353)(3,991)494,656 
3.625% Senior Unsecured Notes due in 2051 (“2051 Notes”)400,000 (4)(4,260)395,736 
Other Debt Facilities, non-current1,648 — — 1,648 
Total Long-Term Debt3,957,257 (5,957)(27,953)3,923,347 
Current Portion of Long-term Debt:
0.550% Senior Unsecured Notes due in 2023 (“2023 Notes”)
467,138 (63)(867)466,208 
Other Debt Facilities, current4,721 — — 4,721 
Total Current Portion of Long-Term Debt471,859 (63)(867)470,929 
Total Debt$4,429,116 $(6,020)$(28,820)$4,394,276 
January 2,
2022
Outstanding Principal
Unamortized Debt Discount
Unamortized Debt Issuance Costs
Net Carrying Amount
(In thousands)
Long-Term Debt:
Senior Unsecured Revolving Credit Facility$— $— $(3,362)$(3,362)
Unsecured Term Loan Credit Facility500,000 (14)(658)499,328 
2023 Notes500,000 (152)(2,093)497,755 
2024 Notes800,000 (447)(4,945)794,608 
2026 Notes568,600 (2,538)(2,280)563,782 
2028 Notes500,000 (348)(4,200)495,452 
2029 Notes850,000 (2,252)(6,234)841,514 
March 2031 Notes400,000 (126)(3,294)396,580 
September 2031 Notes500,000 (1,485)(4,380)494,135 
2051 Notes400,000 (4)(4,335)395,661 
Other Debt Facilities, non-current4,284 — — 4,284 
Total Long-Term Debt5,022,884 (7,366)(35,781)4,979,737 
Current Portion of Long-term Debt:
Other Debt Facilities, current4,240 — — 4,240 
Total Debt$5,027,124 $(7,366)$(35,781)$4,983,977 

Senior Unsecured Revolving Credit Facility. On August 24, 2021, the Company terminated its previous senior unsecured revolving credit facility and entered into a new senior unsecured revolving credit facility with a five-year term and a borrowing capacity of $1.5 billion available through August 24, 2026. As of January 1, 2023, undrawn letters of credit in the aggregate amount of $7.1 million were treated as issued and outstanding when calculating the borrowing availability under the facility. As of January 1, 2023, the Company had $1.49 billion available for additional borrowing under the facility. Borrowings will bear interest, payable quarterly or, if earlier, at the end of any interest period, at the Company’s option at either (a) the base rate (as defined in the credit agreement), or (b) the eurocurrency rate (a publicly published rate), in each case plus a percentage spread based on the credit rating of the Company's debt. The base rate is the highest of (a) the Federal Funds Rate (as defined in the credit agreement) plus 0.50%, (b) the rate of interest in effect for such day as publicly announced from time to time by Bank of America as its “prime rate”, and (c) the Eurocurrency Rate plus 1.00%. The credit agreement for the new facility contains customary affirmative, negative and financial covenants and events of default. The financial covenants include a debt-to-capital ratio that remains applicable for so long as the Company’s debt is rated as investment grade. In the event that the Company’s debt is not rated as investment grade, the debt-to-capital ratio covenant is replaced with leverage ratio and interest coverage ratio covenants.
During the fiscal year 2022, the Company repurchased $32.9 million and $28.3 million in aggregate principal amount of the 2023 Notes and 2024 Notes, respectively, in open market transactions.
Subsequent to fiscal year 2022, the Company repurchased $50.5 million in aggregate principal amount of the 2024 Notes in open market transactions.
The following table summarizes the maturities of the Company’s indebtedness as of January 1, 2023:

v3.22.4
Accrued Expenses and Other Current Liabilities
 12 Months Ended
Jan. 01, 2023
Accounts Payable and Accrued Liabilities, Current [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Payroll and incentives$52,331 $52,116 
Employee benefits51,983 52,199 
Deferred revenue135,531 138,052 
Federal, non-U.S. and state income taxes45,625 88,285 
Operating lease liabilities
31,217 29,313 
Other accrued operating expenses211,176 319,134 
Total accrued expenses and other current liabilities$527,863 $679,099 

v3.22.4
Employee Benefit Plans
 12 Months Ended
Jan. 01, 2023
Retirement Benefits [Abstract]  
Employee Benefit Plans Employee Benefit Plans
 Savings Plan:    The Company has a 401(k) Savings Plan for the benefit of all qualified U.S. employees, with such employees receiving matching contributions in the amount equal to 100.0% of the first 5.0% of eligible compensation up to applicable Internal Revenue Service limits. Savings plan expense was $20.0 million in fiscal year 2022, $16.5 million in fiscal year 2021, and $14.1 million in fiscal year 2020.
Pension Plans:    The Company has a defined benefit pension plan covering certain U.S. employees and non-U.S. pension plans for certain non-U.S. employees. The principal U.S. defined benefit pension plan is closed to new hires and plan benefits have been frozen. The plans provide benefits that are based on an employee’s years of service and compensation near retirement.
 Net periodic pension cost for U.S. and non-U.S. plans included the following components for fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Service and administrative costs$6,331 $5,174 $7,414 
Interest cost10,751 9,440 12,876 
Expected return on plan assets(22,056)(24,417)(21,786)
Actuarial (gain) loss(23,706)(19,514)20,291 
Net periodic pension (credit) cost$(28,680)$(29,317)$18,795 
The Company recognizes actuarial gains and losses, unless an interim remeasurement is required, in the fourth quarter of the year in which the gains and losses occur. Such adjustments for gains and losses are primarily driven by events and circumstances beyond the Company’s control, including changes in interest rates, the performance of the financial markets and mortality assumptions. Actuarial gains and losses, including other components of periodic pension cost, are recognized in the line item “Interest and other expense, net” in the consolidated statements of operations.
The following table sets forth the changes in the funded status of the principal U.S. pension plan and the principal non-U.S. pension plans and the amounts recognized in the Company’s consolidated balance sheets as of January 1, 2023 and January 2, 2022. The pension liability of the Business at the end of fiscal year 2022 that will transfer upon sale was reclassified to discontinued operations, while the prior year was not restated.
 
 January 1, 2023January 2, 2022
Non-U.S.U.S.Non-U.S.U.S.
(In thousands)
Actuarial present value of benefit obligations:
Accumulated benefit obligations$207,503 $231,492 $337,454 $299,826 
Change in benefit obligations:
Projected benefit obligations at beginning of year$339,390 $299,826 $395,339 $317,679 
Service and administrative costs4,956 1,375 4,924 250 
Interest cost3,671 7,080 2,632 6,808 
Benefits paid and plan expenses(14,978)(19,870)(15,299)(18,693)
Benefit obligation classified in discontinued operations(8,261)— — — 
Actuarial gains(88,724)(56,919)(30,705)(6,218)
Effect of exchange rate changes(28,099)— (17,501)— 
Projected benefit obligations at end of year$207,955 $231,492 $339,390 $299,826 
Change in plan assets:
Fair value of plan assets at beginning of year$181,189 $290,116 $204,744 $268,686 
Actual return on plan assets(46,383)(53,498)(13,115)20,123 
Benefits paid and plan expenses(14,978)(19,870)(15,299)(18,693)
Employer’s contributions6,572 — 6,851 20,000 
Effect of exchange rate changes(19,659)— (1,992)— 
Fair value of plan assets at end of year$106,741 $216,748 $181,189 $290,116 
Net liabilities recognized in the consolidated balance sheets$(101,214)$(14,744)$(158,201)$(9,710)
Net amounts recognized in the consolidated balance sheets consist of:
Other assets$19,521 $— $33,084 $— 
Current liabilities(6,568)— (6,966)— 
Long-term liabilities(114,167)(14,744)(184,319)(9,710)
Net liabilities recognized in the consolidated balance sheets$(101,214)$(14,744)$(158,201)$(9,710)
Actuarial assumptions as of the year-end measurement date:
Discount rate4.12 %4.84 %1.41 %2.44 %
Rate of compensation increase3.16 %None2.78 %None
Actuarial assumptions used to determine net periodic pension cost during the year were as follows:
January 1, 2023January 2, 2022January 3, 2021
Non-U.S.U.S.Non-U.S.U.S.Non-U.S.U.S.
Discount rate1.41 %2.44 %0.92 %2.21 %1.34 %3.01 %
Rate of compensation increase2.78 %None2.78 %None3.36 %None
Expected rate of return on assets1.11 %7.25 %2.10 %7.25 %2.20 %7.25 %
 
The Company’s expected rate of return on assets assumptions are derived from management’s estimates, as well as other information compiled by management, including studies that utilize customary procedures and techniques. The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings expected on the funds invested to provide for the pension plans benefits. While the study gives appropriate consideration to recent fund performance and historical returns, the assumption is primarily a long-term, prospective rate.
The Company’s discount rate assumptions are derived from a range of factors, including a yield curve for certain plans, composed of the rates of return on high-quality fixed-income corporate bonds available at the measurement date and the related expected duration for the obligations, and a bond matching approach for certain plans.
The following table provides a breakdown of the non-U.S. benefit obligations and fair value of assets for pension plans that have benefit obligations in excess of plan assets:
January 1,
2023		January 2,
2022
(In thousands)
Pension Plans with Projected Benefit Obligations in Excess of Plan Assets
Projected benefit obligations$120,736 $191,285 
Fair value of plan assets— — 
Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets
Accumulated benefit obligations$120,283 $189,349 
Fair value of plan assets— — 
 Assets of the defined benefit pension plans are primarily equity and debt securities. Asset allocations as of January 1, 2023 and January 2, 2022, and target asset allocations for fiscal year 2023 are as follows:
 Target AllocationPercentage of Plan Assets at
December 31, 2023January 1, 2023January 2, 2022
Asset CategoryNon-U.S.U.S.Non-U.S.U.S.Non-U.S.U.S.
Equity securities0-5%0-10%— %44 %— %46 %
Debt securities0-5%90-100%— %56 %— %54 %
Other95-100%0-10%100 %— %100 %— %
Total100 %100 %100 %100 %100 %100 %
The Company maintains target allocation percentages among various asset classes based on investment policies established for the pension plans which are designed to maximize the total rate of return (income and appreciation) after inflation within the limits of prudent risk taking, while providing for adequate near-term liquidity for benefit payments.
The target allocations for plan assets are listed in the above table. Equity securities primarily include investments in large-cap and mid-cap companies located in the United States and abroad, and equity index funds. Debt securities include corporate bonds of companies from diversified industries, high-yield bonds, and U.S. government securities. Other types of investments include investments in non-U.S. government index linked bonds, multi-strategy hedge funds and venture capital funds that follow several different strategies.
The fair value of the Company’s pension plan assets as of January 1, 2023 and January 2, 2022 by asset category, classified in the three levels of inputs described in Note 20 to the consolidated financial statements are as follows:
 
 Fair Value Measurements at January 1, 2023 Using:
Total Carrying
Value at
January 1, 2023		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
(In thousands)
Cash$14,483 $14,483 $— $— 
Equity securities:
U.S. large-cap61,680 61,680 — — 
International large-cap value20,148 20,148 — — 
Emerging markets growth9,902 9,902 — — 
Fixed income securities:
Corporate and U.S. debt instruments105,126 36,346 68,780 — 
Short-term corporate bonds17,088 — 17,088 — 
Other types of investments:
Foreign liability driven instrument95,062 — — 95,062 
Total assets measured at fair value$323,489 $142,559 $85,868 $95,062 
 Fair Value Measurements at January 2, 2022 Using:
Total Carrying
Value at
January 2, 2022		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
(In thousands)
Cash$22,241 $22,241 $— $— 
Equity Securities:
U.S. large-cap91,601 91,601 — — 
International large-cap value29,803 29,803 — — 
Emerging markets growth12,603 12,603 — — 
Fixed income securities:
Corporate and U.S. debt instruments133,727 41,725 92,002 — 
Corporate bonds15,650 — 15,650 — 
Other types of investments:
Foreign liability driven instrument165,680 — — 165,680 
Total assets measured at fair value$471,305 $197,973 $107,652 $165,680 

Valuation Techniques:    Valuation techniques utilized need to maximize the use of observable inputs and minimize the use of unobservable inputs. There have been no changes in the methodologies utilized at January 1, 2023 compared to January 2, 2022. The following is a description of the valuation techniques utilized to measure the fair value of the assets shown in the table above.

Equity Securities:    Shares of registered investment companies that are publicly traded are categorized as Level 1 assets; they are valued at quoted market prices that represent the net asset value of the fund. These instruments have active markets.

Equity index funds are mutual funds that are not publicly traded and are comprised primarily of underlying equity securities that are publicly traded on exchanges. Price quotes for the assets held by these funds are readily observable and available. Equity index funds are categorized as Level 2 assets.

Fixed Income Securities:    Fixed income mutual funds that are publicly traded are valued at quoted market prices that represent the net asset value of securities held by the fund and are categorized as Level 1 assets.
Fixed income index funds that are not publicly traded are stated at net asset value as determined by the issuer of the fund based on the fair value of the underlying investments and are categorized as Level 2 assets.

Individual fixed income bonds are categorized as Level 2 assets except where sufficient quoted prices exist in active markets, in which case such securities are categorized as Level 1 assets. These securities are valued using third-party pricing services. These services may use, for example, model-based pricing methods that utilize observable market data as inputs. Broker dealer bids or quotes of securities with similar characteristics may also be used.
Other Types of Investments:    Hedge funds, private equity funds, foreign real estate funds and venture capital funds are valued at fair value by using the net asset values provided by the investment managers and are updated, if necessary, using analytical procedures, appraisals, public market data and/or inquiry of the investment managers. The net asset values are determined based upon the fair values of the underlying investments in the funds. These other investments invest primarily in readily available marketable securities and allocate gains, losses, and expense to the investor based on the ownership percentage as described in the fund agreements. They are categorized as Level 3 assets.
In September 2021, the Company’s UK pension scheme executed a buy-in contract with Phoenix Life LTD (“Phoenix”), under which the Company made an upfront payment to Phoenix in exchange for Phoenix agreeing to make the benefit payments under the Company’s UK pension scheme due to specified participants and their beneficiaries, thus transferring most of the investment and longevity risk associated with the covered participants and beneficiaries from the Company to Phoenix. This buy-in contract can be considered a liability-driven investment (“LDI”) solution that hedges not only the investment risk but also the longevity risk under the Company’s UK pension scheme. Like other LDI solutions, it does not eliminate ongoing administrative costs.

The Company’s policy is to recognize significant transfers between levels at the actual date of the event.

A reconciliation of the beginning and ending Level 3 assets for fiscal years 2022, 2021 and 2020 is as follows:
 
 Fair Value Measurements Using
Significant Unobservable Inputs
(Level 3):
Foreign liability driven investmentForeign
Real Estate
Funds		Multi-strategy
Hedge
Funds		Total
(In thousands)
Balance at December 30, 2019$— $22,688 $1,721 $24,409 
Sales— — (1,721)(1,721)
Unrealized gains— 571 — 571 
Balance at January 3, 2021— 23,259 — 23,259 
Sales— (23,115)— (23,115)
Purchases165,680 — — 165,680 
Realized losses— (226)— (226)
Realized gains— 82 — 82 
Balance at January 2, 2022165,680 — — 165,680 
Pension benefits paid(6,639)— — (6,639)
Foreign exchange losses(18,411)— — (18,411)
Return on plan assets(45,568)— — (45,568)
Balance at January 1, 2023$95,062 $— $— $95,062 
 
With respect to plans outside of the United States, the Company expects to contribute $6.8 million in the aggregate during fiscal year 2023. During fiscal year 2023, the Company contributed $10.0 million to its defined benefit pension plan in the United States for the plan year 2022.
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid as follows:
 
Non-U.S.U.S.
(In thousands)
2023$11,907 $19,311 
202412,371 19,267 
202512,442 19,218 
202612,835 19,094 
202712,450 18,906 
2028-203264,237 87,807 
 
The Company also sponsors a supplemental executive retirement plan to provide senior management with benefits in excess of normal pension benefits. Effective July 31, 2000, this plan was closed to new entrants. At January 1, 2023 and January 2, 2022, the projected benefit obligations were $18.9 million and $24.1 million, respectively. Assets with a fair value of $0.9 million and $1.6 million, segregated in a trust (which is included in marketable securities and investments on the consolidated balance sheets), were available to meet this obligation as of January 1, 2023 and January 2, 2022, respectively. Pension expenses and income for this plan netted to income of $3.2 million in fiscal year 2022, expense of $0.2 million in fiscal year 2021 and expense of $2.1 million in fiscal year 2020.
 
Postretirement Medical Plans:    The Company provides healthcare benefits for eligible retired U.S. employees under a comprehensive major medical plan or under health maintenance organizations where available. Eligible U.S. employees qualify for retiree health benefits if they retire directly from the Company and have at least ten years of service. Generally, the major medical plan pays stated percentages of covered expenses after a deductible is met and takes into consideration payments by other group coverage and by Medicare. The plan requires retiree contributions under most circumstances and has provisions for cost-sharing charges. Effective January 1, 2000, this plan was closed to new hires. For employees retiring after 1991, the Company has capped its medical premium contribution based on employees’ years of service. The Company funds the amount allowable under a 401(h) provision in the Company’s defined benefit pension plan. Assets of the plan are primarily equity and debt securities and are available only to pay retiree health benefits. The costs of these plans are not material and the net assets in the plans totaled $17.1 million and $20.7 million at January 1, 2023 and January 2, 2022, respectively.

v3.22.4
Contingencies
 12 Months Ended
Jan. 01, 2023
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is conducting a number of environmental investigations and remedial actions at current and former locations of the Company and, along with other companies, has been named a potentially responsible party (“PRP”) for certain waste disposal sites. The Company accrues for environmental issues in the accounting period that the Company’s responsibility is established and when the cost can be reasonably estimated. The Company has accrued $12.2 million and $11.9 million as of January 1, 2023 and January 2, 2022, respectively, in accrued expenses and other current liabilities, which represents its management’s estimate of the cost of the remediation of known environmental matters, and does not include any potential liability for related personal injury or property damage claims. The Company’s environmental accrual is not discounted and does not reflect the recovery of any material amounts through insurance or indemnification arrangements. The cost estimates are subject to a number of variables, including the stage of the environmental investigations, the magnitude of the possible contamination, the nature of the potential remedies, possible joint and several liability, the time period over which remediation may occur, and the possible effects of changing laws and regulations. For sites where the Company has been named a PRP, management does not currently anticipate any additional liability to result from the inability of other significant named parties to contribute. The Company expects that the majority of such accrued amounts could be paid out over a period of up to ten years. As assessment and remediation activities progress at each individual site, these liabilities are reviewed and adjusted to reflect additional information as it becomes available. There have been no environmental problems to date that have had, or are expected to have, a material adverse effect on the Company’s consolidated financial statements. While it is possible that a loss exceeding the amounts recorded in the consolidated financial statements may be incurred, the potential exposure is not expected to be materially different from those amounts recorded.
The Company is subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of its business activities. Although the Company has established accruals for potential losses that it believes are probable and reasonably estimable, in the opinion of the Company’s management, based on its review of the information available at this time, the total cost of resolving these contingencies at January 1, 2023 should not have a material
adverse effect on the Company’s consolidated financial statements. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to the Company.

v3.22.4
Stock Plans
 12 Months Ended
Jan. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Stock Plans Stock Plans
Stock-Based Compensation:
 
The Company’s 2019 Incentive Plan (the “2019 Plan”) authorizes the issuance of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock-based awards and cash awards as part of the Company’s compensation programs. The 2019 Plan replaced the Company’s 2009 Incentive Plan (the “2009 Plan”). Upon shareholder approval of the 2019 Plan, 6.25 million shares of the Company’s common stock, as well as shares of the Company’s common stock previously granted under the 2009 Plan that expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased by the Company at their original issuance price subject to a contractual repurchase right, became available for grant under the 2019 Plan. Awards granted under the 2009 Plan prior to its expiration remain outstanding. As part of the Company’s compensation programs, the Company also offers shares of its common stock under its Employee Stock Purchase Plan.
 
The following table summarizes total pre-tax compensation expense recognized related to the Company’s stock options, restricted stock, restricted stock units, performance restricted stock units, performance units and stock grants, included in the Company’s consolidated statements of operations for fiscal years 2022, 2021 and 2020:
 
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Cost of product and service revenue$7,459 $3,193 $1,106 
Research and development expenses6,799 2,393 944 
Selling, general and administrative expenses37,260 24,089 24,854 
Total stock-based compensation expense$51,518 $29,675 $26,904 
The total income tax benefit recognized in the consolidated statements of operations for stock-based compensation was $12.8 million in fiscal year 2022, $12.2 million in fiscal year 2021 and $18.0 million in fiscal year 2020. Stock-based compensation costs capitalized as part of inventory were immaterial in all periods presented.

Stock Options:    The Company has granted options to purchase common shares at prices equal to the market price of the common shares on the date the option is granted. Conditions of vesting are determined at the time of grant. Options are generally exercisable in equal annual installments over a period of three years, and will generally expire seven years after the date of grant. Options replaced in association with business combination transactions are generally issued with the same terms of the respective plans under which they were originally issued.
 
The fair value of each option grant is estimated using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. Expected volatility was calculated based on the historical and implied volatility of the Company’s stock. The average expected life was based on the contractual term of the option and historic exercise experience. The risk-free interest rate is based on United States Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant. The Company’s weighted-average assumptions used in the Black-Scholes option pricing model were as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
Risk-free interest rate2.3 %0.9 %0.9 %
Expected dividend yield0.2 %0.2 %0.3 %
Expected lives5 years5 years5 years
Expected stock volatility28.5 %27.3 %23.8 %
The following table summarizes stock option activity for the fiscal year ended January 1, 2023:
 
 Number
of
Shares		Weighted-
Average Exercise
Price
 (Shares in thousands)
Outstanding at beginning of year1,192 $119.33 
Granted184 167.58 
Exercised(195)72.41 
Canceled(4)143.62 
Forfeited(129)152.90 
Outstanding at end of year1,048 $132.32 
Exercisable at end of year461 $102.72 
 
The aggregate intrinsic value for stock options outstanding at January 1, 2023 was $24.4 million with a weighted-average remaining contractual term of 4.7 years. The aggregate intrinsic value for stock options exercisable at January 1, 2023 was $20.1 million with a weighted-average remaining contractual term of 3.6 years. At January 1, 2023, there were 0.6 million stock options that were expected to vest in the future, with an aggregate intrinsic value of $4.3 million and a weighted-average remaining contractual term of 5.6 years.
 
The weighted-average grant-date fair value of options granted during fiscal years 2022, 2021 and 2020 was $48.09, $40.00, and $18.98 per share, respectively. The total intrinsic value of options exercised during fiscal years 2022, 2021 and 2020 was $13.9 million, $32.4 million, and $51.1 million, respectively. Cash received from option exercises for fiscal years 2022, 2021 and 2020 was $14.1 million, $25.1 million, and $37.7 million, respectively. The total compensation expense recognized related to the Company’s outstanding options was $9.5 million in fiscal year 2022, $5.6 million in fiscal year 2021 and $3.1 million in fiscal year 2020.
There was $15.3 million of total unrecognized compensation cost related to nonvested stock options granted as of January 1, 2023. This cost is expected to be recognized over a weighted-average period of 1.9 years.
Restricted Stock Awards:    The Company has awarded shares of restricted stock and restricted stock units to certain employees and non-employee directors at no cost to them, which cannot be sold, assigned, transferred or pledged during the restriction period. The restricted stock and restricted stock units vest through the passage of time, assuming continued employment. The fair value of the award at the time of the grant is expensed on a straight line basis primarily in selling, general and administrative expenses over the vesting period, which is generally 3 years. Recipients of the restricted stock have the right to vote such shares and receive dividends.
 
The following table summarizes restricted stock award activity for the fiscal year ended January 1, 2023:
 
Number
of
Shares		Weighted-
Average
Grant-
Date Fair
Value
 (Shares in thousands)
Nonvested at beginning of year637 $144.62 
Granted134 164.65 
Vested(238)137.90 
Forfeited(80)151.75 
Nonvested at end of year453 $152.79 
 
The fair value of restricted stock awards vested during fiscal years 2022, 2021 and 2020 was $32.8 million, $11.6 million, and $14.0 million, respectively. The total compensation expense recognized related to the restricted stock awards was $34.2 million in fiscal year 2022, $16.3 million in fiscal year 2021 and $8.7 million in fiscal year 2020.
 
As of January 1, 2023, there was $43.5 million of total unrecognized compensation cost, related to nonvested restricted stock awards. That cost is expected to be recognized over a weighted-average period of 1.3 years.
Employee Stock Purchase Plan:
In April 1999, the Company’s shareholders approved the 1998 Employee Stock Purchase Plan. In April 2005, the Compensation and Benefits Committee of the Company's Board of Directors (the “Board”) voted to amend the Employee Stock Purchase Plan, effective July 1, 2005, whereby participating employees have the right to purchase common stock at a price equal to 95% of the closing price on the last day of each six-month offering period. The number of shares which an employee may purchase, subject to certain aggregate limits, is determined by the employee’s voluntary contribution, which may not exceed 10% of the employee’s base compensation. During fiscal year 2022, the Company issued 30,818 shares of common stock under the Company’s Employee Stock Purchase Plan at a weighted-average price of $134.05 per share. During fiscal year 2021, the Company issued 21,578 shares under this plan at a weighted-average price of $168.11 per share. During fiscal year 2020, the Company issued 38,727 shares under this plan at a weighted-average price of $105.23 per share. At January 1, 2023 there remains available for sale to employees an aggregate of 0.7 million shares of the Company’s common stock out of the 5.0 million shares authorized by shareholders for issuance under this plan.

v3.22.4
Stockholders' Equity
 12 Months Ended
Jan. 01, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ Equity
Comprehensive Income:
The components of accumulated other comprehensive (loss) income consisted of the following:
 
Foreign
Currency
Translation
Adjustment,
net of tax		Unrecognized
Prior Service
Costs, net of
tax		Unrealized
(Losses)
Gains on
Securities,
net of tax		Accumulated
Other
Comprehensive
Income (Loss)
 (In thousands)
Balance, December 30, 2019$(200,437)$1,052 $(261)$(199,646)
Current year change169,500 (1,799)(16)167,685 
Balance, January 3, 2021(30,937)(747)(277)(31,961)
Current year change(130,873)(95)237 (130,731)
Balance, January 2, 2022(161,810)(842)(40)(162,692)
Current year change(284,854)44 5 (284,805)
Balance, January 1, 2023$(446,664)$(798)$(35)$(447,497)

Stock Repurchases:
On July 31, 2020, the Company’s Board of Directors (the “Board”) authorized the Company to repurchase shares of common stock for an aggregate amount up to $250.0 million under a stock repurchase program (the “Repurchase Program”). On July 22, 2022, the Repurchase Program was terminated by the Board and the Board authorized the Company to repurchase shares of common stock for an aggregate amount up to $300.0 million under a new stock repurchase program (the “New Repurchase Program”). No shares remain available for repurchase under the Repurchase Program due to its termination. The New Repurchase Program will expire on July 22, 2024 unless terminated earlier by the Board and may be suspended or discontinued at any time. During fiscal year 2022, the Company repurchased 240,000 shares of common stock under the Repurchase Program for an aggregate cost of $43.4 million. During fiscal year 2022, the Company repurchased 138,025 shares of common stock under the New Repurchase Program for an aggregate cost of $19.1 million. As of January 1, 2023, $280.9 million remained available for aggregate repurchases of shares under the New Repurchase Program.
In addition, the Board has authorized the Company to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to the Company’s equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to the Company’s equity incentive plans. During fiscal year 2022, the Company repurchased 115,247 shares of common stock for this purpose at an aggregate cost of $18.1 million. During fiscal year 2021, the Company repurchased 71,248 shares of common stock for this purpose at an aggregate cost of $10.5 million. During fiscal year 2020, the Company repurchased 72,251 shares of common stock for this purpose at an aggregate cost of $6.9 million. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value.
 
Dividends:
The Board declared a regular quarterly cash dividend of $0.07 per share in each quarter of fiscal years 2022, 2021 and 2020. At January 1, 2023, the Company had accrued $8.8 million for a dividend declared in October 2022 for the fourth quarter of fiscal year 2022 that was paid in February 2023. On January 26, 2023, the Company announced that the Board had declared a quarterly dividend of $0.07 per share for the first quarter of fiscal year 2023 that will be payable in May 2023. In the future, the Board may determine to reduce or eliminate the Company’s common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.

v3.22.4
Derivatives And Hedging Activities
 12 Months Ended
Jan. 01, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives and Hedging Activities Derivatives and Hedging Activities
 
The Company uses derivative instruments as part of its risk management strategy only, and includes derivatives utilized as economic hedges that are not designated as hedging instruments. By nature, all financial instruments involve market and credit risks. The Company enters into derivative instruments with major investment grade financial institutions and has policies to monitor the credit risk of those counterparties. The Company does not enter into derivative contracts for trading or other speculative purposes, nor does the Company use leveraged financial instruments. Approximately 55% of the Company’s business is conducted outside of the United States, generally in foreign currencies. As a result, fluctuations in foreign currency exchange rates can increase the costs of financing, investing and operating the business.
In the ordinary course of business, the Company enters into foreign exchange contracts for periods consistent with its committed exposures to mitigate the effect of foreign currency movements on transactions denominated in foreign currencies. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures from these currencies, with gains and losses resulting from the forward currency contracts that hedge these exposures. Transactions covered by hedge contracts include intercompany and third-party receivables and payables. The contracts are primarily in European and Asian currencies, have maturities that do not exceed 12 months, have no cash requirements until maturity, and are recorded at fair value on the Company’s consolidated balance sheets. The unrealized gains and losses on the Company’s foreign currency contracts are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from operating activities within the Company’s consolidated statements of cash flows.
Principal hedged currencies include the Australian Dollar, British Pound, Euro, Indian Rupee, Singapore Dollar and Swedish Krona. The Company held forward foreign exchange contracts, designated as economic hedges, with U.S. dollar equivalent notional amounts totaling $476.9 million at January 1, 2023 $371.9 million at January 2, 2022, and $808.0 million at January 3, 2021, and the fair value of these foreign currency derivative contracts was insignificant. The gains and losses realized on these foreign currency derivative contracts are not material. The duration of these contracts was generally 30 days or less during each of fiscal years 2022, 2021 and 2020.
In addition, in connection with certain intercompany loan agreements utilized to finance its acquisitions and stock repurchase program, the Company enters into forward foreign exchange contracts intended to hedge movements in foreign exchange rates prior to settlement of such intercompany loans denominated in foreign currencies. The Company records these hedges at fair value on the Company’s consolidated balance sheets. The unrealized gains and losses on these hedges, as well as the gains and losses associated with the remeasurement of the intercompany loans, are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from financing activities within the Company’s consolidated statements of cash flows.
The outstanding forward exchange contracts designated as economic hedges, which were intended to hedge movements in foreign exchange rates prior to the settlement of certain intercompany loan agreements, included combined U.S. Dollar notional amounts of $360.2 million as of January 2, 2022. The net gains and losses on these derivatives, combined with the gains and losses on the remeasurement of the hedged intercompany loans were not material.
During fiscal year 2018, the Company designated a portion of the 2026 Notes to hedge its investments in certain foreign subsidiaries. Unrealized translation adjustments from a portion of the 2026 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of January 1, 2023, the total notional amount of the 2026 Notes that was designated to hedge investments in foreign subsidiaries was €497.2 million. The unrealized foreign exchange (gains) losses recorded in AOCI related to the net investment hedge were $(34.5) million, $(33.2) million and $49.6 million during the fiscal years 2022, 2021 and 2020, respectively.
The Company does not expect any material net pre-tax gains or losses to be reclassified from accumulated other comprehensive (loss) income into interest and other expense, net within the next twelve months.

v3.22.4
Fair Value Measurements
 12 Months Ended
Jan. 01, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
 Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash equivalents, derivatives, marketable securities and accounts receivable. The Company believes it had no significant concentrations of credit risk as of January 1, 2023.
 The Company’s financial assets and liabilities carried at fair value are primarily comprised of marketable securities, derivative contracts used to hedge the Company’s currency risk, and acquisition related contingent consideration. The Company has not elected to measure any additional financial instruments or other items at fair value.
 Valuation Hierarchy: The following summarizes the three levels of inputs required to measure fair value. For Level 1 inputs, the Company utilizes quoted market prices as these instruments have active markets. For Level 2 inputs, the Company utilizes quoted market prices in markets that are not active, broker or dealer quotations, or utilizes alternative pricing sources with reasonable levels of price transparency. For Level 3 inputs, the Company utilizes unobservable inputs based on the best information available, including estimates by management primarily based on information provided by third-party fund managers, independent brokerage firms and insurance companies. A financial asset’s or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible.
 The following tables show the assets and liabilities carried at fair value measured on a recurring basis as of January 1, 2023 and January 2, 2022 classified in one of the three classifications described above:
 
 Fair Value Measurements at January 1, 2023 Using:
 Total Carrying
Value at January 1, 2023		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable Inputs
(Level 3)
 (In thousands)
Marketable securities$11,083 $11,083 $— $— 
Foreign exchange derivative assets2,142 — 2,142 — 
Foreign exchange derivative liabilities(1,549)— (1,549)— 
Contingent consideration(46,618)— — (46,618)
 Fair Value Measurements at January 2, 2022 Using:
 Total Carrying
Value at January 2, 2022		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable Inputs
(Level 3)
 (In thousands)
Marketable securities$33,683 $33,683 $— $— 
Foreign exchange derivative assets3,765 — 3,765 — 
Foreign exchange derivative liabilities(3,463)— (3,463)— 
Contingent consideration(57,996)— — (57,996)
 
Level 1 and Level 2 Valuation Techniques: The Company’s Level 1 and Level 2 assets and liabilities are comprised of investments in equity and fixed-income securities as well as derivative contracts. For financial assets and liabilities that utilize Level 1 and Level 2 inputs, the Company utilizes both direct and indirect observable price quotes, including common stock price quotes, foreign exchange forward prices and bank price quotes. Below is a summary of valuation techniques for Level 1 and Level 2 financial assets and liabilities.

Marketable securities: Include equity and fixed-income securities measured at fair value using the quoted market prices in active markets at the reporting date.

Foreign exchange derivative assets and liabilities: Include foreign exchange derivative contracts that are valued using quoted forward foreign exchange prices at the reporting date. The Company’s foreign exchange derivative contracts are subject to master netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company’s consolidated balance sheet on a net basis and are recorded in other assets. As of both January 1, 2023 and January 2, 2022, none of the master netting arrangements involved collateral.
Level 3 Valuation Techniques:    The Company’s Level 3 liabilities are comprised of contingent consideration related to acquisitions. For liabilities that utilize Level 3 inputs, the Company uses significant unobservable inputs. Below is a summary of valuation techniques for Level 3 liabilities.

Contingent consideration:    Contingent consideration is measured at fair value at the acquisition date using projected milestone dates, discount rates, probabilities of success and projected revenues (for revenue-based considerations). Projected risk-adjusted contingent payments are discounted back to the current period using a discounted cash flow model.
The fair values of contingent consideration are calculated on a quarterly basis based on a collaborative effort of the Company’s regulatory, research and development, operations, finance and accounting groups, as appropriate. Potential valuation adjustments are made as additional information becomes available, including the progress towards achieving proof of concept, regulatory approvals and revenue targets as compared to initial projections, the impact of market competition and market landscape shifts from non-invasive prenatal testing products, with the impact of such adjustments being recorded in the consolidated statements of operations.

As of January 1, 2023, the Company may have to pay contingent consideration, related to acquisitions with open contingency periods that are substantially all revenue-based consideration, of up to $106.2 million. The expected maximum earnout period for acquisitions with open contingency period is 5.9 years from January 1, 2023, and the remaining weighted average expected earnout period at January 1, 2023 was 4.9 years.

A reconciliation of the beginning and ending Level 3 net liabilities for contingent consideration is as follows:
 
 (In thousands)
Balance at December 29, 2019$(35,481)
Amounts paid and foreign currency translation23,701 
Change in fair value (included within selling, general and administrative expenses)8,827 
Balance at January 3, 2021(2,953)
Additions(57,431)
Amounts paid and foreign currency translation5,507 
Change in fair value (included within selling, general and administrative expenses)(3,119)
Balance at January 2, 2022(57,996)
Additions(4,961)
Amounts paid and foreign currency translation2,562 
Adjustments recognized in goodwill12,400 
Change in fair value (included within selling, general and administrative expenses)1,377 
Balance at January 1, 2023$(46,618)


Assets and Liabilities Not Carried at Fair Value
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to the short-term maturities of these assets and liabilities. If measured at fair value, cash and cash equivalents would be classified as Level 1.
The Company’s outstanding senior unsecured notes had an aggregate fair value of $3,812.3 million and aggregate carrying value of $4,390.5 million as of January 1, 2023. The Company's outstanding senior unsecured notes had an aggregate fair value of $4,612.8 million and aggregate carrying value of $4,479.5 million as of January 2, 2022. The fair values of the outstanding senior unsecured notes were estimated using market quotes from brokers and were based on current rates offered for similar debt, which are Level 2 measurements.
The Company’s other debt facilities, including the Company's senior revolving credit facility and term loan facility, had an aggregate carrying value of $3.7 million and $504.5 million as of January 1, 2023 and January 2, 2022, respectively. The carrying value approximates fair value and were classified as Level 2.

v3.22.4
Leases (Notes)
 12 Months Ended
Jan. 01, 2023
Disclosure Text Block [Abstract]  
Leases [Text Block] Leases
Lessee Disclosures
The Company leases certain property and equipment under operating and finance leases. The Company’s leases have remaining lease terms of less than 1 year to 30 years, some of which include options to extend the lease for up to 5 years, and some of which include options to terminate the lease within 1 year. Finance leases are not material to the Company.
The components of lease expense were as follows:
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Lease Cost:
Operating lease cost$39,989 $39,516 37,613 
Supplemental cash flow information related to leases was as follows:
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$37,488 $38,970 $34,373 
Right-of-use assets obtained in exchange for new lease obligations:
   Operating leases$55,016 $12,345 $2,605 
Supplemental balance sheet information related to leases was as follows:
 January 1,
2023		January 2,
2022
 (In thousands, except lease term and discount rate)
Operating Leases:
Operating lease right-of-use assets$188,351 $164,040 
Operating lease liabilities included in Accrued expenses and other current liabilities$31,217 $29,313 
Operating lease liabilities169,968 147,395 
Total operating lease liabilities$201,185 $176,708 
Weighted Average Remaining Lease Term in Years
Operating leases6.15.8
Weighted Average Remaining Discount Rate
Operating leases2.6%1.8%
Lease costs from finance leases, short-term leases, variable lease costs and sub-lease income are not material.
Future payments of operating lease liabilities as of January 1, 2023 were as follows:
 (In thousands)
2023$38,452 
202435,361 
202532,080 
202627,064 
202723,983 
2028 and thereafter65,308 
Total lease payments222,248 
Less imputed interest(21,063)
    Total $201,185 

v3.22.4
Industry Segment and Geographic Area Information
 12 Months Ended
Jan. 01, 2023
Segment Reporting [Abstract]  
Industry Segment Information Industry Segment and Geographic Area Information
The Company discloses information about its operating segments based on the way that management organizes the segments within the Company for making operating decisions and assessing financial performance. The Company evaluates the performance of its operating segments based on revenue and operating income. Intersegment revenue and transfers are not significant. The accounting policies of the operating segments are the same as those described in Note 1.
The principal products and services of the Company’s two operating segments are:
•Discovery & Analytical Solutions. Provides products and services targeted towards the life sciences and applied markets.
•Diagnostics. Develops diagnostics, tools and applications focused on clinically-oriented customers, especially within the reproductive health, emerging market diagnostics and applied genomics markets. The Diagnostics segment serves the diagnostics market.
The Company has included the expenses for its corporate headquarters, such as legal, tax, audit, human resources, information technology, and other management and compliance costs, as well as the activity related to the mark-to-market adjustment on postretirement benefit plans, as “Corporate” below. The Company has a process to allocate and recharge expenses to the reportable segments when these costs are administered or paid by the corporate headquarters based on the extent to which the segment benefited from the expenses. These amounts have been calculated in a consistent manner and are included in the Company’s calculations of segment results to internally plan and assess the performance of each segment for all purposes, including determining the compensation of the business leaders for each of the Company’s operating segments.
The primary financial measure by which the Company evaluates the performance of its segments is adjusted operating income, which consists of operating income plus amortization of intangible assets, adjustments to operations arising from purchase accounting (primarily adjustments to the fair value of acquired inventory that are subsequently recognized), acquisition and divestiture-related costs, and other costs that are not expected to recur or are of a non-cash nature, including primarily restructuring actions.
Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Revenues
Discovery & Analytical Solutions$1,292,909 $897,718 $596,585 
Diagnostics2,019,727 2,932,738 2,067,728 
Revenue purchase accounting adjustments(814)(2,648)(1,083)
Total revenues$3,311,822 $3,827,808 $2,663,230 
Segment Operating Income
Discovery & Analytical Solutions$503,243 $281,602 $129,174 
Diagnostics781,985 1,432,769 1,010,361 
Corporate(73,431)(77,364)(73,854)
Subtotal reportable segments1,211,797 1,637,007 1,065,681 
Amortization of intangible assets(370,638)(256,569)(160,991)
Purchase accounting adjustments(45,681)(40,993)(6,382)
Acquisition and divestiture-related costs(39,826)(62,760)(4,335)
Restructuring and other(12,953)(18,228)(26,700)
Operating income from continuing operations742,699 1,258,457 867,273 
Interest and other expense, net90,862 54,875 67,201 
Income from continuing operations before income taxes$651,837 $1,203,582 $800,072 

Additional information relating to the Company’s reporting segments is as follows for the three fiscal years ended January 1, 2023:
 Depreciation and Amortization ExpenseCapital Expenditures
 January 1,
2023		January 2,
2022		January 3,
2021		January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)(In thousands)
Discovery & Analytical Solutions$263,698 $94,700 $48,657 $41,532 $27,818 $6,345 
Diagnostics161,394 214,178 149,738 40,671 57,206 55,236 
Corporate1,908 2,565 3,253 3,429 996 2,053 
Continuing operations$427,000 $311,443 $201,648 $85,632 $86,020 $63,634 

 Total Assets
 January 1,
2023		January 2,
2022
 (In thousands)
Discovery & Analytical Solutions$8,330,045 $8,478,292 
Diagnostics3,991,659 4,692,816 
Corporate114,447 129,904 
Current and long-term assets of discontinued operations1,693,704 1,699,542 
Total assets$14,129,855 $15,000,554 
The following geographic area information for continuing operations includes revenue based on location of external customers for the three fiscal years ended January 1, 2023 and net long-lived assets based on physical location as of January 1, 2023 and January 2, 2022:
 Revenue
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
U.S.$1,546,520 $1,682,294 $921,574 
International:
China476,366 449,588 305,660 
United Kingdom136,017 357,911 323,837 
Other international1,152,919 1,338,015 1,112,159 
Total international1,765,302 2,145,514 1,741,656 
Total revenue$3,311,822 $3,827,808 $2,663,230 
 
 
Net Long-Lived Assets(1)
 January 1,
2023		January 2,
2022
 (In thousands)
U.S.$311,661 $295,397 
International:
Germany147,766 146,633 
China68,072 59,851 
Other international216,235 222,190 
Total international432,073 428,674 
Total net long-lived assets$743,734 $724,071 
(1) Long-lived assets consist of property and equipment, net, operating lease right-of-use assets, rental equipment, software and other long-term assets.

v3.22.4
Quarterly Financial Information (Unaudited)
 12 Months Ended
Jan. 01, 2023
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited)
Selected quarterly financial information is as follows for the fiscal years ended:

First
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter		Year
 (In thousands, except per share data)
January 1, 2023
Revenue$963,163 $895,642 $711,803 $741,214 $3,311,822 
Gross profit594,740 551,717 407,044 436,329 1,989,830 
Operating income from continuing operations261,967 232,486 110,780 137,466 742,699 
Income from continuing operations before income taxes224,904 206,344 82,142 138,447 651,837 
Income from continuing operations184,070 161,601 69,508 97,497 512,676 
(Loss) income from discontinued operations(7,108)17,611 15,839 30,161 56,503 
Net income176,962 179,212 85,347 127,658 569,179 
Basic earnings per share:
Income from continuing operations$1.46 $1.28 $0.55 $0.77 $4.06 
(Loss) income from discontinued operations(0.06)0.14 0.13 0.24 0.45 
Net income1.40 1.42 0.68 1.01 4.51 
Diluted earnings per share:
Income from continuing operations$1.45 $1.28 $0.55 $0.77 $4.06 
(Loss) income from discontinued operations(0.06)0.14 0.13 0.24 0.45 
Net income1.39 1.42 0.67 1.01 4.50 
January 2, 2022
Revenue$1,027,836 $910,747 $861,315 $1,027,910 $3,827,808 
Gross profit693,187 574,143 522,860 643,797 2,433,987 
Operating income from continuing operations455,010 307,999 195,554 299,894 1,258,457 
Income from continuing operations before income taxes467,537 301,329 135,012 299,704 1,203,582 
Income from continuing operations369,859 227,857 107,631 184,089 889,436 
Income from discontinued operations9,446 18,073 20,107 6,095 53,721 
Net income379,305 245,930 127,738 190,184 943,157 
Basic earnings per share:
Income from continuing operations$3.30 $2.03 $0.94 $1.46 $7.66 
Income from discontinued operations0.08 0.16 0.18 0.05 0.46 
Net income3.38 2.19 1.12 1.51 8.12 
Diluted earnings per share:
Income continuing operations$3.29 $2.03 $0.94 $1.45 $7.62 
Income from discontinued operations0.08 0.16 0.17 0.05 0.46 
Net income3.37 2.19 1.11 1.50 8.08 

v3.22.4
Nature of Operations and Accounting Policies Nature of Operations and Accounting Policies (Policies)
 12 Months Ended
Jan. 01, 2023
Accounting Policies [Abstract]  
Consolidation [Policy Text Block] The consolidated financial statements include the accounts of PerkinElmer, Inc. and its subsidiaries (the “Company”). All intercompany balances and transactions have been eliminated in consolidation. In August 2022, the Company announced the proposed sale of certain assets and the equity interests of certain entities constituting the Company’s Analytical, Food and Enterprise Services businesses (the “Business”). The 2021 and 2020 consolidated financial statements presented herein have been retrospectively adjusted to present the Business as discontinued operations for all periods presented.
Fiscal Periods [Policy Text Block] The Company’s fiscal year ends on the Sunday nearest December 31. The Company reports fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. Each of the fiscal years ended January 1, 2023 (“fiscal year 2022”) and January 2, 2022 (“fiscal year 2021”) included 52 weeks. The fiscal year ended January 3, 2021 (“fiscal year 2020”) included 53 weeks.
Accounting Policies and Estimates [Policy Text Block] Accounting Policies and Estimates: The preparation of consolidated financial statements in accordance with United States (“U.S.”) Generally Accepted Accounting Principles (“GAAP”) requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
Revenue Recognition [Policy Text Block] Revenue Recognition:
Inventories [Policy Text Block] Inventories: Inventories, which include material, labor and manufacturing overhead, are valued at the lower of cost or market. Inventories are accounted for using the first-in, first-out method of determining inventory costs. Inventory quantities on-hand are regularly reviewed, and where necessary, provisions for excess and obsolete inventory are recorded based primarily on the Company’s estimated forecast of product demand and production requirements.
Income Taxes [Policy Text Block]
Income Taxes: The Company uses the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. This method also requires the recognition of future tax benefits such as net operating loss carryforwards, to the extent that realization of such benefits is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established for any deferred tax asset for which realization is not more likely than not.
The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions and other issues. These reserves are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. Potential interest and penalties associated with such uncertain tax positions is recorded as a component of income tax expense.
Property, Plant and Equipment [Policy Text Block] Property, Plant and Equipment: The Company depreciates property, plant and equipment using the straight-line method over its estimated useful lives, which generally fall within the following ranges: buildings- 10 to 40 years; leasehold improvements - estimated useful life or remaining term of lease, whichever is shorter; and machinery and equipment- 3 to 8 years. Certain tooling costs are capitalized and amortized over a 3-year life, while repairs and maintenance costs are expensed.
Change in Accounting for Pension and Other Postretirement Benefits [Policy Text Block] Pension and Other Postretirement Benefits: The Company sponsors both funded and unfunded U.S. and non-U.S. defined benefit pension plans and other postretirement benefits. The Company immediately recognizes actuarial gains and losses in operating results in the year in which the gains and losses occur. Actuarial gains and losses are measured annually as of the calendar month-end that is closest to the Company's fiscal year end and accordingly will be recorded in the fourth quarter, unless the Company is required to perform an interim remeasurement. The remaining components of pension expense, primarily service and interest costs and assumed return on plan assets, are recorded on a quarterly basis. The Company’s funding policy provides that payments to the U.S. pension trusts shall at least be equal to the minimum funding requirements of the Employee Retirement Income Security Act of 1974. Non-U.S. plans are accrued for, but generally not fully funded, and benefits are paid from operating funds.
Translation of Foreign Currencies [Policy Text Block] Translation of Foreign Currencies: For foreign operations, asset and liability accounts are translated at current exchange rates; income and expenses are translated using weighted average exchange rates for the reporting period. Resulting translation adjustments, as well as translation gains and losses from certain intercompany transactions considered permanent in nature, are reported in accumulated other comprehensive income (“AOCI”), a separate component of stockholders’ equity. Gains and losses arising from transactions and translation of period-end balances denominated in currencies other than the functional currency are included in other expense, net
Business Combinations [Policy Text Block] Business Combinations: Business combinations are accounted for at fair value. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses. Measurement period adjustments are made in the period in which the amounts are determined and the current period income effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition date. All changes that do not qualify as measurement period adjustments are also included in current period earnings. The accounting for business combinations requires estimates and judgment as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of finite-lived intangible assets, or the recognition of additional consideration which would be expensed.
Goodwill and Other Intangible Assets [Policy Text Block]
Goodwill and Other Intangible Assets:  The Company’s intangible assets consist of (i) goodwill, which is not being amortized; (ii) indefinite lived intangibles, which consist of a trade name that is not subject to amortization; and (iii) amortizing intangibles, which consist of patents, trade names and trademarks, licenses, customer relationships and purchased technologies, which are being amortized over their estimated useful lives.
The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. This annual impairment assessment is performed by the Company on the later of January 1 or the first day of each fiscal year. Indefinite-lived intangibles are also subject to an annual impairment test. The impairment test consists of a comparison of the fair value of the indefinite-lived intangible asset with its carrying amount. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of the amortizing intangible asset. Amortizing intangible assets are reviewed for impairment when indicators of impairment are present. When a potential impairment has been identified, forecasted undiscounted net cash flows of the operations to which the asset relates are compared to the current carrying value of the long-lived assets present in that operation. If such cash flows are less than such carrying amounts, long-lived assets, including such intangibles, are written down to their respective fair values.
Stock-Based Compensation [Policy Text Block] Stock-Based Compensation: The Company accounts for stock-based compensation expense based on estimated grant date fair value, generally using the Black-Scholes option-pricing model. The fair value is recognized as expense in the consolidated financial statements over the requisite service period. The determination of fair value and the timing of expense using option pricing models such as the Black-Scholes model require the input of subjective assumptions, including the expected term and the expected price volatility of the underlying stock. The Company estimates the expected term assumption based on historical experience. In determining the Company’s expected stock price volatility assumption, the Company reviews both the historical and implied volatility of the Company’s common stock.
Marketable Securities and Investments [Policy Text Block] Marketable Securities and Investments:  Investments in debt securities that are classified as available for sale are recorded at fair value with unrealized gains and losses included in AOCI until realized. Investments in equity securities are recorded at their fair values with unrealized holding gains and losses included in earnings. Investments in equity securities without a readily determinable fair value are carried at cost minus impairment, if any. When an observable price change in orderly transactions for the identical or a similar investment of the same issuer has occurred, the Company elects to carry those equity investments at fair value as of the date that the observable transaction occurred.
Cash Flows [Policy Text Block] Cash and Cash Equivalents: The Company considers all highly liquid, unrestricted instruments with a purchased maturity of three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value due to the short maturities of these instruments.
Environmental Matters [Policy Text Block] Environmental Matters: The Company accrues for costs associated with the remediation of environmental pollution when it is probable that a liability has been incurred and the Company’s proportionate share of the amount can be reasonably estimated. The recorded liabilities have not been discounted.
Research and Development Expense, Policy [Policy Text Block] Research and Development: Research and development costs are expensed as incurred. In-process research and development (“IPRD”) costs acquired in a business combination are recorded at fair value as an intangible asset at the acquisition date and amortized once the product is ready for sale or expensed if abandoned.
Restructuring Charges [Policy Text Block] Restructuring and Other Costs: Generally, costs associated with an exit or disposal activity are recognized when the liability is incurred. Prior to recording restructuring charges for employee separation agreements, the Company notifies all employees of termination. Costs related to employee separation arrangements requiring future service beyond a specified minimum retention period are recognized over the service period.
New Accounting Pronouncement or Change in Accounting Principle, Description Comprehensive Income:  Comprehensive income is defined as net income or loss and other changes in stockholders’ equity from transactions and other events from sources other than stockholders. Comprehensive income is reflected in the consolidated statements of comprehensive income.
Derivative Instruments and Hedging [Policy Text Block]
Derivative Instruments and Hedging: Derivatives are recorded on the consolidated balance sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.
For a cash flow hedge, the effective portion of the derivative’s gain or loss is initially reported as a component of other comprehensive income and subsequently amortized into net earnings when the hedged exposure affects net earnings. Cash flow hedges related to anticipated transactions are designated and documented at the inception of each hedge by matching the terms of the contract to the underlying transaction. The Company classifies the cash flows from hedging transactions in the same categories as the cash flows from the respective hedged items. Once established, cash flow hedges are generally recorded in other comprehensive income, unless an anticipated transaction is no longer likely to occur, and subsequently amortized into net earnings when the hedged exposure affects net earnings. Discontinued or dedesignated cash flow hedges are immediately settled with counterparties, and the related accumulated derivative gains or losses are recognized into net earnings on the consolidated financial statements. Settled cash flow hedges related to forecasted transactions that remain probable are recorded as a component of other comprehensive (loss) income and are subsequently amortized into net earnings when the hedged exposure affects net earnings. Forward contract effectiveness for cash flow hedges is calculated by comparing the fair value of the contract to the change in value of the anticipated transaction using forward rates on a monthly basis. The Company also has entered into other foreign currency forward contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into interest and other expense, net on the consolidated financial statements.
The Company also uses foreign currency denominated debt to hedge its investments in certain foreign subsidiaries. Realized and unrealized translation adjustments from these hedges are included in the foreign currency translation component of AOCI, as well as the offset translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold.
Leases: Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities, and operating lease liabilities in the Company's consolidated balance sheet. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining lease payments over the lease term. When the Company’s lease did not provide an implicit rate, the Company used its incremental
borrowing rate in determining the present value of lease payments. The Company used the implicit rate when readily determinable. The operating lease ROU asset excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as cars, the Company accounts for the lease and non-lease components as a single lease component.
The Company has made an accounting policy election not to recognize ROU assets and lease liabilities that arise from short-term leases for facilities and equipment. Instead, the Company recognizes the lease payments in the consolidated statements of operations on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred.
As a lessor, the Company applies the practical expedient to not separate non-lease components from the associated lease component and instead accounts for those components as a single component if the non-lease components otherwise would be accounted for under Accounting Standards Codification 606, Revenue From Contracts With Customers (“ASC 606”), and both of the following criteria are met: 1) the timing and pattern of transfer of the non-lease component or components and associated lease component are the same; and 2) the lease component, if accounted for separately, would be classified as an operating lease. If the non-lease component or components associated with the lease component are the predominant component of the combined component, the Company accounts for the combined component in accordance with ASC 606. Otherwise, the Company accounts for the combined component as an operating lease in accordance with Accounting Standards Codification 842, Leases (“ASC 842”).
Description of New Accounting Pronouncements Not yet Adopted [Text Block] Recently Issued Accounting Pronouncements: From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the “FASB”) and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations.In October 2021, t

v3.22.4
Business Combinations and Asset Purchases (Tables)
 12 Months Ended
Jan. 01, 2023
Business Acquisition [Line Items]  
Business Acquisition, Pro Forma Information [Table Text Block] The following unaudited pro forma information presents the combined financial results for the Company and BioLegend as if the acquisition of BioLegend had been completed at the beginning of fiscal year 2020:
January 2,
2022		January 3,
2021
(In thousands, except per share data)
Pro Forma Statement of Operations Information:
Revenue$4,056,122 $2,905,116 
Income from continuing operations947,387 454,034 
Basic earnings per share:
Income from continuing operations$7.27 $3.62 
Diluted earnings per share:
Income from continuing operations$7.25 $3.60 
Fair Values of the Business Combinations and Allocations for the Acquisitions Completed
The total purchase price for the acquisitions in fiscal year 2021 has been allocated to the estimated fair value of assets acquired and liabilities assumed as follows:
Final
BioLegendOther
(In thousands)
Fair value of business combinations:
Cash payments$3,336,115 $1,128,584 
Common stock issued2,638,369 — 
Other liability6,857 2,910 
Contingent consideration— 45,031 
Working capital and other adjustments— 183 
Less: cash acquired(292,377)(195,010)
Total$5,688,964 $981,698 
Identifiable assets acquired and liabilities assumed:
Current assets$184,704 $71,840 
Property, plant and equipment147,200 26,507 
Other assets9,330 15,527 
Identifiable intangible assets:
Core technology and clone library782,400 290,089 
Trade names and patents38,000 39,476 
Licenses8,979 — 
Customer relationships and backlog1,714,800 141,670 
Goodwill3,509,931 545,262 
Deferred taxes(668,919)(80,923)
Deferred revenue— (1,197)
Debt assumed— (4,628)
Liabilities assumed(37,461)(61,925)
Total$5,688,964 $981,698 
The total purchase price for the acquisitions in fiscal year 2020 has been allocated to the estimated fair value of assets acquired and liabilities assumed as follows:
Final
(In thousands)
Fair value of business combinations:
Cash payments$437,661 
Other liability1,660 
Working capital and other adjustments(384)
Less: cash acquired(26,840)
Total$412,097 
Identifiable assets acquired and liabilities assumed:
Current assets$35,532 
Property, plant and equipment20,302 
Other assets18,114 
Identifiable intangible assets:
Core technology65,730 
Trade names5,580 
Customer relationships and backlog108,523 
IPRD10,700 
Goodwill221,751 
Deferred taxes(25,674)
Deferred revenue(2,031)
Liabilities assumed(46,430)
Total$412,097 

v3.22.4
Revenue from Contract with Customer (Tables)
 12 Months Ended
Jan. 01, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
In the following tables, revenue is disaggregated by primary geographical market, end-markets and timing of revenue recognition.
Reportable Segments
For the fiscal year ended
January 1, 2023January 2, 2022January 3, 2021
Discovery & Analytical SolutionsDiagnosticsTotalDiscovery & Analytical SolutionsDiagnosticsTotalDiscovery & Analytical SolutionsDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$683,170 $979,473 $1,662,643 $444,459 $1,362,213 $1,806,672 $286,354 $750,641 $1,036,995 
Europe297,468 534,343 831,811 234,334 982,476 1,216,810 157,277 864,687 1,021,964 
Asia312,271 505,097 817,368 217,076 587,250 804,326 152,657 451,614 604,271 
$1,292,909 $2,018,913 $3,311,822 $895,869 $2,931,939 $3,827,808 $596,288 $2,066,942 $2,663,230 
Primary end-markets
Diagnostics$— $2,018,913 $2,018,913 $— $2,931,939 $2,931,939 $— $2,066,942 $2,066,942 
Life sciences1,292,909 — 1,292,909 895,869 — 895,869 596,288 — 596,288 
$1,292,909 $2,018,913 $3,311,822 $895,869 $2,931,939 $3,827,808 $596,288 $2,066,942 $2,663,230 
Contract with Customer, Contract Asset, Contract Liability, and Receivable Contract balances were as follows:
January 1, 2023January 2, 2022
(In thousands)
Contract assets$56,631 $61,999 
Contract liabilities$(30,133)$(184,897)

v3.22.4
Discontinued Operations (Tables)
 12 Months Ended
Jan. 01, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]
The summary pre-tax operating results of the discontinued operations, were as follows:
 January 1, 2023January 2, 2022January 3, 2021
 (In thousands)
Revenue$1,298,376 $1,239,361 $1,119,515 
Cost of revenue859,330 822,048 739,817 
Selling, general and administrative expenses306,032 268,760 209,442 
Research and development expenses64,605 74,632 58,948 
Operating income68,409 73,921 111,308 
Other (income) expense, net(5,195)(2,383)5,016 
Income from discontinued operations before income taxes$73,604 $76,304 $106,292 
Schedule of Operating and Investing non-cash items from discontinued operations [Table Text Block]
The following operating and investing non-cash items from discontinued operations were as follows for the fiscal years ended:
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Depreciation
$8,011 $12,897 $13,299 
Amortization
16,984 33,664 31,560 
Capital expenditures10,670 13,868 13,872 
Schedule of carrying amounts of major classes of assets and liabilities included in discontinued operations [Table Text Block] The carrying amounts of the major classes of assets and liabilities included in discontinued operations related to the Business consisted of the following:
January 1, 2023January 2, 2022
 (In thousands)
Cash and cash equivalents$14,999 $14,999 
Accounts receivable343,064 315,851 
Inventories210,367 198,824 
Other current assets32,063 25,700 
Total current assets555,374 
Property, plant and equipment, net60,983 60,074 
Operating lease right-of-use assets41,487 43,735 
Intangible assets, net202,850 241,257 
Goodwill772,812 789,465 
Other assets, net15,079 9,637 
    Total long-term assets
1,144,168 
Total assets of discontinued operations
$1,693,704 $1,699,542 
Accounts payable29,912 30,647 
Accrued expenses and other current liabilities161,260 174,947 
    Total current liabilities205,594 
Deferred taxes and long-term liabilities46,046 53,738 
Operating lease liabilities35,647 37,964 
    Total long-term liabilities91,702 
Total liabilities of discontinued operations$272,865 $297,296 

v3.22.4
Income Taxes (Tables) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Income Tax Disclosure [Abstract]    
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
The components of income from continuing operations before income taxes were as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
U.S.$326,438 $547,705 $210,130 
Non-U.S.325,399 655,877 589,942 
Total$651,837 $1,203,582 $800,072 
  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
The components of the provision for income taxes on continuing operations were as follows:
 
Current
Expense		Deferred 
Expense
(Benefit)		Total
(In thousands)
Fiscal year ended January 1, 2023
Federal$115,436 $(45,246)$70,190 
State27,757 (16,139)11,618 
Non-U.S.101,891 (44,538)57,353 
Total$245,084 $(105,923)$139,161 
Fiscal year ended January 2, 2022
Federal$154,905 $(37,858)$117,047 
State53,961 3,602 57,563 
Non-U.S.160,608 (21,072)139,536 
Total$369,474 $(55,328)$314,146 
Fiscal year ended January 3, 2021
Federal$39,878 $4,875 $44,753 
State15,469 (1,240)14,229 
Non-U.S.149,503 (38,973)110,530 
Total$204,850 $(35,338)$169,512 
  
Schedule of Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations [Table Text Block] The total provision for income taxes included in the consolidated financial statements is as follows for the fiscal years ended: 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Continuing operations$139,161 $314,146 $169,512 
Discontinued operations17,101 22,583 8,889 
Total$156,262 $336,729 $178,401 
  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] A reconciliation of income tax expense at the U.S. federal statutory income tax rate to the recorded tax provision is as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Tax at statutory rate$136,886 $252,752 $168,015 
Non-U.S. rate differential, net(5,221)(33,847)(29,155)
U.S. taxation of multinational operations22,102 7,964 11,468 
State income taxes, net7,820 36,832 13,249 
Prior year tax matters(10,160)1,850 5,532 
Effect of stock compensation845 (2,187)(8,148)
General business tax credits(7,132)(2,715)(2,145)
Change in valuation allowance4,964 (179)(369)
Rate change on long term intangibles— 14,031 — 
Effect of foreign repatriations(4,940)37,147 — 
Foreign consolidations— — 15,222 
Other, net(6,003)2,498 (4,157)
Total$139,161 $314,146 $169,512 
  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
The tax effects of temporary differences and attributes that gave rise to deferred income tax assets and liabilities were as follows:
 
January 1,
2023		January 2,
2022
(In thousands)
Deferred tax assets:
Inventory$17,920 $2,388 
Reserves and accruals70,912 53,403 
Accrued compensation23,868 29,960 
Net operating loss and credit carryforwards117,953 110,149 
Accrued pension11,653 23,714 
Restructuring reserve1,640 1,442 
Deferred revenue22,644 49,207 
Capitalized research and development expenses44,922 12,114 
Operating lease liabilities43,547 37,299 
Unrealized foreign exchange loss
11,158 14,594 
All other, net841 583 
Total deferred tax assets367,058 334,853 
Deferred tax liabilities:
Postretirement health benefits(4,379)(5,303)
Depreciation and amortization(916,581)(1,021,487)
Operating lease right-of-use assets(39,281)(33,607)
Prepaid expenses(3,515)(3,265)
Deferred tax liability on foreign earnings(15,782)(31,239)
Total deferred tax liabilities(979,538)(1,094,901)
Valuation allowance(96,681)(89,523)
Net deferred tax liabilities$(709,161)$(849,571)
  
Components of net deferred tax asset recognized [Table Text Block]
The components of net deferred tax liabilities were recognized in the consolidated balance sheets as follows:

January 1,
2023		January 2,
2022
(In thousands)
Other assets, net$18,527 $18,534 
Deferred taxes and other long-term liabilities(727,688)(868,105)
Total$(709,161)$(849,571)
  
Deferred tax assets, other assets, net $ 18,527 $ 18,534
Deferred tax liabilities, Long-term liabilities (727,688) (868,105)
Deferred Tax Liabilities, Net $ (709,161) $ (849,571)

v3.22.4
Earnings Per Share (Tables)
 12 Months Ended
Jan. 01, 2023
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations The following table reconciles the number of shares utilized in the earnings per share calculations for the fiscal years ended:
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Number of common shares—basic126,155 116,165 111,514 
Effect of dilutive securities:
Stock options249 391 466 
Restricted stock awards22 118 105 
Number of common shares—diluted126,426 116,674 112,085 
Number of potentially dilutive securities excluded from calculation due to antidilutive impact611 487 220 

v3.22.4
Accounts Receivable, Net Accounts Receivable, Net (Tables)
 12 Months Ended
Jan. 01, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
Accounts receivable, net consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Accounts receivable, net$612,780 $707,941 
Long-term accounts receivable, net, included in Other assets, net34,040 29,958 
Total accounts receivable, net$646,820 $737,899 
Accounts Receivable, Allowance for Credit Loss Reserves for credit losses consisted of the following:
Balance at
Beginning of
Year		ProvisionsCharges/
Write-
offs
Other(1)
Balance
at End
of Year
  (In thousands)
Year ended January 3, 2021$23,574 $10,294 $(1,895)$1,524 $33,497 
Year ended January 2, 202233,497 6,854 (2,198)101 38,254 
Year ended January 1, 202338,254 9,857 (9,672)(896)37,543 

v3.22.4
Inventories, Net (Tables)
 12 Months Ended
Jan. 01, 2023
Inventory Disclosure [Abstract]  
Schedule of Net Inventories
Inventories consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Raw materials$190,640 $166,486 
Work in progress68,206 63,580 
Finished goods146,616 195,824 
Total inventories$405,462 $425,890 

v3.22.4
Property, Plant and Equipment, Net (Tables)
 12 Months Ended
Jan. 01, 2023
Property, Plant and Equipment, Net [Abstract]  
Property, Plant and Equipment [Table Text Block]
Property, plant and equipment consisted of the following:
January 1,
2023		January 2,
2022
(In thousands)
At cost:
Land$28,340 $28,540 
Building and leasehold improvements346,164 351,084 
Machinery and equipment482,639 464,856 
Total property, plant and equipment857,143 844,480 
Accumulated depreciation(374,193)(358,949)
Total property, plant and equipment, net$482,950 $485,531 

v3.22.4
Marketable Securities and Investments (Tables)
 12 Months Ended
Jan. 01, 2023
Marketable Securities [Abstract]  
Schedule of Investments, Noncurrent [Table Text Block] Investments, which are classified in Other assets, net, consisted of the following: 
January 1,
2023		January 2,
2022
(In thousands)
Marketable securities$11,083 $33,683 
Equity investments54,503 33,801 
Investments in debt securities42,500 13,500 
$108,086 $80,984 
Equity Securities without Readily Determinable Fair Value Equity investments as of January 1, 2023 and January 2, 2022 consisted of the following:
January 1,
2023		January 2,
2022
(In thousands)
Equity investments, carried at cost minus impairment, if any$50,654 $29,738 
Equity investments, carried at fair value3,849 4,063 
$54,503 $33,801 
Marketable Securities Classified as Available for Sale [Table Text Block]
Marketable securities classified as available for sale consisted of the following:
 
 Market ValueGross Unrealized Holding
CostGains(Losses)
(In thousands)
January 1, 2023
Equity securities$6,775 $6,775 $— $— 
Other4,308 4,308 — — 
$11,083 $11,083 $— $— 
January 2, 2022
Equity securities$29,768 $29,768 $— $— 
Fixed-income securities7 7 — — 
Other3,908 3,971 — (63)
$33,683 $33,746 $— $(63)

v3.22.4
Goodwill and Intangible Assets, Net (Tables)
 12 Months Ended
Jan. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in the Carrying Amount of Goodwill
The changes in the carrying amount of goodwill for fiscal years 2022 and 2021 are as follows:
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Balance at January 3, 2021$948,360 $1,691,227 $2,639,587 
Foreign currency translation(33,901)(40,557)(74,458)
Acquisitions, earnouts and measurement period adjustments3,742,310 319,680 4,061,990 
Balance at January 2, 20224,656,769 1,970,350 6,627,119 
Foreign currency translation(98,268)(41,617)(139,885)
Acquisitions, earnouts and measurement period adjustments(6,926)1,460 (5,466)
Balance at January 1, 2023$4,551,575 $1,930,193 $6,481,768 
Identifiable Intangible Asset Balances
Identifiable intangible asset balances at January 1, 2023 by category and segment were as follows:
 
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Patents$25,312 $2,708 $28,020 
Less: Accumulated amortization(25,099)(956)(26,055)
Net patents213 1,752 1,965 
Trade names and trademarks76,521 72,932 149,453 
Less: Accumulated amortization(36,945)(26,645)(63,590)
Net trade names and trademarks39,576 46,287 85,863 
Licenses54,478 8,136 62,614 
Less: Accumulated amortization(49,582)(4,672)(54,254)
Net licenses4,896 3,464 8,360 
Core technology1,080,611 476,129 1,556,740 
Less: Accumulated amortization(209,247)(240,442)(449,689)
Net core technology871,364 235,687 1,107,051 
Customer relationships2,123,266 820,495 2,943,761 
Less: Accumulated amortization(358,402)(416,702)(775,104)
Net customer relationships1,764,864 403,793 2,168,657 
IPRD5,278 — 5,278 
Net amortizable intangible assets$2,686,191 $690,983 $3,377,174 

Identifiable intangible asset balances at January 2, 2022 by category and segment were as follows:
 
Discovery & Analytical Solutions DiagnosticsConsolidated
(In thousands)
Patents$25,524 $2,709 $28,233 
Less: Accumulated amortization(25,161)(732)(25,893)
Net patents363 1,977 2,340 
Trade names and trademarks77,181 79,683 156,864 
Less: Accumulated amortization(32,005)(21,969)(53,974)
Net trade names and trademarks45,176 57,714 102,890 
Licenses54,217 8,410 62,627 
Less: Accumulated amortization(48,670)(3,968)(52,638)
Net licenses5,547 4,442 9,989 
Core technology1,072,700 519,864 1,592,564 
Less: Accumulated amortization(126,374)(208,833)(335,207)
Net core technology946,326 311,031 1,257,357 
Customer relationships2,149,765 884,105 3,033,870 
Less: Accumulated amortization(224,461)(366,058)(590,519)
Net customer relationships1,925,304 518,047 2,443,351 
IPRD5,920 — 5,920 
Net amortizable intangible assets$2,928,636 $893,211 $3,821,847 

v3.22.4
Debt (Tables)
 12 Months Ended
Jan. 01, 2023
Debt Disclosure [Abstract]  
Schedule of Maturities of Long-term Debt [Table Text Block]
The following table summarizes the maturities of the Company’s indebtedness as of January 1, 2023: 
202320242025202620272028 and thereafterTotal before unamortized discount and debt issuance costsUnamortized discount and issuance costTotal
(In thousands)
Senior Unsecured Revolving Credit Facility$— $— $— $— $— $— $— $(2,641)$(2,641)
2023 Notes467,138 — — — — — 467,138 (930)466,208 
2024 Notes— 771,659 — — — — 771,659 (3,419)768,240 
2026 Notes— — — 533,950 — — 533,950 (3,681)530,269 
2028 Notes— — — — — 500,000 500,000 (3,932)496,068 
2029 Notes— — — — — 850,000 850,000 (7,537)842,463 
March 2031 Notes— — — — — 400,000 400,000 (3,092)396,908 
September 2031 Notes— — — — — 500,000 500,000 (5,344)494,656 
2051 Notes— — — — — 400,000 400,000 (4,264)395,736 
Other Debt Facilities4,721 1,200 201 115 89 43 6,369 — 6,369 
Total$471,859 $772,859 $201 $534,065 $89 $2,650,043 $4,429,116 $(34,840)$4,394,276 
Schedule of Debt The Company’s debt consisted of the following:
January 1,
2023
Outstanding Principal
Unamortized Debt Discount
Unamortized Debt Issuance Costs
Net Carrying Amount
(In thousands)
Long-Term Debt:
Senior Unsecured Revolving Credit Facility$— $— $(2,641)$(2,641)
0.850% Senior Unsecured Notes due in 2024 (“2024 Notes”)
771,659 (283)(3,136)768,240 
€500,000 Principal 1.875% Senior Unsecured Notes due in 2026 (“2026 Notes”)533,950 (1,902)(1,779)530,269 
1.900% Senior Unsecured Notes due in 2028 (“2028 Notes”)
500,000 (301)(3,631)496,068 
3.3% Senior Unsecured Notes due in 2029 (“2029 Notes”)850,000 (2,000)(5,537)842,463 
2.55% Senior Unsecured Notes due in March 2031 (“March 2031 Notes”)400,000 (114)(2,978)396,908 
2.250% Senior Unsecured Notes due in September 2031 (“September 2031 Notes”)
500,000 (1,353)(3,991)494,656 
3.625% Senior Unsecured Notes due in 2051 (“2051 Notes”)400,000 (4)(4,260)395,736 
Other Debt Facilities, non-current1,648 — — 1,648 
Total Long-Term Debt3,957,257 (5,957)(27,953)3,923,347 
Current Portion of Long-term Debt:
0.550% Senior Unsecured Notes due in 2023 (“2023 Notes”)
467,138 (63)(867)466,208 
Other Debt Facilities, current4,721 — — 4,721 
Total Current Portion of Long-Term Debt471,859 (63)(867)470,929 
Total Debt$4,429,116 $(6,020)$(28,820)$4,394,276 
January 2,
2022
Outstanding Principal
Unamortized Debt Discount
Unamortized Debt Issuance Costs
Net Carrying Amount
(In thousands)
Long-Term Debt:
Senior Unsecured Revolving Credit Facility$— $— $(3,362)$(3,362)
Unsecured Term Loan Credit Facility500,000 (14)(658)499,328 
2023 Notes500,000 (152)(2,093)497,755 
2024 Notes800,000 (447)(4,945)794,608 
2026 Notes568,600 (2,538)(2,280)563,782 
2028 Notes500,000 (348)(4,200)495,452 
2029 Notes850,000 (2,252)(6,234)841,514 
March 2031 Notes400,000 (126)(3,294)396,580 
September 2031 Notes500,000 (1,485)(4,380)494,135 
2051 Notes400,000 (4)(4,335)395,661 
Other Debt Facilities, non-current4,284 — — 4,284 
Total Long-Term Debt5,022,884 (7,366)(35,781)4,979,737 
Current Portion of Long-term Debt:
Other Debt Facilities, current4,240 — — 4,240 
Total Debt$5,027,124 $(7,366)$(35,781)$4,983,977 

v3.22.4
Accrued Expenses and Other Current Liabilities (Tables)
 12 Months Ended
Jan. 01, 2023
Accounts Payable and Accrued Liabilities, Current [Abstract]  
Schedule of Accrued Liabilities [Table Text Block]
Accrued expenses and other current liabilities consisted of the following:
 
January 1,
2023		January 2,
2022
(In thousands)
Payroll and incentives$52,331 $52,116 
Employee benefits51,983 52,199 
Deferred revenue135,531 138,052 
Federal, non-U.S. and state income taxes45,625 88,285 
Operating lease liabilities
31,217 29,313 
Other accrued operating expenses211,176 319,134 
Total accrued expenses and other current liabilities$527,863 $679,099 

v3.22.4
Employee Benefit Plans (Tables) - Pension Plans, Defined Benefit
 12 Months Ended
Jan. 01, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]  
Components of Net Periodic Benefit Cost (Credit) Net periodic pension cost for U.S. and non-U.S. plans included the following components for fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
(In thousands)
Service and administrative costs$6,331 $5,174 $7,414 
Interest cost10,751 9,440 12,876 
Expected return on plan assets(22,056)(24,417)(21,786)
Actuarial (gain) loss(23,706)(19,514)20,291 
Net periodic pension (credit) cost$(28,680)$(29,317)$18,795 
Schedule of Net Funded Status
The following table sets forth the changes in the funded status of the principal U.S. pension plan and the principal non-U.S. pension plans and the amounts recognized in the Company’s consolidated balance sheets as of January 1, 2023 and January 2, 2022. The pension liability of the Business at the end of fiscal year 2022 that will transfer upon sale was reclassified to discontinued operations, while the prior year was not restated.
 
 January 1, 2023January 2, 2022
Non-U.S.U.S.Non-U.S.U.S.
(In thousands)
Actuarial present value of benefit obligations:
Accumulated benefit obligations$207,503 $231,492 $337,454 $299,826 
Change in benefit obligations:
Projected benefit obligations at beginning of year$339,390 $299,826 $395,339 $317,679 
Service and administrative costs4,956 1,375 4,924 250 
Interest cost3,671 7,080 2,632 6,808 
Benefits paid and plan expenses(14,978)(19,870)(15,299)(18,693)
Benefit obligation classified in discontinued operations(8,261)— — — 
Actuarial gains(88,724)(56,919)(30,705)(6,218)
Effect of exchange rate changes(28,099)— (17,501)— 
Projected benefit obligations at end of year$207,955 $231,492 $339,390 $299,826 
Change in plan assets:
Fair value of plan assets at beginning of year$181,189 $290,116 $204,744 $268,686 
Actual return on plan assets(46,383)(53,498)(13,115)20,123 
Benefits paid and plan expenses(14,978)(19,870)(15,299)(18,693)
Employer’s contributions6,572 — 6,851 20,000 
Effect of exchange rate changes(19,659)— (1,992)— 
Fair value of plan assets at end of year$106,741 $216,748 $181,189 $290,116 
Net liabilities recognized in the consolidated balance sheets$(101,214)$(14,744)$(158,201)$(9,710)
Net amounts recognized in the consolidated balance sheets consist of:
Other assets$19,521 $— $33,084 $— 
Current liabilities(6,568)— (6,966)— 
Long-term liabilities(114,167)(14,744)(184,319)(9,710)
Net liabilities recognized in the consolidated balance sheets$(101,214)$(14,744)$(158,201)$(9,710)
Actuarial assumptions as of the year-end measurement date:
Discount rate4.12 %4.84 %1.41 %2.44 %
Rate of compensation increase3.16 %None2.78 %None
Actuarial assumptions used to determine net periodic pension cost during the year were as follows:
January 1, 2023January 2, 2022January 3, 2021
Non-U.S.U.S.Non-U.S.U.S.Non-U.S.U.S.
Discount rate1.41 %2.44 %0.92 %2.21 %1.34 %3.01 %
Rate of compensation increase2.78 %None2.78 %None3.36 %None
Expected rate of return on assets1.11 %7.25 %2.10 %7.25 %2.20 %7.25 %
Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]
The following table provides a breakdown of the non-U.S. benefit obligations and fair value of assets for pension plans that have benefit obligations in excess of plan assets:
January 1,
2023		January 2,
2022
(In thousands)
Pension Plans with Projected Benefit Obligations in Excess of Plan Assets
Projected benefit obligations$120,736 $191,285 
Fair value of plan assets— — 
Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets
Accumulated benefit obligations$120,283 $189,349 
Fair value of plan assets— — 
Schedule of Allocation of Plan Assets Assets of the defined benefit pension plans are primarily equity and debt securities. Asset allocations as of January 1, 2023 and January 2, 2022, and target asset allocations for fiscal year 2023 are as follows:
 Target AllocationPercentage of Plan Assets at
December 31, 2023January 1, 2023January 2, 2022
Asset CategoryNon-U.S.U.S.Non-U.S.U.S.Non-U.S.U.S.
Equity securities0-5%0-10%— %44 %— %46 %
Debt securities0-5%90-100%— %56 %— %54 %
Other95-100%0-10%100 %— %100 %— %
Total100 %100 %100 %100 %100 %100 %
Schedule of Changes in Fair Value of Plan Assets
The fair value of the Company’s pension plan assets as of January 1, 2023 and January 2, 2022 by asset category, classified in the three levels of inputs described in Note 20 to the consolidated financial statements are as follows:
 
 Fair Value Measurements at January 1, 2023 Using:
Total Carrying
Value at
January 1, 2023		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
(In thousands)
Cash$14,483 $14,483 $— $— 
Equity securities:
U.S. large-cap61,680 61,680 — — 
International large-cap value20,148 20,148 — — 
Emerging markets growth9,902 9,902 — — 
Fixed income securities:
Corporate and U.S. debt instruments105,126 36,346 68,780 — 
Short-term corporate bonds17,088 — 17,088 — 
Other types of investments:
Foreign liability driven instrument95,062 — — 95,062 
Total assets measured at fair value$323,489 $142,559 $85,868 $95,062 
 Fair Value Measurements at January 2, 2022 Using:
Total Carrying
Value at
January 2, 2022		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
(In thousands)
Cash$22,241 $22,241 $— $— 
Equity Securities:
U.S. large-cap91,601 91,601 — — 
International large-cap value29,803 29,803 — — 
Emerging markets growth12,603 12,603 — — 
Fixed income securities:
Corporate and U.S. debt instruments133,727 41,725 92,002 — 
Corporate bonds15,650 — 15,650 — 
Other types of investments:
Foreign liability driven instrument165,680 — — 165,680 
Total assets measured at fair value$471,305 $197,973 $107,652 $165,680 
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets
A reconciliation of the beginning and ending Level 3 assets for fiscal years 2022, 2021 and 2020 is as follows:
 
 Fair Value Measurements Using
Significant Unobservable Inputs
(Level 3):
Foreign liability driven investmentForeign
Real Estate
Funds		Multi-strategy
Hedge
Funds		Total
(In thousands)
Balance at December 30, 2019$— $22,688 $1,721 $24,409 
Sales— — (1,721)(1,721)
Unrealized gains— 571 — 571 
Balance at January 3, 2021— 23,259 — 23,259 
Sales— (23,115)— (23,115)
Purchases165,680 — — 165,680 
Realized losses— (226)— (226)
Realized gains— 82 — 82 
Balance at January 2, 2022165,680 — — 165,680 
Pension benefits paid(6,639)— — (6,639)
Foreign exchange losses(18,411)— — (18,411)
Return on plan assets(45,568)— — (45,568)
Balance at January 1, 2023$95,062 $— $— $95,062 
Schedule of Expected Benefit Payments
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid as follows:
 
Non-U.S.U.S.
(In thousands)
2023$11,907 $19,311 
202412,371 19,267 
202512,442 19,218 
202612,835 19,094 
202712,450 18,906 
2028-203264,237 87,807 

v3.22.4
Stock Plans (Tables)
 12 Months Ended
Jan. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Total Compensation Recognized Related to Outstanding Equity Awards
The following table summarizes total pre-tax compensation expense recognized related to the Company’s stock options, restricted stock, restricted stock units, performance restricted stock units, performance units and stock grants, included in the Company’s consolidated statements of operations for fiscal years 2022, 2021 and 2020:
 
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Cost of product and service revenue$7,459 $3,193 $1,106 
Research and development expenses6,799 2,393 944 
Selling, general and administrative expenses37,260 24,089 24,854 
Total stock-based compensation expense$51,518 $29,675 $26,904 
Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model The Company’s weighted-average assumptions used in the Black-Scholes option pricing model were as follows for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
Risk-free interest rate2.3 %0.9 %0.9 %
Expected dividend yield0.2 %0.2 %0.3 %
Expected lives5 years5 years5 years
Expected stock volatility28.5 %27.3 %23.8 %
Summary of Stock Option Activity
The following table summarizes stock option activity for the fiscal year ended January 1, 2023:
 
 Number
of
Shares		Weighted-
Average Exercise
Price
 (Shares in thousands)
Outstanding at beginning of year1,192 $119.33 
Granted184 167.58 
Exercised(195)72.41 
Canceled(4)143.62 
Forfeited(129)152.90 
Outstanding at end of year1,048 $132.32 
Exercisable at end of year461 $102.72 
Summary of Restricted Stock Award Activity
The following table summarizes restricted stock award activity for the fiscal year ended January 1, 2023:
 
Number
of
Shares		Weighted-
Average
Grant-
Date Fair
Value
 (Shares in thousands)
Nonvested at beginning of year637 $144.62 
Granted134 164.65 
Vested(238)137.90 
Forfeited(80)151.75 
Nonvested at end of year453 $152.79 

v3.22.4
Stockholders' Equity (Tables)
 12 Months Ended
Jan. 01, 2023
Stockholders' Equity Note [Abstract]  
Components of Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive (loss) income consisted of the following:
 
Foreign
Currency
Translation
Adjustment,
net of tax		Unrecognized
Prior Service
Costs, net of
tax		Unrealized
(Losses)
Gains on
Securities,
net of tax		Accumulated
Other
Comprehensive
Income (Loss)
 (In thousands)
Balance, December 30, 2019$(200,437)$1,052 $(261)$(199,646)
Current year change169,500 (1,799)(16)167,685 
Balance, January 3, 2021(30,937)(747)(277)(31,961)
Current year change(130,873)(95)237 (130,731)
Balance, January 2, 2022(161,810)(842)(40)(162,692)
Current year change(284,854)44 5 (284,805)
Balance, January 1, 2023$(446,664)$(798)$(35)$(447,497)

v3.22.4
Fair Value Measurements (Tables)
 12 Months Ended
Jan. 01, 2023
Fair Value Disclosures [Abstract]  
Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis The following tables show the assets and liabilities carried at fair value measured on a recurring basis as of January 1, 2023 and January 2, 2022 classified in one of the three classifications described above:
 
 Fair Value Measurements at January 1, 2023 Using:
 Total Carrying
Value at January 1, 2023		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable Inputs
(Level 3)
 (In thousands)
Marketable securities$11,083 $11,083 $— $— 
Foreign exchange derivative assets2,142 — 2,142 — 
Foreign exchange derivative liabilities(1,549)— (1,549)— 
Contingent consideration(46,618)— — (46,618)
 Fair Value Measurements at January 2, 2022 Using:
 Total Carrying
Value at January 2, 2022		Quoted Prices in
Active Markets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable Inputs
(Level 3)
 (In thousands)
Marketable securities$33,683 $33,683 $— $— 
Foreign exchange derivative assets3,765 — 3,765 — 
Foreign exchange derivative liabilities(3,463)— (3,463)— 
Contingent consideration(57,996)— — (57,996)
Reconciliation of Beginning and Ending Level 3 Net Liabilities
A reconciliation of the beginning and ending Level 3 net liabilities for contingent consideration is as follows:
 
 (In thousands)
Balance at December 29, 2019$(35,481)
Amounts paid and foreign currency translation23,701 
Change in fair value (included within selling, general and administrative expenses)8,827 
Balance at January 3, 2021(2,953)
Additions(57,431)
Amounts paid and foreign currency translation5,507 
Change in fair value (included within selling, general and administrative expenses)(3,119)
Balance at January 2, 2022(57,996)
Additions(4,961)
Amounts paid and foreign currency translation2,562 
Adjustments recognized in goodwill12,400 
Change in fair value (included within selling, general and administrative expenses)1,377 
Balance at January 1, 2023$(46,618)

v3.22.4
Leases (Tables)
 12 Months Ended
Jan. 01, 2023
Leases [Abstract]  
Lease, Cost [Table Text Block]
The components of lease expense were as follows:
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Lease Cost:
Operating lease cost$39,989 $39,516 37,613 
Supplemental Cash Flow Information Related To Leases [Table Text Block]
Supplemental cash flow information related to leases was as follows:
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$37,488 $38,970 $34,373 
Right-of-use assets obtained in exchange for new lease obligations:
   Operating leases$55,016 $12,345 $2,605 
Supplemental Balance Sheet Information Related To Leases [Table Text Block]
Supplemental balance sheet information related to leases was as follows:
 January 1,
2023		January 2,
2022
 (In thousands, except lease term and discount rate)
Operating Leases:
Operating lease right-of-use assets$188,351 $164,040 
Operating lease liabilities included in Accrued expenses and other current liabilities$31,217 $29,313 
Operating lease liabilities169,968 147,395 
Total operating lease liabilities$201,185 $176,708 
Weighted Average Remaining Lease Term in Years
Operating leases6.15.8
Weighted Average Remaining Discount Rate
Operating leases2.6%1.8%
Lease costs from finance leases, short-term leases, variable lease costs and sub-lease income are not material.
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Future payments of operating lease liabilities as of January 1, 2023 were as follows:
 (In thousands)
2023$38,452 
202435,361 
202532,080 
202627,064 
202723,983 
2028 and thereafter65,308 
Total lease payments222,248 
Less imputed interest(21,063)
    Total $201,185 

v3.22.4
Industry Segment and Geographic Area Information (Tables)
 12 Months Ended
Jan. 01, 2023
Segment Reporting [Abstract]  
Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations
Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below for the fiscal years ended:
 
January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
Revenues
Discovery & Analytical Solutions$1,292,909 $897,718 $596,585 
Diagnostics2,019,727 2,932,738 2,067,728 
Revenue purchase accounting adjustments(814)(2,648)(1,083)
Total revenues$3,311,822 $3,827,808 $2,663,230 
Segment Operating Income
Discovery & Analytical Solutions$503,243 $281,602 $129,174 
Diagnostics781,985 1,432,769 1,010,361 
Corporate(73,431)(77,364)(73,854)
Subtotal reportable segments1,211,797 1,637,007 1,065,681 
Amortization of intangible assets(370,638)(256,569)(160,991)
Purchase accounting adjustments(45,681)(40,993)(6,382)
Acquisition and divestiture-related costs(39,826)(62,760)(4,335)
Restructuring and other(12,953)(18,228)(26,700)
Operating income from continuing operations742,699 1,258,457 867,273 
Interest and other expense, net90,862 54,875 67,201 
Income from continuing operations before income taxes$651,837 $1,203,582 $800,072 
Schedule of Depreciation, Amortization and Capital Expenditures
Additional information relating to the Company’s reporting segments is as follows for the three fiscal years ended January 1, 2023:
 Depreciation and Amortization ExpenseCapital Expenditures
 January 1,
2023		January 2,
2022		January 3,
2021		January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)(In thousands)
Discovery & Analytical Solutions$263,698 $94,700 $48,657 $41,532 $27,818 $6,345 
Diagnostics161,394 214,178 149,738 40,671 57,206 55,236 
Corporate1,908 2,565 3,253 3,429 996 2,053 
Continuing operations$427,000 $311,443 $201,648 $85,632 $86,020 $63,634 
Schedule of Total Assets by Segment
 Total Assets
 January 1,
2023		January 2,
2022
 (In thousands)
Discovery & Analytical Solutions$8,330,045 $8,478,292 
Diagnostics3,991,659 4,692,816 
Corporate114,447 129,904 
Current and long-term assets of discontinued operations1,693,704 1,699,542 
Total assets$14,129,855 $15,000,554 
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas The following geographic area information for continuing operations includes revenue based on location of external customers for the three fiscal years ended January 1, 2023 and net long-lived assets based on physical location as of January 1, 2023 and January 2, 2022:
 Revenue
 January 1,
2023		January 2,
2022		January 3,
2021
 (In thousands)
U.S.$1,546,520 $1,682,294 $921,574 
International:
China476,366 449,588 305,660 
United Kingdom136,017 357,911 323,837 
Other international1,152,919 1,338,015 1,112,159 
Total international1,765,302 2,145,514 1,741,656 
Total revenue$3,311,822 $3,827,808 $2,663,230 
 
 
Net Long-Lived Assets(1)
 January 1,
2023		January 2,
2022
 (In thousands)
U.S.$311,661 $295,397 
International:
Germany147,766 146,633 
China68,072 59,851 
Other international216,235 222,190 
Total international432,073 428,674 
Total net long-lived assets$743,734 $724,071 

v3.22.4
Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited) (Tables)
 12 Months Ended
Jan. 01, 2023
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
Selected quarterly financial information is as follows for the fiscal years ended:

First
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter		Year
 (In thousands, except per share data)
January 1, 2023
Revenue$963,163 $895,642 $711,803 $741,214 $3,311,822 
Gross profit594,740 551,717 407,044 436,329 1,989,830 
Operating income from continuing operations261,967 232,486 110,780 137,466 742,699 
Income from continuing operations before income taxes224,904 206,344 82,142 138,447 651,837 
Income from continuing operations184,070 161,601 69,508 97,497 512,676 
(Loss) income from discontinued operations(7,108)17,611 15,839 30,161 56,503 
Net income176,962 179,212 85,347 127,658 569,179 
Basic earnings per share:
Income from continuing operations$1.46 $1.28 $0.55 $0.77 $4.06 
(Loss) income from discontinued operations(0.06)0.14 0.13 0.24 0.45 
Net income1.40 1.42 0.68 1.01 4.51 
Diluted earnings per share:
Income from continuing operations$1.45 $1.28 $0.55 $0.77 $4.06 
(Loss) income from discontinued operations(0.06)0.14 0.13 0.24 0.45 
Net income1.39 1.42 0.67 1.01 4.50 
January 2, 2022
Revenue$1,027,836 $910,747 $861,315 $1,027,910 $3,827,808 
Gross profit693,187 574,143 522,860 643,797 2,433,987 
Operating income from continuing operations455,010 307,999 195,554 299,894 1,258,457 
Income from continuing operations before income taxes467,537 301,329 135,012 299,704 1,203,582 
Income from continuing operations369,859 227,857 107,631 184,089 889,436 
Income from discontinued operations9,446 18,073 20,107 6,095 53,721 
Net income379,305 245,930 127,738 190,184 943,157 
Basic earnings per share:
Income from continuing operations$3.30 $2.03 $0.94 $1.46 $7.66 
Income from discontinued operations0.08 0.16 0.18 0.05 0.46 
Net income3.38 2.19 1.12 1.51 8.12 
Diluted earnings per share:
Income continuing operations$3.29 $2.03 $0.94 $1.45 $7.62 
Income from discontinued operations0.08 0.16 0.17 0.05 0.46 
Net income3.37 2.19 1.11 1.50 8.08 

v3.22.4
Business Combinations and Asset Purchases (Narrative) (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Jan. 01, 2023
USD ($)
employees
Oct. 02, 2022
USD ($)
Jul. 03, 2022
USD ($)
Apr. 03, 2022
USD ($)
Jan. 02, 2022
USD ($)
employees
Oct. 03, 2021
USD ($)
Jul. 04, 2021
USD ($)
Apr. 04, 2021
USD ($)
Jan. 01, 2023
USD ($)
employees
Jan. 02, 2022
USD ($)
employees
$ / shares
shares
Jan. 03, 2021
USD ($)
employees
$ / shares
Sep. 17, 2021
$ / shares
Business Acquisition [Line Items]                        
Revenue $ 741,214 $ 711,803 $ 895,642 $ 963,163 $ 1,027,910 $ 861,315 $ 910,747 $ 1,027,836 $ 3,311,822 $ 3,827,808    
Business Combination, Contingent Consideration, Liability, Current (3,600)       (1,300)       (3,600) (1,300)    
Business Combination, Contingent Consideration, Liability, Noncurrent 43,000       56,700       43,000 56,700    
Business Combination, Contingent Consideration, Liability, Total (46,600)       (58,000)       $ (46,600) (58,000)    
Business Combination, Contingent Consideration Arrangements, Maximum Period                 5 years 10 months 24 days      
Goodwill $ 6,481,768       $ 6,627,119       $ 6,481,768 6,627,119 $ 2,639,587  
Business Combination, Contingent Consideration Arrangements, Weighted Average Period                 4 years 10 months 24 days      
Business Combination, Acquisition Related Costs                 $ 39,800 $ 80,800 $ 4,900  
Horizon Discovery Group plc [Member]                        
Business Acquisition [Line Items]                        
Entity Number of Employees | employees                     400  
Fiscal Year 2020 Acquisitions [Member]                        
Business Acquisition [Line Items]                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets                     $ 35,532  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment                     20,302  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets                     18,114  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net                     412,097  
Business Acquisition, Cost of Acquired Entity, Cash Paid                     437,661  
Business Combination, Consideration Transferred, Liabilities Incurred                     $ 1,660  
Weighted average amortization period (in years)                     11 years  
Goodwill                     $ 221,751  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total                     (25,674)  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue                     2,031  
Working capital and other adjustments                     (384)  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt                     (46,430)  
Cash Acquired                     26,840  
Business Combination, Consideration Transferred                     412,097  
Oxford Immunotec                        
Business Acquisition [Line Items]                        
Entity Number of Employees | employees         275         275    
Nexcelom Bioscience                        
Business Acquisition [Line Items]                        
Entity Number of Employees | employees 130               130      
BioLegend [Member]                        
Business Acquisition [Line Items]                        
Business Acquisition, Pro Forma Revenue                   $ 4,056,122 2,905,116  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets         $ 184,704         184,704    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities         0         0    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment         147,200         147,200    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets         9,330         9,330    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net         $ 5,688,964         5,688,964    
Business Acquisition, Cost of Acquired Entity, Cash Paid                   3,336,115    
Business Combination, Consideration Transferred, Liabilities Incurred                   $ 6,857    
Weighted average amortization period (in years)                   16 years 3 months 18 days    
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual                   $ 91,700    
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual                   25,800    
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value                   0    
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                   $ 0    
Entity Number of Employees | employees         700         700    
Goodwill         $ 3,509,931         $ 3,509,931    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total         (668,919)         (668,919)    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue         0         0    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt         (37,461)         (37,461)    
Cash Acquired from Acquisition                   292,400    
Cash Acquired                   (292,377)    
Business Combination, Consideration Transferred                   5,688,964    
Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax                   $ 947,387 $ 454,034  
Business Acquisition, Pro Forma Earnings Per Share, Basic | $ / shares                   $ 7,270 $ 3,620  
Business Acquisition, Pro Forma Earnings Per Share, Diluted | $ / shares                   $ 7,250 $ 3,600  
Foreign Currency Transaction Gain (Loss), before Tax                   $ (5,400)    
Interest Expense                   23,400 $ 500  
Cash Acquired from Acquisition                   (292,400)    
Business Acquisition, Cost of Acquired Entity, Consideration Paid in Common Stock                   $ 2,600,000    
Business Acquisition, Share Price | $ / shares                       $ 187.56
Stock Issued During Period, Shares, Acquisitions | shares                   14,066,799    
Business Combination, Acquisition Related Costs, Excluded From Proforma Income (Loss) From Continuing Operations                   $ 43,200    
Business Combination, Bridge Financing and Debt Pre-issuance Hedging Costs, Excluded From Proforma Income (Loss) From Continuing Operations                   23,300    
Business Combination, Pro Forma Information, Amortization of Acquired Intangible Assets                   47,000    
Business Acquisition, Cost of Acquired Entity, Consideration Paid in Cash                   3,300,000    
Acquisition-related stock compensation expense                 $ 26,500 6,900    
Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]                        
Business Acquisition [Line Items]                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets         71,840         71,840    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities         (4,628)         (4,628)    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment         26,507         26,507    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets         15,527         15,527    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net         981,698         981,698    
Business Acquisition, Cost of Acquired Entity, Cash Paid                   1,128,584    
Business Combination, Consideration Transferred, Liabilities Incurred                   $ 2,910    
Weighted average amortization period (in years)                   12 years 4 months 24 days    
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value                   $ (45,031)    
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                   183    
Goodwill         545,262         545,262    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total         (80,923)         (80,923)    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue         1,197         1,197    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt         (61,925)         (61,925)    
Cash Acquired                   (195,010)    
Business Combination, Consideration Transferred                   981,698    
Biosense, Sirion and Qognit [Member]                        
Business Acquisition [Line Items]                        
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 106,200               $ 106,200      
Fiscal Year 2022 Acquisitions                        
Business Acquisition [Line Items]                        
Weighted average amortization period (in years)                 5 years      
Core Technology [Member] | Fiscal Year 2020 Acquisitions [Member]                        
Business Acquisition [Line Items]                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                     65,730  
Trade Names [Member] | Fiscal Year 2020 Acquisitions [Member]                        
Business Acquisition [Line Items]                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                     5,580  
In Process Research and Development [Member] | Fiscal Year 2020 Acquisitions [Member]                        
Business Acquisition [Line Items]                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                     10,700  
Diagnostics [Member]                        
Business Acquisition [Line Items]                        
Goodwill 1,930,193       1,970,350       $ 1,930,193 1,970,350 1,691,227  
Discovery & Analytical Solutions [Member]                        
Business Acquisition [Line Items]                        
Goodwill $ 4,551,575       $ 4,656,769       4,551,575 4,656,769 948,360  
United States of America, Dollars | Fiscal Year 2021 Other Acquisitions                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                   318,600    
United States of America, Dollars | Fiscal Year 2020 Other Acquisitions [Member]                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                     39,100  
United States of America, Dollars | Horizon Discovery Group plc [Member]                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                     399,800  
United States of America, Dollars | Fiscal Year 2020 Acquisitions [Member]                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                     438,900  
United States of America, Dollars | Oxford Immunotec                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                   590,900    
United States of America, Dollars | Nexcelom Bioscience                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                   267,300    
United States of America, Dollars | BioLegend [Member]                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                   5,700,000    
United States of America, Dollars | Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                   $ 1,200,000    
United States of America, Dollars | Fiscal Year 2022 Acquisitions                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                 $ 13,300      
United Kingdom, Pounds | Horizon Discovery Group plc [Member]                        
Business Acquisition [Line Items]                        
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments                     $ 296,000  

v3.22.4
Business Combinations and Asset Purchases (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 02, 2022
Jan. 03, 2021
Jan. 01, 2023
Business Acquisition [Line Items]      
Goodwill $ 6,627,119 $ 2,639,587 $ 6,481,768
BioLegend [Member]      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid 3,336,115    
Less: cash acquired 292,377    
Business Combination, Consideration Transferred 5,688,964    
Current assets 184,704    
Property, plant and equipment 147,200    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets 9,330    
Goodwill 3,509,931    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total (668,919)    
Liabilities assumed 0    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt (37,461)    
Total 5,688,964    
Business Combination, Consideration Transferred, Liabilities Incurred 6,857    
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 2,638,369    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue 0    
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value 0    
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments 0    
BioLegend [Member] | United States of America, Dollars      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments 5,700,000    
Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid 1,128,584    
Less: cash acquired 195,010    
Business Combination, Consideration Transferred 981,698    
Current assets 71,840    
Property, plant and equipment 26,507    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets 15,527    
Goodwill 545,262    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total (80,923)    
Liabilities assumed (4,628)    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt (61,925)    
Total 981,698    
Business Combination, Consideration Transferred, Liabilities Incurred 2,910    
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 0    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue (1,197)    
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value 45,031    
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments 183    
Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member] | United States of America, Dollars      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments 1,200,000    
Fiscal Year 2021 Other Acquisitions | United States of America, Dollars      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments 318,600    
Fiscal Year 2020 Other Acquisitions [Member] | United States of America, Dollars      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments   39,100  
Horizon Discovery Group plc [Member] | United States of America, Dollars      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments   399,800  
Fiscal Year 2020 Acquisitions [Member]      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid   437,661  
Working capital and other adjustments   (384)  
Less: cash acquired   (26,840)  
Business Combination, Consideration Transferred   412,097  
Current assets   35,532  
Property, plant and equipment   20,302  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets   18,114  
Goodwill   221,751  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total   (25,674)  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt   (46,430)  
Total   412,097  
Business Combination, Consideration Transferred, Liabilities Incurred   1,660  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue   (2,031)  
Fiscal Year 2020 Acquisitions [Member] | United States of America, Dollars      
Business Acquisition [Line Items]      
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments   438,900  
Core Technology [Member] | Fiscal Year 2020 Acquisitions [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   65,730  
Trade Names [Member] | Fiscal Year 2020 Acquisitions [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   5,580  
In Process Research and Development [Member] | Fiscal Year 2020 Acquisitions [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   10,700  
License | BioLegend [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 8,979    
License | Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 0    
Customer Relationships and Backlog [Member] | BioLegend [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 1,714,800    
Customer Relationships and Backlog [Member] | Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 141,670    
Customer Relationships and Backlog [Member] | Fiscal Year 2020 Acquisitions [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   108,523  
Trade Names and Patents [Member] | BioLegend [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 38,000    
Trade Names and Patents [Member] | Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 39,476    
Core technology and Clone Library [Member] | BioLegend [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 782,400    
Core technology and Clone Library [Member] | Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 290,089    
Diagnostics [Member]      
Business Acquisition [Line Items]      
Goodwill 1,970,350 1,691,227 1,930,193
Discovery & Analytical Solutions [Member]      
Business Acquisition [Line Items]      
Goodwill $ 4,656,769 $ 948,360 $ 4,551,575

v3.22.4
Nature of Operations and Accounting Policies Nature of Operations and Accounting Policies (Narrative) (Details) (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Jan. 01, 2023
USD ($)
segments
Jan. 02, 2022
USD ($)
Jan. 03, 2021
USD ($)
Number of Operating Segments | segments   2    
Unamortized Debt Issuance Expense   $ 28,820 $ 35,781  
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents   $ (33,747) $ (22,926) $ 25,913
Fiscal Year Week Format   52    
Minimum [Member] | Building [Member]        
Property, Plant and Equipment, Useful Life, Maximum   10 years    
Minimum [Member] | Tools, Dies and Molds [Member]        
Property, Plant and Equipment, Useful Life, Maximum   3 years    
Maximum [Member] | Building [Member]        
Property, Plant and Equipment, Useful Life, Maximum   40 years    
Maximum [Member] | Machinery and Equipment [Member]        
Property, Plant and Equipment, Useful Life, Maximum   8 years    
Subsequent Event [Member]        
Fiscal Year Week Format 52      

v3.22.4
Revenue from Contract with Customer (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 3,311,822 $ 3,827,808 $ 2,663,230
Contract with Customer, Asset, Net, Current 56,631 61,999  
Contract with Customer, Liability, Current (30,133) (184,897)  
Contract with Customer, Asset and Liability [Abstract]      
Contract with Customer, Asset, Net, Current 56,631 61,999  
Contract with Customer, Liability, Current (30,133) (184,897)  
Americas [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,662,643 1,806,672 1,036,995
Europe [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 831,811 1,216,810 1,021,964
Asia [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 817,368 804,326 604,271
Discovery & Analytical Solutions [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,292,909 895,869 596,288
Discovery & Analytical Solutions [Member] | Americas [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 683,170 444,459 286,354
Discovery & Analytical Solutions [Member] | Europe [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 297,468 234,334 157,277
Discovery & Analytical Solutions [Member] | Asia [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 312,271 217,076 152,657
Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 2,018,913 2,931,939 2,066,942
Diagnostics [Member] | Customer Concentration Risk [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 330,700 638,600 97,800
Diagnostics [Member] | Americas [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 979,473 1,362,213 750,641
Diagnostics [Member] | Europe [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 534,343 982,476 864,687
Diagnostics [Member] | Asia [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 505,097 587,250 451,614
Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,292,909 895,869 596,288
Life Sciences [Member] | Discovery & Analytical Solutions [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,292,909 895,869 596,288
Life Sciences [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0
Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 2,018,913 2,931,939 2,066,942
Diagnostics [Member] | Discovery & Analytical Solutions [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0
Diagnostics [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 2,018,913 $ 2,931,939 $ 2,066,942

v3.22.4
Discontinued Operations Narrative (Details) - USD ($)
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Aug. 01, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
(Loss) gain on disposition of discontinued operations before income taxes $ 0 $ 0 $ (76,000)  
(Benefit from) provision for income taxes on discontinued operations and dispositions 17,101,000 22,583,000 8,889,000  
Disposal Group, Including Discontinued Operation, Assets, Current 1,693,704,000 555,374,000    
Disposal Group, Including Discontinued Operation, Assets, Noncurrent 0 1,144,168,000    
Disposal Group, Including Discontinued Operation, Assets 1,693,704,000 1,699,542,000    
Disposal Group, Including Discontinued Operation, Liabilities, Current 272,865,000 205,594,000    
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent 0 91,702,000    
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 14,999,000 14,999,000 14,982,000  
Analytical, Food and Enterprise Services businesses        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Depreciation, Discontinued Operations 8,011,000 12,897,000 13,299,000  
Amortization, Discontinued Operations 16,984,000 33,664,000 31,560,000  
Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net 343,064,000 315,851,000    
Disposal Group, Including Discontinued Operation, Consideration       $ 2,450,000,000
Disposal Group, Including Discontinued Operation, Inventory, Current 210,367,000 198,824,000    
Disposal Group, Including Discontinued Operation, Other Assets, Current 32,063,000 25,700,000    
Disposal Group, Including Discontinued Operation, Assets, Current   555,374,000    
Disposal Group, Including Discontinued Operation, Assets, Noncurrent   1,144,168,000    
Disposal Group, Including Discontinued Operation, Assets 1,693,704,000 1,699,542,000    
Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current 161,260,000 174,947,000    
Disposal Group, Including Discontinued Operation, Liabilities, Current   205,594,000    
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent   91,702,000    
Disposal Group, Including Discontinued Operation, Liabilities 272,865,000 297,296,000    
Capital Expenditure, Discontinued Operations 10,670,000 13,868,000 $ 13,872,000  
Disposal Group, Consideration, Receivable at Closing       2,300,000,000
Disposal Group, Consideration, Receivable at Closing, Deferred Payments Tied to Transfer of the PKI Brand and Related Trademarks       75,000,000
Disposal Group, Consideration, Contingent on Exit Valuation       $ 150,000,000
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 14,999,000 14,999,000    
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current 60,983,000 60,074,000    
Disposal Group, Including Discontinued Operation, Operating lease right-of-use assets, current 41,487,000 43,735,000    
Disposal Group, Including Discontinued Operation, Intangible Assets, Current 202,850,000 241,257,000    
Disposal Group, Including Discontinued Operation, Goodwill, Current 772,812,000 789,465,000    
Disposal Group, Including Discontinued Operation, Other assets, net, Current 15,079,000 9,637,000    
Disposal Group, Including Discontinued Operation, Accounts Payable 29,912,000 30,647,000    
Disposal Group, Including Discontinued Operation, Deferred taxes and long-term liabilities, Current 46,046,000 53,738,000    
Disposal Group, Including Discontinued Operation, Operating lease liabilities, Current 35,647,000 37,964,000    
Disposal Group, Including Discontinued Operation, Net Assets $ 1,420,000,000 $ 1,400,000,000    

v3.22.4
Summary Operating Results of Discontinued Operations for the Periods Prior to Disposition (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income from discontinued operations before income taxes $ 73,604 $ 76,304 $ 106,292
Analytical, Food and Enterprise Services businesses      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Disposal Group, Including Discontinued Operation, Revenue 1,298,376 1,239,361 1,119,515
Disposal Group, Including Discontinued Operation, Costs of Goods Sold 859,330 822,048 739,817
Disposal Group, Including Discontinued Operation, General and Administrative Expense 306,032 268,760 209,442
Disposal Group, Including Discontinued Operations, Research and development expenses 64,605 74,632 58,948
Disposal Group, Including Discontinued Operation, Operating Income (Loss) 68,409 73,921 111,308
Disposal Group, Including Discontinued Operation, Other expense (income), net (5,195) (2,383) 5,016
Income from discontinued operations before income taxes $ 73,604 $ 76,304 $ 106,292

v3.22.4
Restructuring and Contract Termination Charges, Net (Narrative) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring and other costs, net $ (13,580) $ 14,358 $ 7,661

v3.22.4
Restructuring and Contract Termination Charges, Net Restructuring and Contract Termination Charges, Net (Schedule of Initial Charges) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring and other costs, net $ (13,580) $ 14,358 $ 7,661

v3.22.4
Restructuring and Contract Termination Charges, Net (Schedule of Restructuring Plan Activity) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Restructuring Reserve [Roll Forward]      
Restructuring and other costs, net $ (13,580) $ 14,358 $ 7,661

v3.22.4
Income Taxes (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Income Tax Contingency [Line Items]      
Income Tax Holiday, Aggregate Dollar Amount $ (1,100) $ (18,200) $ (12,700)
Effective Tax Rate, Income Tax on Repatriation of Foreign Earnings $ 15,800 $ 37,100  
Impact of benefits derived from tax holidays on earnings per share, basic $ 0.01 $ (0.16) $ (0.11)
Impact of benefits derived from tax holidays on earnings per share, diluted $ (0.01) $ (0.16) $ (0.11)
Valuation Allowance, Amount $ 96,681 $ 89,523  
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Unrecognized tax benefits, beginning of period 61,658 38,773 $ 35,547
Gross increases - tax positions in prior period 1,489 2,877 4,974
Gross decreases - tax positions in prior period (2,519) 0 (2,471)
Gross increases - current-period tax positions 7,187 149 151
Unrecognized Tax Benefits, Increase Resulting from Acquisition 0 22,697 158
Settlements 0 (2,252) 0
Lapse of statute of limitations (8,625) (563) 0
Foreign currency translation adjustments (1,242) (23) 414
Unrecognized tax benefits, end of period   61,658 38,773
Income Tax Penalties and Interest Accrued 7,200 7,600  
Income Tax Penalties and Interest Expense (500) 1,800 1,800
Unrecognized Tax Benefits, Ending Balance 57,948 61,658 38,773
Unrecognized Tax Benefits Expected To Be Resolved With In A Year 17,800    
Undistributed Earnings of Foreign Subsidiaries Not Meeting Requirements to be Reinvested 879,000    
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount (4,940) $ 37,147 $ 0
General Business [Member]      
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Tax Credit Carryforward, Amount 100    
State and Local Jurisdiction [Member]      
Income Tax Contingency [Line Items]      
Operating Loss Carryforwards 4,900    
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Tax Credit Carryforward, Amount 13,800    
Foreign Tax Authority [Member]      
Income Tax Contingency [Line Items]      
Operating Loss Carryforwards 458,000    
Internal Revenue Service (IRS) [Member]      
Income Tax Contingency [Line Items]      
Operating Loss Carryforwards $ 67,500    

v3.22.4
Income Taxes Income Before Income taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Jan. 01, 2023
Oct. 02, 2022
Jul. 03, 2022
Apr. 03, 2022
Jan. 02, 2022
Oct. 03, 2021
Jul. 04, 2021
Apr. 04, 2021
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Income Tax Contingency [Line Items]                      
U.S.                 $ 326,438 $ 547,705 $ 210,130
Non-U.S.                 325,399 655,877 589,942
Income from continuing operations before income taxes $ 138,447 $ 82,142 $ 206,344 $ 224,904 $ 299,704 $ 135,012 $ 301,329 $ 467,537 651,837 1,203,582  
Income from continuing operations before income taxes                 $ 651,837 $ 1,203,582 $ 800,072

v3.22.4
Income Taxes Components of the Provision (Benefits from) Income Tax (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Income Tax Contingency [Line Items]      
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount $ (5,221) $ (33,847) $ (29,155)
Federal current 115,436 154,905 39,878
Federal deferred expense (benefit) (45,246) (37,858) 4,875
Federal total 70,190 117,047 44,753
State current 27,757 53,961 15,469
State deferred expense (benefit) (16,139) 3,602 (1,240)
State total 11,618 57,563 14,229
Non-U.S. current 101,891 160,608 149,503
Non-U.S.deferred expense benefit (44,538) (21,072) (38,973)
Non-U.S. total 57,353 139,536 110,530
Total current 245,084 369,474 204,850
Total deferred expense (benefit) (105,923) (55,328) (35,338)
Total 139,161 314,146 169,512
Discontinued operations 17,101 22,583 8,889
Total provision for income taxes $ 156,262 $ 336,729 $ 178,401

v3.22.4
Income Taxes Reconciliation of Income Tax Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Income Tax Contingency [Line Items]      
Tax at statutory rate $ 136,886 $ 252,752 $ 168,015
Non-U.S. rate differential, net (5,221) (33,847) (29,155)
U.S. taxation of multinational operations 22,102 7,964 11,468
State income taxes, net 7,820 36,832 13,249
Prior year tax matters (10,160) 1,850 5,532
Effect of Stock Compensation 845 (2,187) (8,148)
Federal tax credits (7,132) (2,715) (2,145)
Change in valuation allowance 4,964 (179) (369)
Rate change on long term intangibles 0 14,031 0
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount (4,940) 37,147 0
Foreign consolidations 0 0 15,222
Other, net (6,003) 2,498 (4,157)
Total $ 139,161 $ 314,146 $ 169,512

v3.22.4
Income Taxes Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Income Tax Contingency [Line Items]    
Inventory $ 17,920 $ 2,388
Reserves and accruals 70,912 53,403
Accrued compensation 23,868 29,960
Net operating loss and credit carryforwards 117,953 110,149
Accrued pension 11,653 23,714
Restructuring reserve 1,640 1,442
Deferred revenue 22,644 49,207
Capitalized research and development expenses 44,922 12,114
Deferred Tax Assets, Unrealized Foreign Exchange Losses 11,158 14,594
Deferred tax assets, operating lease liabilities 43,547 37,299
All other, net 841 583
Deferred Tax Assets, Gross 367,058 334,853
Postretirement health benefits (4,379) (5,303)
Depreciation and amortization (916,581) (1,021,487)
Deferred Tax Liabilities, Prepaid Expenses (3,515) (3,265)
Deferred tax liability on foreign earnings 15,782 (31,239)
Deferred tax liabilities, operating lease right-of-use assets (39,281) 33,607
Total deferred tax liabilities (979,538) (1,094,901)
Valuation allowance (96,681) (89,523)
Deferred Tax Liabilities, Net (709,161) $ (849,571)
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount $ (7,200)  

v3.22.4
Income Taxes Summary of Loss and Tax Credit Carryforwards (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Income Tax Contingency [Line Items]    
Valuation Allowance, Amount $ 96,681 $ 89,523
State and Local Jurisdiction [Member]    
Income Tax Contingency [Line Items]    
Operating Loss Carryforwards 4,900  
Tax Credit Carryforward, Amount 13,800  
Foreign Tax Authority [Member]    
Income Tax Contingency [Line Items]    
Operating Loss Carryforwards 458,000  
Internal Revenue Service (IRS) [Member]    
Income Tax Contingency [Line Items]    
Operating Loss Carryforwards 67,500  
General Business [Member]    
Income Tax Contingency [Line Items]    
Tax Credit Carryforward, Amount $ 100  

v3.22.4
Earnings Per Share (Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations) (Details) - shares
shares in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Earnings Per Share [Abstract]      
Number of common shares-basic 126,155 116,165 111,514
Effect of dilutive securities, Stock options 249 391 466
Effect of dilutive securities, Restricted stock 22 118 105
Number of common shares-diluted 126,426 116,674 112,085
Number of potentially dilutive securities excluded from calculation due to antidilutive impact 611 487 220

v3.22.4
Accounts Receivable, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts receivable, net $ 612,780 $ 707,941  
Accounts Receivable, after Allowance for Credit Loss, Noncurrent 34,040 29,958  
Accounts Receivable, after Allowance for Credit Loss 646,820 737,899  
Accounts Receivable, Allowance for Credit Loss [Roll Forward]      
Accounts Receivable, Allowance for Credit Loss, Beginning Balance 38,254 33,497 $ 23,574
Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9,857 6,854 10,294
Accounts Receivable, Allowance for Credit Loss, Writeoff (9,672) (2,198) (1,895)
Allowance for Credit Loss, Receivable, Other, Current (896) 101 1,524
Accounts Receivable, Allowance for Credit Loss, Ending Balance $ 37,543 $ 38,254 $ 33,497

v3.22.4
Inventories, Net (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 190,640 $ 166,486
Work in progress 68,206 63,580
Finished goods 146,616 195,824
Total inventories $ 405,462 $ 425,890

v3.22.4
Property, Plant and Equipment, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 857,143 $ 844,480  
Accumulated depreciation (374,193) (358,949)  
Total property, plant and equipment, net 482,950 485,531  
Depreciation expense 56,400 54,900 $ 40,700
Land [Member]      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 28,340 28,540  
Building and leasehold Improvements [Member]      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 346,164 351,084  
Machinery and Equipment [Member]      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 482,639 $ 464,856  

v3.22.4
Investments, Debt and Equity Securities (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Equity Securities without Readily Determinable Fair Value [Line Items]      
Marketable Securities, Noncurrent $ 11,083 $ 33,683  
Equity Securities without Readily Determinable Fair Value, Amount 54,503 33,801  
Investments in debt securities, Noncurrent 25,500    
Equity investments, carried at cost minus impairment, if any 50,654 29,738  
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount 30,700 27,800  
Equity Securities, FV-NI and without Readily Determinable Fair Value 3,849 4,063  
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 2,900 $ 19,600  
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount     $ 4,900
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount $ 5,000    

v3.22.4
Marketable Securities and Investments (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Debt Securities, Available-for-sale [Line Items]      
Marketable Securities, Noncurrent $ 11,083 $ 33,683  
Unrealized gains (losses) on securities, net of tax 5 237 $ (16)
Marketable Securities and Investments 108,086 80,984  
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount     $ 4,900
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount 5,000    
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount 30,700 27,800  
Investments in debt securities 42,500 13,500  
Investments in debt securities, Noncurrent 25,500    
Investments in debt securities, Convertible to Equity Securities or are due and payable upon event of default 17,000    
Equity Securities [Member]      
Debt Securities, Available-for-sale [Line Items]      
Marketable Securities Classified as Available for Sale 6,775 29,768  
Marketable Securities Classified as Available for Sale, Amortized Cost Basis 6,775 29,768  
Marketable Securities Classified as Available for Sale, Gross Unrealized Gain, before Tax 0 0  
Marketable Securities Classified as Available for Sale, Gross Unrealized Loss, before Tax 0 0  
Fixed Income Securities [Member]      
Debt Securities, Available-for-sale [Line Items]      
Marketable Securities Classified as Available for Sale   7  
Marketable Securities Classified as Available for Sale, Amortized Cost Basis   7  
Marketable Securities Classified as Available for Sale, Gross Unrealized Gain, before Tax   0  
Marketable Securities Classified as Available for Sale, Gross Unrealized Loss, before Tax   0  
Available-for-sale Securities, Other [Member]      
Debt Securities, Available-for-sale [Line Items]      
Marketable Securities Classified as Available for Sale 4,308 3,908  
Marketable Securities Classified as Available for Sale, Amortized Cost Basis 4,308 3,971  
Marketable Securities Classified as Available for Sale, Gross Unrealized Gain, before Tax 0 0  
Marketable Securities Classified as Available for Sale, Gross Unrealized Loss, before Tax 0 63  
Available-for-sale Securities [Member]      
Debt Securities, Available-for-sale [Line Items]      
Marketable Securities Classified as Available for Sale 11,083 33,683  
Marketable Securities Classified as Available for Sale, Amortized Cost Basis 11,083 33,746  
Marketable Securities Classified as Available for Sale, Gross Unrealized Gain, before Tax 0 0  
Marketable Securities Classified as Available for Sale, Gross Unrealized Loss, before Tax $ 0 $ 63  

v3.22.4
Goodwill and Intangible Assets, Net (Narrative) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Goodwill and Intangible Assets Net [Line Items]      
Total amortization expense related to finite-lived intangible assets $ 370,600 $ 256,600 $ 161,000
Future Amortization Expense, Year One 363,800    
Future Amortization Expense, Year Two 355,200    
Future Amortization Expense, Year Three 334,000    
Future Amortization Expense, Year Four 327,000    
Future Amortization Expense, Year Five 299,600    
Finite-Lived Intangible Assets, Net 3,377,174 3,821,847  
Goodwill $ 6,481,768 6,627,119 2,639,587
Impairment Testing Date January 3, 2022    
Trade Names And Trademarks [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net $ 85,863 102,890  
Licenses [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net 8,360 9,989  
Discovery & Analytical Solutions [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net 2,686,191 2,928,636  
Goodwill 4,551,575 4,656,769 948,360
Discovery & Analytical Solutions [Member] | Trade Names And Trademarks [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net 39,576 45,176  
Discovery & Analytical Solutions [Member] | Licenses [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net 4,896 5,547  
Diagnostics [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net 690,983 893,211  
Goodwill 1,930,193 1,970,350 $ 1,691,227
Diagnostics [Member] | Trade Names And Trademarks [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net 46,287 57,714  
Diagnostics [Member] | Licenses [Member]      
Goodwill and Intangible Assets Net [Line Items]      
Finite-Lived Intangible Assets, Net $ 3,464 $ 4,442  

v3.22.4
Goodwill and Intangible Assets, Net (Changes in the Carrying Amount of Goodwill) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Changes in the carrying amount of goodwill    
Foreign currency translation $ (139,885) $ (74,458)
Acquisitions, earn outs and other (5,466) 4,061,990
Ending balance 6,481,768 6,627,119
Diagnostics [Member]    
Changes in the carrying amount of goodwill    
Foreign currency translation (41,617) (40,557)
Acquisitions, earn outs and other 1,460 319,680
Ending balance 1,930,193 1,970,350
Discovery & Analytical Solutions [Member]    
Changes in the carrying amount of goodwill    
Foreign currency translation (98,268) (33,901)
Acquisitions, earn outs and other (6,926) 3,742,310
Ending balance $ 4,551,575 $ 4,656,769

v3.22.4
Goodwill and Intangible Assets, Net (Identifiable Intangible Asset Balances) (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Net amortizable intangible assets $ 3,377,174 $ 3,821,847
Totals 3,377,174 3,821,847
Patents [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 28,020 28,233
Less: Accumulated amortization (26,055) (25,893)
Net amortizable intangible assets 1,965 2,340
Trade Names And Trademarks [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 149,453 156,864
Less: Accumulated amortization (63,590) (53,974)
Net amortizable intangible assets 85,863 102,890
Licenses [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 62,614 62,627
Less: Accumulated amortization (54,254) (52,638)
Net amortizable intangible assets 8,360 9,989
Core Technology [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 1,556,740 1,592,564
Less: Accumulated amortization (449,689) (335,207)
Net amortizable intangible assets 1,107,051 1,257,357
Customer Relationships [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 2,943,761 3,033,870
Less: Accumulated amortization (775,104) (590,519)
Net amortizable intangible assets 2,168,657 2,443,351
In Process Research and Development [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 5,278 5,920
Diagnostics [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Net amortizable intangible assets 690,983 893,211
Diagnostics [Member] | Patents [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 2,708 2,709
Less: Accumulated amortization (956) (732)
Net amortizable intangible assets 1,752 1,977
Diagnostics [Member] | Trade Names And Trademarks [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 72,932 79,683
Less: Accumulated amortization (26,645) (21,969)
Net amortizable intangible assets 46,287 57,714
Diagnostics [Member] | Licenses [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 8,136 8,410
Less: Accumulated amortization (4,672) (3,968)
Net amortizable intangible assets 3,464 4,442
Diagnostics [Member] | Core Technology [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 476,129 519,864
Less: Accumulated amortization (240,442) (208,833)
Net amortizable intangible assets 235,687 311,031
Diagnostics [Member] | Customer Relationships [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 820,495 884,105
Less: Accumulated amortization (416,702) (366,058)
Net amortizable intangible assets 403,793 518,047
Diagnostics [Member] | In Process Research and Development [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 0 0
Discovery & Analytical Solutions [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Net amortizable intangible assets 2,686,191 2,928,636
Discovery & Analytical Solutions [Member] | Patents [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 25,312 25,524
Less: Accumulated amortization (25,099) (25,161)
Net amortizable intangible assets 213 363
Discovery & Analytical Solutions [Member] | Trade Names And Trademarks [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 76,521 77,181
Less: Accumulated amortization (36,945) (32,005)
Net amortizable intangible assets 39,576 45,176
Discovery & Analytical Solutions [Member] | Licenses [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 54,478 54,217
Less: Accumulated amortization (49,582) (48,670)
Net amortizable intangible assets 4,896 5,547
Discovery & Analytical Solutions [Member] | Core Technology [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 1,080,611 1,072,700
Less: Accumulated amortization (209,247) (126,374)
Net amortizable intangible assets 871,364 946,326
Discovery & Analytical Solutions [Member] | Customer Relationships [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets 2,123,266 2,149,765
Less: Accumulated amortization (358,402) (224,461)
Net amortizable intangible assets 1,764,864 1,925,304
Discovery & Analytical Solutions [Member] | In Process Research and Development [Member]    
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]    
Gross amortizable intangible assets $ 5,278 $ 5,920

v3.22.4
Debt (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Apr. 02, 2023
Jan. 02, 2022
Aug. 24, 2021
Unamortized discount and debt issuance costs $ 34,840      
Unamortized Debt Issuance Expense 28,820   $ 35,781  
Maturities of Long-term Debt [Abstract]        
2022 471,859      
2023 772,859      
2024 201      
2025 534,065      
2026 89      
2027 and Thereafter 2,650,043      
Long-term Debt Before Unamortized Discount 4,429,116      
Total (4,394,276)      
Other Long-term Debt, Current 470,929   4,240  
Debt Instrument, Unamortized Discount 6,020   7,366  
Long-term Debt, Gross 3,957,257   5,022,884  
Debt, Long-term and Short-term, Combined Amount 4,429,116   5,027,124  
Current Portion of Long-Term Debt, Gross 471,859      
Current portion of long-term debt 470,929      
Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (3,923,347)   (4,979,737)  
Debt, Long-term and Short-term, Combined Amount 4,394,276   4,983,977  
Long-term Debt        
Unamortized Debt Issuance Expense 27,953   35,781  
Maturities of Long-term Debt [Abstract]        
Debt Instrument, Unamortized Discount 5,957   7,366  
Long-term Debt - Current Portion [Member]        
Unamortized Debt Issuance Expense 867      
Maturities of Long-term Debt [Abstract]        
Debt Instrument, Unamortized Discount 63      
Line of Credit, Maturing September 17, 2024 [Member]        
Aggregate borrowings under the amended facility     0  
Unamortized Debt Issuance Expense     3,362  
Maturities of Long-term Debt [Abstract]        
Total     (3,362)  
Debt Instrument, Unamortized Discount     0  
Other Debt Facilities [Member]        
Unamortized discount and debt issuance costs 0      
Maturities of Long-term Debt [Abstract]        
2022 4,721      
2023 1,200      
2024 201      
2025 115      
2026 89      
2027 and Thereafter 43      
Long-term Debt Before Unamortized Discount 6,369      
Total (6,369)      
3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]        
Unamortized discount and debt issuance costs 7,537      
Unamortized Debt Issuance Expense 5,537   6,234  
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 0      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 850,000      
Long-term Debt Before Unamortized Discount 850,000      
Total (842,463)      
Debt Instrument, Unamortized Discount 2,000   2,252  
Long-term Debt, Gross 850,000   850,000  
3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member] | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (842,463)   (841,514)  
1.875 Percent Ten Year Senior Unsecured Notes [Member]        
Unamortized discount and debt issuance costs 3,681      
Unamortized Debt Issuance Expense 1,779   2,280  
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 0      
2024 0      
2025 533,950      
2026 0      
2027 and Thereafter 0      
Long-term Debt Before Unamortized Discount 533,950      
Total (530,269)      
Debt Instrument, Unamortized Discount 1,902   2,538  
Long-term Debt, Gross 533,950   568,600  
1.875 Percent Ten Year Senior Unsecured Notes [Member] | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (530,269)   (563,782)  
Line of Credit, Maturing August 24, 2026        
Unsecured revolving credit facility, amount       $ 1,500,000
Line of Credit Facility, Remaining Borrowing Capacity 1,490,000      
Letters of credit issued and outstanding 7,100      
Aggregate borrowings under the amended facility 0      
Unamortized discount and debt issuance costs 2,641      
Unamortized Debt Issuance Expense 2,641      
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 0      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 0      
Long-term Debt Before Unamortized Discount 0      
Total (2,641)      
Debt Instrument, Unamortized Discount $ 0      
Line of Credit, Maturing August 24, 2026 | Unsecured Revolving Credit Facility [Member] | Base Rate Option Two [Member]        
Maturities of Long-term Debt [Abstract]        
Debt Instrument, Basis Spread on Variable Rate 0.50%      
Line of Credit, Maturing August 24, 2026 | Unsecured Revolving Credit Facility [Member] | Base Rate Option Three [Member]        
Maturities of Long-term Debt [Abstract]        
Debt Instrument, Basis Spread on Variable Rate 1.00%      
Term Loan Credit Facility Maturing 2024        
Unamortized Debt Issuance Expense     658  
Maturities of Long-term Debt [Abstract]        
Debt Instrument, Unamortized Discount     14  
Long-term Debt, Gross     500,000  
Term Loan Credit Facility Maturing 2024 | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total     (499,328)  
0.550% Senior Unsecured Notes due 2023        
Unamortized discount and debt issuance costs $ 930      
Unamortized Debt Issuance Expense 867   2,093  
Maturities of Long-term Debt [Abstract]        
2022 467,138      
2023 0      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 0      
Long-term Debt Before Unamortized Discount 467,138      
Total (466,208)      
Debt Instrument, Unamortized Discount 63   152  
Long-term Debt, Gross     500,000  
Current portion of long-term debt 467,138      
Debt Instrument, Repurchase Amount 32,900      
0.550% Senior Unsecured Notes due 2023 | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total     (497,755)  
Current portion of long-term debt 466,208      
0.850% Senior Unsecured Notes due 2024        
Unamortized discount and debt issuance costs 3,419      
Unamortized Debt Issuance Expense 3,136   4,945  
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 771,659      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 0      
Long-term Debt Before Unamortized Discount 771,659      
Total (768,240)      
Debt Instrument, Unamortized Discount 283   447  
Long-term Debt, Gross 771,659   800,000  
Debt Instrument, Repurchase Amount 28,300      
0.850% Senior Unsecured Notes due 2024 | Subsequent Event [Member]        
Maturities of Long-term Debt [Abstract]        
Debt Instrument, Repurchase Amount   $ 50,500    
0.850% Senior Unsecured Notes due 2024 | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (768,240)   (794,608)  
1.900% Senior Unsecured Notes due 2028        
Unamortized discount and debt issuance costs 3,932      
Unamortized Debt Issuance Expense 3,631   4,200  
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 0      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 500,000      
Long-term Debt Before Unamortized Discount 500,000      
Total (496,068)      
Debt Instrument, Unamortized Discount 301   348  
Long-term Debt, Gross 500,000   500,000  
1.900% Senior Unsecured Notes due 2028 | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (496,068)   (495,452)  
2.55 Percent Senior Unsecured Notes due in 2031        
Unamortized discount and debt issuance costs 3,092      
Unamortized Debt Issuance Expense 2,978   3,294  
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 0      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 400,000      
Long-term Debt Before Unamortized Discount 400,000      
Total (396,908)      
Debt Instrument, Unamortized Discount 114   126  
Long-term Debt, Gross 400,000   400,000  
2.55 Percent Senior Unsecured Notes due in 2031 | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (396,908)   (396,580)  
2.250% Senior Unsecured Notes due in 2031        
Unamortized discount and debt issuance costs 5,344      
Unamortized Debt Issuance Expense 3,991   4,380  
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 0      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 500,000      
Long-term Debt Before Unamortized Discount 500,000      
Total (494,656)      
Debt Instrument, Unamortized Discount 1,353   1,485  
Long-term Debt, Gross 500,000   500,000  
2.250% Senior Unsecured Notes due in 2031 | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (494,656)   (494,135)  
3.625 Percent Senior Unsecured Notes due in 2051        
Unamortized discount and debt issuance costs 4,264      
Unamortized Debt Issuance Expense 4,260   4,335  
Maturities of Long-term Debt [Abstract]        
2022 0      
2023 0      
2024 0      
2025 0      
2026 0      
2027 and Thereafter 400,000      
Long-term Debt Before Unamortized Discount 400,000      
Total (395,736)      
Debt Instrument, Unamortized Discount 4   4  
Long-term Debt, Gross 400,000   400,000  
3.625 Percent Senior Unsecured Notes due in 2051 | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Total (395,736)   (395,661)  
Other Debt Facilities - Non-current        
Unamortized Debt Issuance Expense 0   0  
Maturities of Long-term Debt [Abstract]        
Other Long-term Debt, Noncurrent 1,648   4,284  
Debt Instrument, Unamortized Discount 0   0  
Other Debt Facilities - Non-current | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Other Long-term Debt, Noncurrent 1,648   4,284  
Other Debt Facilities - Current        
Unamortized Debt Issuance Expense 0   0  
Maturities of Long-term Debt [Abstract]        
Other Long-term Debt, Current 4,721      
Debt Instrument, Unamortized Discount 0   0  
Current portion of long-term debt     4,240  
Other Debt Facilities - Current | Fair Value, Inputs, Level 2 [Member]        
Maturities of Long-term Debt [Abstract]        
Other Long-term Debt, Current $ 4,721      
Current portion of long-term debt     $ 4,240  

v3.22.4
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Accounts Payable and Accrued Liabilities, Current [Abstract]    
Payroll and incentives $ 52,331 $ 52,116
Employee benefits 51,983 52,199
Deferred revenue 135,531 138,052
Federal, non-U.S. and state income taxes 45,625 88,285
Operating Lease liabilities, Accrued, Current 31,217 29,313
Contract with Customer, Liability, Current 30,133 184,897
Other accrued operating expenses 211,176 319,134
Accrued expenses and other current liabilities $ 527,863 $ 679,099

v3.22.4
Employee Benefit Plans (Schedule of Net Benefit Costs, Pension Plans) (Details) - Pension Plans, Defined Benefit - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Defined Benefit Plan Disclosure [Line Items]      
Service cost $ 6,331 $ 5,174 $ 7,414
Interest cost 10,751 9,440 12,876
Expected return on plan assets (22,056) (24,417) (21,786)
Actuarial loss (gain) (23,706) (19,514) 20,291
Net periodic benefit cost $ (28,680) $ (29,317) $ 18,795

v3.22.4
Employee Benefit Plans (Schedule of Net Funded Status, Pension Plans) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Apr. 02, 2023
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Dec. 29, 2019
Actuarial assumptions as of the year-end measurement date:          
Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Projected Benefit Obligation   $ 120,283 $ 189,349    
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets   0 0    
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation   120,736 191,285    
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets   0 $ 0    
UNITED STATES | Subsequent Event [Member]          
Change in plan assets:          
Employer's contributions $ 10,000        
Other Pension Plan [Member]          
Actuarial assumptions as of the year-end measurement date:          
Rate of compensation increase     2.78%    
Other Postretirement Benefit Plans, Defined Benefit [Member]          
Net amounts recognized in the consolidated balance sheets consist of:          
Net amounts recognized in the consolidated balance sheets   (17,100) $ (20,700)    
Foreign Plan [Member]          
Actuarial present value of benefit obligations: [Abstract]          
Accumulated benefit obligations   207,503 337,454    
Change in benefit obligations:          
Projected benefit obligations at beginning of year 207,955 339,390 395,339    
Service cost   4,956 4,924    
Interest cost   3,671 2,632    
Benefit obligation classified in discontinued operations   8,261 0    
Benefit obligation classified in discontinued operations   (8,261) 0    
Actuarial loss (gain)   (88,724) (30,705)    
Effect of exchange rate changes   (28,099) (17,501)    
Projected benefit obligations at end of year   207,955 339,390 $ 395,339  
Change in plan assets:          
Fair value of plan assets at beginning of year 106,741 181,189 204,744    
Actual return on plan assets   (46,383) (13,115)    
Benefits paid and plan expenses   (14,978) (15,299)    
Employer's contributions   6,572 6,851    
Effect of exchange rate changes   (19,659) (1,992)    
Fair value of plan assets at end of year   106,741 181,189 $ 204,744  
Net amounts recognized in the consolidated balance sheets consist of:          
Net amounts recognized in the consolidated balance sheets   (101,214) (158,201)    
Assets for Plan Benefits, Defined Benefit Plan   19,521 33,084    
Current liabilities   (6,568) (6,966)    
Noncurrent liabilities   $ (114,167) $ (184,319)    
Actuarial assumptions as of the year-end measurement date:          
Discount rate   4.12% 1.41% 0.92% 1.34%
Rate of compensation increase   3.16% 2.78% 2.78% 3.36%
Expected rate of return on assets     1.11% 2.10% 2.20%
Defined Benefit Plan, Benefit Obligation, Benefits Paid   $ 14,978 $ 15,299    
UNITED STATES          
Actuarial present value of benefit obligations: [Abstract]          
Accumulated benefit obligations   231,492 299,826    
Change in benefit obligations:          
Projected benefit obligations at beginning of year 231,492 299,826 317,679    
Service cost   1,375 250    
Interest cost   7,080 6,808    
Benefit obligation classified in discontinued operations   0 0    
Benefit obligation classified in discontinued operations   0 0    
Actuarial loss (gain)   (56,919) (6,218)    
Effect of exchange rate changes   0 0    
Projected benefit obligations at end of year   231,492 299,826 $ 317,679  
Change in plan assets:          
Fair value of plan assets at beginning of year $ 216,748 290,116 268,686    
Actual return on plan assets   (53,498) 20,123    
Benefits paid and plan expenses   (19,870) (18,693)    
Employer's contributions   0 20,000    
Effect of exchange rate changes   0 0    
Fair value of plan assets at end of year   216,748 290,116 $ 268,686  
Net amounts recognized in the consolidated balance sheets consist of:          
Net amounts recognized in the consolidated balance sheets   (14,744) (9,710)    
Assets for Plan Benefits, Defined Benefit Plan   0 0    
Current liabilities   0 0    
Noncurrent liabilities   $ (14,744) $ (9,710)    
Actuarial assumptions as of the year-end measurement date:          
Discount rate   4.84% 2.44% 2.21% 3.01%
Rate of compensation increase   0.00% 0.00% 0.00% 0.00%
Expected rate of return on assets     7.25% 7.25% 7.25%
Defined Benefit Plan, Benefit Obligation, Benefits Paid   $ 19,870 $ 18,693    

v3.22.4
Employee Benefit Plans (Schedule of Allocation of Plan Assets, Pension Plans) (Details)
 12 Months Ended
Dec. 31, 2023
Jan. 01, 2023
Jan. 02, 2022
Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   100.00% 100.00%
UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   100.00% 100.00%
Other Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   100.00% 100.00%
Other Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   0.00% 0.00%
Debt Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   0.00% 0.00%
Debt Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   56.00% 54.00%
Equity Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   0.00% 0.00%
Equity Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities   44.00% 46.00%
Forecast [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities 100.00%    
Forecast [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Equity Securities 100.00%    
Forecast [Member] | Minimum [Member] | Equity Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 0.00%    
Forecast [Member] | Minimum [Member] | Equity Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 40.00%    
Forecast [Member] | Minimum [Member] | Debt Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 0.00%    
Forecast [Member] | Minimum [Member] | Debt Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 40.00%    
Forecast [Member] | Minimum [Member] | Trading Assets, Excluding Debt and Equity Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 95.00%    
Forecast [Member] | Minimum [Member] | Trading Assets, Excluding Debt and Equity Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 0.00%    
Forecast [Member] | Maximum [Member] | Equity Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 5.00%    
Forecast [Member] | Maximum [Member] | Equity Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 60.00%    
Forecast [Member] | Maximum [Member] | Debt Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 5.00%    
Forecast [Member] | Maximum [Member] | Debt Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 60.00%    
Forecast [Member] | Maximum [Member] | Trading Assets, Excluding Debt and Equity Securities [Member] | Foreign Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 100.00%    
Forecast [Member] | Maximum [Member] | Trading Assets, Excluding Debt and Equity Securities [Member] | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit, Target Asset Allocation Percentage 10.00%    

v3.22.4
Employee Benefit Plans (Schedule of Changes in Fair Value of Plan Assets, Pension Plans) (Details) - Pension Plans, Defined Benefit - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Dec. 29, 2019
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets $ 323,489 $ 471,305    
Cash [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 14,483 22,241    
Equity Securities, U.S. Large-cap [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 61,680 91,601    
Equity Securities, International large-cap value[Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 20,148 29,803    
Equity Securities, Emerging Markets Growth [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 9,902 12,603    
Fixed Income Funds, Corporate Debt Instruments [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 105,126 133,727    
Fixed Income Funds, Corporate Bonds [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 17,088 15,650    
Foreign liability driven investment [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 95,062 165,680    
Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 142,559 197,973    
Fair Value, Inputs, Level 1 [Member] | Cash [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 14,483 22,241    
Fair Value, Inputs, Level 1 [Member] | Equity Securities, U.S. Large-cap [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 61,680 91,601    
Fair Value, Inputs, Level 1 [Member] | Equity Securities, International large-cap value[Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 20,148 29,803    
Fair Value, Inputs, Level 1 [Member] | Equity Securities, Emerging Markets Growth [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 9,902 12,603    
Fair Value, Inputs, Level 1 [Member] | Fixed Income Funds, Corporate Debt Instruments [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 36,346 41,725    
Fair Value, Inputs, Level 1 [Member] | Fixed Income Funds, Corporate Bonds [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 1 [Member] | Foreign liability driven investment [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 85,868 107,652    
Fair Value, Inputs, Level 2 [Member] | Cash [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 2 [Member] | Equity Securities, U.S. Large-cap [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 2 [Member] | Equity Securities, International large-cap value[Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 2 [Member] | Equity Securities, Emerging Markets Growth [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 2 [Member] | Fixed Income Funds, Corporate Debt Instruments [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 68,780 92,002    
Fair Value, Inputs, Level 2 [Member] | Fixed Income Funds, Corporate Bonds [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 17,088 15,650    
Fair Value, Inputs, Level 2 [Member] | Foreign liability driven investment [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 95,062 165,680 $ 23,259 $ 24,409
Fair Value, Inputs, Level 3 [Member] | Cash [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 3 [Member] | Equity Securities, U.S. Large-cap [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 3 [Member] | Equity Securities, International large-cap value[Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 3 [Member] | Equity Securities, Emerging Markets Growth [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 3 [Member] | Equity Securities, Foreign Real Estate Funds [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0 23,259 22,688
Fair Value, Inputs, Level 3 [Member] | Fixed Income Funds, Corporate Debt Instruments [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 3 [Member] | Fixed Income Funds, Corporate Bonds [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fair Value, Inputs, Level 3 [Member] | Other Types of Investments, Multi-strategy hedge funds [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0 0 1,721
Fair Value, Inputs, Level 3 [Member] | Foreign liability driven investment [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets $ 95,062 $ 165,680 $ 0 $ 0

v3.22.4
Employee Benefit Plans (Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets, Pension Plans) (Details) - Pension Plans, Defined Benefit - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year $ 471,305    
Fair value of plan assets at end of year 323,489 $ 471,305  
Foreign liability driven investment [Member]      
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year 165,680    
Fair value of plan assets at end of year 95,062 165,680  
Equity Securities, Emerging Markets Growth [Member]      
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year 12,603    
Fair value of plan assets at end of year 9,902 12,603  
Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Decrease for Sale   (23,115) $ (1,721)
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase   165,680  
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year 165,680 23,259 24,409
Defined Benefit Plan, Realized losses   (226)  
Fair value of plan assets at end of year 95,062 165,680 23,259
Defined Benefit Plan, Unrealized Gains     571
Defined Benefit Plan, Realized Gains   82  
Defined Benefit Plan, Foreign exchange losses (18,411)    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held (45,568)    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Pension Benefits Paid (6,639)    
Fair Value, Inputs, Level 3 [Member] | Foreign Real Estate Funds [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase   0  
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Defined Benefit Plan, Realized losses   (226)  
Fair Value, Inputs, Level 3 [Member] | Multi-strategy hedge funds [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Decrease for Sale   0 (1,721)
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase   0  
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year 0 0 1,721
Defined Benefit Plan, Realized losses   0  
Fair value of plan assets at end of year 0 0 0
Defined Benefit Plan, Unrealized Gains     0
Defined Benefit Plan, Realized Gains   0  
Defined Benefit Plan, Foreign exchange losses 0    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held 0    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Pension Benefits Paid 0    
Fair Value, Inputs, Level 3 [Member] | Foreign liability driven investment [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Decrease for Sale   0 0
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase   165,680  
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year 165,680 0 0
Defined Benefit Plan, Realized losses   0  
Fair value of plan assets at end of year 95,062 165,680 0
Defined Benefit Plan, Unrealized Gains     0
Defined Benefit Plan, Realized Gains   0  
Defined Benefit Plan, Foreign exchange losses (18,411)    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held (45,568)    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Pension Benefits Paid (6,639)    
Fair Value, Inputs, Level 3 [Member] | Equity Securities, Foreign Real Estate Funds [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Decrease for Sale   23,115 0
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year 0 23,259 22,688
Fair value of plan assets at end of year 0 0 23,259
Defined Benefit Plan, Unrealized Gains     $ 571
Defined Benefit Plan, Realized Gains   82  
Defined Benefit Plan, Foreign exchange losses 0    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held 0    
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Pension Benefits Paid 0    
Fair Value, Inputs, Level 3 [Member] | Equity Securities, Emerging Markets Growth [Member]      
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
Fair value of plan assets at beginning of year 0    
Fair value of plan assets at end of year $ 0 $ 0  

v3.22.4
Employee Benefit Plans (Schedule of Expected Benefit Payments, Pension Plans) (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Jan. 01, 2023
Foreign Plan [Member]    
Defined Benefit Plan Disclosure [Line Items]    
2018   $ 11,907
2019   12,371
2020   12,442
2021   12,835
2022   12,450
2023-2026   64,237
Foreign Plan [Member] | Forecast [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Expected contributions in next fiscal year $ 6,800  
UNITED STATES    
Defined Benefit Plan Disclosure [Line Items]    
2018   19,311
2019   19,267
2020   19,218
2021   19,094
2022   18,906
2023-2026   $ 87,807

v3.22.4
Employee Benefit Plans (Schedule of Net Benefit Costs, Other Postretirement Benefits) (Details) - Pension Plans, Defined Benefit - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Defined Benefit Plan Disclosure [Line Items]      
Service cost $ 6,331 $ 5,174 $ 7,414
Interest cost 10,751 9,440 12,876
Expected return on plan assets (22,056) (24,417) (21,786)
Actuarial loss (gain) 23,706 19,514 (20,291)
Net periodic benefit cost $ (28,680) $ (29,317) $ 18,795

v3.22.4
Employee Benefit Plans (Schedule of Net Funded Status, Other Postretirement Benefit Plans) (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Other Postretirement Benefit Plans, Defined Benefit [Member]    
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]    
Net amounts recognized in the consolidated balance sheets $ (17,100) $ (20,700)

v3.22.4
Employee Benefit Plans (Schedule of Changes in Fair Value of Plan Assets, Other Postretirement Benefit Plans) (Details) - Pension Plans, Defined Benefit - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Dec. 29, 2019
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets $ 323,489 $ 471,305    
Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 142,559 197,973    
Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 85,868 107,652    
Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 95,062 165,680 $ 23,259 $ 24,409
Cash [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 14,483 22,241    
Cash [Member] | Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 14,483 22,241    
Cash [Member] | Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Cash [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Equity Securities, U.S. Large-cap [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 61,680 91,601    
Equity Securities, U.S. Large-cap [Member] | Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 61,680 91,601    
Equity Securities, U.S. Large-cap [Member] | Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Equity Securities, U.S. Large-cap [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Equity Securities, International large-cap value[Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 20,148 29,803    
Equity Securities, International large-cap value[Member] | Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 20,148 29,803    
Equity Securities, International large-cap value[Member] | Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Equity Securities, International large-cap value[Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Equity Securities, Foreign Real Estate Funds [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0 23,259 22,688
Fixed Income Funds, Corporate Debt Instruments [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 105,126 133,727    
Fixed Income Funds, Corporate Debt Instruments [Member] | Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 36,346 41,725    
Fixed Income Funds, Corporate Debt Instruments [Member] | Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 68,780 92,002    
Fixed Income Funds, Corporate Debt Instruments [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fixed Income Funds, Corporate Bonds [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 17,088 15,650    
Fixed Income Funds, Corporate Bonds [Member] | Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Fixed Income Funds, Corporate Bonds [Member] | Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 17,088 15,650    
Fixed Income Funds, Corporate Bonds [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Other Types of Investments, Multi-strategy hedge funds [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0 0 1,721
Foreign liability driven investment [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 95,062 165,680    
Foreign liability driven investment [Member] | Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Foreign liability driven investment [Member] | Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Foreign liability driven investment [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 95,062 165,680 $ 0 $ 0
Equity Securities, Emerging Markets Growth [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 9,902 12,603    
Equity Securities, Emerging Markets Growth [Member] | Fair Value, Inputs, Level 1 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 9,902 12,603    
Equity Securities, Emerging Markets Growth [Member] | Fair Value, Inputs, Level 2 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets 0 0    
Equity Securities, Emerging Markets Growth [Member] | Fair Value, Inputs, Level 3 [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Fair value of plan assets $ 0 $ 0    

v3.22.4
Employee Benefit Plans (Schedule of Expected Benefit Payments, Other Postretirement Benefits) (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Jan. 01, 2023
Foreign Plan [Member]    
Defined Benefit Plan Disclosure [Line Items]    
2018   $ 11,907
2019   12,371
2020   12,442
2021   12,835
2022   12,450
2023-2026   64,237
UNITED STATES    
Defined Benefit Plan Disclosure [Line Items]    
2018   19,311
2019   19,267
2020   19,218
2021   19,094
2022   18,906
2023-2026   $ 87,807
Forecast [Member] | Foreign Plan [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year $ 6,800  

v3.22.4
Employee Benefit Plans (Savings Plan) (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, 401(k) Savings Plan, Employer Contribution Match of Employees Eligible Compensation 100.00%    
Defined Benefit Plan, 401(k) Savings Plan, Maximum Employee Match Percent for Employer Match 5.00%    
Defined Benefit, 401(k) Savings Plan Expense $ 20.0 $ 16.5 $ 14.1

v3.22.4
Employee Benefit Plans (Supplemental Executive Retirement Plan) (Details) - Supplemental Employee Retirement Plans, Defined Benefit [Member] - USD ($)
$ in Millions
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Defined Benefit Plan Disclosure [Line Items]      
Projected benefit obligation $ 18.9 $ 24.1  
Fair value of plan assets 0.9 1.6  
Pension expense $ (3.2) $ 0.2 $ 2.1

v3.22.4
Contingencies (Details)
$ in Millions
 12 Months Ended
Jan. 01, 2023
USD ($)
years
Jan. 02, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]    
Management's estimate of total cost of ultimate disposition of known environmental matters | $ $ 12.2 $ 11.9
Number of years over which estimated environmental cost will be paid | years 10  

v3.22.4
Stock Plans (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total income tax benefit recognized for stock-based compensation $ 12,800 $ 12,200 $ 18,000
Aggregate intrinsic value for stock options outstanding $ 24,400    
Weighted average remaining contractual term of options (in years) 4 years 8 months 12 days    
Aggregate intrinsic value for stock options exercisable $ 20,100    
Weighted average remaining contractual term of options exercisable (in years) 3 years 7 months 6 days    
Number of shares vested and expected to vest in the future 600,000    
Aggregate intrinsic value of vested and expected to vest stock options $ 4,300    
Weighted average remaining contractual term for options vested and expected to vest 5 years 7 months 6 days    
Total pre-tax stock-based compensation expense $ 51,518 29,675 26,904
Restricted Stock Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average grant-date fair value of stock granted (per share) $ 164.65    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 80,000    
Fair value of restricted stock awards vested $ 32,800 11,600 14,000
Total pre-tax stock-based compensation expense 34,200 $ 16,300 $ 8,700
Total unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock, granted $ 43,500    
Shares/units granted 134,000    
Awards/units outstanding 453,000 637,000  
Weighted-average period for recognition of unrecognized compensation cost, years 1 year 3 months 18 days    
Option vesting period (in years) 3 years    
Employee Stock Purchase Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares authorized under plan 5,000,000    
Weighted-average grant-date fair value of stock granted (per share) $ 134.05 $ 168.11 $ 105.23
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date 95.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate 10.00%    
Shares/units granted 30,818 21,578 38,727
Shares available for grant under employee stock purchase plan 700,000    
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average grant-date fair value of options $ 48.09 $ 40.00 $ 18.98
Total intrinsic value of options exercised $ 13,900 $ 32,400 $ 51,100
Cash received from option exercises 14,100 25,100 37,700
Total pre-tax stock-based compensation expense 9,500 $ 5,600 $ 3,100
Total unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock, granted $ 15,300    
Weighted-average period for recognition of unrecognized compensation cost, years 1 year 10 months 24 days    
Option vesting period (in years) 3 years    
Stock Options Expiration Period After Date of Grant 7 years    
2019 Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares authorized under plan     6,250,000

v3.22.4
Stock Plans (Summary of Total Compensation Recognized Related to Outstanding Stock Options) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense $ 51,518 $ 29,675 $ 26,904
Cost of sales [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 7,459 3,193 1,106
Research and development expenses [Member ]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 6,799 2,393 944
Selling, general and administrative and other expenses [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense $ 37,260 $ 24,089 $ 24,854

v3.22.4
Stock Plans (Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model) (Details)
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Share-Based Payment Arrangement [Abstract]      
Risk-free interest rate 2.30% 0.90% 0.90%
Expected dividend yield 0.20% 0.20% 0.30%
Expected lives, years 5 years 5 years 5 years
Expected stock volatility 28.50% 27.30% 23.80%

v3.22.4
Stock Plans (Summary of Stock Option Activity) (Details)
shares in Thousands
 12 Months Ended
Jan. 01, 2023
$ / shares
shares
Stock option activity  
Shares outstanding at beginning of the year 1,192
Shares granted 184
Shares exercised (195)
Shares canceled (4)
Shares forfeited (129)
Shares outstanding at end of year 1,048
Shares exercisable at end of year 461
Number of shares vested and expected to vest in the future 600
Weighted-average price, outstanding at beginning of year (per share) | $ / shares $ 119.33
Weighted-average price, granted (per share) | $ / shares 167.58
Weighted-average price, exercised (per share) | $ / shares 72.41
Weighted-average price, canceled (per share) | $ / shares 143.62
Weighted-average price, forfeited (per share) | $ / shares 152.90
Weighted-average price, outstanding at end of year (per share) | $ / shares 132.32
Weighted-average price, exercisable at end of year (per share) | $ / shares $ 102.72

v3.22.4
Stock Plans (Summary of Restricted Stock Award Activity) (Details) - Restricted Stock Awards [Member]
shares in Thousands
 12 Months Ended
Jan. 01, 2023
$ / shares
shares
Restricted stock award activity  
Nonvested at beginning of year | shares 637
Shares, granted | shares 134
Shares, vested | shares (238)
Shares, forfeited | shares (80)
Nonvested at end of year | shares 453
Weighted-average grant-date fair value, nonvested at beginning of year (per share) | $ / shares $ 144.62
Weighted-average grant-date fair value of stock granted (per share) | $ / shares 164.65
Weighted-average grant-date fair value, vested (per share) | $ / shares 137.90
Weighted-average grant-date fair value, forfeited (per share) | $ / shares 151.75
Weighted-average grant-date fair value, nonvested at end of year (per share) | $ / shares $ 152.79

v3.22.4
Stockholders' Equity (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Apr. 02, 2023
Jan. 01, 2023
Oct. 02, 2022
Jul. 03, 2022
Apr. 03, 2022
Oct. 03, 2021
Jul. 04, 2021
Apr. 04, 2021
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Jul. 22, 2022
Jul. 31, 2020
Schedule of Stockholders' Equity [Line Items]                          
Repurchased Common Shares For Activity Pursuant to Equity Incentive Plans                 115,247 71,248 72,251    
Aggregate Cost of Repurchased Common Shares for Activity Pursuant to Equity Incentive Plans                 $ 18,100 $ 10,500 $ 6,900    
Cash dividends (per share)   $ 0.07 $ 0.07 $ 0.07 $ 0.07 $ 0.07 $ 0.07 $ 0.07          
Cost of Repurchased Common Shares, Repurchase Plan and Amount for Statutory Tax Withholding Obligations                 80,638 73,072 6,944    
Dividends accrued   $ 8,800             8,800        
Unrecognized prior service credit (cost), net of tax                 $ 44 $ (95) $ (1,799)    
Repurchase Program, 07/31/2020 [Member]                          
Schedule of Stockholders' Equity [Line Items]                          
Number of common stock repurchased in open market                 240,000        
Stock Repurchase Program, Authorized Amount                         $ 250,000
Aggregate Cost of Repurchased Common Shares Under Repurchase Program                 $ 43,400        
Repurchase Program, 07/22/2022                          
Schedule of Stockholders' Equity [Line Items]                          
Number of common stock repurchased in open market                 138,025        
Stock Repurchase Program, Remaining Authorized Repurchase Amount   $ 280,900             $ 280,900        
Stock Repurchase Program, Authorized Amount                       $ 300,000  
Aggregate Cost of Repurchased Common Shares Under Repurchase Program                 $ 19,100        
Subsequent Event [Member]                          
Schedule of Stockholders' Equity [Line Items]                          
Cash dividends (per share) $ 0.07                        
Dividends Payable, Date Declared Jan. 26, 2023                        

v3.22.4
Stockholders' Equity (Components Of Accumulated Other Comprehensive Loss) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Dec. 29, 2019
Cumulative Translation Adjustment Summary [Roll Forward]        
Foreign currency translation adjustment, net of tax, beginning of year $ (161,810) $ (30,937) $ (200,437)  
Current year change (284,854) (130,873) 169,500  
Foreign currency translation adjustment, net of tax, end of year (446,664) (161,810) (30,937)  
Other Comprehensive Income (Loss), after Reclassifications, Net of Tax (284,805) (130,731) 167,685  
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax     167,685  
Unrecognized prior service costs, net of tax (798) (842) (747) $ 1,052
Unrecognized prior service costs, net of tax, current year change 44 (95) (1,799)  
Unrealized (losses) gains on securities, net of tax (35) (40) (277) (261)
Unrealized (losses) gains on securities, net of tax, current year change 5 237 (16)  
Other comprehensive (loss) income (284,805) (130,731) 167,685  
Accumulated other comprehensive income (loss) $ (447,497) $ (162,692) $ (31,961) $ (199,646)

v3.22.4
Derivatives And Hedging Activities (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Derivative [Line Items]      
Company's business conducted outside United States 55.00%    
Payments for (Proceeds from) Hedge, Financing Activities $ 762 $ 4,482 $ 4,554
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months $ 0    
European And Asian Currencies [Member]      
Derivative [Line Items]      
Maximum maturity period for foreign exchange contracts, in months 12 months    
Duration of foreign currency derivative contract, days 30 days    
Fair Value Hedging [Member]      
Derivative [Line Items]      
Derivative, Notional Amount $ 476,900 371,900 808,000
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]      
Derivative [Line Items]      
Foreign Currency Contract, Asset, Fair Value Disclosure (2,142) (3,765)  
Notional Amount of US Dollar Derivatives [Member] | Cash Flow Hedging [Member]      
Derivative [Line Items]      
Derivative, Notional Amount   360,200  
1.875 Percent Ten Year Senior Unsecured Notes [Member] | Net Investment Hedging [Member]      
Derivative [Line Items]      
Notional Amount of Nonderivative Instruments 497,200    
Unrealized Gain (Loss) on Net Investment Hedge in AOCI $ 34,500 $ 33,200 $ (49,600)

v3.22.4
Fair Value Measurements (Narrative) (Details)
$ in Thousands, € in Millions
 12 Months Ended
Jan. 01, 2023
USD ($)
Jan. 02, 2022
USD ($)
Jan. 03, 2021
USD ($)
Jan. 01, 2023
EUR (€)
Jan. 02, 2022
EUR (€)
Dec. 29, 2019
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $ 46,618 $ 57,996 $ 2,953     $ 35,481
Long-term Debt 4,394,276          
Discount on senior unsecured notes (6,020) (7,366)        
Unamortized Debt Issuance Expense $ 28,820 35,781        
Business Combination, Contingent Consideration Arrangements, Maximum Period 5 years 10 months 24 days          
Business Combination, Contingent Consideration Arrangements, Weighted Average Period 4 years 10 months 24 days          
Payments for acquisition related contingent consideration $ (5) (2,208) $ (10,363)      
Line of Credit, Maturing September 17, 2024 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Long-term Debt   3,362        
Revolving credit facility outstanding balance   0        
Discount on senior unsecured notes   0        
Unamortized Debt Issuance Expense   3,362        
3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Long-term Debt 842,463          
Discount on senior unsecured notes (2,000) (2,252)        
Unamortized Debt Issuance Expense 5,537 6,234        
1.875 Percent Ten Year Senior Unsecured Notes [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Long-term Debt 530,269          
Discount on senior unsecured notes (1,902) (2,538)        
Unamortized Debt Issuance Expense 1,779 2,280        
Senior Unsecured Notes            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Unsecured senior notes, fair value 3,812,300 4,612,800        
Fair Value, Inputs, Level 2 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Long-term Debt 3,923,347 4,979,737        
Fair Value, Inputs, Level 2 [Member] | 3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Long-term Debt 842,463 841,514        
Fair Value, Inputs, Level 2 [Member] | 1.875 Percent Ten Year Senior Unsecured Notes [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Long-term Debt 530,269 563,782        
Fair Value, Inputs, Level 2 [Member] | Senior Unsecured Notes            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Long-term Debt $ 4,390,500 $ 4,479,500        
Fair Value, Inputs, Level 2 [Member] | Other Debt Facilities, including the senior revolving credit facility            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Other Long-term Debt | €       € 3.7 € 504.5  

v3.22.4
Fair Value Measurements (Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis) (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Dec. 29, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $ 46,618 $ 57,996 $ 2,953 $ 35,481
Fair Value, Recurring [Member] | Carrying Value [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities (11,083) (33,683)    
Foreign Currency Contract, Asset, Fair Value Disclosure 2,142 3,765    
Foreign exchange derivative liabilities, net (1,549) (3,463)    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value 46,618 57,996    
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities (11,083) (33,683)    
Foreign Currency Contract, Asset, Fair Value Disclosure 0 0    
Foreign exchange derivative liabilities, net 0 0    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value 0 0    
Fair Value, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
Foreign Currency Contract, Asset, Fair Value Disclosure 2,142 3,765    
Foreign exchange derivative liabilities, net (1,549) (3,463)    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value 0 0    
Fair Value, Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
Foreign Currency Contract, Asset, Fair Value Disclosure 0 0    
Foreign exchange derivative liabilities, net 0 0    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $ 46,618 $ 57,996    

v3.22.4
Fair Value Measurements (Reconciliation of Beginning and Ending Level 3 Net Liabilities) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Balance beginning of period $ (57,996) $ (2,953) $ (35,481)
Additions (4,961) (57,431)  
Payments (2,562) (5,507) (23,701)
Adjustments Recognized in Goodwill 12,400    
Change in fair value (included within selling, general and administrative expenses) 1,377 (3,119) 8,827
Balance end of period $ (46,618) $ (57,996) $ (2,953)

v3.22.4
Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Leases [Abstract]      
Operating Lease, Cost $ 39,989 $ 39,516 $ 37,613
Schedule Of Supplemental Cash Flow Information Related To Leases [Line Items]      
Operating Lease, Payments 37,488 38,970 34,373
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability $ 55,016 $ 12,345 $ 2,605

v3.22.4
Leases Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Schedule of Supplemental Balance Sheet Information Related To Leases [Line Items]    
Operating Lease, Right-of-Use Asset $ 188,351 $ 164,040
Operating Lease, Liability, Noncurrent 169,968 147,395
Operating Lease, Liability $ 201,185 $ 176,708
Operating Lease, Weighted Average Remaining Lease Term 6 years 1 month 6 days 5 years 9 months 18 days
Operating Lease, Weighted Average Discount Rate, Percent 2.60% 1.80%
Other Current Liabilities [Member]    
Schedule of Supplemental Balance Sheet Information Related To Leases [Line Items]    
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current Other Liabilities, Current
Other Noncurrent Liabilities [Member]    
Schedule of Supplemental Balance Sheet Information Related To Leases [Line Items]    
Operating Lease, Liability, Noncurrent $ 169,968 $ 147,395

v3.22.4
Leases Lessee, Operating Lease, Liability, Maturity (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Operating Lease Liabilities, Maturity [Line Items]      
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months $ 38,452    
Lessee, Operating Lease, Liability, Payments, Due Year Two 35,361    
Lessee, Operating Lease, Liability, Payments, Due Year Three 32,080    
Lessee, Operating Lease, Liability, Payments, Due Year Four 27,064    
Lessee, Operating Lease, Liability, Payments, Due Year Five 23,983    
Lessee, Operating Lease, Liability, Payments, Due after Year Five 65,308    
Operating Lease, Payments 37,488 $ 38,970 $ 34,373
Lessee, Operating Lease, Liability, Payments, Due 222,248    
Lessee, Operating Lease, Liability, Undiscounted Excess Amount (21,063)    
Operating Lease, Liability $ 201,185 $ 176,708  

v3.22.4
Schedule of Sales and Operating Income from Continuing Operations by Operating Segment (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Jan. 01, 2023
USD ($)
Oct. 02, 2022
USD ($)
Jul. 03, 2022
USD ($)
Apr. 03, 2022
USD ($)
Jan. 02, 2022
USD ($)
Oct. 03, 2021
USD ($)
Jul. 04, 2021
USD ($)
Apr. 04, 2021
USD ($)
Jan. 01, 2023
USD ($)
segments
Jan. 02, 2022
USD ($)
Jan. 03, 2021
USD ($)
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Operating income from continuing operations $ 137,466 $ 110,780 $ 232,486 $ 261,967 $ 299,894 $ 195,554 $ 307,999 $ 455,010 $ 742,699 $ 1,258,457 $ 867,273
Number of Operating Segments | segments                 2    
Revenue from Contract with Customer, Excluding Assessed Tax                 $ 3,311,822 3,827,808 2,663,230
Interest and other expense (income), net                 90,862 54,875 67,201
Income from continuing operations before income taxes $ 138,447 $ 82,142 $ 206,344 $ 224,904 $ 299,704 $ 135,012 $ 301,329 $ 467,537 651,837 1,203,582  
Income from continuing operations before income taxes                 651,837 1,203,582 800,072
Asset Impairment Charges                 0 3,868 7,937
Amortization of Intangible Assets                 370,600 256,600 161,000
Acquisition and divestiture-related costs                 39,800 80,800 4,900
Restructuring and other costs, net                 (13,580) 14,358 7,661
Reportable Segment Revenue [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Revenue from Contract with Customer, Excluding Assessed Tax                 3,311,822 3,827,808 2,663,230
Reportable Segment Revenue [Member] | Revenue Purchase Accounting Adjustments [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Revenue from Contract with Customer, Excluding Assessed Tax                 (814) (2,648) (1,083)
Segment Operating Income [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Reportable segment operating income (loss)                 1,211,797 1,637,007 1,065,681
Amortization of Intangible Assets                 (370,638) (256,569) (160,991)
Purchase accounting adjustments                 (45,681) (40,993) (6,382)
Acquisition and divestiture-related costs                 (39,826) (62,760) (4,335)
Restructuring and other costs, net                 (12,953) (18,228) (26,700)
Diagnostics [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Reportable segment operating income (loss)                 781,985 1,432,769 1,010,361
Revenue from Contract with Customer, Excluding Assessed Tax                 2,018,913 2,931,939 2,066,942
Diagnostics [Member] | Reportable Segment Revenue [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Revenue from Contract with Customer, Excluding Assessed Tax                 2,019,727 2,932,738 2,067,728
Discovery & Analytical Solutions [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Reportable segment operating income (loss)                 503,243 281,602 129,174
Revenue from Contract with Customer, Excluding Assessed Tax                 1,292,909 895,869 596,288
Discovery & Analytical Solutions [Member] | Reportable Segment Revenue [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Revenue from Contract with Customer, Excluding Assessed Tax                 1,292,909 897,718 596,585
Corporate [Member]                      
Schedule of Segment Reporting Information, by Segment [Line Items]                      
Reportable segment operating income (loss)                 $ (73,431) $ (77,364) $ (73,854)

v3.22.4
Industry Segment and Geographic Area Information Schedule of Depreciation, Amortization and Capital Expenditures (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Schedule of Segment Reporting Information, by Segment [Line Items]      
Depreciation and amortization expense $ 427,000 $ 311,443 $ 201,648
Payments to Acquire Property, Plant, and Equipment 85,632 86,020 63,634
Diagnostics [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Depreciation and amortization expense 161,394 214,178 149,738
Payments to Acquire Property, Plant, and Equipment 40,671 57,206 55,236
Discovery & Analytical Solutions [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Depreciation and amortization expense 263,698 94,700 48,657
Payments to Acquire Property, Plant, and Equipment 41,532 27,818 6,345
Corporate [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Depreciation and amortization expense 1,908 2,565 3,253
Payments to Acquire Property, Plant, and Equipment 3,429 996 2,053
All Segments [Member]      
Schedule of Segment Reporting Information, by Segment [Line Items]      
Depreciation and amortization expense 427,000 311,443 201,648
Payments to Acquire Property, Plant, and Equipment $ 85,632 $ 86,020 $ 63,634

v3.22.4
Industry Segment and Geographic Area Information Schedule of Total Assets by Segment (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Schedule of Total Assets, by segment [Line Items]    
Assets $ 14,129,855 $ 15,000,554
Disposal Group, Including Discontinued Operation, Assets, Current 1,693,704 555,374
Diagnostics [Member]    
Schedule of Total Assets, by segment [Line Items]    
Assets 3,991,659 4,692,816
Discovery & Analytical Solutions [Member]    
Schedule of Total Assets, by segment [Line Items]    
Assets 8,330,045 8,478,292
Corporate [Member]    
Schedule of Total Assets, by segment [Line Items]    
Assets $ 114,447 $ 129,904

v3.22.4
Industry Segment and Geographic Area Information Schedule of Revenue by Geographic Area (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Sales by Geographic Area [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 3,311,822 $ 3,827,808 $ 2,663,230
UNITED STATES      
Sales by Geographic Area [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,546,520 1,682,294 921,574
CHINA      
Sales by Geographic Area [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 476,366 449,588 305,660
UNITED KINGDOM      
Sales by Geographic Area [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 136,017 357,911 323,837
Other International [Member]      
Sales by Geographic Area [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,152,919 1,338,015 1,112,159
Total international [Member]      
Sales by Geographic Area [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 1,765,302 $ 2,145,514 $ 1,741,656

v3.22.4
Industry Segment and Geographic Area Information Schedule of Long-Lived Assets by Geographic Location (Details) - USD ($)
$ in Thousands
Jan. 01, 2023
Jan. 02, 2022
Long-lived assets by Geographic Area [Line Items]    
Total net long-lived assets $ 743,734 $ 724,071
UNITED STATES    
Long-lived assets by Geographic Area [Line Items]    
Total net long-lived assets 311,661 295,397
GERMANY    
Long-lived assets by Geographic Area [Line Items]    
Total net long-lived assets 147,766 146,633
CHINA    
Long-lived assets by Geographic Area [Line Items]    
Total net long-lived assets 68,072 59,851
Other International [Member]    
Long-lived assets by Geographic Area [Line Items]    
Total net long-lived assets 216,235 222,190
Total international [Member]    
Long-lived assets by Geographic Area [Line Items]    
Total net long-lived assets $ 432,073 $ 428,674

v3.22.4
Quarterly Financial Information (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Jan. 01, 2023
Oct. 02, 2022
Jul. 03, 2022
Apr. 03, 2022
Jan. 02, 2022
Oct. 03, 2021
Jul. 04, 2021
Apr. 04, 2021
Jan. 01, 2023
Jan. 02, 2022
Jan. 03, 2021
Quarterly Financial Data [Abstract]                      
Revenue $ 741,214 $ 711,803 $ 895,642 $ 963,163 $ 1,027,910 $ 861,315 $ 910,747 $ 1,027,836 $ 3,311,822 $ 3,827,808  
Gross profit 436,329 407,044 551,717 594,740 643,797 522,860 574,143 693,187 1,989,830 2,433,987  
Restructuring and other costs, net                 (13,580) 14,358 $ 7,661
Operating income from continuing operations 137,466 110,780 232,486 261,967 299,894 195,554 307,999 455,010 742,699 1,258,457 867,273
Income from continuing operations before income taxes 138,447 82,142 206,344 224,904 299,704 135,012 301,329 467,537 651,837 1,203,582  
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 30,161 15,839 17,611 (7,108) 6,095 20,107 18,073 9,446 56,503 53,721 97,327
Operating income from continuing operations 97,497 69,508 161,601 184,070 184,089 107,631 227,857 369,859 512,676 889,436 630,560
Net income $ 127,658 $ 85,347 $ 179,212 $ 176,962 $ 190,184 $ 127,738 $ 245,930 $ 379,305 $ 569,179 $ 943,157 $ 727,887
Basic earnings per share:                      
Income from continuing operations $ 0.77 $ 0.55 $ 1.28 $ 1.46 $ 1.46 $ 0.94 $ 2.03 $ 3.30 $ 4.06 $ 7.66 $ 5.65
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 0.24 0.13 0.14 (0.06) 0.05 0.18 0.16 0.08 0.45 0.46 0.87
Net income 1.01 0.68 1.42 1.40 1.51 1.12 2.19 3.38 4.51 8.12 6.52
Diluted earnings per share:                      
Income from continuing operations 0.77 0.55 1.28 1.45 1.45 0.94 2.03 3.29 4.06 7.62 5.63
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share 0.24 0.13 0.14 (0.06) 0.05 0.17 0.16 0.08 0.45 0.46 0.87
Net income 1.01 0.67 1.42 1.39 $ 1.50 1.11 2.19 3.37 $ 4.50 $ 8.08 $ 6.49
Cash dividends per common share $ 0.07 $ 0.07 $ 0.07 $ 0.07   $ 0.07 $ 0.07 $ 0.07      

v3.22.4
Subsequent Events (Details) - Horizon Discovery Group plc [Member]
$ in Thousands
 12 Months Ended
Jan. 03, 2021
USD ($)
employees
Subsequent Event [Line Items]  
Entity Number of Employees | employees 400
United States of America, Dollars  
Subsequent Event [Line Items]  
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments | $ $ 399,800

v3.22.4
Label Element Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $ 191,894,000 

{
 "instance": {
  "pki-20230101.htm": {
   "axisCustom": 9,
   "axisStandard": 34,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1944,
    "http://xbrl.sec.gov/dei/2022": 46
   },
   "contextCount": 549,
   "dts": {
    "calculationLink": {
     "local": [
      "pki-20230101_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pki-20230101_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pki-20230101.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pki-20230101_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pki-20230101_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pki-20230101.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd"
     ]
    }
   },
   "elementCount": 1505,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 26,
    "http://www.perkinelmer.com/20230101": 12,
    "http://xbrl.sec.gov/dei/2022": 9,
    "total": 47
   },
   "keyCustom": 113,
   "keyStandard": 515,
   "memberCustom": 73,
   "memberStandard": 67,
   "nsprefix": "pki",
   "nsuri": "http://www.perkinelmer.com/20230101",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentAnnualReport",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.perkinelmer.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "lang": "en-US",
      "name": "dei:IcfrAuditorAttestationFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000010 - Statement - Interest and Other Expense (Income), Net",
     "menuCat": "Statements",
     "order": "10",
     "role": "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet",
     "shortName": "Interest and Other Expense (Income), Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ife6bd29edce6404caa516d8728764b5a_I20220102",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000116 - Disclosure - Stockholders' Equity (Components Of Accumulated Other Comprehensive Loss) (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Stockholders' Equity (Components Of Accumulated Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i39378520630945e2861e1951d1ca9ed0_I20191229",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "pki:PercentageOfBusinessOutsideDomesticCountry",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000117 - Disclosure - Derivatives And Hedging Activities (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
     "shortName": "Derivatives And Hedging Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "pki:PercentageOfBusinessOutsideDomesticCountry",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000118 - Disclosure - Fair Value Measurements (Narrative) (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ia55935c33b774ad694766b582492bc49_I20230101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000119 - Disclosure - Fair Value Measurements (Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis) (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements (Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "if9b522563f0a48c99f90698e591369b3_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ife6bd29edce6404caa516d8728764b5a_I20220102",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000120 - Disclosure - Fair Value Measurements (Reconciliation of Beginning and Ending Level 3 Net Liabilities) (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails",
     "shortName": "Fair Value Measurements (Reconciliation of Beginning and Ending Level 3 Net Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000121 - Disclosure - Leases (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.perkinelmer.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000122 - Disclosure - Leases Supplemental Balance Sheet Information Related to Leases (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails",
     "shortName": "Leases Supplemental Balance Sheet Information Related to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pki:SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000123 - Disclosure - Leases Lessee, Operating Lease, Liability, Maturity (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails",
     "shortName": "Leases Lessee, Operating Lease, Liability, Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "icd13c8dc9cf347a9887615192f2604b2_D20221003-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000125 - Disclosure - Schedule of Sales and Operating Income from Continuing Operations by Operating Segment (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails",
     "shortName": "Schedule of Sales and Operating Income from Continuing Operations by Operating Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i5ffeb0f988a74df395b62cd11fb12c77_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000126 - Disclosure - Industry Segment and Geographic Area Information Schedule of Depreciation, Amortization and Capital Expenditures (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
     "shortName": "Industry Segment and Geographic Area Information Schedule of Depreciation, Amortization and Capital Expenditures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pki:ScheduleOfDepreciationAmortizationAndCapitalExpendituresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i437901feb5c544beab1ce23f3701c80f_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000011 - Statement - Interest and Other Expense (Income), Net",
     "menuCat": "Statements",
     "order": "11",
     "role": "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_1",
     "shortName": "Interest and Other Expense (Income), Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000127 - Disclosure - Industry Segment and Geographic Area Information Schedule of Total Assets by Segment (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
     "shortName": "Industry Segment and Geographic Area Information Schedule of Total Assets by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ib7b20c7e984146b49765d4c5ec178503_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000128 - Disclosure - Industry Segment and Geographic Area Information Schedule of Revenue by Geographic Area (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails",
     "shortName": "Industry Segment and Geographic Area Information Schedule of Revenue by Geographic Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i374a7c7dacdf48ea83cbf863cd0129b2_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000129 - Disclosure - Industry Segment and Geographic Area Information Schedule of Long-Lived Assets by Geographic Location (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
     "shortName": "Industry Segment and Geographic Area Information Schedule of Long-Lived Assets by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "icd13c8dc9cf347a9887615192f2604b2_D20221003-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000130 - Disclosure - Quarterly Financial Information (Unaudited) (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
     "shortName": "Quarterly Financial Information (Unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "icd13c8dc9cf347a9887615192f2604b2_D20221003-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ia2fb0e5fc8f8471da74a1c3abfbc07c9_I20210103",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityNumberOfEmployees",
      "reportCount": 1,
      "unitRef": "employees",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000131 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://www.perkinelmer.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pki:ChangeInFairValueOfFinancialSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000012 - Statement - Interest and Other Expense (Income), Net",
     "menuCat": "Statements",
     "order": "12",
     "role": "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
     "shortName": "Interest and Other Expense (Income), Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Business Combinations and Asset Purchases",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchases",
     "shortName": "Business Combinations and Asset Purchases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Nature of Operations and Accounting Policies",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPolicies",
     "shortName": "Nature of Operations and Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Revenue from Contract with Customer",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.perkinelmer.com/role/RevenuefromContractwithCustomer",
     "shortName": "Revenue from Contract with Customer",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Discontinued Operations",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.perkinelmer.com/role/DiscontinuedOperations",
     "shortName": "Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.perkinelmer.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.perkinelmer.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Accounts Receivable, Net",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.perkinelmer.com/role/AccountsReceivableNet",
     "shortName": "Accounts Receivable, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.perkinelmer.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Inventories, Net",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.perkinelmer.com/role/InventoriesNet",
     "shortName": "Inventories, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Property, Plant and Equipment, Net",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNet",
     "shortName": "Property, Plant and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Marketable Securities and Investments",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestments",
     "shortName": "Marketable Securities and Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Goodwill and Intangible Assets, Net",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.perkinelmer.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pki:AccruedLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pki:AccruedLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Employee Benefit Plans",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.perkinelmer.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Stock Plans",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.perkinelmer.com/role/StockPlans",
     "shortName": "Stock Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.perkinelmer.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000003 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "3",
     "role": "http://www.perkinelmer.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "lang": "en-US",
      "name": "dei:DocumentsIncorporatedByReferenceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Derivatives And Hedging Activities",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.perkinelmer.com/role/DerivativesAndHedgingActivities",
     "shortName": "Derivatives And Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://www.perkinelmer.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pki:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Leases (Notes)",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://www.perkinelmer.com/role/LeasesNotes",
     "shortName": "Leases (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pki:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Industry Segment and Geographic Area Information",
     "menuCat": "Notes",
     "order": "33",
     "role": "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformation",
     "shortName": "Industry Segment and Geographic Area Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Quarterly Financial Information (Unaudited)",
     "menuCat": "Notes",
     "order": "34",
     "role": "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnaudited",
     "shortName": "Quarterly Financial Information (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Nature of Operations and Accounting Policies Nature of Operations and Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "35",
     "role": "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies",
     "shortName": "Nature of Operations and Accounting Policies Nature of Operations and Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Business Combinations and Asset Purchases (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesTables",
     "shortName": "Business Combinations and Asset Purchases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Revenue from Contract with Customer (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerTables",
     "shortName": "Revenue from Contract with Customer (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Discontinued Operations (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.perkinelmer.com/role/DiscontinuedOperationsTables",
     "shortName": "Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.perkinelmer.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.perkinelmer.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Accounts Receivable, Net Accounts Receivable, Net (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.perkinelmer.com/role/AccountsReceivableNetAccountsReceivableNetTables",
     "shortName": "Accounts Receivable, Net Accounts Receivable, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Inventories, Net (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.perkinelmer.com/role/InventoriesNetTables",
     "shortName": "Inventories, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Property, Plant and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetTables",
     "shortName": "Property, Plant and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pki:ScheduleOfInvestmentsNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Marketable Securities and Investments (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsTables",
     "shortName": "Marketable Securities and Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pki:ScheduleOfInvestmentsNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://www.perkinelmer.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i7beced6d3897470aa567a942030a49d3_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Employee Benefit Plans (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables",
     "shortName": "Employee Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i7beced6d3897470aa567a942030a49d3_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Stock Plans (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://www.perkinelmer.com/role/StockPlansTables",
     "shortName": "Stock Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "50",
     "role": "http://www.perkinelmer.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "51",
     "role": "http://www.perkinelmer.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "52",
     "role": "http://www.perkinelmer.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Industry Segment and Geographic Area Information (Tables)",
     "menuCat": "Tables",
     "order": "53",
     "role": "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationTables",
     "shortName": "Industry Segment and Geographic Area Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited) (Tables)",
     "menuCat": "Tables",
     "order": "54",
     "role": "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnauditedTables",
     "shortName": "Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "icd13c8dc9cf347a9887615192f2604b2_D20221003-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Business Combinations and Asset Purchases (Narrative) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
     "shortName": "Business Combinations and Asset Purchases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i07efc1c1073a42c19559b282ae071cf5_D20191230-20210103",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ife6bd29edce6404caa516d8728764b5a_I20220102",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Business Combinations and Asset Purchases (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
     "shortName": "Business Combinations and Asset Purchases (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i29cc361d906446eca50671562a44ba4c_D20210104-20220102",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Nature of Operations and Accounting Policies Nature of Operations and Accounting Policies (Narrative) (Details) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
     "shortName": "Nature of Operations and Accounting Policies Nature of Operations and Accounting Policies (Narrative) (Details) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FiscalPeriod",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "0",
      "lang": "en-US",
      "name": "pki:FiscalYearWeekFormat",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Revenue from Contract with Customer (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
     "shortName": "Revenue from Contract with Customer (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ic6ed40650bdb4ea8bad0abcd7e0139ee_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Discontinued Operations Narrative (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
     "shortName": "Discontinued Operations Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Summary Operating Results of Discontinued Operations for the Periods Prior to Disposition (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails",
     "shortName": "Summary Operating Results of Discontinued Operations for the Periods Prior to Disposition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i166a31764f73415eb8eee6da37c895b8_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Restructuring and Contract Termination Charges, Net (Narrative) (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
     "shortName": "Restructuring and Contract Termination Charges, Net (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Restructuring and Contract Termination Charges, Net Restructuring and Contract Termination Charges, Net (Schedule of Initial Charges) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
     "shortName": "Restructuring and Contract Termination Charges, Net Restructuring and Contract Termination Charges, Net (Schedule of Initial Charges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Restructuring and Contract Termination Charges, Net (Schedule of Restructuring Plan Activity) (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails",
     "shortName": "Restructuring and Contract Termination Charges, Net (Schedule of Restructuring Plan Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxHolidayAggregateDollarAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.perkinelmer.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxHolidayAggregateDollarAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Income Taxes Income Before Income taxes (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
     "shortName": "Income Taxes Income Before Income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Income Taxes Components of the Provision (Benefits from) Income Tax (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
     "shortName": "Income Taxes Components of the Provision (Benefits from) Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Income Taxes Reconciliation of Income Tax Expense (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes Reconciliation of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Income Taxes Components of Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes Components of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Income Taxes Summary of Loss and Tax Credit Carryforwards (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails",
     "shortName": "Income Taxes Summary of Loss and Tax Credit Carryforwards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Balance Sheet Parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical",
     "shortName": "Consolidated Balance Sheet Parenthetical",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Earnings Per Share (Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails",
     "shortName": "Earnings Per Share (Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Accounts Receivable, Net (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
     "shortName": "Accounts Receivable, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Inventories, Net (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.perkinelmer.com/role/InventoriesNetDetails",
     "shortName": "Inventories, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Property, Plant and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails",
     "shortName": "Property, Plant and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Investments, Debt and Equity Securities (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
     "shortName": "Investments, Debt and Equity Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Marketable Securities and Investments (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails",
     "shortName": "Marketable Securities and Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pki:MarketableSecuritiesandInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Goodwill and Intangible Assets, Net (Narrative) (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Goodwill and Intangible Assets, Net (Changes in the Carrying Amount of Goodwill) (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Changes in the Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pki:ScheduleOfIdentifiableIntangibleAssetBalancesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Goodwill and Intangible Assets, Net (Identifiable Intangible Asset Balances) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Identifiable Intangible Asset Balances) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pki:ScheduleOfIdentifiableIntangibleAssetBalancesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ia404b1620a92453890cd6af62803f1ff_I20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pki:Unamortizeddiscountanddebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Debt (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.perkinelmer.com/role/DebtDetails",
     "shortName": "Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pki:Unamortizeddiscountanddebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i87330a490bbe4521880df5f388b1a097_I20191229",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i87330a490bbe4521880df5f388b1a097_I20191229",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i7beced6d3897470aa567a942030a49d3_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Employee Benefit Plans (Schedule of Net Benefit Costs, Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Net Benefit Costs, Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Employee Benefit Plans (Schedule of Net Funded Status, Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Net Funded Status, Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ib761bacf19ef40c99f0e53b3d2f5a721_I20230101",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Employee Benefit Plans (Schedule of Allocation of Plan Assets, Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Allocation of Plan Assets, Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ib761bacf19ef40c99f0e53b3d2f5a721_I20230101",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3c42b3b2d16547138f95f4db2946b21f_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Employee Benefit Plans (Schedule of Changes in Fair Value of Plan Assets, Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Changes in Fair Value of Plan Assets, Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i9750f7376c5343f180c4d79dc5114a1c_I20220102",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Employee Benefit Plans (Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets, Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets, Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i4504233095fe4b97b36a0546a3230076_D20210104-20220102",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationDecreaseForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ib761bacf19ef40c99f0e53b3d2f5a721_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Employee Benefit Plans (Schedule of Expected Benefit Payments, Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Expected Benefit Payments, Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i7beced6d3897470aa567a942030a49d3_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Employee Benefit Plans (Schedule of Net Benefit Costs, Other Postretirement Benefits) (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
     "shortName": "Employee Benefit Plans (Schedule of Net Benefit Costs, Other Postretirement Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i4754a7a93890471f8a030034850b889a_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Employee Benefit Plans (Schedule of Net Funded Status, Other Postretirement Benefit Plans) (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Net Funded Status, Other Postretirement Benefit Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3c42b3b2d16547138f95f4db2946b21f_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Employee Benefit Plans (Schedule of Changes in Fair Value of Plan Assets, Other Postretirement Benefit Plans) (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
     "shortName": "Employee Benefit Plans (Schedule of Changes in Fair Value of Plan Assets, Other Postretirement Benefit Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iee465793b5f24c798540e37f3db22ab4_I20210103",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ib761bacf19ef40c99f0e53b3d2f5a721_I20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Employee Benefit Plans (Schedule of Expected Benefit Payments, Other Postretirement Benefits) (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
     "shortName": "Employee Benefit Plans (Schedule of Expected Benefit Payments, Other Postretirement Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "pki:DefinedBenefitPlan401KSavingsPlanEmployerContributionMatchOfEmployeesEligibleCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Employee Benefit Plans (Savings Plan) (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails",
     "shortName": "Employee Benefit Plans (Savings Plan) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "pki:DefinedBenefitPlan401KSavingsPlanEmployerContributionMatchOfEmployeesEligibleCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i16082460624d4b5eb5f51ed0b8e22fb3_I20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - Employee Benefit Plans (Supplemental Executive Retirement Plan) (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails",
     "shortName": "Employee Benefit Plans (Supplemental Executive Retirement Plan) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i16082460624d4b5eb5f51ed0b8e22fb3_I20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - Contingencies (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.perkinelmer.com/role/ContingenciesDetails",
     "shortName": "Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "iadb6bf93e29f451badc901dd1f28b546_I20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - Stock Plans (Narrative) (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
     "shortName": "Stock Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - Stock Plans (Summary of Total Compensation Recognized Related to Outstanding Stock Options) (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails",
     "shortName": "Stock Plans (Summary of Total Compensation Recognized Related to Outstanding Stock Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i2ed995d7852d4a1980ebfc0ac191e521_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - Stock Plans (Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model) (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.perkinelmer.com/role/StockPlansWeightedAverageAssumptionsUsedintheBlackScholesOptionPricingModelDetails",
     "shortName": "Stock Plans (Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ife6bd29edce6404caa516d8728764b5a_I20220102",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - Stock Plans (Summary of Stock Option Activity) (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails",
     "shortName": "Stock Plans (Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ife6bd29edce6404caa516d8728764b5a_I20220102",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i7536d6208cb0420fbe16371d229ef0d9_I20220102",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - Stock Plans (Summary of Restricted Stock Award Activity) (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails",
     "shortName": "Stock Plans (Summary of Restricted Stock Award Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "ib7d5561c169942bf9b152d62630c5e2a_D20220103-20230101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "pki:RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000115 - Disclosure - Stockholders' Equity (Narrative) (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i3ac9b9f13f9246cf906d4b5bace88ee6_D20220103-20230101",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "pki:RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i39378520630945e2861e1951d1ca9ed0_I20191229",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - pki-20230101.htm",
     "menuCat": "Cover",
     "order": "115",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - pki-20230101.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pki-20230101.htm",
      "contextRef": "i39378520630945e2861e1951d1ca9ed0_I20191229",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 148,
   "tag": {
    "country_BR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BRAZIL",
        "terseLabel": "BRAZIL"
       }
      }
     },
     "localname": "BR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "GERMANY"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINLAND",
        "terseLabel": "FINLAND"
       }
      }
     },
     "localname": "FI",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "FRANCE"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "UNITED KINGDOM"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INDIA",
        "terseLabel": "INDIA"
       }
      }
     },
     "localname": "IN",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ITALY",
        "terseLabel": "ITALY"
       }
      }
     },
     "localname": "IT",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "JAPAN"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_KR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KOREA, REPUBLIC OF",
        "terseLabel": "KOREA, REPUBLIC OF"
       }
      }
     },
     "localname": "KR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_NL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NETHERLANDS",
        "terseLabel": "NETHERLANDS"
       }
      }
     },
     "localname": "NL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "POLAND",
        "terseLabel": "POLAND"
       }
      }
     },
     "localname": "PL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_SE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWEDEN",
        "terseLabel": "SWEDEN"
       }
      }
     },
     "localname": "SE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_SG": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SINGAPORE",
        "terseLabel": "SINGAPORE"
       }
      }
     },
     "localname": "SG",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "United Kingdom, Pounds"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_INR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "India, Rupees",
        "terseLabel": "India, Rupees"
       }
      }
     },
     "localname": "INR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r1146",
      "r1148",
      "r1149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r1146",
      "r1148",
      "r1149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r1146",
      "r1148",
      "r1149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r1146",
      "r1148",
      "r1149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date",
        "terseLabel": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r1147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r1150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r1145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "terseLabel": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r1142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r1151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]",
        "terseLabel": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]",
        "terseLabel": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees",
        "terseLabel": "Entity Number of Employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r1142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r1142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r1146",
      "r1148",
      "r1149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_CBSX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CBOE STOCK EXCHANGE [Member]",
        "terseLabel": "CBOE STOCK EXCHANGE [Member]"
       }
      }
     },
     "localname": "CBSX",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_GSXC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GSX CHINA [Member]",
        "terseLabel": "GSX CHINA [Member]"
       }
      }
     },
     "localname": "GSXC",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_XSES": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SINGAPORE EXCHANGE [Member]",
        "terseLabel": "SINGAPORE EXCHANGE [Member]"
       }
      }
     },
     "localname": "XSES",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A0.60Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.60% Notes due 2021 [Member]",
        "label": "0.60% Notes due 2021 [Member]",
        "terseLabel": "0.60% Notes due 2021 [Member]"
       }
      }
     },
     "localname": "A0.60Notesdue2021Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A0.6PercentSeniorUnsecuredNotesdueinApril2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.6 Percent Senior Unsecured Notes due in April 2021 [Member]",
        "label": "0.6 Percent Senior Unsecured Notes due in April 2021 [Member]",
        "terseLabel": "0.6 Percent Senior Unsecured Notes due in April 2021 [Member]"
       }
      }
     },
     "localname": "A0.6PercentSeniorUnsecuredNotesdueinApril2021Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A0550SeniorUnsecuredNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.550% Senior Unsecured Notes due 2023",
        "label": "0.550% Senior Unsecured Notes due 2023 [Member]",
        "terseLabel": "0.550% Senior Unsecured Notes due 2023"
       }
      }
     },
     "localname": "A0550SeniorUnsecuredNotesDue2023Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A0850SeniorUnsecuredNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.850% Senior Unsecured Notes due 2024",
        "label": "0.850% Senior Unsecured Notes due 2024 [Member]",
        "terseLabel": "0.850% Senior Unsecured Notes due 2024"
       }
      }
     },
     "localname": "A0850SeniorUnsecuredNotesDue2024Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A1.875Notesdue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.875% Notes due 2026 [Member]",
        "label": "1.875% Notes due 2026 [Member]",
        "terseLabel": "1.875% Notes due 2026 [Member]"
       }
      }
     },
     "localname": "A1.875Notesdue2026Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A1.875PercentTenYearSeniorUnsecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.875 Percent Ten Year Senior Unsecured Notes",
        "label": "1.875 Percent Ten Year Senior Unsecured Notes [Member]",
        "terseLabel": "1.875 Percent Ten Year Senior Unsecured Notes [Member]"
       }
      }
     },
     "localname": "A1.875PercentTenYearSeniorUnsecuredNotesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A1900SeniorUnsecuredNotesDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.900% Senior Unsecured Notes due 2028",
        "label": "1.900% Senior Unsecured Notes due 2028 [Member]",
        "terseLabel": "1.900% Senior Unsecured Notes due 2028"
       }
      }
     },
     "localname": "A1900SeniorUnsecuredNotesDue2028Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2015AcquisitionsexcludingVanadisDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Acquisitions (excluding Vanadis) [Domain]",
        "label": "2015 Acquisitions (excluding Vanadis) [Domain]",
        "terseLabel": "2015 Acquisitions (excluding Vanadis) [Domain]"
       }
      }
     },
     "localname": "A2015AcquisitionsexcludingVanadisDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2015ContractTerminationChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Contract Termination Charges [Member]",
        "label": "2015 Contract Termination Charges [Member]",
        "terseLabel": "2015 Contract Termination Charges [Member]"
       }
      }
     },
     "localname": "A2015ContractTerminationChargesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2016AcquisitionsexcludingBiooMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Acquisitions (excluding Bioo) [Member]",
        "label": "2016 Acquisitions (excluding Bioo) [Member]",
        "terseLabel": "2016 Acquisitions (excluding Bioo) [Member]"
       }
      }
     },
     "localname": "A2016AcquisitionsexcludingBiooMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2016ContractTerminationChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Contract Termination Charges [Member]",
        "label": "2016 Contract Termination Charges [Member]",
        "terseLabel": "2016 Contract Termination Charges [Member]"
       }
      }
     },
     "localname": "A2016ContractTerminationChargesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2017ContractTerminationChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Contract Termination Charges [Member]",
        "label": "2017 Contract Termination Charges [Member]",
        "terseLabel": "2017 Contract Termination Charges [Member]"
       }
      }
     },
     "localname": "A2017ContractTerminationChargesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2017TaxCutsandJobsActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Tax Cuts and Jobs Act [Member]",
        "label": "2017 Tax Cuts and Jobs Act [Member]",
        "terseLabel": "2017 Tax Cuts and Jobs Act [Member]"
       }
      }
     },
     "localname": "A2017TaxCutsandJobsActMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2017TaxCutsandJobsActRefinementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Tax Cuts and Jobs Act, Refinement [Member]",
        "label": "2017 Tax Cuts and Jobs Act, Refinement [Member]",
        "terseLabel": "2017 Tax Cuts and Jobs Act, Refinement [Member]"
       }
      }
     },
     "localname": "A2017TaxCutsandJobsActRefinementMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2017TaxCutsandJobsActRemeasurementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Tax Cuts and Jobs Act, Remeasurement [Member]",
        "label": "2017 Tax Cuts and Jobs Act, Remeasurement [Member]",
        "terseLabel": "2017 Tax Cuts and Jobs Act, Remeasurement [Member]"
       }
      }
     },
     "localname": "A2017TaxCutsandJobsActRemeasurementMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2018ContractTerminationChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Contract Termination Charges [Member]",
        "label": "2018 Contract Termination Charges [Member]",
        "terseLabel": "2018 Contract Termination Charges [Member]"
       }
      }
     },
     "localname": "A2018ContractTerminationChargesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2019ContractTerminationChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Contract Termination Charges [Member]",
        "label": "2019 Contract Termination Charges [Member]",
        "terseLabel": "2019 Contract Termination Charges [Member]"
       }
      }
     },
     "localname": "A2019ContractTerminationChargesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2019IncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Incentive Plan [Member]",
        "label": "2019 Incentive Plan [Member]",
        "terseLabel": "2019 Incentive Plan [Member]"
       }
      }
     },
     "localname": "A2019IncentivePlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2020ContractTerminationChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Contract Termination Charges",
        "label": "2020 Contract Termination Charges [Member]",
        "terseLabel": "2020 Contract Termination Charges [Member]"
       }
      }
     },
     "localname": "A2020ContractTerminationChargesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A2250SeniorUnsecuredNotesDueIn2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.250% Senior Unsecured Notes due in 2031",
        "label": "2.250% Senior Unsecured Notes due in 2031 [Member]",
        "terseLabel": "2.250% Senior Unsecured Notes due in 2031"
       }
      }
     },
     "localname": "A2250SeniorUnsecuredNotesDueIn2031Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A255PercentSeniorUnsecuredNotesDueIn2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.55 Percent Senior Unsecured Notes due in 2031",
        "label": "2.55 Percent Senior Unsecured Notes due in 2031 [Member]",
        "terseLabel": "2.55 Percent Senior Unsecured Notes due in 2031"
       }
      }
     },
     "localname": "A255PercentSeniorUnsecuredNotesDueIn2031Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A3.3PercentTenYearSeniorUnsecuredNotesdueinSept2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]",
        "label": "3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]",
        "terseLabel": "3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]"
       }
      }
     },
     "localname": "A3.3PercentTenYearSeniorUnsecuredNotesdueinSept2029Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_A3625PercentSeniorUnsecuredNotesDueIn2051Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.625 Percent Senior Unsecured Notes due in 2051",
        "label": "3.625 Percent Senior Unsecured Notes due in 2051 [Member]",
        "terseLabel": "3.625 Percent Senior Unsecured Notes due in 2051"
       }
      }
     },
     "localname": "A3625PercentSeniorUnsecuredNotesDueIn2051Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Accelerationofexecutivecompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acceleration of executive compensation",
        "label": "Acceleration of executive compensation",
        "terseLabel": "Acceleration of executive compensation"
       }
      }
     },
     "localname": "Accelerationofexecutivecompensation",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails",
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AccruedExpensesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in accrued expenses and all other operating activities that are not separately stated on the cash flow statement",
        "label": "Accrued expenses and other",
        "terseLabel": "Accrued expenses and other"
       }
      }
     },
     "localname": "AccruedExpensesAndOther",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AccruedLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Liabilities Disclosure, Current [Text Block]",
        "label": "Accrued Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_AccruedexpensesandothercurrentliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and other current liabilities [Member]",
        "label": "Accrued expenses and other current liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities [Member]"
       }
      }
     },
     "localname": "AccruedexpensesandothercurrentliabilitiesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_AcquiredFiniteLivedIntangibleAssetAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Finite-lived Intangible Asset [Axis]",
        "label": "Acquired Finite-lived Intangible Asset [Axis]",
        "terseLabel": "Acquired Finite-lived Intangible Asset [Axis]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_AcquiredFiniteLivedIntangibleAssetDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Acquired Finite-lived Intangible Asset [Axis]",
        "label": "Acquired Finite-lived Intangible Asset [Domain]",
        "terseLabel": "Acquired Finite-lived Intangible Asset [Domain]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_AcquisitionRelatedStockCompensationExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related stock compensation expense",
        "label": "Acquisition-related stock compensation expense",
        "terseLabel": "Acquisition-related stock compensation expense"
       }
      }
     },
     "localname": "AcquisitionRelatedStockCompensationExpense",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ActiveEmployeesEligibleToRetireMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Active Employees Eligible to Retire [Member]",
        "label": "Active Employees Eligible to Retire [Member]",
        "terseLabel": "Active Employees Eligible to Retire [Member]"
       }
      }
     },
     "localname": "ActiveEmployeesEligibleToRetireMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ActuarialPresentValueOfBenefitObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial present value of benefit obligations: [Abstract]",
        "label": "Actuarial present value of benefit obligations: [Abstract]",
        "terseLabel": "Actuarial present value of benefit obligations: [Abstract]"
       }
      }
     },
     "localname": "ActuarialPresentValueOfBenefitObligationsAbstract",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_AdditionalFinancingLeaseObligationsfundedbylessors": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Financing Lease Obligations, funded by lessors",
        "label": "Additional Financing Lease Obligations, funded by lessors",
        "terseLabel": "Additional Financing Lease Obligations"
       }
      }
     },
     "localname": "AdditionalFinancingLeaseObligationsfundedbylessors",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AggregateCostOfRepurchasedCommonSharesForStatutoryTaxWithholdingObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cost of shares repurchased to satisfy minimum statutory tax withholding obligations in connection with the vesting of stock compensation awards.",
        "label": "Aggregate Cost of Repurchased Common Shares for Statutory Tax Withholding Obligations",
        "terseLabel": "Aggregate cost of repurchased common stock to satisfy statutory tax withholding obligation requirements"
       }
      }
     },
     "localname": "AggregateCostOfRepurchasedCommonSharesForStatutoryTaxWithholdingObligations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AggregateCostOfRepurchasedCommonSharesUnderRepurchaseProgram": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Cost of Repurchased Common Shares Under Repurchase Program",
        "label": "Aggregate Cost of Repurchased Common Shares Under Repurchase Program",
        "terseLabel": "Aggregate Cost of Repurchased Common Shares Under Repurchase Program"
       }
      }
     },
     "localname": "AggregateCostOfRepurchasedCommonSharesUnderRepurchaseProgram",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AggregateCostofRepurchasedCommonSharesforActivityPursuanttoEquityIncentivePlans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Cost of Repurchased Common Shares for Activity Pursuant to Equity Incentive Plans",
        "label": "Aggregate Cost of Repurchased Common Shares for Activity Pursuant to Equity Incentive Plans",
        "terseLabel": "Aggregate Cost of Repurchased Common Shares for Activity Pursuant to Equity Incentive Plans"
       }
      }
     },
     "localname": "AggregateCostofRepurchasedCommonSharesforActivityPursuanttoEquityIncentivePlans",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AggregateRevenuefromImmaterialAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Revenue from Immaterial Acquisitions",
        "label": "Aggregate Revenue from Immaterial Acquisitions",
        "terseLabel": "Aggregate Revenue from Immaterial Acquisitions"
       }
      }
     },
     "localname": "AggregateRevenuefromImmaterialAcquisitions",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AllSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Segments",
        "label": "All Segments [Member]",
        "terseLabel": "All Segments [Member]"
       }
      }
     },
     "localname": "AllSegmentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_AmortizationDiscontinuedOperations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization, Discontinued Operations",
        "label": "Amortization, Discontinued Operations",
        "terseLabel": "Amortization, Discontinued Operations"
       }
      }
     },
     "localname": "AmortizationDiscontinuedOperations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AmortizationOfAcquiredInventoryRevaluation": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amortization of the step-up in fair value of inventory of acquired inventory",
        "label": "Amortization of acquired inventory revaluation",
        "terseLabel": "Amortization of acquired inventory revaluation"
       }
      }
     },
     "localname": "AmortizationOfAcquiredInventoryRevaluation",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_AnalyticalFoodAndEnterpriseServicesBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Analytical, Food and Enterprise Services businesses",
        "label": "Analytical, Food and Enterprise Services businesses [Member]",
        "terseLabel": "Analytical, Food and Enterprise Services businesses"
       }
      }
     },
     "localname": "AnalyticalFoodAndEnterpriseServicesBusinessesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_AppliedMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applied Markets [Member]",
        "label": "Applied Markets [Member]",
        "terseLabel": "Applied Markets [Member]"
       }
      }
     },
     "localname": "AppliedMarketsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_AssertionsRegardingReinvestmentOfForeignEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assertions Regarding Reinvestment of Foreign Earnings",
        "label": "Assertions Regarding Reinvestment of Foreign Earnings [Member]",
        "terseLabel": "Assertions Regarding Reinvestment of Foreign Earnings"
       }
      }
     },
     "localname": "AssertionsRegardingReinvestmentOfForeignEarningsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]",
        "terseLabel": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "xbrltype": "stringItemType"
    },
    "pki_AvailableForSaleSecuritiesOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available-for-sale Securities, Other [Member]",
        "label": "Available-for-sale Securities, Other [Member]",
        "terseLabel": "Available-for-sale Securities, Other [Member]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesOtherMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_AwardTypeOtherAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award Type Other [Axis]",
        "label": "Award Type Other [Axis]",
        "terseLabel": "Award Type Other [Axis]"
       }
      }
     },
     "localname": "AwardTypeOtherAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_AwardTypeOtherDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Award Type Other [Axis]",
        "label": "Award Type Other [Domain]",
        "terseLabel": "Award Type Other [Domain]"
       }
      }
     },
     "localname": "AwardTypeOtherDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance Sheet Parenthetical [Abstract]",
        "label": "Balance Sheet Parenthetical [Abstract]",
        "terseLabel": "Balance Sheet Parenthetical [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetParentheticalAbstract",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "xbrltype": "stringItemType"
    },
    "pki_BaseRateOptionThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Base Rate Option Three [Member]",
        "label": "Base Rate Option Three [Member]",
        "terseLabel": "Base Rate Option Three [Member]"
       }
      }
     },
     "localname": "BaseRateOptionThreeMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BaseRateOptionTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Base Rate Option Two [Member]",
        "label": "Base Rate Option Two [Member]",
        "terseLabel": "Base Rate Option Two [Member]"
       }
      }
     },
     "localname": "BaseRateOptionTwoMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BenefitObligationCategoriesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Benefit Obligation Categories [Domain]",
        "label": "Benefit Obligation Categories [Domain]",
        "terseLabel": "Benefit Obligation Categories [Domain]"
       }
      }
     },
     "localname": "BenefitObligationCategoriesDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BioLegendMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BioLegend",
        "label": "BioLegend [Member]",
        "terseLabel": "BioLegend [Member]"
       }
      }
     },
     "localname": "BioLegendMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BiooScientificCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bioo Scientific Corporation [Member]",
        "label": "Bioo Scientific Corporation [Member]",
        "terseLabel": "Bioo Scientific Corporation [Member]"
       }
      }
     },
     "localname": "BiooScientificCorporationMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BiosenseSirionAndQognitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biosense, Sirion and Qognit",
        "label": "Biosense, Sirion and Qognit [Member]",
        "terseLabel": "Biosense, Sirion and Qognit [Member]"
       }
      }
     },
     "localname": "BiosenseSirionAndQognitMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BusinessAcquisitionCostOfAcquiredEntityCashPaidIncludingWorkingCapitalAndOtherAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments",
        "label": "Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments",
        "terseLabel": "Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityCashPaidIncludingWorkingCapitalAndOtherAdjustments",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessAcquisitionCostOfAcquiredEntityConsiderationPaidInCash": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cost of Acquired Entity, Consideration Paid in Cash",
        "label": "Business Acquisition, Cost of Acquired Entity, Consideration Paid in Cash",
        "terseLabel": "Business Acquisition, Cost of Acquired Entity, Consideration Paid in Cash"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityConsiderationPaidInCash",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessAcquisitionCostOfAcquiredEntityConsiderationPaidInCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cost of Acquired Entity, Consideration Paid in Common Stock",
        "label": "Business Acquisition, Cost of Acquired Entity, Consideration Paid in Common Stock",
        "terseLabel": "Business Acquisition, Cost of Acquired Entity, Consideration Paid in Common Stock"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityConsiderationPaidInCommonStock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value",
        "label": "Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value",
        "negatedTerseLabel": "Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value",
        "terseLabel": "Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessAcquisitionCostOfAcquiredEntityWorkingCapitalAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments",
        "label": "Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments",
        "terseLabel": "Working capital and other adjustments"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityWorkingCapitalAdjustments",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessAcquisitionPurchasePriceAllocationCurrentAndNonCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of acquisition cost of a business combination allocated to current and non-current deferred revenue of the acquired entity.",
        "label": "Business Acquisition, Purchase Price Allocation, Current and Non-current Liabilities, Deferred Revenue",
        "terseLabel": "Business Acquisition, Purchase Price Allocation, Current and Non-current Liabilities, Deferred Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationCurrentAndNonCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessAcquisitionandDivestitureTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition and Divestiture, Transaction Costs",
        "label": "Business Acquisition and Divestiture, Transaction Costs",
        "terseLabel": "Business Acquisition and Divestiture, Transaction Costs"
       }
      }
     },
     "localname": "BusinessAcquisitionandDivestitureTransactionCosts",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationAcquisitionRelatedCostsExcludedFromProformaIncomeLossFromContinuingOperations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Acquisition Related Costs, Excluded From Proforma Income (Loss) From Continuing Operations",
        "label": "Business Combination, Acquisition Related Costs, Excluded From Proforma Income (Loss) From Continuing Operations",
        "terseLabel": "Business Combination, Acquisition Related Costs, Excluded From Proforma Income (Loss) From Continuing Operations"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCostsExcludedFromProformaIncomeLossFromContinuingOperations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationBridgeFinancingAndDebtPreIssuanceHedgingCostsExcludedFromProformaIncomeLossFromContinuingOperations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Bridge Financing and Debt Pre-issuance Hedging Costs, Excluded From Proforma Income (Loss) From Continuing Operations",
        "label": "Business Combination, Bridge Financing and Debt Pre-issuance Hedging Costs, Excluded From Proforma Income (Loss) From Continuing Operations",
        "terseLabel": "Business Combination, Bridge Financing and Debt Pre-issuance Hedging Costs, Excluded From Proforma Income (Loss) From Continuing Operations"
       }
      }
     },
     "localname": "BusinessCombinationBridgeFinancingAndDebtPreIssuanceHedgingCostsExcludedFromProformaIncomeLossFromContinuingOperations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationContingentConsiderationArrangementsMaximumPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Maximum Period",
        "label": "Business Combination, Contingent Consideration Arrangements, Maximum Period",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Maximum Period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsMaximumPeriod",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pki_BusinessCombinationContingentConsiderationArrangementsWeightedAveragePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Weighted Average Period",
        "label": "Business Combination, Contingent Consideration Arrangements, Weighted Average Period",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Weighted Average Period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsWeightedAveragePeriod",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pki_BusinessCombinationIncreaseDecreaseinCurrentAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Increase (Decrease) in Current Assets",
        "label": "Business Combination, Increase (Decrease) in Current Assets",
        "terseLabel": "Business Combination, Increase (Decrease) in Current Assets"
       }
      }
     },
     "localname": "BusinessCombinationIncreaseDecreaseinCurrentAssets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationIncreaseDecreaseinDeferredTaxLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Increase (Decrease) in Deferred Tax Liabilities",
        "label": "Business Combination, Increase (Decrease) in Deferred Tax Liabilities",
        "terseLabel": "Business Combination, Increase (Decrease) in Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationIncreaseDecreaseinDeferredTaxLiabilities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationIncreaseDecreaseinIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Increase (Decrease) in Intangible Assets",
        "label": "Business Combination, Increase (Decrease) in Intangible Assets",
        "terseLabel": "Business Combination, Increase (Decrease) in Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationIncreaseDecreaseinIntangibleAssets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationIncreaseDecreaseinLiabilitiesAssumed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Increase (Decrease) in Liabilities Assumed",
        "label": "Business Combination, Increase (Decrease) in Liabilities Assumed",
        "terseLabel": "Business Combination, Increase (Decrease) in Liabilities Assumed"
       }
      }
     },
     "localname": "BusinessCombinationIncreaseDecreaseinLiabilitiesAssumed",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationIncreaseDecreaseinOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Increase (Decrease) in Other Assets",
        "label": "Business Combination, Increase (Decrease) in Other Assets",
        "terseLabel": "Business Combination, Increase (Decrease) in Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationIncreaseDecreaseinOtherAssets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationIncreaseDecreaseinPropertyandEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Increase (Decrease) in Property and Equipment",
        "label": "Business Combination, Increase (Decrease) in Property and Equipment",
        "terseLabel": "Business Combination, Increase (Decrease) in Property and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationIncreaseDecreaseinPropertyandEquipment",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationPaymentofStayBonus": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Payment of Stay Bonus",
        "label": "Business Combination, Payment of Stay Bonus",
        "terseLabel": "Business Combination, Payment of Stay Bonus"
       }
      }
     },
     "localname": "BusinessCombinationPaymentofStayBonus",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationProFormaInformationAmortizationOfAcquiredIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Pro Forma Information, Amortization of Acquired Intangible Assets",
        "label": "Business Combination, Pro Forma Information, Amortization of Acquired Intangible Assets",
        "terseLabel": "Business Combination, Pro Forma Information, Amortization of Acquired Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationAmortizationOfAcquiredIntangibleAssets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDeferredTaxLiabilitiesTotal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDeferredTaxLiabilitiesTotal",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationRemainingStayBonusToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Remaining Stay Bonus To Be Paid",
        "label": "Business Combination, Remaining Stay Bonus To Be Paid",
        "terseLabel": "Business Combination, Remaining Stay Bonus To Be Paid"
       }
      }
     },
     "localname": "BusinessCombinationRemainingStayBonusToBePaid",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_BusinessCombinationSourceofConsiderationTransferredAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Source of Consideration Transferred [Axis]",
        "label": "Business Combination, Source of Consideration Transferred [Axis]",
        "terseLabel": "Business Combination, Source of Consideration Transferred [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSourceofConsiderationTransferredAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_BusinessCombinationSourceofConsiderationTransferredDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Business Combination, Source of Consideration Transferred [Axis]",
        "label": "Business Combination, Source of Consideration Transferred [Domain]",
        "terseLabel": "Business Combination, Source of Consideration Transferred [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSourceofConsiderationTransferredDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_BusinessCombinationsIdentifiableIntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations, Identifiable Intangible Assets Acquired",
        "label": "Business Combinations, Identifiable Intangible Assets Acquired",
        "terseLabel": "Business Combinations, Identifiable Intangible Assets Acquired"
       }
      }
     },
     "localname": "BusinessCombinationsIdentifiableIntangibleAssetsAcquired",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Capitallossondispositionofabusiness": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital loss on disposition of a business",
        "label": "Capital loss on disposition of a business",
        "terseLabel": "Capital loss on disposition of a business"
       }
      }
     },
     "localname": "Capitallossondispositionofabusiness",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_CashAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash acquired from acquisition.",
        "label": "Cash Acquired",
        "negatedLabel": "Less: cash acquired",
        "terseLabel": "Cash Acquired"
       }
      }
     },
     "localname": "CashAcquired",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ChangeInAccumulatedBenefitObligationsDuringYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in accumulated benefit obligations during the year",
        "label": "Change in accumulated benefit obligations during the year",
        "terseLabel": "Change in accumulated benefit obligations during the year"
       }
      }
     },
     "localname": "ChangeInAccumulatedBenefitObligationsDuringYear",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ChangeInAnyOneOfInputAssumptionsForVariousReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage change in any of the input assumptions used in the income approach to estimate the fair value",
        "label": "Change in any one of the input assumptions for the various reporting units",
        "terseLabel": "Change in any one of the input assumptions for the various reporting units"
       }
      }
     },
     "localname": "ChangeInAnyOneOfInputAssumptionsForVariousReportingUnits",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_ChangeInFairValueOfFinancialSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of financial securities",
        "label": "Change in fair value of financial securities",
        "terseLabel": "Change in fair value of financial securities"
       }
      }
     },
     "localname": "ChangeInFairValueOfFinancialSecurities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ChangeinallocationoffunctionalCostsEffectonoperatingincomeloss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in allocation of functional Costs, Effect on operating income (loss)",
        "label": "Change in allocation of functional Costs, Effect on operating income (loss)",
        "terseLabel": "Change in allocation of functional Costs, Effect on operating income (loss)"
       }
      }
     },
     "localname": "ChangeinallocationoffunctionalCostsEffectonoperatingincomeloss",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_CisbioBioassaysSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cisbio Bioassays SAS [Member]",
        "label": "Cisbio Bioassays SAS [Member]",
        "terseLabel": "Cisbio Bioassays SAS [Member]"
       }
      }
     },
     "localname": "CisbioBioassaysSASMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_CommonCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Collective Trusts [Member]",
        "label": "Common Collective Trusts [Member]",
        "terseLabel": "Common Collective Trusts [Member]"
       }
      }
     },
     "localname": "CommonCollectiveTrustsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_CommonStockSharesOutstandingComponentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock, Shares, outstanding, components",
        "label": "Common stock, Shares, outstanding, components [Axis]",
        "terseLabel": "Common stock, Shares, outstanding, components [Axis]"
       }
      }
     },
     "localname": "CommonStockSharesOutstandingComponentsAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_CommonStockSharesOutstandingComponentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock, Shares, outstanding, components",
        "label": "Common stock, Shares, outstanding, components [Domain]",
        "terseLabel": "Common stock, Shares, outstanding, components [Domain]"
       }
      }
     },
     "localname": "CommonStockSharesOutstandingComponentsDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Commonstock1parvaluepershareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock, $1 par value per share [Member]",
        "label": "Common stock, $1 par value per share [Member]",
        "terseLabel": "Common stock, $1 par value per share [Member]"
       }
      }
     },
     "localname": "Commonstock1parvaluepershareMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ComponentsofnetdeferredtaxassetrecognizedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of net deferred tax asset recognized [Table Text Block]",
        "label": "Components of net deferred tax asset recognized [Table Text Block]",
        "terseLabel": "Components of net deferred tax asset recognized [Table Text Block]"
       }
      }
     },
     "localname": "ComponentsofnetdeferredtaxassetrecognizedTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_Conditionalprobabilityofsuccess": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conditional probability of success",
        "label": "Conditional probability of success",
        "terseLabel": "Conditional probability of success"
       }
      }
     },
     "localname": "Conditionalprobabilityofsuccess",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_ContractLiabilityAccruedCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Liability, Accrued, Current",
        "label": "Contract Liability, Accrued, Current",
        "terseLabel": "Contract Liability, Accrued, Current"
       }
      }
     },
     "localname": "ContractLiabilityAccruedCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ContractWithCustomerAssetIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Asset, Increase (Decrease)",
        "label": "Contract with Customer, Asset, Increase (Decrease)",
        "terseLabel": "Contract with Customer, Asset, Increase (Decrease)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetIncreaseDecrease",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ContractwithCustomerLiabilityIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Liability, Increase (Decrease)",
        "label": "Contract with Customer, Liability, Increase (Decrease)",
        "terseLabel": "Contract with Customer, Liability, Increase (Decrease)"
       }
      }
     },
     "localname": "ContractwithCustomerLiabilityIncreaseDecrease",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_CoreTechnologyAndCloneLibraryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Core technology and Clone Library",
        "label": "Core technology and Clone Library [Member]",
        "terseLabel": "Core technology and Clone Library [Member]"
       }
      }
     },
     "localname": "CoreTechnologyAndCloneLibraryMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_CoreTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Core Technology [Member]",
        "label": "Core Technology [Member]",
        "terseLabel": "Core Technology [Member]"
       }
      }
     },
     "localname": "CoreTechnologyMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_CostMethodInvestmentsPercentageofEquityPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Method Investments, Percentage of Equity Purchased",
        "label": "Cost Method Investments, Percentage of Equity Purchased",
        "terseLabel": "Cost Method Investments, Percentage of Equity Purchased"
       }
      }
     },
     "localname": "CostMethodInvestmentsPercentageofEquityPurchased",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of Repurchased Common Shares, Repurchase Plan and Amount for Statutory Tax Withholding Obligations",
        "label": "Cost of Repurchased Common Shares, Repurchase Plan and Amount for Statutory Tax Withholding Obligations",
        "terseLabel": "Cost of Repurchased Common Shares, Repurchase Plan and Amount for Statutory Tax Withholding Obligations"
       }
      }
     },
     "localname": "CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_CostsTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs Type [Axis]",
        "label": "Costs Type [Axis]",
        "terseLabel": "Costs Type [Axis]"
       }
      }
     },
     "localname": "CostsTypeAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_CostsTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Costs Type [Axis]",
        "label": "Costs Type [Domain]",
        "terseLabel": "Costs Type [Domain]"
       }
      }
     },
     "localname": "CostsTypeDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_CrosscurrencySwapAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross-currency Swap [Axis]",
        "label": "Cross-currency Swap [Axis]",
        "terseLabel": "Cross-currency Swap [Axis]"
       }
      }
     },
     "localname": "CrosscurrencySwapAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_CrosscurrencySwapDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Cross-currency Swap [Axis]",
        "label": "Cross-currency Swap [Domain]",
        "terseLabel": "Cross-currency Swap [Domain]"
       }
      }
     },
     "localname": "CrosscurrencySwapDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_CrosscurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross-currency Swap [Member]",
        "label": "Cross-currency Swap [Member]",
        "terseLabel": "Cross-currency Swap [Member]"
       }
      }
     },
     "localname": "CrosscurrencySwapMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_CumulativeEffectOfNewAccountingPronouncementInPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect of New Accounting Pronouncement in Period of Adoption",
        "label": "Cumulative Effect of New Accounting Pronouncement in Period of Adoption",
        "terseLabel": "Cumulative Effect of New Accounting Pronouncement in Period of Adoption"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPronouncementInPeriodOfAdoption",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_CumulativeEffectOfNewAccountingPronouncementPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect of New Accounting Pronouncement, Period of Adoption",
        "label": "Cumulative Effect of New Accounting Pronouncement, Period of Adoption",
        "terseLabel": "Cumulative Effect of New Accounting Pronouncement, Period of Adoption"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPronouncementPeriodOfAdoption",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Cumulativeprobabilityofsuccess": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative probability of success",
        "label": "Cumulative probability of success",
        "terseLabel": "Cumulative probability of success"
       }
      }
     },
     "localname": "Cumulativeprobabilityofsuccess",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_CurrentPortionOfLongTermDebtGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Portion of Long-Term Debt, Gross",
        "label": "Current Portion of Long-Term Debt, Gross",
        "terseLabel": "Current Portion of Long-Term Debt, Gross"
       }
      }
     },
     "localname": "CurrentPortionOfLongTermDebtGross",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_CustomerRelationshipsAndBacklogMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Relationships and Backlog",
        "label": "Customer Relationships and Backlog [Member]",
        "terseLabel": "Customer Relationships and Backlog [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsAndBacklogMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DNALabsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DNA Labs [Member]",
        "label": "DNA Labs [Member]",
        "terseLabel": "DNA Labs [Member]"
       }
      }
     },
     "localname": "DNALabsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DebtInstrumentIssuanceAsPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Issuance as Percentage of Principal Amount",
        "label": "Debt Instrument, Issuance as Percentage of Principal Amount",
        "terseLabel": "Senior unsecured notes issuance as percentage of principal amount"
       }
      }
     },
     "localname": "DebtInstrumentIssuanceAsPercentageOfPrincipalAmount",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_DebtInstrumentRedemptionPercentageUponChangeOfControlAndDowngradeOfDebtInstrument": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption Percentage Upon Change of Control and Downgrade of Debt Instrument",
        "label": "Debt Instrument, Redemption Percentage Upon Change of Control and Downgrade of Debt Instrument",
        "terseLabel": "Debt Instrument, Redemption Percentage Upon Change of Control and Downgrade of Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPercentageUponChangeOfControlAndDowngradeOfDebtInstrument",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_DebtRedemptionDeferredcostsandOriginalIssueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption, Deferred costs and Original Issue Discount",
        "label": "Debt Redemption, Deferred costs and Original Issue Discount",
        "terseLabel": "Debt Redemption, Deferred costs and Original Issue Discount"
       }
      }
     },
     "localname": "DebtRedemptionDeferredcostsandOriginalIssueDiscount",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DebtRedemptionMakewhole": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption, Make-whole",
        "label": "Debt Redemption, Make-whole",
        "terseLabel": "Debt Redemption, Make-whole"
       }
      }
     },
     "localname": "DebtRedemptionMakewhole",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DebtRedemptionPretaxNonoperatingCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption, Pre-tax Non-operating Charges",
        "label": "Debt Redemption, Pre-tax Non-operating Charges",
        "terseLabel": "Debt Redemption, Pre-tax Non-operating Charges"
       }
      }
     },
     "localname": "DebtRedemptionPretaxNonoperatingCharges",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DeferredIncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations",
        "terseLabel": "Deferred Income Tax Expense (Benefit), Continuing Operations, Discontinuing Operations"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DeferredTaxAssetsAndLiabilitiesInConnectionWithUnitedKingdomFinanceAct2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets and Liabilities in Connection with United Kingdom Finance Act 2021",
        "label": "Deferred Tax Assets and Liabilities in Connection with United Kingdom Finance Act 2021 [Member]",
        "terseLabel": "Deferred Tax Assets and Liabilities in Connection with United Kingdom Finance Act 2021 [Member]"
       }
      }
     },
     "localname": "DeferredTaxAssetsAndLiabilitiesInConnectionWithUnitedKingdomFinanceAct2021Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DeferredTaxAssetsNetOperatingLossAndCreditCarryforwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Net Operating Loss and Credit Carryforwards",
        "label": "Deferred Tax Assets, Net Operating Loss and Credit Carryforwards",
        "terseLabel": "Net operating loss and credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOperatingLossAndCreditCarryforwards",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Depreciation and Amortization",
        "label": "Deferred Tax Liabilities, Depreciation and Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DeferredTaxLiabilitiesPostretirementHealthBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Postretirement Health Benefits",
        "label": "Deferred Tax Liabilities, Postretirement Health Benefits",
        "negatedTerseLabel": "Postretirement health benefits"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPostretirementHealthBenefits",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DeferredTaxLiabilityOnForeignEarnings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liability on foreign earnings",
        "label": "Deferred tax liability on foreign earnings",
        "terseLabel": "Deferred tax liability on foreign earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilityOnForeignEarnings",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Deferredtaxassetsoperatingleaseliabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, operating lease liabilities",
        "label": "Deferred tax assets, operating lease liabilities",
        "terseLabel": "Deferred tax assets, operating lease liabilities"
       }
      }
     },
     "localname": "Deferredtaxassetsoperatingleaseliabilities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Deferredtaxassetsotherassetsnet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, other assets, net",
        "label": "Deferred tax assets, other assets, net",
        "terseLabel": "Deferred tax assets, other assets, net"
       }
      }
     },
     "localname": "Deferredtaxassetsotherassetsnet",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DeferredtaxliabilitiesLongtermliabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, Long-term liabilities",
        "label": "Deferred tax liabilities, Long-term liabilities",
        "negatedTerseLabel": "Deferred tax liabilities, Long-term liabilities"
       }
      }
     },
     "localname": "DeferredtaxliabilitiesLongtermliabilities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Deferredtaxliabilitiesoperatingleaserightofuseassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, operating lease right-of-use assets",
        "label": "Deferred tax liabilities, operating lease right-of-use assets",
        "negatedTerseLabel": "Deferred tax liabilities, operating lease right-of-use assets"
       }
      }
     },
     "localname": "Deferredtaxliabilitiesoperatingleaserightofuseassets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefit401KSavingsPlanExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit, 401(k) Savings Plan Expense",
        "label": "Defined Benefit, 401(k) Savings Plan Expense",
        "terseLabel": "Defined Benefit, 401(k) Savings Plan Expense"
       }
      }
     },
     "localname": "DefinedBenefit401KSavingsPlanExpense",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefitPlan401KSavingsPlanEmployerContributionMatchOfEmployeesEligibleCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, 401(k) Savings Plan, Employer Contribution Match of Employees Eligible Compensation",
        "label": "Defined Benefit Plan, 401(k) Savings Plan, Employer Contribution Match of Employees Eligible Compensation",
        "terseLabel": "Defined Benefit Plan, 401(k) Savings Plan, Employer Contribution Match of Employees Eligible Compensation"
       }
      }
     },
     "localname": "DefinedBenefitPlan401KSavingsPlanEmployerContributionMatchOfEmployeesEligibleCompensation",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_DefinedBenefitPlan401KSavingsPlanMaximumEmployeeMatchPercentForEmployerMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, 401(k) Savings Plan, Maximum Employee Match Percent for Employer Match",
        "label": "Defined Benefit Plan, 401(k) Savings Plan, Maximum Employee Match Percent for Employer Match",
        "terseLabel": "Defined Benefit Plan, 401(k) Savings Plan, Maximum Employee Match Percent for Employer Match"
       }
      }
     },
     "localname": "DefinedBenefitPlan401KSavingsPlanMaximumEmployeeMatchPercentForEmployerMatch",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_DefinedBenefitPlanAccumulatedBenefitObligationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Accumulated Benefit Obligation [Axis]",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation [Axis]",
        "terseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligationAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_DefinedBenefitPlanPlanAssetsLevel3ReconciliationForeignExchangeLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Foreign exchange losses",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Foreign exchange losses",
        "terseLabel": "Defined Benefit Plan, Foreign exchange losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationForeignExchangeLosses",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefitPlanPlanAssetsLevel3ReconciliationPensionBenefitsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Pension Benefits Paid",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Pension Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Pension Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationPensionBenefitsPaid",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefitPlanPurchasesSalesAndSettlementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Purchases, Sales, and Settlements [Axis]",
        "label": "Defined Benefit Plan, Purchases, Sales, and Settlements [Axis]",
        "terseLabel": "Defined Benefit Plan, Purchases, Sales, and Settlements [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlementsAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_DefinedBenefitPlanPurchasesSalesAndSettlementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Defined Benefit Plan, Purchases, Sales, and Settlements [Axis]",
        "label": "Defined Benefit Plan, Purchases, Sales, and Settlements [Domain]",
        "terseLabel": "Defined Benefit Plan, Purchases, Sales, and Settlements [Domain]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlementsDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DefinedBenefitPlanRealizedGains": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Realized Gains",
        "label": "Defined Benefit Plan, Realized Gains",
        "terseLabel": "Defined Benefit Plan, Realized Gains"
       }
      }
     },
     "localname": "DefinedBenefitPlanRealizedGains",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefitPlanRealizedLosses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Realized losses",
        "label": "Defined Benefit Plan, Realized losses",
        "terseLabel": "Defined Benefit Plan, Realized losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanRealizedLosses",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefitPlanRecognizedNetGainLossOnMarkToMarket": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Recognized Net Gain (Loss) on Mark-to-Market",
        "label": "Defined Benefit Plan, Recognized Net Gain (Loss) on Mark-to-Market",
        "terseLabel": "Defined Benefit Plan, Recognized Net Gain (Loss) on Mark-to-Market"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossOnMarkToMarket",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefitPlanUnrealizedGains": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Unrealized Gains",
        "label": "Defined Benefit Plan, Unrealized Gains",
        "terseLabel": "Defined Benefit Plan, Unrealized Gains"
       }
      }
     },
     "localname": "DefinedBenefitPlanUnrealizedGains",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DefinedBenefitTargetAssetAllocationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit, Target Asset Allocation Percentage",
        "label": "Defined Benefit, Target Asset Allocation Percentage",
        "terseLabel": "Defined Benefit, Target Asset Allocation Percentage"
       }
      }
     },
     "localname": "DefinedBenefitTargetAssetAllocationPercentage",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_DepreciationExpDiscontinuedOperations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation Exp, Discontinued Operations",
        "label": "Depreciation Exp, Discontinued Operations",
        "terseLabel": "Depreciation, Discontinued Operations"
       }
      }
     },
     "localname": "DepreciationExpDiscontinuedOperations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DerivativeNotionalCurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Notional Amount [Axis]",
        "label": "Derivative Notional Currency [Axis]",
        "terseLabel": "Derivative Notional Currency [Axis]"
       }
      }
     },
     "localname": "DerivativeNotionalCurrencyAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_DerivativesNotionalCurrencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivatives Notional Currency [Domain]",
        "label": "Derivatives Notional Currency [Domain]",
        "terseLabel": "Derivatives Notional Currency [Domain]"
       }
      }
     },
     "localname": "DerivativesNotionalCurrencyDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics [Member]",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics [Member]"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DiscountRatesForReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rates for reporting units",
        "label": "Discount rates for reporting units",
        "terseLabel": "Discount rates for reporting units"
       }
      }
     },
     "localname": "DiscountRatesForReportingUnits",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_DiscoveryAnalyticalSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discovery & Analytical Solutions [Member]",
        "label": "Discovery & Analytical Solutions [Member]",
        "terseLabel": "Discovery & Analytical Solutions [Member]"
       }
      }
     },
     "localname": "DiscoveryAnalyticalSolutionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DiscoveryAnalyticalSolutionsandDiagnostcsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discovery & Analytical Solutions and Diagnostcs [Member]",
        "label": "Discovery & Analytical Solutions and Diagnostcs [Member]",
        "terseLabel": "Discovery & Analytical Solutions and Diagnostcs [Member]"
       }
      }
     },
     "localname": "DiscoveryAnalyticalSolutionsandDiagnostcsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DiscreteIncomeTaxExpenseBenefitTaxReformTrueup": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discrete Income Tax Expense (Benefit), Tax Reform Trueup",
        "label": "Discrete Income Tax Expense (Benefit), Tax Reform Trueup",
        "terseLabel": "Discrete Income Tax Expense (Benefit), Tax Reform Trueup"
       }
      }
     },
     "localname": "DiscreteIncomeTaxExpenseBenefitTaxReformTrueup",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DiscreteTaxBenefitsRelatedATransactionCompletedInSecondQuarterOfFiscalYear2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discrete Tax Benefits Related a Transaction Completed in Second Quarter of Fiscal Year 2021",
        "label": "Discrete Tax Benefits Related a Transaction Completed in Second Quarter of Fiscal Year 2021 [Member]",
        "terseLabel": "Discrete Tax Benefits Related a Transaction Completed in Second Quarter of Fiscal Year 2021 [Member]"
       }
      }
     },
     "localname": "DiscreteTaxBenefitsRelatedATransactionCompletedInSecondQuarterOfFiscalYear2021Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DisposalGroupConsiderationContingentOnExitValuation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Consideration, Contingent on Exit Valuation",
        "label": "Disposal Group, Consideration, Contingent on Exit Valuation",
        "terseLabel": "Disposal Group, Consideration, Contingent on Exit Valuation"
       }
      }
     },
     "localname": "DisposalGroupConsiderationContingentOnExitValuation",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupConsiderationReceivableAtClosing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Consideration, Receivable at Closing",
        "label": "Disposal Group, Consideration, Receivable at Closing",
        "terseLabel": "Disposal Group, Consideration, Receivable at Closing"
       }
      }
     },
     "localname": "DisposalGroupConsiderationReceivableAtClosing",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupConsiderationReceivableAtClosingDeferredPaymentsTiedToTransferOfThePKIBrandAndRelatedTrademarks": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Consideration, Receivable at Closing, Deferred Payments Tied to Transfer of the PKI Brand and Related Trademarks",
        "label": "Disposal Group, Consideration, Receivable at Closing, Deferred Payments Tied to Transfer of the PKI Brand and Related Trademarks",
        "terseLabel": "Disposal Group, Consideration, Receivable at Closing, Deferred Payments Tied to Transfer of the PKI Brand and Related Trademarks"
       }
      }
     },
     "localname": "DisposalGroupConsiderationReceivableAtClosingDeferredPaymentsTiedToTransferOfThePKIBrandAndRelatedTrademarks",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationAccruedrestructuringandcontractterminationchargesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Accrued restructuring and contract termination charges, Current",
        "label": "Disposal Group, Including Discontinued Operation, Accrued restructuring and contract termination charges, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued restructuring and contract termination charges, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedrestructuringandcontractterminationchargesCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationDeferredTaxesAndLongTermLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred taxes and long-term liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Deferred taxes and long-term liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Deferred taxes and long-term liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxesAndLongTermLiabilitiesCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationNetAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Net Assets",
        "label": "Disposal Group, Including Discontinued Operation, Net Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Net Assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNetAssets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating lease liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating lease liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Operating lease liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating lease right-of-use assets, current",
        "label": "Disposal Group, Including Discontinued Operation, Operating lease right-of-use assets, current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Operating lease right-of-use assets, current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationOtherAssetsNetCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other assets, net, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other assets, net, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other assets, net, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssetsNetCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationOtherExpenseIncomeNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other expense (income), net",
        "label": "Disposal Group, Including Discontinued Operation, Other expense (income), net",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other expense (income), net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherExpenseIncomeNet",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationPrepaidincometaxesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Prepaid income taxes Current",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid income taxes, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Prepaid income taxes, Current [Abstract]"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidincometaxesCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Working Capital Adjustment",
        "label": "Disposal Group, Including Discontinued Operation, Working Capital Adjustment",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Working Capital Adjustment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationWorkingCapitalAdjustment",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationsResearchanddevelopmentexpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Research and development expenses",
        "label": "Disposal Group, Including Discontinued Operations, Research and development expenses",
        "terseLabel": "Disposal Group, Including Discontinued Operations, Research and development expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsResearchanddevelopmentexpenses",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationsRestructuringandcontractterminationchargesnet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Restructuring and contract termination charges, net",
        "label": "Disposal Group, Including Discontinued Operations, Restructuring and contract termination charges, net",
        "terseLabel": "Disposal Group, Including Discontinued Operations, Restructuring and contract termination charges, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsRestructuringandcontractterminationchargesnet",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DisposalGroupIncludingDiscontinuedOperationsSeveranceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Severance Costs",
        "label": "Disposal Group, Including Discontinued Operations, Severance Costs",
        "terseLabel": "Disposal Group, Including Discontinued Operations, Severance Costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsSeveranceCosts",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_DividendsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends",
        "label": "Dividends [Member]",
        "terseLabel": "Dividends [Member]"
       }
      }
     },
     "localname": "DividendsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_DurationOfForeignCurrencyDerivatives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Duration Of Foreign Currency Derivatives",
        "label": "Duration Of Foreign Currency Derivatives",
        "terseLabel": "Duration of foreign currency derivative contract, days"
       }
      }
     },
     "localname": "DurationOfForeignCurrencyDerivatives",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pki_EUROIMMUMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EUROIMMUM [Member]",
        "label": "EUROIMMUM [Member]",
        "terseLabel": "EUROIMMUM [Member]"
       }
      }
     },
     "localname": "EUROIMMUMMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EffectiveIncomeTaxRateReconciliationEffectofStockCompensationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Effect of Stock Compensation, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Effect of Stock Compensation, Amount",
        "terseLabel": "Effect of Stock Compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationEffectofStockCompensationAmount",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EffectiveIncomeTaxRateReconciliationForeignFiscalUnityAdjAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Fiscal Unity Adj., Amount",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Fiscal Unity Adj., Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Foreign Fiscal Unity Adj., Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignFiscalUnityAdjAmount",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EffectiveIncomeTaxRateReconciliationTaxElectionsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Elections, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Tax Elections, Amount",
        "terseLabel": "Tax Elections"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxElectionsAmount",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EffectiveTaxRateIncomeTaxOnRepatriationOfForeignEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate, Income Tax on Repatriation of Foreign Earnings",
        "label": "Effective Tax Rate, Income Tax on Repatriation of Foreign Earnings",
        "terseLabel": "Effective Tax Rate, Income Tax on Repatriation of Foreign Earnings"
       }
      }
     },
     "localname": "EffectiveTaxRateIncomeTaxOnRepatriationOfForeignEarnings",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EmployeeSeveranceandFacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Severance and Facility Closing [Member]",
        "label": "Employee Severance and Facility Closing [Member]",
        "terseLabel": "Employee Severance and Facility Closing [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceandFacilityClosingMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EnvironmentalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental Health [Member]",
        "label": "Environmental Health [Member]",
        "terseLabel": "Environmental Health [Member]"
       }
      }
     },
     "localname": "EnvironmentalHealthMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EnzoBiochemInc.ComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enzo Biochem, Inc. Complaint [Member]",
        "label": "Enzo Biochem, Inc. Complaint [Member]",
        "terseLabel": "Enzo Biochem, Inc. Complaint [Member]"
       }
      }
     },
     "localname": "EnzoBiochemInc.ComplaintMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquityInvestmentsCarriedAtCostMinusImpairmentIfAny": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments, carried at cost minus impairment, if any",
        "label": "Equity investments, carried at cost minus impairment, if any",
        "terseLabel": "Equity investments, carried at cost minus impairment, if any"
       }
      }
     },
     "localname": "EquityInvestmentsCarriedAtCostMinusImpairmentIfAny",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EquityIssuedForBusinessCombinationNetOfIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity issued for business combination, net of issuance costs",
        "label": "Equity issued for business combination, net of issuance costs",
        "terseLabel": "Equity issued for business combination, net of issuance costs"
       }
      }
     },
     "localname": "EquityIssuedForBusinessCombinationNetOfIssuanceCosts",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EquitySecuritiesCommodityFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, Commodity Funds [Member]",
        "label": "Equity Securities, Commodity Funds [Member]",
        "terseLabel": "Equity Securities, Commodity Funds [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesCommodityFundsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesDomesticRealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Domestic real estate funds [Member]",
        "label": "Equity Securities, Domestic Real Estate Funds [Member]",
        "terseLabel": "Equity Securities, Domestic Real Estate Funds [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesDomesticRealEstateFundsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesEmergingMarketsGrowthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, Emerging Markets Growth [Member]",
        "label": "Equity Securities, Emerging Markets Growth [Member]",
        "terseLabel": "Equity Securities, Emerging Markets Growth [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesEmergingMarketsGrowthMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesEquityIndexFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, Equity Index Funds [Member]",
        "label": "Equity Securities, Equity Index Funds [Member]",
        "terseLabel": "Equity Securities, Equity Index Funds [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesEquityIndexFundsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesForeignLiabilityDrivenInstrumentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, Foreign liability driven instrument",
        "label": "Equity Securities, Foreign liability driven instrument [Member]",
        "terseLabel": "Equity Securities, Foreign liability driven instrument [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesForeignLiabilityDrivenInstrumentMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesForeignRealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, Foreign Real Estate Funds [Member]",
        "label": "Equity Securities, Foreign Real Estate Funds [Member]",
        "terseLabel": "Equity Securities, Foreign Real Estate Funds [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesForeignRealEstateFundsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesInternationalLargeCapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, International Large-cap [Member]",
        "label": "Equity Securities, International Large-cap [Member]",
        "terseLabel": "Equity Securities, International large-cap value[Member]"
       }
      }
     },
     "localname": "EquitySecuritiesInternationalLargeCapMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesMarketValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities. Market Value",
        "label": "Equity Securities. Market Value",
        "terseLabel": "Equity Securities. Market Value"
       }
      }
     },
     "localname": "EquitySecuritiesMarketValue",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EquitySecuritiesUSLargeCapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, U.S. Large-cap [Member]",
        "label": "Equity Securities, U.S. Large-cap [Member]",
        "terseLabel": "Equity Securities, U.S. Large-cap [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesUSLargeCapMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EquitySecuritiesUSSmallCapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, U.S. Small-cap [Member]",
        "label": "Equity Securities, U.S. Small-cap [Member]",
        "terseLabel": "Equity Securities, U.S. Small-cap [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesUSSmallCapMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EstimatedTaxesOnRepatriation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Taxes on Repatriation",
        "label": "Estimated Taxes on Repatriation",
        "negatedTerseLabel": "Estimated Taxes on Repatriation"
       }
      }
     },
     "localname": "EstimatedTaxesOnRepatriation",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_EuriborRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euribor Rate [Member]",
        "label": "Euribor Rate [Member]",
        "terseLabel": "Euribor Rate [Member]"
       }
      }
     },
     "localname": "EuriborRateMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EuroCurrencyRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Currency Rate [Member]",
        "label": "Euro Currency Rate [Member]",
        "terseLabel": "Eurocurrency Rate [Member]"
       }
      }
     },
     "localname": "EuroCurrencyRateMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_EurocurrencyMarginBasisPoint": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eurocurrency Margin Basis Point",
        "label": "Eurocurrency Margin Basis Point",
        "terseLabel": "Eurocurrency Margin Basis Point"
       }
      }
     },
     "localname": "EurocurrencyMarginBasisPoint",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pki_EuropeanAndAsianCurrenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European And Asian Currencies [Member]",
        "label": "European And Asian Currencies [Member]",
        "terseLabel": "European And Asian Currencies [Member]"
       }
      }
     },
     "localname": "EuropeanAndAsianCurrenciesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ExcesstaxbenefitsonstockcompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess tax benefits on stock compensation [Member]",
        "label": "Excess tax benefits on stock compensation [Member]",
        "terseLabel": "Excess tax benefits on stock compensation [Member]"
       }
      }
     },
     "localname": "ExcesstaxbenefitsonstockcompensationMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ExerciseOfEmployeeStockOptionsAndRelatedIncomeTaxBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of employee stock options and related income tax benefits",
        "label": "Exercise of employee stock options and related income tax benefits [Member]",
        "terseLabel": "Exercise of employee stock options and related income tax benefits [Member]"
       }
      }
     },
     "localname": "ExerciseOfEmployeeStockOptionsAndRelatedIncomeTaxBenefitsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FacilityRelocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility Relocation [Member]",
        "label": "Facility Relocation [Member]",
        "terseLabel": "Facility Relocation [Member]"
       }
      }
     },
     "localname": "FacilityRelocationMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FairValueMeasurementWithUnobservableInputsReconciliationAdjustmentsRecognizedInGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Adjustments Recognized in Goodwill",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Adjustments Recognized in Goodwill",
        "terseLabel": "Adjustments Recognized in Goodwill"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationAdjustmentsRecognizedInGoodwill",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_FairValueofCrosscurrencySwap": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value of Cross-currency Swap",
        "label": "Fair Value of Cross-currency Swap",
        "terseLabel": "Fair Value of Cross-currency Swap"
       }
      }
     },
     "localname": "FairValueofCrosscurrencySwap",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_FinancingLeaseObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Lease Obligations [Member]",
        "label": "Financing Lease Obligations [Member]",
        "terseLabel": "Financing Lease Obligations [Member]"
       }
      }
     },
     "localname": "FinancingLeaseObligationsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite and Indefinite Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite and Indefinite Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite and Indefinite Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]",
        "label": "Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]",
        "terseLabel": "Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_FiniteAndIndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite and Indefinite Lived Intangible Assets Major Class Name [Domain]",
        "label": "Finite and Indefinite Lived Intangible Assets Major Class Name [Domain]",
        "terseLabel": "Finite and Indefinite Lived Intangible Assets Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FirstAmountRemovedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Amount Removed",
        "label": "First Amount Removed [Member]",
        "terseLabel": "First Amount Removed [Member]"
       }
      }
     },
     "localname": "FirstAmountRemovedMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FirstSwaptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Swaption",
        "label": "First Swaption [Member]",
        "terseLabel": "First Swaption"
       }
      }
     },
     "localname": "FirstSwaptionMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2014AcquisitionsexcludingPertenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2014 Acquisitions (excluding Perten) [Member]",
        "label": "Fiscal Year 2014 Acquisitions (excluding Perten) [Member]",
        "terseLabel": "Fiscal Year 2014 Acquisitions (excluding Perten) [Member]"
       }
      }
     },
     "localname": "FiscalYear2014AcquisitionsexcludingPertenMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2015AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2015 Acquisitions [Member]",
        "label": "Fiscal Year 2015 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2015 Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2015AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2016AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2016 Acquisitions [Member]",
        "label": "Fiscal Year 2016 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2016 Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2016AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2017AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2017 Acquisitions [Member]",
        "label": "Fiscal Year 2017 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2017 Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2017AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2017OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2017 Other Acquisitions [Member]",
        "label": "Fiscal Year 2017 Other Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2017 Other Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2017OtherAcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2018AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2018 Acquisitions [Member]",
        "label": "Fiscal Year 2018 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2018 Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2018AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2018OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2018 Other Acquisitions [Member]",
        "label": "Fiscal Year 2018 Other Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2018 Other Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2018OtherAcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2019AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2019 Acquisitions [Member]",
        "label": "Fiscal Year 2019 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2019 Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2019AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2019And2018OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2019 and 2018 Other Acquisitions",
        "label": "Fiscal Year 2019 and 2018 Other Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2019 and 2018 Other Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2019And2018OtherAcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2019OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2019 Other Acquisitions [Member]",
        "label": "Fiscal Year 2019 Other Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2019 Other Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2019OtherAcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2020AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2020 Acquisitions",
        "label": "Fiscal Year 2020 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2020 Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2020AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2020OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2020 Other Acquisitions",
        "label": "Fiscal Year 2020 Other Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2020 Other Acquisitions [Member]"
       }
      }
     },
     "localname": "FiscalYear2020OtherAcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2021AcquisitionsExcludingBioLegendMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2021 Acquisitions (Excluding BioLegend)",
        "label": "Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]",
        "terseLabel": "Fiscal Year 2021 Acquisitions (Excluding BioLegend) [Member]"
       }
      }
     },
     "localname": "FiscalYear2021AcquisitionsExcludingBioLegendMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2021AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2021 Acquisitions",
        "label": "Fiscal Year 2021 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2021 Acquisitions"
       }
      }
     },
     "localname": "FiscalYear2021AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2021OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2021 Other Acquisitions",
        "label": "Fiscal Year 2021 Other Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2021 Other Acquisitions"
       }
      }
     },
     "localname": "FiscalYear2021OtherAcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYear2022AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2022 Acquisitions",
        "label": "Fiscal Year 2022 Acquisitions [Member]",
        "terseLabel": "Fiscal Year 2022 Acquisitions"
       }
      }
     },
     "localname": "FiscalYear2022AcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FiscalYearWeekFormat": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year Week Format",
        "label": "Fiscal Year Week Format",
        "terseLabel": "Fiscal Year Week Format"
       }
      }
     },
     "localname": "FiscalYearWeekFormat",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pki_FivePercentTenYearSeniorUnsecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Percent Ten Year Senior Unsecured Notes [Member]",
        "label": "Five Percent Ten Year Senior Unsecured Notes [Member]",
        "terseLabel": "2021 Notes [Member]"
       }
      }
     },
     "localname": "FivePercentTenYearSeniorUnsecuredNotesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FixedIncomeFundsCorporateAndUSDebtInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Income Funds, Corporate and U.S. Debt Instruments",
        "label": "Fixed Income Funds, Corporate and U.S. Debt Instruments [Member]",
        "terseLabel": "Fixed Income Funds, Corporate and U.S. Debt Instruments [Member]"
       }
      }
     },
     "localname": "FixedIncomeFundsCorporateAndUSDebtInstrumentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FixedIncomeFundsCorporateBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Income Funds, Corporate bonds [Member]",
        "label": "Fixed Income Funds, Corporate bonds [Member]",
        "terseLabel": "Fixed Income Funds, Corporate Bonds [Member]"
       }
      }
     },
     "localname": "FixedIncomeFundsCorporateBondsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FixedIncomeFundsCorporateDebtInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Income Funds, Corporate Debt Instruments [Member]",
        "label": "Fixed Income Funds, Corporate Debt Instruments [Member]",
        "terseLabel": "Fixed Income Funds, Corporate Debt Instruments [Member]"
       }
      }
     },
     "localname": "FixedIncomeFundsCorporateDebtInstrumentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FixedIncomeFundsHighYieldBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Income Funds, High Yield Bonds [Member]",
        "label": "Fixed Income Funds, High Yield Bonds [Member]",
        "terseLabel": "Fixed Income Funds, High Yield Bonds [Member]"
       }
      }
     },
     "localname": "FixedIncomeFundsHighYieldBondsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_FluidSciencesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fluid Sciences Segment [Member]",
        "label": "Fluid Sciences Segment [Member]",
        "terseLabel": "Fluid Sciences Segment [Member]"
       }
      }
     },
     "localname": "FluidSciencesSegmentMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ForeignConsolidations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign consolidations",
        "label": "Foreign consolidations",
        "terseLabel": "Foreign consolidations"
       }
      }
     },
     "localname": "ForeignConsolidations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ForeignEarningsInvestedOutsideUS": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Earnings Invested Outside U.S.",
        "label": "Foreign Earnings Invested Outside U.S.",
        "terseLabel": "Foreign earnings invested outside U.S."
       }
      }
     },
     "localname": "ForeignEarningsInvestedOutsideUS",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ForeignFiscalUnityAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign fiscal unity adjustments",
        "label": "Foreign fiscal unity adjustments [Member]",
        "terseLabel": "Foreign fiscal unity adjustments"
       }
      }
     },
     "localname": "ForeignFiscalUnityAdjustmentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ForeignLiabilityDrivenInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign liability driven investment",
        "label": "Foreign liability driven investment [Member]",
        "terseLabel": "Foreign liability driven investment [Member]"
       }
      }
     },
     "localname": "ForeignLiabilityDrivenInvestmentMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ForeignRealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Real Estate Funds [Member]",
        "label": "Foreign Real Estate Funds [Member]",
        "terseLabel": "Foreign Real Estate Funds [Member]"
       }
      }
     },
     "localname": "ForeignRealEstateFundsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ForeignTaxRateChangesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign tax rate changes",
        "label": "Foreign tax rate changes [Member]",
        "terseLabel": "Foreign tax rate changes"
       }
      }
     },
     "localname": "ForeignTaxRateChangesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_GCLibrariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GC Libraries [Member]",
        "label": "GC Libraries [Member]",
        "terseLabel": "GC Libraries [Member]"
       }
      }
     },
     "localname": "GCLibrariesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Gainondispositionofbusinessesandassetsnet": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on disposition of businesses and assets, net",
        "label": "Gain on disposition of businesses and assets, net",
        "negatedTerseLabel": "Gain on disposition of businesses and assets, net"
       }
      }
     },
     "localname": "Gainondispositionofbusinessesandassetsnet",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_GainsOnStepAcquisitionsAndDispositionsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains on step acquisitions and dispositions, net",
        "label": "Gains On Step Acquisitions And Dispositions, Net",
        "terseLabel": "(Gain) loss on disposition of businesses and assets, net"
       }
      }
     },
     "localname": "GainsOnStepAcquisitionsAndDispositionsNet",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_GoodwillAcquisitionEarnOutsAndOtherAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Acquisition, Earn Outs and Other Adjustments",
        "label": "Goodwill, Acquisition, Earn Outs and Other Adjustments",
        "terseLabel": "Acquisitions, earn outs and other"
       }
      }
     },
     "localname": "GoodwillAcquisitionEarnOutsAndOtherAdjustments",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_GoodwillAndIntangibleAssetsNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Intangible Assets Net [Line Items]",
        "label": "Goodwill and Intangible Assets Net [Line Items]",
        "terseLabel": "Goodwill and Intangible Assets Net [Line Items]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsNetLineItems",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_GoodwillAndIntangibleAssetsNetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill And Intangible Assets Net [Table]",
        "label": "Goodwill And Intangible Assets Net [Table]",
        "terseLabel": "Goodwill And Intangible Assets Net [Table]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsNetTable",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_HorizonDiscoveryGroupPlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Horizon Discovery Group plc",
        "label": "Horizon Discovery Group plc [Member]",
        "terseLabel": "Horizon Discovery Group plc [Member]"
       }
      }
     },
     "localname": "HorizonDiscoveryGroupPlcMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_HumanHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Human Health [Member]",
        "label": "Human Health [Member]",
        "terseLabel": "Human Health [Member]"
       }
      }
     },
     "localname": "HumanHealthMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ImpactofNewAccountingPrincipleCashFlows": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principle, Cash Flows",
        "label": "Impact of New Accounting Principle, Cash Flows",
        "terseLabel": "Impact of New Accounting Principle, Cash Flows"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrincipleCashFlows",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofNewAccountingPrincipleDeferredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principle, Deferred Revenue",
        "label": "Impact of New Accounting Principle, Deferred Revenue",
        "terseLabel": "Impact of New Accounting Principle, Deferred Revenue"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrincipleDeferredRevenue",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofNewAccountingPrincipleLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principle, Lease Liabilities",
        "label": "Impact of New Accounting Principle, Lease Liabilities",
        "terseLabel": "Impact of New Accounting Principle, Lease Liabilities"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrincipleLeaseLiabilities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofNewAccountingPrinciplePropertyandEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principle, Property and Equipment",
        "label": "Impact of New Accounting Principle, Property and Equipment",
        "terseLabel": "Impact of New Accounting Principle, Property and Equipment"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrinciplePropertyandEquipment",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofNewAccountingPrincipleRightofuseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principle, Right-of-use Asset",
        "label": "Impact of New Accounting Principle, Right-of-use Asset",
        "terseLabel": "Impact of New Accounting Principle, Right-of-use Asset"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrincipleRightofuseAsset",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofNewAccountingPrinciplesDeferredTaxAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principles, Deferred Tax Assets",
        "label": "Impact of New Accounting Principles, Deferred Tax Assets",
        "terseLabel": "Impact of New Accounting Principles, Deferred Tax Assets"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrinciplesDeferredTaxAssets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofNewAccountingPrinciplesPrepaidTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principles, Prepaid Taxes",
        "label": "Impact of New Accounting Principles, Prepaid Taxes",
        "terseLabel": "Impact of New Accounting Principles, Prepaid Taxes"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrinciplesPrepaidTaxes",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofNewAccountingPrinciplesReserveforDoubtfulAccounts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of New Accounting Principles, Reserve for Doubtful Accounts",
        "label": "Impact of New Accounting Principles, Reserve for Doubtful Accounts",
        "terseLabel": "Impact of New Accounting Principles, Reserve for Doubtful Accounts"
       }
      }
     },
     "localname": "ImpactofNewAccountingPrinciplesReserveforDoubtfulAccounts",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpactofU.S.TaxAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of U.S. Tax Act",
        "label": "Impact of U.S. Tax Act",
        "terseLabel": "Impact of U.S. Tax Act"
       }
      }
     },
     "localname": "ImpactofU.S.TaxAct",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ImpairmentTestingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Testing Date",
        "label": "Impairment Testing Date",
        "terseLabel": "Impairment Testing Date"
       }
      }
     },
     "localname": "ImpairmentTestingDate",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_IncomeLossFromDiscontinuedOperationsAndDispositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from discontinued operations and dispositions",
        "label": "Income (Loss) from discontinued operations and dispositions",
        "terseLabel": "Income (Loss) from discontinued operations and dispositions"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsAndDispositions",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_IncomeTaxExpenseBenefitsOnRepatriatedEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefits) on Repatriated Earnings",
        "label": "Income Tax Expense (Benefits) on Repatriated Earnings",
        "terseLabel": "Income Tax Expense (Benefits) on Repatriated Earnings"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitsOnRepatriatedEarnings",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_IncomeTaxExpenseBenefitsonUndistributedForeignEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefits) on Undistributed Foreign Earnings",
        "label": "Income Tax Expense (Benefits) on Undistributed Foreign Earnings",
        "terseLabel": "Income Tax Expense (Benefits) on Undistributed Foreign Earnings"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitsonUndistributedForeignEarnings",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_IncomeTaxHolidayIncomeTaxbenefitspersharebasic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Holiday, Income Tax benefits per share, basic",
        "label": "Income Tax Holiday, Income Tax benefits per share, basic",
        "terseLabel": "Impact of benefits derived from tax holidays on earnings per share, basic"
       }
      }
     },
     "localname": "IncomeTaxHolidayIncomeTaxbenefitspersharebasic",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pki_IncomeTaxHolidayIncomeTaxbenefitspersharediluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Holiday, Income Tax benefits per share, diluted",
        "label": "Income Tax Holiday, Income Tax benefits per share, diluted",
        "terseLabel": "Impact of benefits derived from tax holidays on earnings per share, diluted"
       }
      }
     },
     "localname": "IncomeTaxHolidayIncomeTaxbenefitspersharediluted",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pki_IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements stock options using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Share Based Payment Arrangements, Stock Options",
        "terseLabel": "Effect of dilutive securities, Stock options"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pki_IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements restricted stock awards using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Share Based Payments Arrangements, Restricted Stock Awards",
        "terseLabel": "Effect of dilutive securities, Restricted stock"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pki_InformaticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Informatics [Member]",
        "label": "Informatics [Member]",
        "terseLabel": "Informatics [Member]"
       }
      }
     },
     "localname": "InformaticsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_InterestAndOtherExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and other expense, net",
        "label": "Interest And Other Expense Net",
        "terseLabel": "Interest and other expense, net"
       }
      }
     },
     "localname": "InterestAndOtherExpenseNet",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_InterestExpenseIncludingCostsOfBridgeFinancing": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense including costs of bridge financing",
        "label": "Interest expense including costs of bridge financing",
        "terseLabel": "Interest expense including costs of bridge financing"
       }
      }
     },
     "localname": "InterestExpenseIncludingCostsOfBridgeFinancing",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_InterestOnUncertainTaxPositionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest on uncertain tax positions",
        "label": "Interest on uncertain tax positions [Member]",
        "terseLabel": "Interest on uncertain tax positions"
       }
      }
     },
     "localname": "InterestOnUncertainTaxPositionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_InterestRateCashFlowHedgeGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cash Flow Hedge (Gain) Loss",
        "label": "Interest Rate Cash Flow Hedge (Gain) Loss",
        "terseLabel": "Interest Rate Cash Flow Hedge (Gain) Loss"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLoss",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_InterestRateSwaptionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaption",
        "label": "Interest Rate Swaption [Axis]",
        "terseLabel": "Interest Rate Swaption [Axis]"
       }
      }
     },
     "localname": "InterestRateSwaptionAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_InterestRateSwaptionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaption",
        "label": "Interest Rate Swaption [Domain]",
        "terseLabel": "Interest Rate Swaption [Domain]"
       }
      }
     },
     "localname": "InterestRateSwaptionDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_InterestRateSwaptionFirstSwaptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaption , First Swaption",
        "label": "Interest Rate Swaption , First Swaption [Member]",
        "terseLabel": "Interest Rate Swaption , First Swaption [Member]"
       }
      }
     },
     "localname": "InterestRateSwaptionFirstSwaptionMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_InterestRateSwaptionSecondSwaptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaption , Second Swaption",
        "label": "Interest Rate Swaption , Second Swaption [Member]",
        "terseLabel": "Interest Rate Swaption , Second Swaption [Member]"
       }
      }
     },
     "localname": "InterestRateSwaptionSecondSwaptionMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_IssuanceOfCommonStockForBusinessCombinationNetOfIssuanceCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock for business combination, net of issuance costs",
        "label": "Issuance of common stock for business combination, net of issuance costs [Member]",
        "terseLabel": "Issuance of common stock for business combination, net of issuance costs [Member]"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForBusinessCombinationNetOfIssuanceCostsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_IssuanceOfCommonStockForEmployeeStockPurchasePlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock for employee stock purchase plans",
        "label": "Issuance of common stock for employee stock purchase plans [Member]",
        "terseLabel": "Issuance of common stock for employee stock purchase plans [Member]"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForEmployeeStockPurchasePlansMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_IssuanceOfCommonStockForLongTermIncentiveProgram": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock for long-term incentive program",
        "label": "Issuance of common stock for long-term incentive program",
        "terseLabel": "Issuance of common stock for long-term incentive program"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForLongTermIncentiveProgram",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_IssuanceOfCommonStockForLongTermIncentiveProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock for long-term incentive program",
        "label": "Issuance of common stock for long-term incentive program [Member]",
        "terseLabel": "Issuance of common stock for long-term incentive program [Member]"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForLongTermIncentiveProgramMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_LeasesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases [Policy Text Block]",
        "label": "Leases [Policy Text Block]",
        "terseLabel": "Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LeasesPolicyTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_LeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases [Text Block]",
        "label": "Leases [Text Block]",
        "terseLabel": "Leases [Text Block]"
       }
      }
     },
     "localname": "LeasesTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Due After Year Six",
        "label": "Lessee, Operating Lease, Liability, Payments, Due After Year Six",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due After Year Six"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_LesseeOperatingLeaseLiabilityPaymentsDueYearSix": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Due Year Six",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Six",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Six"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearSix",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_LicenseAndServicesRevenueAsPercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and services revenue as a percentage of total revenue",
        "label": "License and services revenue as a percentage of total revenue",
        "terseLabel": "License and services revenue as a percentage of total revenue"
       }
      }
     },
     "localname": "LicenseAndServicesRevenueAsPercentageOfTotalRevenue",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_LifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Sciences [Member]",
        "label": "Life Sciences [Member]",
        "terseLabel": "Life Sciences [Member]"
       }
      }
     },
     "localname": "LifeSciencesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_LineOfCreditMaturingAugust242026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit, Maturing August 24, 2026",
        "label": "Line of Credit, Maturing August 24, 2026 [Member]",
        "terseLabel": "Line of Credit, Maturing August 24, 2026"
       }
      }
     },
     "localname": "LineOfCreditMaturingAugust242026Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_LineofCreditMaturingAugust112021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit, Maturing August 11, 2021 [Member]",
        "label": "Line of Credit, Maturing August 11, 2021 [Member]",
        "terseLabel": "Line of Credit, Maturing August 11, 2021 [Member]"
       }
      }
     },
     "localname": "LineofCreditMaturingAugust112021Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_LineofCreditMaturingDecember162016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit, Maturing December 16, 2016 [Member]",
        "label": "Line of Credit, Maturing December 16, 2016 [Member]",
        "terseLabel": "Line of Credit, Maturing December 16, 2016 [Member]"
       }
      }
     },
     "localname": "LineofCreditMaturingDecember162016Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_LineofCreditMaturingSeptember172024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit, Maturing September 17, 2024 [Member]",
        "label": "Line of Credit, Maturing September 17, 2024 [Member]",
        "terseLabel": "Line of Credit, Maturing September 17, 2024 [Member]"
       }
      }
     },
     "localname": "LineofCreditMaturingSeptember172024Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_LongTermDebtBeforeUnamortizedDiscount": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt Before Unamortized Discount",
        "label": "Long-term Debt Before Unamortized Discount",
        "totalLabel": "Long-term Debt Before Unamortized Discount"
       }
      }
     },
     "localname": "LongTermDebtBeforeUnamortizedDiscount",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_LongTermDebtCurrentPortionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt - Current Portion",
        "label": "Long-term Debt - Current Portion [Member]",
        "terseLabel": "Long-term Debt - Current Portion [Member]"
       }
      }
     },
     "localname": "LongTermDebtCurrentPortionMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_LongTermTerminalGrowthRatesForReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term terminal growth rates for reporting units",
        "label": "Long-term terminal growth rates for reporting units",
        "terseLabel": "Long-term terminal growth rates for reporting units"
       }
      }
     },
     "localname": "LongTermTerminalGrowthRatesForReportingUnits",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_LongtermliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term liabilities [Member]",
        "label": "Long-term liabilities [Member]",
        "terseLabel": "Long-term liabilities [Member]"
       }
      }
     },
     "localname": "LongtermliabilitiesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_MarketableSecuritiesClassifiedAsAvailableForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities Classified as Available for Sale",
        "label": "Marketable Securities Classified as Available for Sale",
        "terseLabel": "Marketable Securities Classified as Available for Sale"
       }
      }
     },
     "localname": "MarketableSecuritiesClassifiedAsAvailableForSale",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_MarketableSecuritiesClassifiedAsAvailableForSaleAmortizedCostBasis": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities Classified as Available for Sale, Amortized Cost Basis",
        "label": "Marketable Securities Classified as Available for Sale, Amortized Cost Basis",
        "terseLabel": "Marketable Securities Classified as Available for Sale, Amortized Cost Basis"
       }
      }
     },
     "localname": "MarketableSecuritiesClassifiedAsAvailableForSaleAmortizedCostBasis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_MarketableSecuritiesClassifiedAsAvailableForSaleGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities Classified as Available for Sale, Gross Unrealized Gain, before Tax",
        "label": "Marketable Securities Classified as Available for Sale, Gross Unrealized Gain, before Tax",
        "terseLabel": "Marketable Securities Classified as Available for Sale, Gross Unrealized Gain, before Tax"
       }
      }
     },
     "localname": "MarketableSecuritiesClassifiedAsAvailableForSaleGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_MarketableSecuritiesClassifiedAsAvailableForSaleGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities Classified as Available for Sale, Gross Unrealized Loss, before Tax",
        "label": "Marketable Securities Classified as Available for Sale, Gross Unrealized Loss, before Tax",
        "terseLabel": "Marketable Securities Classified as Available for Sale, Gross Unrealized Loss, before Tax"
       }
      }
     },
     "localname": "MarketableSecuritiesClassifiedAsAvailableForSaleGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_MarketableSecuritiesClassifiedAsAvailableForSaleTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities Classified as Available for Sale",
        "label": "Marketable Securities Classified as Available for Sale [Table Text Block]",
        "terseLabel": "Marketable Securities Classified as Available for Sale [Table Text Block]"
       }
      }
     },
     "localname": "MarketableSecuritiesClassifiedAsAvailableForSaleTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_MarketableSecuritiesandInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities and Investments",
        "label": "Marketable Securities and Investments",
        "terseLabel": "Marketable Securities and Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesandInvestments",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_MeasurementInputsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Inputs, Discount Rate",
        "label": "Measurement Inputs, Discount Rate",
        "terseLabel": "Measurement Inputs, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputsDiscountRate",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_MedicalImagingBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Imaging Business [Member]",
        "label": "Medical Imaging Business [Member]",
        "terseLabel": "Medical Imaging Business [Member]"
       }
      }
     },
     "localname": "MedicalImagingBusinessMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_MicroarraybaseddiagnostictestinglaboratoryintheUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Microarray-based diagnostic testing laboratory [Member]",
        "label": "Microarray-based diagnostic testing laboratory in the United States [Member]",
        "terseLabel": "Microarray-based diagnostic testing laboratory in the United States [Member]"
       }
      }
     },
     "localname": "MicroarraybaseddiagnostictestinglaboratoryintheUnitedStatesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_MultispectralImagingBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multispectral Imaging Business [Member]",
        "label": "Multispectral Imaging Business [Member]",
        "terseLabel": "Multispectral Imaging Business [Member]"
       }
      }
     },
     "localname": "MultispectralImagingBusinessMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NetIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income",
        "label": "Net Income [Member]",
        "terseLabel": "Net Income [Member]"
       }
      }
     },
     "localname": "NetIncomeMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NetInvestmentHedgeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net investment hedge [Domain]",
        "label": "Net investment hedge [Domain]",
        "terseLabel": "Net investment hedge [Domain]"
       }
      }
     },
     "localname": "NetInvestmentHedgeDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NetInvestmentsHedgeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Investments Hedge [Domain]",
        "label": "Net Investments Hedge [Domain]",
        "terseLabel": "Net Investments Hedge [Domain]"
       }
      }
     },
     "localname": "NetInvestmentsHedgeDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NetinvestmenthedgeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net investment hedge [Axis]",
        "label": "Net investment hedge [Axis]",
        "terseLabel": "Net investment hedge [Axis]"
       }
      }
     },
     "localname": "NetinvestmenthedgeAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_NewAccountingPronouncementorChangeinAccountingPrincipleDescriptionofPriorperiodInfoRetrospectivelyAdjusted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Accounting Pronouncement or Change in Accounting Principle, Description of Prior-period Info Retrospectively Adjusted",
        "label": "New Accounting Pronouncement or Change in Accounting Principle, Description of Prior-period Info Retrospectively Adjusted",
        "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Description of Prior-period Info Retrospectively Adjusted"
       }
      }
     },
     "localname": "NewAccountingPronouncementorChangeinAccountingPrincipleDescriptionofPriorperiodInfoRetrospectivelyAdjusted",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_NewNonemployeeDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Non-employee Director [Member]",
        "label": "New Non-employee Director [Member]",
        "terseLabel": "New Non-employee Director [Member]"
       }
      }
     },
     "localname": "NewNonemployeeDirectorMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NexcelomBioscienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nexcelom Bioscience",
        "label": "Nexcelom Bioscience [Member]",
        "terseLabel": "Nexcelom Bioscience"
       }
      }
     },
     "localname": "NexcelomBioscienceMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NoncashFinanceLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash Finance Lease, Liabilities",
        "label": "Non-cash Finance Lease, Liabilities",
        "terseLabel": "Non-cash Finance Lease, Liabilities"
       }
      }
     },
     "localname": "NoncashFinanceLeaseLiabilities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_NotionalAmountofEuroDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional Amount of Euro Derivatives [Member]",
        "label": "Notional Amount of Euro Derivatives [Member]",
        "terseLabel": "Notional Amount of Euro Derivatives [Member]"
       }
      }
     },
     "localname": "NotionalAmountofEuroDerivativesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NotionalAmountofSEKDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional Amount of SEK Derivatives [Member]",
        "label": "Notional Amount of SEK Derivatives [Member]",
        "terseLabel": "Notional Amount of SEK Derivatives [Member]"
       }
      }
     },
     "localname": "NotionalAmountofSEKDerivativesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NotionalAmountofUSDollarDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional Amount of US Dollar Derivatives [Member]",
        "label": "Notional Amount of US Dollar Derivatives [Member]",
        "terseLabel": "Notional Amount of US Dollar Derivatives [Member]"
       }
      }
     },
     "localname": "NotionalAmountofUSDollarDerivativesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_NumberOfYearsInMeasurementPeriodFromAcquisitionDateToChangeUnderlyingAssumptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Years in Measurement Period from Acquisition Date to Change Underlying Assumptions",
        "label": "Number of Years in Measurement Period from Acquisition Date to Change Underlying Assumptions",
        "terseLabel": "Number of Years in Measurement Period from Acquisition Date to Change Underlying Assumptions"
       }
      }
     },
     "localname": "NumberOfYearsInMeasurementPeriodFromAcquisitionDateToChangeUnderlyingAssumptions",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pki_NumberOfYearsOverWhichEstimatedEnvironmentalCostWillBePaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Years Over Which Estimated Environmental Cost Will Be Paid",
        "label": "Number Of Years Over Which Estimated Environmental Cost Will Be Paid",
        "terseLabel": "Number of years over which estimated environmental cost will be paid"
       }
      }
     },
     "localname": "NumberOfYearsOverWhichEstimatedEnvironmentalCostWillBePaid",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pki_NumberofStockbasedCompensationPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Stock-based Compensation Plans",
        "label": "Number of Stock-based Compensation Plans",
        "terseLabel": "Number of Stock-based Compensation Plans"
       }
      }
     },
     "localname": "NumberofStockbasedCompensationPlans",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pki_OneTimeTransitionTaxOnUnremittedForeignEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time Transition Tax on Unremitted Foreign Earnings",
        "label": "One-time Transition Tax on Unremitted Foreign Earnings",
        "terseLabel": "One-time Transition Tax on Unremitted Foreign Earnings"
       }
      }
     },
     "localname": "OneTimeTransitionTaxOnUnremittedForeignEarnings",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OpenTaxYearsByMajorTaxJurisdictionBeginDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Tax Years by Major Tax Jurisdiction, Begin Date",
        "label": "Open Tax Years by Major Tax Jurisdiction, Begin Date",
        "terseLabel": "Open Tax Years by Major Tax Jurisdiction, Begin Date"
       }
      }
     },
     "localname": "OpenTaxYearsByMajorTaxJurisdictionBeginDate",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "pki_OperatingIncomeLossFromImmaterialAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) From Immaterial Acquisitions",
        "label": "Operating Income (Loss) From Immaterial Acquisitions",
        "terseLabel": "Operating Income (Loss) From Immaterial Acquisitions"
       }
      }
     },
     "localname": "OperatingIncomeLossFromImmaterialAcquisitions",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OperatingLeaseLiabilitiesAccruedCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease liabilities, Accrued, Current",
        "label": "Operating Lease liabilities, Accrued, Current",
        "terseLabel": "Operating Lease liabilities, Accrued, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesAccruedCurrent",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OperatingLeaseLiabilitiesMaturityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Operating Lease Liabilities, Maturity [Table]",
        "label": "Operating Lease Liabilities, Maturity [Line Items]",
        "terseLabel": "Operating Lease Liabilities, Maturity [Line Items]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesMaturityLineItems",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_OperatingLeaseLiabilitiesMaturityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liabilities, Maturity [Table]",
        "label": "Operating Lease Liabilities, Maturity [Table]",
        "terseLabel": "Operating Lease Liabilities, Maturity [Table]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesMaturityTable",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_OperatingLeaseRightOfUseAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease right-of-use assets",
        "label": "Operating lease right-of-use assets [Member]",
        "terseLabel": "Operating lease right-of-use assets [Member]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OperatingResultsofDiscontinuedOperationsPriortoDispositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Results of Discontinued Operations Prior to Disposition [Abstract]",
        "label": "Operating Results of Discontinued Operations Prior to Disposition [Abstract]",
        "terseLabel": "Operating Results of Discontinued Operations Prior to Disposition [Abstract]"
       }
      }
     },
     "localname": "OperatingResultsofDiscontinuedOperationsPriortoDispositionAbstract",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "xbrltype": "stringItemType"
    },
    "pki_OperatingleaseliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease liabilities [Member]",
        "label": "Operating lease liabilities [Member]",
        "terseLabel": "Operating lease liabilities [Member]"
       }
      }
     },
     "localname": "OperatingleaseliabilitiesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherActiveEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Active Employees [Member]",
        "label": "Other Active Employees [Member]",
        "terseLabel": "Other Active Employees [Member]"
       }
      }
     },
     "localname": "OtherActiveEmployeesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherAssetAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Asset Acquisitions [Member]",
        "label": "Other Asset Acquisitions [Member]",
        "terseLabel": "Other Asset Acquisitions [Member]"
       }
      }
     },
     "localname": "OtherAssetAcquisitionsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherAssetAcquisitionsextensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Asset Acquisitions extension [Member]",
        "label": "Other Asset Acquisitions extension [Member]",
        "terseLabel": "Other Asset Acquisitions extension [Member]"
       }
      }
     },
     "localname": "OtherAssetAcquisitionsextensionMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherComponentsOfNetPeriodicPensionCreditCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other components of net periodic pension (credit) cost",
        "label": "Other components of net periodic pension (credit) cost",
        "terseLabel": "Other components of net periodic pension (credit) cost"
       }
      }
     },
     "localname": "OtherComponentsOfNetPeriodicPensionCreditCost",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentsReclassificationFromAOCItoEarningsDuetoASU201802": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustments Reclassification From AOCI to Earnings Due to ASU 2018-02",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustments Reclassification From AOCI to Earnings Due to ASU 2018-02",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustments Reclassification From AOCI to Earnings Due to ASU 2018-02"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentsReclassificationFromAOCItoEarningsDuetoASU201802",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentsReclassificationFromAOCItoEarningsNetofTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustments Reclassification From AOCI to Earnings, Net of Tax",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustments Reclassification From AOCI to Earnings, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustments Reclassification From AOCI to Earnings, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentsReclassificationFromAOCItoEarningsNetofTax",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OtherComprehensiveIncomeLossRelatedToSwaption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other comprehensive (income) loss related to Swaption",
        "label": "Other comprehensive (income) loss related to Swaption",
        "terseLabel": "Other comprehensive (income) loss related to Swaption"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossRelatedToSwaption",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OtherComprehensiveIncomeLossafterReclassificationsNetofTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), after Reclassifications, Net of Tax",
        "label": "Other Comprehensive Income (Loss), after Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), after Reclassifications, Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), after Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossafterReclassificationsNetofTax",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OtherComprehensiveLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other comprehensive loss",
        "label": "Other comprehensive loss [Member]",
        "terseLabel": "Other comprehensive loss [Member]"
       }
      }
     },
     "localname": "OtherComprehensiveLossMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherDebtFacilitiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Debt Facilities - Current",
        "label": "Other Debt Facilities - Current [Member]",
        "terseLabel": "Other Debt Facilities - Current"
       }
      }
     },
     "localname": "OtherDebtFacilitiesCurrentMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherDebtFacilitiesEUROIMMUNMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Debt Facilities - EUROIMMUN [Member]",
        "label": "Other Debt Facilities - EUROIMMUN [Member]",
        "terseLabel": "Other Debt Facilities - EUROIMMUN [Member]"
       }
      }
     },
     "localname": "OtherDebtFacilitiesEUROIMMUNMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherDebtFacilitiesIncludingTheSeniorRevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Debt Facilities, including the senior revolving credit facility",
        "label": "Other Debt Facilities, including the senior revolving credit facility [Member]",
        "terseLabel": "Other Debt Facilities, including the senior revolving credit facility"
       }
      }
     },
     "localname": "OtherDebtFacilitiesIncludingTheSeniorRevolvingCreditFacilityMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherDebtFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Debt Facilities [Member]",
        "label": "Other Debt Facilities [Member]",
        "terseLabel": "Other Debt Facilities [Member]"
       }
      }
     },
     "localname": "OtherDebtFacilitiesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherDebtFacilitiesNonCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Debt Facilities - Non-current",
        "label": "Other Debt Facilities - Non-current [Member]",
        "terseLabel": "Other Debt Facilities - Non-current"
       }
      }
     },
     "localname": "OtherDebtFacilitiesNonCurrentMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherDiscontinuedOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Discontinued Operations [Member]",
        "label": "Other Discontinued Operations [Member]",
        "terseLabel": "Other Discontinued Operations [Member]"
       }
      }
     },
     "localname": "OtherDiscontinuedOperationsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other International [Member]",
        "label": "Other International [Member]",
        "terseLabel": "Other International [Member]"
       }
      }
     },
     "localname": "OtherInternationalMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherSecuredBankLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Secured Bank Loan [Member]",
        "label": "Other Secured Bank Loan [Member]",
        "terseLabel": "Other Secured Bank Loan [Member]"
       }
      }
     },
     "localname": "OtherSecuredBankLoanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Securities [Member]",
        "label": "Other Securities [Member]",
        "terseLabel": "Other Securities [Member]"
       }
      }
     },
     "localname": "OtherSecuritiesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherTaxMattersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Tax Matters [Member]",
        "label": "Other Tax Matters [Member]",
        "terseLabel": "Other Tax Matters [Member]"
       }
      }
     },
     "localname": "OtherTaxMattersMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherTypesOfInvestmentsNonUSGovernmentIndexLinkedBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Types of Investments, Non U.S. Government Index Linked Bonds [Member]",
        "label": "Other Types of Investments, Non U.S. Government Index Linked Bonds [Member]",
        "terseLabel": "Other Types of Investments, Non U.S. Government Index Linked Bonds [Member]"
       }
      }
     },
     "localname": "OtherTypesOfInvestmentsNonUSGovernmentIndexLinkedBondsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OtherUnsecuredRevolvingCreditFacilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Unsecured Revolving Credit Facilities",
        "label": "Other Unsecured Revolving Credit Facilities",
        "terseLabel": "Other Unsecured Revolving Credit Facility"
       }
      }
     },
     "localname": "OtherUnsecuredRevolvingCreditFacilities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_OtherUnsecuredRevolvingDebtFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Unsecured Revolving Debt Facilities [Member]",
        "label": "Other Unsecured Revolving Debt Facilities [Member]",
        "terseLabel": "Other Unsecured Revolving Debt Facilities [Member]"
       }
      }
     },
     "localname": "OtherUnsecuredRevolvingDebtFacilitiesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OxfordImmunotecGlobalPLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oxford Immunotec Global PLC",
        "label": "Oxford Immunotec Global PLC [Member]",
        "terseLabel": "Oxford Immunotec Global PLC [Member]"
       }
      }
     },
     "localname": "OxfordImmunotecGlobalPLCMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_OxfordImmunotecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oxford Immunotec",
        "label": "Oxford Immunotec [Member]",
        "terseLabel": "Oxford Immunotec"
       }
      }
     },
     "localname": "OxfordImmunotecMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PKI21AMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PKI 21A [Member]",
        "label": "PKI 21A [Member]",
        "terseLabel": "PKI 21A [Member]"
       }
      }
     },
     "localname": "PKI21AMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PKI21BMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PKI 21B [Member]",
        "label": "PKI 21B [Member]",
        "terseLabel": "PKI 21B [Member]"
       }
      }
     },
     "localname": "PKI21BMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PKIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PKI [Member]",
        "label": "PKI [Member]",
        "terseLabel": "PKI [Member]"
       }
      }
     },
     "localname": "PKIMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PaymentsForAcquisitionRelatedContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for acquisition related contingent consideration",
        "label": "Payments for acquisition related contingent consideration",
        "terseLabel": "Payments for acquisition related contingent consideration",
        "verboseLabel": "Payments for acquisition-related contingent consideration"
       }
      }
     },
     "localname": "PaymentsForAcquisitionRelatedContingentConsideration",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for acquisitions and investments, net of cash and cash equivalents acquired",
        "label": "Payments for acquisitions and investments, net of cash and cash equivalents acquired",
        "negatedLabel": "Cash paid for acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_PercentageOfBusinessOutsideDomesticCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Business Outside Domestic Country",
        "label": "Percentage Of Business Outside Domestic Country",
        "terseLabel": "Company's business conducted outside United States"
       }
      }
     },
     "localname": "PercentageOfBusinessOutsideDomesticCountry",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_PercentageOfRedemptionOfSeniorNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Redemption Of Senior Notes",
        "label": "Percentage Of Redemption Of Senior Notes",
        "terseLabel": "Percentage of redemption of senior notes on or after August 15, 2021"
       }
      }
     },
     "localname": "PercentageOfRedemptionOfSeniorNotes",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_PerformanceFactorPercentageMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Factor Percentage Maximum",
        "label": "Performance Factor Percentage Maximum",
        "terseLabel": "Performance factor percentage maximum"
       }
      }
     },
     "localname": "PerformanceFactorPercentageMaximum",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_PerformanceFactorPercentageMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Factor Percentage Minimum",
        "label": "Performance Factor Percentage Minimum",
        "terseLabel": "Performance factor percentage minimum"
       }
      }
     },
     "localname": "PerformanceFactorPercentageMinimum",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pki_PerformanceRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Restricted Stock Units [Member]",
        "label": "Performance Restricted Stock Units [Member]",
        "terseLabel": "Performance Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "PerformanceRestrictedStockUnitsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PerformanceUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Units [Member]",
        "label": "Performance Units [Member]",
        "terseLabel": "Performance Units [Member]"
       }
      }
     },
     "localname": "PerformanceUnitsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PeriodOfWarrantyProtectionBeyondDateOfSaleInYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of Warranty Protection Beyond Date of Sale (in Years)",
        "label": "Period of Warranty Protection Beyond Date of Sale (in Years)",
        "terseLabel": "Period of warranty protection beyond date of sale (in years)"
       }
      }
     },
     "localname": "PeriodOfWarrantyProtectionBeyondDateOfSaleInYears",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pki_PerkinElmerLabsInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PerkinElmer Labs, Inc. [Member]",
        "label": "PerkinElmer Labs, Inc. [Member]",
        "terseLabel": "PerkinElmer Labs, Inc. [Member]"
       }
      }
     },
     "localname": "PerkinElmerLabsInc.Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PertenInstrumentsGroupABMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Perten Instruments Group AB [Member]",
        "label": "Perten Instruments Group AB [Member]",
        "terseLabel": "Perten Instruments Group AB [Member]"
       }
      }
     },
     "localname": "PertenInstrumentsGroupABMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PrepaidRoyaltiesOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Royalties, Other Assets",
        "label": "Prepaid Royalties, Other Assets",
        "terseLabel": "Prepaid Royalties, Other Assets"
       }
      }
     },
     "localname": "PrepaidRoyaltiesOtherAssets",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_PrepaidRoyaltiesOtherCurrentAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Royalties, Other Current Asset",
        "label": "Prepaid Royalties, Other Current Asset",
        "terseLabel": "Prepaid Royalties, Other Current Asset"
       }
      }
     },
     "localname": "PrepaidRoyaltiesOtherCurrentAsset",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_PrepaidRoyaltiesToBePaidWithinOneYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Royalties To Be Paid Within One Year",
        "label": "Prepaid Royalties To Be Paid Within One Year",
        "terseLabel": "Prepaid Royalties To Be Paid Within One Year"
       }
      }
     },
     "localname": "PrepaidRoyaltiesToBePaidWithinOneYear",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Pretaxgainondispositionofdiscontinuedoperations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-tax gain on disposition of discontinued operations",
        "label": "Pre-tax gain on disposition of discontinued operations",
        "terseLabel": "Pre-tax gain on disposition of discontinued operations"
       }
      }
     },
     "localname": "Pretaxgainondispositionofdiscontinuedoperations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_PreviousRestructuringAndIntegrationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previous restructuring and integration plans [Member]",
        "label": "Previous restructuring and integration plans [Member]",
        "terseLabel": "Previous restructuring and integration plans [Member]"
       }
      }
     },
     "localname": "PreviousRestructuringAndIntegrationPlansMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_PrimaryendmarketsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary end-markets [Axis]",
        "label": "Primary end-markets [Axis]",
        "terseLabel": "Primary end-markets [Axis]"
       }
      }
     },
     "localname": "PrimaryendmarketsAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_PrimaryendmarketsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Primary end-markets [Axis]",
        "label": "Primary end-markets [Domain]",
        "terseLabel": "Primary end-markets [Domain]"
       }
      }
     },
     "localname": "PrimaryendmarketsDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ProceedsFromTermLoan": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from term loan",
        "label": "Proceeds from term loan",
        "terseLabel": "Proceeds from term loan"
       }
      }
     },
     "localname": "ProceedsFromTermLoan",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Projectedmilestonedate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Projected milestone date",
        "label": "Projected milestone date",
        "terseLabel": "Projected milestone date"
       }
      }
     },
     "localname": "Projectedmilestonedate",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "pki_ProvisionForIncomeTaxesOnDiscontinuedOperationsAndDispositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for income taxes on discontinued operations and dispositions.",
        "label": "Provision For Income Taxes On Discontinued Operations And Dispositions",
        "negatedTerseLabel": "(Benefit from) provision for income taxes on discontinued operations and dispositions"
       }
      }
     },
     "localname": "ProvisionForIncomeTaxesOnDiscontinuedOperationsAndDispositions",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_PurchaseAccountingAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase accounting adjustments",
        "label": "Purchase accounting adjustments",
        "terseLabel": "Purchase accounting adjustments"
       }
      }
     },
     "localname": "PurchaseAccountingAdjustments",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_PurchasesOfCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of common stock",
        "label": "Purchases of common stock [Member]",
        "terseLabel": "Purchases of common stock [Member]"
       }
      }
     },
     "localname": "PurchasesOfCommonStockMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q12014RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q1 2014 Restructuring Plan [Member]",
        "label": "Q1 2014 Restructuring Plan [Member]",
        "terseLabel": "Q1 2014 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q12014RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q12017RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q1 2017 Restructuring Plan [Member]",
        "label": "Q1 2017 Restructuring Plan [Member]",
        "terseLabel": "Q1 2017 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q12017RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q12018RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q1 2018 Restructuring Plan [Member]",
        "label": "Q1 2018 Restructuring Plan [Member]",
        "terseLabel": "Q1 2018 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q12018RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q12019RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q1 2019 Restructuring Plan [Member]",
        "label": "Q1 2019 Restructuring Plan [Member]",
        "terseLabel": "Q1 2019 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q12019RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q12020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q1 2020 Restructuring Plan",
        "label": "Q1 2020 Restructuring Plan [Member]",
        "terseLabel": "Q1 2020 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q12020RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q12021RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q1 2021 Restructuring Plan",
        "label": "Q1 2021 Restructuring Plan [Member]",
        "terseLabel": "Q1 2021 Restructuring Plan"
       }
      }
     },
     "localname": "Q12021RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q22014RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 2014 Restructuring Plan [Member]",
        "label": "Q2 2014 Restructuring Plan [Member]",
        "terseLabel": "Q2 2014 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q22014RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q22015RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 2015 Restructuring Plan [Member]",
        "label": "Q2 2015 Restructuring Plan [Member]",
        "terseLabel": "Q2 2015 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q22015RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q22016RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 2016 Restructuring Plan [Member]",
        "label": "Q2 2016 Restructuring Plan [Member]",
        "terseLabel": "Q2 2016 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q22016RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q22019RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 2019 Restructuring Plan [Member]",
        "label": "Q2 2019 Restructuring Plan [Member]",
        "terseLabel": "Q2 2019 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q22019RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q22021RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 2021 Restructuring Plan",
        "label": "Q2 2021 Restructuring Plan [Member]",
        "terseLabel": "Q2 2021 Restructuring Plan"
       }
      }
     },
     "localname": "Q22021RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q32014RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q3 2014 Restructuring Plan",
        "label": "Q3 2014 Restructuring Plan [Member]",
        "terseLabel": "Q3 2014 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q32014RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q32016RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q3 2016 Restructuring Plan [Member]",
        "label": "Q3 2016 Restructuring Plan [Member]",
        "terseLabel": "Q3 2016 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q32016RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q32017RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q3 2017 Restructuring Plan [Member] [Domain]",
        "label": "Q3 2017 Restructuring Plan [Member]",
        "terseLabel": "Q3 2017 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q32017RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q32018RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q3 2018 Restructuring Plan [Member]",
        "label": "Q3 2018 Restructuring Plan [Member]",
        "terseLabel": "Q3 2018 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q32018RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q32019RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q3 2019 Restructuring Plan [Member]",
        "label": "Q3 2019 Restructuring Plan [Member]",
        "terseLabel": "Q3 2019 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q32019RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q32020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q3 2020 Restructuring Plan",
        "label": "Q3 2020 Restructuring Plan [Member]",
        "terseLabel": "Q3 2020 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q32020RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q32021RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q3 2021 Restructuring Plan",
        "label": "Q3 2021 Restructuring Plan [Member]",
        "terseLabel": "Q3 2021 Restructuring Plan"
       }
      }
     },
     "localname": "Q32021RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q42015RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q4 2015 Restructuring Plan [Member]",
        "label": "Q4 2015 Restructuring Plan [Member]",
        "terseLabel": "Q4 2015 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q42015RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q42017RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q4 2017 Restructuring Plan [Member]",
        "label": "Q4 2017 Restructuring Plan [Member]",
        "terseLabel": "Q4 2017 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q42017RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q42018RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q4 2018 Restructuring Plan [Member]",
        "label": "Q4 2018 Restructuring Plan [Member]",
        "terseLabel": "Q4 2018 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q42018RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q42019RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q4 2019 Restructuring Plan [Member]",
        "label": "Q4 2019 Restructuring Plan [Member]",
        "terseLabel": "Q4 2019 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q42019RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q42020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q4 2020 Restructuring Plan",
        "label": "Q4 2020 Restructuring Plan [Member]",
        "terseLabel": "Q4 2020 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "Q42020RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Q42021RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q4 2021 Restructuring Plan",
        "label": "Q4 2021 Restructuring Plan [Member]",
        "terseLabel": "Q4 2021 Restructuring Plan"
       }
      }
     },
     "localname": "Q42021RestructuringPlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RateBasisByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate Basis by Type [Axis]",
        "label": "Rate Basis by Type [Axis]",
        "terseLabel": "Rate Basis by Type [Axis]"
       }
      }
     },
     "localname": "RateBasisByTypeAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_RateBasisByTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate Basis by Type [Domain]",
        "label": "Rate Basis by Type [Domain]",
        "terseLabel": "Rate Basis by Type [Domain]"
       }
      }
     },
     "localname": "RateBasisByTypeDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RateBasisTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate Basis, Type [Domain]",
        "label": "Rate Basis, Type [Domain]",
        "terseLabel": "Rate Basis, Type [Domain]"
       }
      }
     },
     "localname": "RateBasisTypeDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RateChangeOnLongTermIntangibles": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate change on long term intangibles",
        "label": "Rate change on long term intangibles",
        "terseLabel": "Rate change on long term intangibles"
       }
      }
     },
     "localname": "RateChangeOnLongTermIntangibles",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_RealizedGainLossOnDerivatives": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized Gain (Loss) on Derivatives",
        "label": "Realized Gain (Loss) on Derivatives",
        "terseLabel": "Realized Losses (Gains) on Derivatives"
       }
      }
     },
     "localname": "RealizedGainLossOnDerivatives",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ReallocationOfGoodwillResultingFromRealignmentWithinOperatingSegments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reallocation of Goodwill Resulting from Realignment Within Operating Segments",
        "label": "Reallocation of Goodwill Resulting from Realignment Within Operating Segments",
        "terseLabel": "Reallocation of Goodwill Resulting from Realignment Within Operating Segments"
       }
      }
     },
     "localname": "ReallocationOfGoodwillResultingFromRealignmentWithinOperatingSegments",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_RemainingAmountRemovedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining Amount Removed",
        "label": "Remaining Amount Removed [Member]",
        "terseLabel": "Remaining Amount Removed [Member]"
       }
      }
     },
     "localname": "RemainingAmountRemovedMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RemeasurementOfDeferredTaxLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remeasurement of Deferred Tax Liabilities",
        "label": "Remeasurement of Deferred Tax Liabilities [Member]",
        "terseLabel": "Remeasurement of Deferred Tax Liabilities [Member]"
       }
      }
     },
     "localname": "RemeasurementOfDeferredTaxLiabilitiesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RemovalOfHedgingRelationshipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Removal of Hedging Relationship",
        "label": "Removal of Hedging Relationship [Axis]",
        "terseLabel": "Removal of Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "RemovalOfHedgingRelationshipAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_RemovalOfHedgingRelationshipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Removal of Hedging Relationship",
        "label": "Removal of Hedging Relationship [Domain]",
        "terseLabel": "Removal of Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "RemovalOfHedgingRelationshipDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RepaymentsOfTermLoan": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of Term Loan",
        "label": "Repayments of Term Loan",
        "terseLabel": "Repayments of Term Loan"
       }
      }
     },
     "localname": "RepaymentsOfTermLoan",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ReportableSegmentOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reportable segment operating income (loss)",
        "label": "Reportable segment operating income (loss)",
        "terseLabel": "Reportable segment operating income (loss)"
       }
      }
     },
     "localname": "ReportableSegmentOperatingIncomeLoss",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ReportableSegmentRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reportable Segment Revenue",
        "label": "Reportable Segment Revenue [Member]",
        "terseLabel": "Reportable Segment Revenue [Member]"
       }
      }
     },
     "localname": "ReportableSegmentRevenueMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RepurchaseProgram07222022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase Program, 07/22/2022",
        "label": "Repurchase Program, 07/22/2022 [Member]",
        "terseLabel": "Repurchase Program, 07/22/2022"
       }
      }
     },
     "localname": "RepurchaseProgram07222022Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RepurchaseProgram07232018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase Program, 07/23/2018 [Member]",
        "label": "Repurchase Program, 07/23/2018 [Member]",
        "terseLabel": "Repurchase Program, 07/23/2018 [Member]"
       }
      }
     },
     "localname": "RepurchaseProgram07232018Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RepurchaseProgram07312020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase Program, 07/31/2020",
        "label": "Repurchase Program, 07/31/2020 [Member]",
        "terseLabel": "Repurchase Program, 07/31/2020 [Member]"
       }
      }
     },
     "localname": "RepurchaseProgram07312020Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchased Common Shares For Activity Pursuant to Equity Incentive Plans",
        "label": "Repurchased Common Shares For Activity Pursuant to Equity Incentive Plans",
        "terseLabel": "Repurchased Common Shares For Activity Pursuant to Equity Incentive Plans"
       }
      }
     },
     "localname": "RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pki_RepurchasedCommonSharesForStatutoryTaxWithholdingObligations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares repurchased to satisfy minimum statutory tax withholding obligations in connection with the vesting of stock compensation awards.",
        "label": "Repurchased Common Shares For Statutory Tax Withholding Obligations",
        "terseLabel": "Repurchased shares of common stock to satisfy statutory tax withholding obligation requirements"
       }
      }
     },
     "localname": "RepurchasedCommonSharesForStatutoryTaxWithholdingObligations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pki_RestrictedStockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Awards [Member]",
        "label": "Restricted Stock Awards [Member]",
        "terseLabel": "Restricted Stock Awards [Member]"
       }
      }
     },
     "localname": "RestrictedStockAwardsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RestructuringChargesandChangesinEstimates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges and Changes in Estimates",
        "label": "Restructuring Charges and Changes in Estimates",
        "terseLabel": "Restructuring Charges and Changes in Estimates"
       }
      }
     },
     "localname": "RestructuringChargesandChangesinEstimates",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_RestructuringReserve1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve1",
        "label": "Restructuring Reserve1",
        "terseLabel": "Restructuring Reserve1"
       }
      }
     },
     "localname": "RestructuringReserve1",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_RestructuringReserveCurrentOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve, Current Other",
        "label": "Restructuring Reserve, Current Other",
        "terseLabel": "Restructuring Reserve, Current Other"
       }
      }
     },
     "localname": "RestructuringReserveCurrentOther",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_RestructuringReserveSettledWithCashAndTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring reserve settled with cash and translation adjustment",
        "label": "Restructuring reserve Settled with Cash and Translation Adjustment",
        "negatedLabel": "Amounts paid and foreign currency translation"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithCashAndTranslationAdjustment",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_RestructuringandContractTerminationChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Contract Termination Charges [Abstract]",
        "label": "Restructuring and Contract Termination Charges [Abstract]",
        "terseLabel": "Restructuring and Contract Termination Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringandContractTerminationChargesAbstract",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "xbrltype": "stringItemType"
    },
    "pki_RetireesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirees [Member]",
        "label": "Retirees [Member]",
        "terseLabel": "Retirees [Member]"
       }
      }
     },
     "localname": "RetireesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RevenuePurchaseAccountingAdjustmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Purchase Accounting Adjustments",
        "label": "Revenue Purchase Accounting Adjustments [Axis]",
        "terseLabel": "Revenue Purchase Accounting Adjustments [Axis]"
       }
      }
     },
     "localname": "RevenuePurchaseAccountingAdjustmentsAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_RevenuePurchaseAccountingAdjustmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Purchase Accounting Adjustments",
        "label": "Revenue Purchase Accounting Adjustments [Domain]",
        "terseLabel": "Revenue Purchase Accounting Adjustments [Domain]"
       }
      }
     },
     "localname": "RevenuePurchaseAccountingAdjustmentsDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_RevenuePurchaseAccountingAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Purchase Accounting Adjustments",
        "label": "Revenue Purchase Accounting Adjustments [Member]",
        "terseLabel": "Revenue Purchase Accounting Adjustments [Member]"
       }
      }
     },
     "localname": "RevenuePurchaseAccountingAdjustmentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ReverseTreasuryRateLockSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Treasury Rate Lock Settlement",
        "label": "Reverse Treasury Rate Lock Settlement",
        "terseLabel": "Reverse Treasury Rate Lock Settlement"
       }
      }
     },
     "localname": "ReverseTreasuryRateLockSettlement",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ScheduleOfDeferredIncomeTaxesDomesticAndForeignTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Deferred Income Taxes, Domestic and Foreign [Table Text Block]",
        "label": "Schedule of Deferred Income Taxes, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Deferred Income Taxes, Domestic and Foreign [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredIncomeTaxesDomesticAndForeignTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_ScheduleOfDepreciationAmortizationAndCapitalExpendituresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Depreciation, Amortization and Capital Expenditures [Table]",
        "label": "Schedule of Depreciation, Amortization and Capital Expenditures [Table]",
        "terseLabel": "Schedule of Depreciation, Amortization and Capital Expenditures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDepreciationAmortizationAndCapitalExpendituresTable",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleOfDepreciationAmortizationAndCapitalExpendituresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Depreciation, Amortization and Capital Expenditures [Table Text Block]",
        "label": "Schedule of Depreciation, Amortization and Capital Expenditures [Table Text Block]",
        "terseLabel": "Schedule of Depreciation, Amortization and Capital Expenditures"
       }
      }
     },
     "localname": "ScheduleOfDepreciationAmortizationAndCapitalExpendituresTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite and Indefinite Lived Intangible Assets by Major Class [Table]",
        "label": "Schedule of Finite and Indefinite Lived Intangible Assets by Major Class [Table]",
        "terseLabel": "Schedule of Finite and Indefinite Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleOfIdentifiableIntangibleAssetBalancesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Identifiable Intangible Asset Balances [Text Block]",
        "label": "Schedule of Identifiable Intangible Asset Balances [Text Block]",
        "terseLabel": "Identifiable Intangible Asset Balances"
       }
      }
     },
     "localname": "ScheduleOfIdentifiableIntangibleAssetBalancesTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_ScheduleOfIncomeTaxExpenseBenefitContinuingOperationsAndDiscontinuedOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations [Table Text Block]",
        "label": "Schedule of Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIncomeTaxExpenseBenefitContinuingOperationsAndDiscontinuedOperationsTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_ScheduleOfInvestmentsNoncurrentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Investments, Noncurrent [Table Text Block]",
        "label": "Schedule of Investments, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Investments, Noncurrent [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsNoncurrentTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule Of Supplemental Cash Flow Information Related To Leases [Table]",
        "label": "Schedule Of Supplemental Cash Flow Information Related To Leases [Line Items]",
        "terseLabel": "Schedule Of Supplemental Cash Flow Information Related To Leases [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeasesLineItems",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Supplemental Cash Flow Information Related To Leases [Table]",
        "label": "Schedule Of Supplemental Cash Flow Information Related To Leases [Table]",
        "terseLabel": "Schedule Of Supplemental Cash Flow Information Related To Leases [Table]"
       }
      }
     },
     "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTable",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleofGainsandLossesonDispositionofDiscontinuedOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Gains and Losses on Disposition of Discontinued Operations [Table Text Block]",
        "label": "Schedule of Gains and Losses on Disposition of Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Gains and Losses on Disposition of Discontinued Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofGainsandLossesonDispositionofDiscontinuedOperationsTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_ScheduleofOperatingandInvestingnoncashitemsfromdiscontinuedoperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Operating and Investing non-cash items from discontinued operations [Table Text Block]",
        "label": "Schedule of Operating and Investing non-cash items from discontinued operations [Table Text Block]",
        "terseLabel": "Schedule of Operating and Investing non-cash items from discontinued operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofOperatingandInvestingnoncashitemsfromdiscontinuedoperationsTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_ScheduleofStockholdersEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Stockholders' Equity [Table]",
        "label": "Schedule of Stockholders' Equity [Line Items]",
        "terseLabel": "Schedule of Stockholders' Equity [Line Items]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityLineItems",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleofStockholdersEquityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Stockholders' Equity [Table]",
        "label": "Schedule of Stockholders' Equity [Table]",
        "terseLabel": "Schedule of Stockholders' Equity [Table]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityTable",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleofSupplementalBalanceSheetInformationRelatedToLeasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Supplemental Balance Sheet Information Related To Leases [Table]",
        "label": "Schedule of Supplemental Balance Sheet Information Related To Leases [Line Items]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information Related To Leases [Line Items]"
       }
      }
     },
     "localname": "ScheduleofSupplementalBalanceSheetInformationRelatedToLeasesLineItems",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleofSupplementalBalanceSheetInformationRelatedToLeasesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Supplemental Balance Sheet Information Related To Leases [Table]",
        "label": "Schedule of Supplemental Balance Sheet Information Related To Leases [Table]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information Related To Leases [Table]"
       }
      }
     },
     "localname": "ScheduleofSupplementalBalanceSheetInformationRelatedToLeasesTable",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_ScheduleofcarryingamountsofmajorclassesofassetsandliabilitiesincludedindiscontinuedoperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of carrying amounts of major classes of assets and liabilities included in discontinued operations [Table Text Block]",
        "label": "Schedule of carrying amounts of major classes of assets and liabilities included in discontinued operations [Table Text Block]",
        "terseLabel": "Schedule of carrying amounts of major classes of assets and liabilities included in discontinued operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofcarryingamountsofmajorclassesofassetsandliabilitiesincludedindiscontinuedoperationsTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_SecondSwaptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Swaption",
        "label": "Second Swaption [Member]",
        "terseLabel": "Second Swaption"
       }
      }
     },
     "localname": "SecondSwaptionMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SegmentOperatingIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Operating Income",
        "label": "Segment Operating Income [Member]",
        "terseLabel": "Segment Operating Income [Member]"
       }
      }
     },
     "localname": "SegmentOperatingIncomeMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SegmentReportingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting",
        "label": "Segment Reporting [Axis]",
        "terseLabel": "Segment Reporting [Axis]"
       }
      }
     },
     "localname": "SegmentReportingAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_SegmentReportingRevenueDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting, Revenue",
        "label": "Segment Reporting, Revenue [Domain]",
        "terseLabel": "Segment Reporting [Domain]"
       }
      }
     },
     "localname": "SegmentReportingRevenueDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SeniorUnsecuredNotesIssuedOnMarch82021AndSeptember102021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Issued on March 8, 2021 and September 10, 2021",
        "label": "Senior Unsecured Notes Issued on March 8, 2021 and September 10, 2021 [Member]",
        "terseLabel": "Senior Unsecured Notes Issued on March 8, 2021 and September 10, 2021 [Member]"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesIssuedOnMarch82021AndSeptember102021Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SeniorUnsecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes",
        "label": "Senior Unsecured Notes [Member]",
        "terseLabel": "Senior Unsecured Notes"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SettlementOfSwaps": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement of swaps",
        "label": "Settlement of swaps",
        "terseLabel": "Settlement of swaps"
       }
      }
     },
     "localname": "SettlementOfSwaps",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ShandongMeizhengMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shandong Meizheng [Member]",
        "label": "Shandong Meizheng [Member]",
        "terseLabel": "Shandong Meizheng [Member]"
       }
      }
     },
     "localname": "ShandongMeizhengMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentOtherThanOptionsEquityAwardGrantedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Award, Equity Instrument Other than Options, Equity Award Granted, Value",
        "label": "Share-based Compensation Arrangement by Share-based Award, Equity Instrument Other than Options, Equity Award Granted, Value",
        "terseLabel": "Stock award program for non-employees Directors, fair market value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentOtherThanOptionsEquityAwardGrantedValue",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ShorttermaccruedrestructuringandothercostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term accrued restructuring and other costs [Member]",
        "label": "Short-term accrued restructuring and other costs [Member]",
        "terseLabel": "Short-term accrued restructuring and other costs [Member]"
       }
      }
     },
     "localname": "ShorttermaccruedrestructuringandothercostsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SignificantDiagnosticsMatterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Diagnostics Matter [Member]",
        "label": "Significant Diagnostics Matter [Member]",
        "terseLabel": "Particular Diagnostics Case [Member]"
       }
      }
     },
     "localname": "SignificantDiagnosticsMatterMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SignificantDiscoveryAnalyticalSolutionsMattersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Discovery & Analytical Solutions Matter(s) [Member]",
        "label": "Significant Discovery & Analytical Solutions Matter(s) [Member]",
        "terseLabel": "Particular Discovery & Analytical Solutions Case [Member]"
       }
      }
     },
     "localname": "SignificantDiscoveryAnalyticalSolutionsMattersMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SignificantEnvironmentalMatters": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant environmental matters",
        "label": "Significant environmental matters",
        "terseLabel": "Significant environmental matters"
       }
      }
     },
     "localname": "SignificantEnvironmentalMatters",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_SingaporeFinlandNetherlandsandChinaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Singapore, Finland, Netherlands and China [Member]",
        "label": "Singapore, Finland, Netherlands and China [Member]",
        "terseLabel": "Singapore, Finland, Netherlands and China [Member]"
       }
      }
     },
     "localname": "SingaporeFinlandNetherlandsandChinaMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_SingaporeFinlandandTheNetherlandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Singapore, Finland, and The Netherlands [Member]",
        "label": "Singapore, Finland, and The Netherlands [Member]",
        "terseLabel": "Singapore, Finland, and The Netherlands [Member]"
       }
      }
     },
     "localname": "SingaporeFinlandandTheNetherlandsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_StockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Awards [Member]",
        "label": "Stock Awards [Member]",
        "terseLabel": "Stock Awards [Member]"
       }
      }
     },
     "localname": "StockAwardsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_StockCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock compensation",
        "label": "Stock compensation [Member]",
        "terseLabel": "Stock compensation [Member]"
       }
      }
     },
     "localname": "StockCompensationMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_StockIssuedDuringPeriodValueStockOptionsExercisedAndRelatedIncomeTaxBenefit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Value Stock Options Exercised and Related Income Tax Benefit",
        "label": "Stock Issued During Period Value Stock Options Exercised and Related Income Tax Benefit",
        "terseLabel": "Exercise of employee stock options and related income tax benefits"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedAndRelatedIncomeTaxBenefit",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_StockOptionsExpirationPeriodAfterDateOfGrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options Expiration Period After Date of Grant",
        "label": "Stock Options Expiration Period After Date of Grant",
        "terseLabel": "Stock Options Expiration Period After Date of Grant"
       }
      }
     },
     "localname": "StockOptionsExpirationPeriodAfterDateOfGrant",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pki_SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information Related To Leases [Table Text Block]",
        "label": "Supplemental Balance Sheet Information Related To Leases [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information Related To Leases [Table Text Block]"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] Supplemental Cash Flow Information Related To Leases [Table]",
        "label": "Supplemental Cash Flow Information Related To Leases [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information Related To Leases [Table Text Block]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pki_SuzhouPerkinElmerMedicalLaboratoryCo.LtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Suzhou PerkinElmer Medical Laboratory Co. Ltd [Member]",
        "label": "Suzhou PerkinElmer Medical Laboratory Co. Ltd [Member]",
        "terseLabel": "Suzhou PerkinElmer Medical Laboratory Co. Ltd [Member]"
       }
      }
     },
     "localname": "SuzhouPerkinElmerMedicalLaboratoryCo.LtdMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TaxAdjustmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Adjustments [Axis]",
        "label": "Tax Adjustments [Axis]",
        "terseLabel": "Tax Adjustments [Axis]"
       }
      }
     },
     "localname": "TaxAdjustmentsAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_TaxAdjustmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Tax Adjustments [Axis]",
        "label": "Tax Adjustments [Domain]",
        "terseLabel": "Tax Adjustments [Domain]"
       }
      }
     },
     "localname": "TaxAdjustmentsDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TaxImpactofCumulativeAdjustmentsDeferredTaxLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Impact of Cumulative Adjustments,, Deferred Tax Liabilities",
        "label": "Tax Impact of Cumulative Adjustments,, Deferred Tax Liabilities",
        "terseLabel": "Tax Impact of Cumulative Adjustments, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "TaxImpactofCumulativeAdjustmentsDeferredTaxLiabilities",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Taxeffectofdispositionofabusiness": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax effect of disposition of a business",
        "label": "Tax effect of disposition of a business",
        "terseLabel": "Tax effect of disposition of a business"
       }
      }
     },
     "localname": "Taxeffectofdispositionofabusiness",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_TaxelectionsadjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax elections adjustments [Member]",
        "label": "Tax elections adjustments [Member]",
        "terseLabel": "Tax elections adjustments [Member]"
       }
      }
     },
     "localname": "TaxelectionsadjustmentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TaximpactofCumulativeAdjustmentsDeferredIncomeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax impact of Cumulative Adjustments, Deferred Income Tax",
        "label": "Tax impact of Cumulative Adjustments, Deferred Income Tax",
        "terseLabel": "Tax impact of Cumulative Adjustments, Deferred Income Tax"
       }
      }
     },
     "localname": "TaximpactofCumulativeAdjustmentsDeferredIncomeTax",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_TechnicalServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technical Services Business [Member]",
        "label": "Technical Services Business [Member]",
        "terseLabel": "Technical Services Business [Member]"
       }
      }
     },
     "localname": "TechnicalServicesBusinessMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TermLoanCreditFacility12MonthsMaturityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Credit Facility, 12 Months Maturity [Member]",
        "label": "Term Loan Credit Facility, 12 Months Maturity [Member]",
        "terseLabel": "Term Loan Credit Facility, 12 Months Maturity [Member]"
       }
      }
     },
     "localname": "TermLoanCreditFacility12MonthsMaturityMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TermLoanCreditFacilityMaturing2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Credit Facility Maturing 2024",
        "label": "Term Loan Credit Facility Maturing 2024 [Member]",
        "terseLabel": "Term Loan Credit Facility Maturing 2024"
       }
      }
     },
     "localname": "TermLoanCreditFacilityMaturing2024Member",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TermLoanCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Credit Facility, Maximum Borrowing Capacity",
        "label": "Term Loan Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Term Loan Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "TermLoanCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_TermLoanCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Credit Facility",
        "label": "Term Loan Credit Facility [Member]",
        "terseLabel": "Term Loan Credit Facility [Member]"
       }
      }
     },
     "localname": "TermLoanCreditFacilityMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_Terminationfees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination fees",
        "label": "Termination fees",
        "terseLabel": "Termination fees"
       }
      }
     },
     "localname": "Terminationfees",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_TotalInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total international [Member]",
        "label": "Total international [Member]",
        "terseLabel": "Total international [Member]"
       }
      }
     },
     "localname": "TotalInternationalMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TradeNamesAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Names and Patents",
        "label": "Trade Names and Patents [Member]",
        "terseLabel": "Trade Names and Patents [Member]"
       }
      }
     },
     "localname": "TradeNamesAndPatentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TradeNamesAndTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Names and Trademarks [Member]",
        "label": "Trade Names And Trademarks [Member]",
        "terseLabel": "Trade Names And Trademarks [Member]"
       }
      }
     },
     "localname": "TradeNamesAndTrademarksMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TradingSymbolAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading Symbol [Axis]",
        "label": "Trading Symbol [Axis]",
        "terseLabel": "Trading Symbol [Axis]"
       }
      }
     },
     "localname": "TradingSymbolAxis",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "pki_TradingSymbolDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Trading Symbol [Axis]",
        "label": "Trading Symbol [Domain]",
        "terseLabel": "Trading Symbol [Domain]"
       }
      }
     },
     "localname": "TradingSymbolDomain",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TreasuryRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Rate [Member]",
        "label": "Treasury Rate [Member]",
        "terseLabel": "Treasury Rate [Member]"
       }
      }
     },
     "localname": "TreasuryRateMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TrueupofReturntoProvisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "True-up of Return-to-Provision [Member]",
        "label": "True-up of Return-to-Provision [Member]",
        "terseLabel": "True-up of Return-to-Provision [Member]"
       }
      }
     },
     "localname": "TrueupofReturntoProvisionMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TulipDiagnosticsPrivateLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tulip Diagnostics Private Limited [Member]",
        "label": "Tulip Diagnostics Private Limited [Member]",
        "terseLabel": "Tulip Diagnostics Private Limited [Member]"
       }
      }
     },
     "localname": "TulipDiagnosticsPrivateLimitedMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_TwoThousandNineIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Nine Incentive Plan [Member]",
        "label": "Two Thousand Nine Incentive Plan [Member]",
        "terseLabel": "Two Thousand Nine Incentive Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandNineIncentivePlanMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_USTaxationOfMultinationalOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. taxation of multinational operations",
        "label": "U.S. taxation of multinational operations",
        "terseLabel": "U.S. taxation of multinational operations"
       }
      }
     },
     "localname": "USTaxationOfMultinationalOperations",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Unamortizeddiscountanddebtissuancecosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unamortized discount and debt issuance costs",
        "label": "Unamortized discount and debt issuance costs",
        "terseLabel": "Unamortized discount and debt issuance costs"
       }
      }
     },
     "localname": "Unamortizeddiscountanddebtissuancecosts",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UnbilledReceivablesTransferredToAccountsReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled Receivables Transferred To Accounts Receivables",
        "label": "Unbilled Receivables Transferred To Accounts Receivables",
        "terseLabel": "Unbilled Receivables Transferred To Accounts Receivables"
       }
      }
     },
     "localname": "UnbilledReceivablesTransferredToAccountsReceivables",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UncertainTaxBenefitsIfRecognizedThatCouldAffectTheDiscontinuingOperationsEffectiveTaxRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncertain tax benefits if recognized that could affect the discontinuing operations effective tax rate",
        "label": "Uncertain tax benefits if recognized that could affect the discontinuing operations effective tax rate",
        "terseLabel": "Uncertain tax benefits if recognized that could affect the discontinuing operations effective tax rate"
       }
      }
     },
     "localname": "UncertainTaxBenefitsIfRecognizedThatCouldAffectTheDiscontinuingOperationsEffectiveTaxRate",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UndistributedEarningsofForeignSubsidiariesNotMeetingRequirementstobeReinvested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undistributed Earnings of Foreign Subsidiaries Not Meeting Requirements to be Reinvested",
        "label": "Undistributed Earnings of Foreign Subsidiaries Not Meeting Requirements to be Reinvested",
        "terseLabel": "Undistributed Earnings of Foreign Subsidiaries Not Meeting Requirements to be Reinvested"
       }
      }
     },
     "localname": "UndistributedEarningsofForeignSubsidiariesNotMeetingRequirementstobeReinvested",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UnrealizedGainLossonNetInvestmentHedgeinAOCI": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized Gain (Loss) on Net Investment Hedge in AOCI",
        "label": "Unrealized Gain (Loss) on Net Investment Hedge in AOCI",
        "terseLabel": "Unrealized Gain (Loss) on Net Investment Hedge in AOCI"
       }
      }
     },
     "localname": "UnrealizedGainLossonNetInvestmentHedgeinAOCI",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UnrecognizedTaxBenefitsDiscreteTaxActivitiesDuringtheYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Discrete Tax Activities During the Year",
        "label": "Unrecognized Tax Benefits, Discrete Tax Activities During the Year",
        "terseLabel": "Contingencies and Non-Cash Tax Matters"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDiscreteTaxActivitiesDuringtheYear",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UnrecognizedTaxBenefitsEndingBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Ending Balance",
        "label": "Unrecognized Tax Benefits, Ending Balance",
        "terseLabel": "Unrecognized Tax Benefits, Ending Balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsEndingBalance",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UnrecognizedTaxBenefitsExpectedToBeResolvedWithInYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncertain tax positions, including accrued interest, net of tax benefits and penalities, which are expected to be resolved within the next year.",
        "label": "Unrecognized Tax Benefits Expected To Be Resolved With In A Year",
        "terseLabel": "Unrecognized Tax Benefits Expected To Be Resolved With In A Year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsExpectedToBeResolvedWithInYear",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UnrecognizedTaxBenefitsExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax (benefits) expense",
        "label": "Unrecognized tax (benefits) expense [Member]",
        "terseLabel": "Unrecognized tax (benefits) expense [Member]"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsExpenseMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslationAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation Adjustments",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation Adjustments",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslationAdjustments",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increases Resulting from Acquisitions",
        "label": "Unrecognized Tax Benefits, Increases Resulting from Acquisitions",
        "terseLabel": "Unrecognized Tax Benefits, Increases Resulting from Acquisitions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisitions",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_Unrecognizedpriorservicecreditcostnetoftax1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized prior service credit (cost), net of tax1",
        "label": "Unrecognized prior service credit (cost), net of tax1",
        "terseLabel": "Unrecognized prior service credit (cost), net of tax1"
       }
      }
     },
     "localname": "Unrecognizedpriorservicecreditcostnetoftax1",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pki_ValuationallowanceadjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance adjustments [Member]",
        "label": "Valuation allowance adjustments [Member]",
        "terseLabel": "Valuation allowance adjustments [Member]"
       }
      }
     },
     "localname": "ValuationallowanceadjustmentsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_VanadisDiagnosticsABDNALabsAndBiosenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vanadis Diagnostics AB, DNA Labs and Biosense",
        "label": "Vanadis Diagnostics AB, DNA Labs and Biosense [Member]",
        "terseLabel": "Vanadis Diagnostics AB, DNA Labs and Biosense [Member]"
       }
      }
     },
     "localname": "VanadisDiagnosticsABDNALabsAndBiosenseMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_VanadisDiagnosticsABMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vanadis Diagnostics AB [Member]",
        "label": "Vanadis Diagnostics AB [Member]",
        "terseLabel": "Vanadis Diagnostics AB [Member]"
       }
      }
     },
     "localname": "VanadisDiagnosticsABMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_VanadisDiagnosticsABSSIAndDNALabsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vanadis Diagnostics AB, SSI and DNA Labs",
        "label": "Vanadis Diagnostics AB, SSI and DNA Labs [Member]",
        "terseLabel": "Vanadis Diagnostics AB, SSI and DNA Labs [Member]"
       }
      }
     },
     "localname": "VanadisDiagnosticsABSSIAndDNALabsMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_WeightedAverageEffectiveEurocurrencyRateIncludingTheMarginMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average effective Eurocurrency Rate, including the margin",
        "label": "Weighted average effective Eurocurrency Rate, including the margin [Member]",
        "terseLabel": "Weighted average effective Eurocurrency Rate, including the margin"
       }
      }
     },
     "localname": "WeightedAverageEffectiveEurocurrencyRateIncludingTheMarginMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pki_WeightedAverageEurocurrencyInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average Eurocurrency interest rate",
        "label": "Weighted average Eurocurrency interest rate [Member]",
        "terseLabel": "Weighted average Eurocurrency interest rate"
       }
      }
     },
     "localname": "WeightedAverageEurocurrencyInterestRateMember",
     "nsuri": "http://www.perkinelmer.com/20230101",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas [Member]"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia [Member]"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r427",
      "r476",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r504",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r599",
      "r601",
      "r603",
      "r604",
      "r1216",
      "r1217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r427",
      "r476",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r504",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r599",
      "r601",
      "r603",
      "r604",
      "r1216",
      "r1217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r424",
      "r425",
      "r609",
      "r637",
      "r1078",
      "r1080"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r510",
      "r1114",
      "r1222",
      "r1362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetAccountsReceivableNetTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ManagementMember": {
     "auth_ref": [
      "r1188",
      "r1345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management [Member]",
        "terseLabel": "Management [Member]"
       }
      }
     },
     "localname": "ManagementMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansNonqualifiedDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r588",
      "r589",
      "r591",
      "r592",
      "r746",
      "r985",
      "r1016",
      "r1047",
      "r1048",
      "r1111",
      "r1129",
      "r1137",
      "r1218",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r588",
      "r589",
      "r591",
      "r592",
      "r746",
      "r985",
      "r1016",
      "r1047",
      "r1048",
      "r1111",
      "r1129",
      "r1137",
      "r1218",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r510",
      "r1114",
      "r1222",
      "r1362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetAccountsReceivableNetTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r506",
      "r990",
      "r1112",
      "r1135",
      "r1213",
      "r1214",
      "r1222",
      "r1361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r506",
      "r990",
      "r1112",
      "r1135",
      "r1213",
      "r1214",
      "r1222",
      "r1361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r588",
      "r589",
      "r591",
      "r592",
      "r694",
      "r746",
      "r779",
      "r780",
      "r781",
      "r961",
      "r985",
      "r1016",
      "r1047",
      "r1048",
      "r1111",
      "r1129",
      "r1137",
      "r1207",
      "r1218",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r588",
      "r589",
      "r591",
      "r592",
      "r694",
      "r746",
      "r779",
      "r780",
      "r781",
      "r961",
      "r985",
      "r1016",
      "r1047",
      "r1048",
      "r1111",
      "r1129",
      "r1137",
      "r1207",
      "r1218",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r424",
      "r425",
      "r609",
      "r637",
      "r1079",
      "r1080"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r747",
      "r1184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r446",
      "r747",
      "r1156",
      "r1184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r507",
      "r508",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1113",
      "r1136",
      "r1222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Segment, Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r507",
      "r508",
      "r1030",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1113",
      "r1136",
      "r1222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]",
        "verboseLabel": "Statement, Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r446",
      "r747",
      "r1156",
      "r1157",
      "r1184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Statement, Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r1188",
      "r1345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansNonqualifiedDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansNonqualifiedDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetAccountsReceivableNetTables",
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by billing status of receivables.",
        "label": "Billing Status, Type [Axis]",
        "terseLabel": "Billing Status, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by industry of counterparty. A counterparty is the other party that participates in a financial transaction.",
        "label": "Industry of Counterparty, Type [Axis]",
        "terseLabel": "Industry of Counterparty, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.",
        "label": "Legal Entity of Counterparty, Type [Axis]",
        "terseLabel": "Legal Entity of Counterparty, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42",
      "r1134"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r1194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetAccountsReceivableNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r1010",
      "r1032"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r512",
      "r513"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetNoncurrent": {
     "auth_ref": [
      "r512",
      "r1003",
      "r1010"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Noncurrent"
       }
      }
     },
     "localname": "AccountsReceivableNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r590",
      "r1100",
      "r1154",
      "r1155",
      "r1208",
      "r1212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Management's estimate of total cost of ultimate disposition of known environmental matters"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingenciesComponentAmount": {
     "auth_ref": [
      "r1105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded amount of the accrual for a material component of an environmental loss contingency.",
        "label": "Accrual for Environmental Loss Contingencies, Component Amount",
        "negatedTerseLabel": "Accrual for Environmental Loss Contingencies, Component Amount"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingenciesComponentAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxes": {
     "auth_ref": [
      "r27",
      "r29",
      "r234",
      "r315",
      "r339"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.",
        "label": "Accrued Income Taxes",
        "terseLabel": "Federal, non-U.S. and state income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r46",
      "r1074"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Payroll and incentives"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r159",
      "r372"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r1163"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax",
        "terseLabel": "Unrealized (losses) gains on securities, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r57",
      "r61",
      "r1265"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Unrecognized prior service costs, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r390",
      "r392",
      "r393",
      "r394",
      "r885"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Foreign currency translation adjustment, net of tax, end of year",
        "periodStartLabel": "Foreign currency translation adjustment, net of tax, beginning of year"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r383",
      "r1011",
      "r1024",
      "r1028"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r58",
      "r61",
      "r272",
      "r950",
      "r1019",
      "r1020",
      "r1164",
      "r1165",
      "r1166",
      "r1181",
      "r1182",
      "r1183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average amortization period (in years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r789",
      "r790",
      "r791",
      "r1181",
      "r1182",
      "r1183",
      "r1334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital In Excess of Par Value [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": {
     "auth_ref": [
      "r433",
      "r434",
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Axis]",
        "terseLabel": "Adjustments for Change in Accounting Principle [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForChangeInAccountingPrincipleAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r433",
      "r434",
      "r435",
      "r437",
      "r446",
      "r516",
      "r517",
      "r529",
      "r530",
      "r531",
      "r532",
      "r535",
      "r536",
      "r789",
      "r790",
      "r791",
      "r819",
      "r820",
      "r821",
      "r822",
      "r842",
      "r843",
      "r844",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r897",
      "r898",
      "r917",
      "r918",
      "r923",
      "r924",
      "r925",
      "r926",
      "r944",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r994",
      "r995",
      "r996",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r224",
      "r225",
      "r751"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total pre-tax stock-based compensation expense",
        "verboseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r384",
      "r515",
      "r537",
      "r539",
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Accounts Receivable, Allowance for Credit Loss, Ending Balance",
        "periodStartLabel": "Accounts Receivable, Allowance for Credit Loss, Beginning Balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r384",
      "r515",
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Reserves for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": {
     "auth_ref": [
      "r1194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Accounts Receivable, Allowance for Credit Loss, Writeoff"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "terseLabel": "Allowance for Credit Loss, Receivable, Other, Current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r628",
      "r920",
      "r1109",
      "r1110",
      "r1174"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "verboseLabel": "Amortization of deferred debt issuance costs, interest rate hedge and accretion of discounts"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r100",
      "r143",
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Total amortization expense related to finite-lived intangible assets",
        "verboseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Number of potentially dilutive securities excluded from calculation due to antidilutive impact"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r100",
      "r155"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetRetirementObligationsPolicy": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset.",
        "label": "Asset Retirement Obligation [Policy Text Block]",
        "terseLabel": "Asset Retirement Obligations [Policy Text Block]"
       }
      }
     },
     "localname": "AssetRetirementObligationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r313",
      "r337",
      "r376",
      "r419",
      "r484",
      "r496",
      "r502",
      "r527",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r600",
      "r602",
      "r604",
      "r605",
      "r849",
      "r852",
      "r887",
      "r1134",
      "r1216",
      "r1217",
      "r1346"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]",
        "terseLabel": "Assets and Liabilities, Lessee [Abstract]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r366",
      "r388",
      "r419",
      "r527",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r600",
      "r602",
      "r604",
      "r605",
      "r849",
      "r852",
      "r887",
      "r1134",
      "r1216",
      "r1217",
      "r1346"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r161",
      "r364",
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161",
      "r364",
      "r365"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "verboseLabel": "Current assets of discontinued operations"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r131",
      "r520",
      "r546",
      "r1002"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Investments in debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r130",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Investments in debt securities, Current"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r130",
      "r370",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Investments in debt securities, Noncurrent"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income.",
        "label": "Available-for-Sale Securities, Noncurrent",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Available-for-Sale Securities [Table Text Block]",
        "terseLabel": "Available-for-sale Securities [Table Text Block]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesMember": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available-for-Sale Securities [Member]",
        "terseLabel": "Available-for-sale Securities [Member]"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r754",
      "r755",
      "r756",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r282",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ChangesinAccountingPoliciesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and leasehold Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r840",
      "r1123",
      "r1126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesTables",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r249",
      "r250",
      "r840",
      "r1123",
      "r1126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesTables",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business Acquisition, Transaction Costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r1327",
      "r1328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Business Acquisition, Pro Forma Earnings Per Share, Basic"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r1327",
      "r1328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Business Acquisition, Pro Forma Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r1327",
      "r1328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information [Table Text Block]"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Business Acquisition, Goodwill, Expected Tax Deductible Amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
     "auth_ref": [
      "r838",
      "r839"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax",
        "terseLabel": "Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r838",
      "r839"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business Combination, Acquisition Related Costs",
        "verboseLabel": "Acquisition and divestiture-related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r259",
      "r260",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r259",
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r257",
      "r259",
      "r260",
      "r846"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Business Combination, Consideration Transferred, Liabilities Incurred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r848",
      "r1173"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents a description of such arrangements.",
        "label": "Business Combination, Contingent Consideration Arrangements, Description",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Description"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r258",
      "r261",
      "r847"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "negatedTerseLabel": "Business Combination, Contingent Consideration, Liability, Total"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r258",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "negatedTerseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r258",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r267",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "Business Combinations and Asset Purchases"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r251",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedLabel": "Liabilities assumed",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r251",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r251",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations [Policy Text Block]"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r107",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Nature of Operations and Accounting Policies"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpenditureDiscontinuedOperations": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capital expenditure attributable to discontinued operations.",
        "label": "Capital Expenditure, Discontinued Operations",
        "terseLabel": "Capital Expenditure, Discontinued Operations"
       }
      }
     },
     "localname": "CapitalExpenditureDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value [Member]"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "negatedTerseLabel": "Cash Acquired from Acquisition",
        "terseLabel": "Cash Acquired from Acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r102",
      "r369",
      "r1071"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash [Member]",
        "verboseLabel": "Cash and Cash Equivalents [Member]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Flows [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r95",
      "r102",
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r95",
      "r305"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "terseLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Cash Provided by (Used in) Financing Activities, Discontinued Operations",
        "terseLabel": "Net cash used in financing activities of discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r16",
      "r95"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "verboseLabel": "Net cash used in investing activities of discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r16",
      "r95"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by operating activities of discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleMember": {
     "auth_ref": [
      "r433",
      "r434",
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Domain]",
        "terseLabel": "Adjustments for Change in Accounting Principle [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis": {
     "auth_ref": [
      "r1090"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of borrower determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Type of Borrower [Axis]",
        "terseLabel": "Type of Borrower [Axis]"
       }
      }
     },
     "localname": "ClassOfFinancingReceivableTypeOfBorrowerAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of entity or individual who borrows funds.",
        "label": "Class of Financing Receivable, Type of Borrower [Domain]",
        "terseLabel": "Class of Financing Receivable, Type of Borrower [Domain]"
       }
      }
     },
     "localname": "ClassOfFinancingReceivableTypeOfBorrowerDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r419",
      "r451",
      "r452",
      "r454",
      "r456",
      "r466",
      "r467",
      "r527",
      "r593",
      "r596",
      "r597",
      "r598",
      "r604",
      "r605",
      "r635",
      "r636",
      "r639",
      "r643",
      "r650",
      "r887",
      "r1049",
      "r1153",
      "r1177",
      "r1185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollateralAxis": {
     "auth_ref": [
      "r1093"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Axis]",
        "terseLabel": "Collateral [Axis]"
       }
      }
     },
     "localname": "CollateralAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Domain]",
        "terseLabel": "Collateral [Domain]"
       }
      }
     },
     "localname": "CollateralDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r51",
      "r321",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (see Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r173",
      "r585",
      "r586",
      "r1034",
      "r1215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends (per share)",
        "verboseLabel": "Cash dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r1181",
      "r1182",
      "r1334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock Amount [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.perkinelmer.com/role/CoverPage"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r33",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r33",
      "r1134"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock\u2014$1 par value per share, authorized 300,000,000 shares; issued and outstanding 126,300,000 and 126,241,000 shares at January 1, 2023 and January 2, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold": {
     "auth_ref": [
      "r1167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold.",
        "label": "Compensation Expense, Excluding Cost of Good and Service Sold",
        "terseLabel": "Compensation Expense, Excluding Cost of Good and Service Sold"
       }
      }
     },
     "localname": "CompensationExpenseExcludingCostOfGoodAndServiceSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r64",
      "r398",
      "r400",
      "r408",
      "r1005",
      "r1013"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Description"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r115",
      "r116",
      "r303",
      "r304",
      "r510",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r115",
      "r116",
      "r303",
      "r304",
      "r510",
      "r1029",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r115",
      "r116",
      "r303",
      "r304",
      "r510",
      "r1033",
      "r1364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r115",
      "r116",
      "r303",
      "r304",
      "r510",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r271",
      "r1081"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation [Policy Text Block]"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractTerminationMember": {
     "auth_ref": [
      "r1101",
      "r1102",
      "r1103",
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Contract Termination [Member]",
        "terseLabel": "Contract Termination [Member]"
       }
      }
     },
     "localname": "ContractTerminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]",
        "terseLabel": "Contract with Customer, Asset and Liability [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r1221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Contract Asset, Contract Liability, and Receivable"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r652",
      "r654",
      "r665"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract with Customer, Asset, Net, Current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r652",
      "r653",
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "negatedLabel": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract with Customer, Liability, Current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Investments in debt securities, Convertible to Equity Securities or are due and payable upon event of default"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r1186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate [Member]"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r74",
      "r990"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r168",
      "r169",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring Charges [Policy Text Block]"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CumulativeTranslationAdjustmentSummaryRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Cumulative Translation Adjustment Summary [Roll Forward]",
        "terseLabel": "Cumulative Translation Adjustment Summary [Roll Forward]"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustmentSummaryRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r1180",
      "r1321",
      "r1324"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r1180",
      "r1321"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Non-U.S. current"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r243",
      "r816",
      "r829",
      "r1180"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r1180",
      "r1321",
      "r1324"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r114",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r187",
      "r417",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r622",
      "r629",
      "r630",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r314",
      "r318",
      "r334",
      "r427",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r612",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r921",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r28",
      "r318",
      "r334",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r308",
      "r310",
      "r606",
      "r921",
      "r1107",
      "r1108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Unsecured senior notes, face value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r620",
      "r886",
      "r1107",
      "r1108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Unsecured senior notes, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r48",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Unsecured senior notes, interest rate percent",
        "verboseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r389",
      "r1106",
      "r1336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r49",
      "r427",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r612",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r921",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Debt Instrument, Repurchase Amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r49",
      "r189",
      "r190",
      "r191",
      "r192",
      "r307",
      "r308",
      "r310",
      "r331",
      "r427",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r612",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r631",
      "r921",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r307",
      "r310",
      "r1219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Discount on senior unsecured notes",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "terseLabel": "Debt, Long-term and Short-term, Combined Amount"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities [Member]"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.",
        "label": "Deferred Compensation Arrangement with Individual, Recorded Liability",
        "terseLabel": "Deferred Compensation Arrangement with Individual, Recorded Liability"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRecordedLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansNonqualifiedDeferredCompensationPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.",
        "label": "Deferred Compensation Share-Based Arrangements, Liability, Current and Noncurrent",
        "terseLabel": "Deferred compensation liability"
       }
      }
     },
     "localname": "DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r1180",
      "r1322",
      "r1324"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal deferred expense (benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r243",
      "r1180",
      "r1322"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Non-U.S.deferred expense benefit"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r100",
      "r243",
      "r817",
      "r828",
      "r829",
      "r1180"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred taxes",
        "totalLabel": "Total deferred expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r30",
      "r31",
      "r316",
      "r333",
      "r810"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r1161"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r1180",
      "r1322",
      "r1324"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State deferred expense (benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r811"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred Tax Assets, Gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r1319"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "All other, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions": {
     "auth_ref": [
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from pension benefits.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Pensions",
        "terseLabel": "Accrued pension"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Reserves and accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from restructuring reserve.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "terseLabel": "Deferred Tax Assets, Unrealized Foreign Exchange Losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r812"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance",
        "terseLabel": "Valuation Allowance, Amount"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r230",
      "r1319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTerseLabel": "Deferred Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedTerseLabel": "Deferred Tax Liabilities, Inventory"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs",
        "terseLabel": "Capitalized research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Deferred Tax Liabilities, Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "negatedTerseLabel": "Deferred Tax Liabilities, Prepaid Expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains": {
     "auth_ref": [
      "r240",
      "r1320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on foreign currency transactions.",
        "label": "Deferred Tax Liabilities, Unrealized Currency Transaction Gains",
        "negatedTerseLabel": "Deferred Tax Liabilities, Unrealized Currency Transaction Gains"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r703"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r685",
      "r1121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": {
     "auth_ref": [
      "r699",
      "r1121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held",
        "terseLabel": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r678"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial loss (gain)",
        "terseLabel": "Actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r671",
      "r710",
      "r734",
      "r1121",
      "r1122"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "terseLabel": "Realized gains (losses)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r671",
      "r711",
      "r735",
      "r1121",
      "r1122"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r200",
      "r202"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Net amounts recognized in the consolidated balance sheets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]",
        "terseLabel": "Net amounts recognized in the consolidated balance sheets consist of:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]",
        "terseLabel": "Net amounts recognized in accumulated other comprehensive income consist of:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r312",
      "r336",
      "r669",
      "r670",
      "r693",
      "r1121"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Assets for Plan Benefits, Defined Benefit Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r718",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected rate of return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligations at end of year",
        "periodStartLabel": "Projected benefit obligations at beginning of year",
        "verboseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r680",
      "r742"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "auth_ref": [
      "r682"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Business Combination"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r721",
      "r1119",
      "r1120",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligations:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "verboseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r687",
      "r697",
      "r738",
      "r1119",
      "r1120",
      "r1121",
      "r1122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer's contributions",
        "verboseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanCurtailments": {
     "auth_ref": [
      "r675"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansNonqualifiedDeferredCompensationPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresBenefitObligation": {
     "auth_ref": [
      "r683"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Benefit Obligation, Divestiture",
        "negatedTerseLabel": "Benefit obligation classified in discontinued operations",
        "terseLabel": "Benefit obligation classified in discontinued operations"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": {
     "auth_ref": [
      "r1272"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year",
        "terseLabel": "Unrealized gains (losses)"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": {
     "auth_ref": [
      "r1272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year",
        "negatedTerseLabel": "Prior service cost",
        "terseLabel": "Prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2023-2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r705",
      "r1122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "verboseLabel": "Expected contributions in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r671",
      "r709",
      "r733",
      "r1121",
      "r1122"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      },
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r684",
      "r695",
      "r697",
      "r698",
      "r1119",
      "r1120",
      "r1121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "periodStartLabel": "Fair value of plan assets at beginning of year",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r679"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of exchange rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r671",
      "r676",
      "r708",
      "r732",
      "r1121",
      "r1122"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription": {
     "auth_ref": [
      "r1245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of investment policy and strategy for defined benefit plan asset. Includes, but is not limited to, investment allocation decision and factor pertinent to understanding investment policy and strategy for plan asset. Factor includes, but is not limited to, investment goal, risk management practice, permitted and prohibited investment including use of derivative, diversification, and relationship between plan asset and obligation.",
        "label": "Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description"
       }
      }
     },
     "localname": "DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r706",
      "r730",
      "r1121",
      "r1122"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan cost (credit), classified as other.",
        "label": "Defined Benefit Plan, Other Cost (Credit)",
        "terseLabel": "Defined Benefit Plan, Other Cost (Credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": {
     "auth_ref": [
      "r728",
      "r1121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": {
     "auth_ref": [
      "r728",
      "r1121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r728",
      "r729",
      "r1121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Projected Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "auth_ref": [
      "r728",
      "r729",
      "r1121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r689",
      "r1286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedLabel": "Benefits paid and plan expenses",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r688"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Participant's contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of exchange rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationDecreaseForSale": {
     "auth_ref": [
      "r1250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of decrease in plan asset of defined benefit plan from sale.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Decrease for Sale",
        "negatedTerseLabel": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Decrease for Sale",
        "terseLabel": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Decrease for Sale"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationDecreaseForSale",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase": {
     "auth_ref": [
      "r1250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase in plan asset of defined benefit plan from purchase.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase",
        "terseLabel": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": {
     "auth_ref": [
      "r700",
      "r1121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement",
        "negatedTerseLabel": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r672",
      "r713",
      "r737"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r674",
      "r707",
      "r731",
      "r1121",
      "r1122"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r692"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Defined Benefit Plan, Plan Assets, Payment for Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r1245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Defined Benefit Plan, Equity Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Actuarial assumptions as of the year-end measurement date:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r100",
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r100",
      "r479"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative, Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeGainOnDerivative": {
     "auth_ref": [
      "r854"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain on Derivative",
        "terseLabel": "Derivative, Gain on Derivative"
       }
      }
     },
     "localname": "DerivativeGainOnDerivative",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r283",
      "r284",
      "r287",
      "r288",
      "r1080"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r295",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r280",
      "r283",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1332",
      "r1333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r280",
      "r281",
      "r286",
      "r287",
      "r289",
      "r291",
      "r293",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r274",
      "r275",
      "r280",
      "r281",
      "r290",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging [Policy Text Block]"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r664",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r1222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r753",
      "r785",
      "r786",
      "r788",
      "r793",
      "r1130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "Stock Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block [Abstract]",
        "terseLabel": "Disclosure Text Block [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r2",
      "r4",
      "r6"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "terseLabel": "(Loss) gain on disposition of discontinued operations before income taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r14",
      "r69",
      "r346"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Income from discontinued operations before income taxes",
        "verboseLabel": "Income from discontinued operations before income taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of expected continuing involvement with a discontinued operation after the disposal date, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Discontinued Operation, Period of Continuing Involvement after Disposal",
        "terseLabel": "Discontinued Operation, Period of Continuing Involvement after Disposal"
       }
      }
     },
     "localname": "DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r14",
      "r20",
      "r798",
      "r827",
      "r833"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "terseLabel": "Discontinued operations",
        "verboseLabel": "(Benefit from) provision for income taxes on discontinued operations and dispositions"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r6",
      "r20",
      "r1325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation",
        "terseLabel": "Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r154",
      "r161",
      "r364",
      "r365"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent",
        "terseLabel": "Long-term assets of discontinued operations",
        "verboseLabel": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "auth_ref": [
      "r15",
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "terseLabel": "Disposal Group, Including Discontinued Operation, General and Administrative Expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Goodwill, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r154",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r154",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r154",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r154",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r154",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r15",
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r24",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r1123",
      "r1126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]",
        "verboseLabel": "Disposal Groups, Including Discontinued Operations, Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date to be Paid",
        "terseLabel": "Dividends Payable, Date to be Paid"
       }
      }
     },
     "localname": "DividendPayableDateToBePaidDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r193",
      "r330"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r27",
      "r29",
      "r317",
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends accrued"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date Declared",
        "terseLabel": "Dividends Payable, Date Declared"
       }
      }
     },
     "localname": "DividendsPayableDateDeclaredDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Country [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r409",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r449",
      "r451",
      "r454",
      "r455",
      "r456",
      "r460",
      "r868",
      "r869",
      "r1006",
      "r1014",
      "r1085"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r409",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r451",
      "r454",
      "r455",
      "r456",
      "r460",
      "r868",
      "r869",
      "r1006",
      "r1014",
      "r1085"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r905"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r784"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Stock-based compensation costs capitalized as part of inventory"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r787"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock, granted"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for recognition of unrecognized compensation cost, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Total income tax benefit recognized for stock-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r188",
      "r359",
      "r402",
      "r403",
      "r404",
      "r428",
      "r429",
      "r430",
      "r434",
      "r443",
      "r445",
      "r465",
      "r532",
      "r651",
      "r789",
      "r790",
      "r791",
      "r821",
      "r822",
      "r867",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r914",
      "r950",
      "r1019",
      "r1020",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesByIndustryAxis": {
     "auth_ref": [
      "r1092"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.",
        "label": "Industry Sector [Axis]",
        "terseLabel": "Industry Sector [Axis]"
       }
      }
     },
     "localname": "EquitySecuritiesByIndustryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "auth_ref": [
      "r883"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "terseLabel": "Equity Securities, FV-NI and without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesIndustryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.",
        "label": "Industry Sector [Domain]",
        "terseLabel": "Industry Sector [Domain]"
       }
      }
     },
     "localname": "EquitySecuritiesIndustryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r139",
      "r335",
      "r1138",
      "r1139",
      "r1140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity Securities without Readily Determinable Fair Value [Line Items]",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value [Line Items]"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable": {
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value [Table]",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value [Table]"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock": {
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value [Table Text Block]",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Closure Of Excess Facility Space [Member]",
        "verboseLabel": "Facility Closing [Member]"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r874",
      "r875",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r296",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r620",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r875",
      "r958",
      "r959",
      "r960",
      "r1107",
      "r1108",
      "r1119",
      "r1120",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Defined Benefit Plan, Fair Value of Plan Assets by Measurement [Axis]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r296",
      "r300",
      "r620",
      "r1107",
      "r1108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r874",
      "r875",
      "r877",
      "r878",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Fair Value by Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r620",
      "r1107",
      "r1108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging [Member]"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r620",
      "r697",
      "r702",
      "r875",
      "r958",
      "r1119",
      "r1120",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r620",
      "r697",
      "r702",
      "r875",
      "r959",
      "r1107",
      "r1108",
      "r1119",
      "r1120",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Significant Other Observable Inputs (Level 2) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r620",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r875",
      "r960",
      "r1107",
      "r1108",
      "r1119",
      "r1120",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Significant Unobservable Inputs (Level 3) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r297",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Level 3 Net Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": {
     "auth_ref": [
      "r879"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3",
        "terseLabel": "Reclassified to other current liabilities for milestone achieved"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "negatedTerseLabel": "Change in fair value (included within selling, general and administrative expenses)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "negatedLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "negatedPeriodEndLabel": "Balance end of period",
        "negatedPeriodStartLabel": "Balance beginning of period",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationofBeginningandEndingLevel3NetLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r620",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r958",
      "r959",
      "r960",
      "r1107",
      "r1108",
      "r1119",
      "r1120",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value Plan Asset Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r880",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r420",
      "r798"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "Federal total"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r930",
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r521",
      "r522",
      "r538",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r548",
      "r549",
      "r631",
      "r648",
      "r856",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r1097",
      "r1190",
      "r1191",
      "r1192",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]",
        "verboseLabel": "Schedule of Trading Securities and Other Trading Assets, Major Types of Trading Securities and Assets [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablePortfolioSegmentAxis": {
     "auth_ref": [
      "r538",
      "r542",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1088",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.",
        "label": "Financing Receivable Portfolio Segment [Axis]",
        "terseLabel": "Financing Receivable Portfolio Segment [Axis]"
       }
      }
     },
     "localname": "FinancingReceivablePortfolioSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablePortfolioSegmentDomain": {
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.",
        "label": "Financing Receivable Portfolio Segment [Domain]",
        "terseLabel": "Financing Receivable Portfolio Segment [Domain]"
       }
      }
     },
     "localname": "FinancingReceivablePortfolioSegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": {
     "auth_ref": [
      "r127",
      "r128",
      "r514",
      "r543",
      "r544",
      "r545",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1089",
      "r1091",
      "r1095",
      "r1096",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Axis]",
        "terseLabel": "Class of Financing Receivable [Axis]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": {
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Domain]",
        "terseLabel": "Class of Financing Receivable [Domain]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r374",
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Future Amortization Expense, Year One"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Future Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Future Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Future Amortization Expense, Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Future Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r993",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r149",
      "r1000"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross amortizable intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r144",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r149",
      "r993"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net amortizable intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for purchase accounting adjustments.",
        "label": "Finite-Lived Intangible Assets, Purchase Accounting Adjustments",
        "terseLabel": "Finite-Lived Intangible Assets, Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Periods [Policy Text Block]"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r1121",
      "r1246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Fixed Income Securities [Member]"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "negatedTerseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "negatedLabel": "Foreign exchange derivative liabilities, net"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r899",
      "r901",
      "r903",
      "r904"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation of Foreign Currencies [Policy Text Block]"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward [Member]"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r1246",
      "r1363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Debt Security, Government, Non-US [Member]"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "Non-U.S. total"
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r1287",
      "r1288",
      "r1289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan [Member]"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r1174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "terseLabel": "Gain (Loss) on Disposition of Assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r851",
      "r1174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Gain (Loss) on Disposition of Business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "auth_ref": [
      "r1168",
      "r1169",
      "r1174",
      "r1356",
      "r1360"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
        "label": "Gain on Sale of Investments",
        "negatedTerseLabel": "Gain on Sale of Investments"
       }
      }
     },
     "localname": "GainOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r100",
      "r185",
      "r186"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralBusinessMember": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforwards which include, but are not limited to, investment, alcohol fuels, low income housing, alternative fuels, alternative motor vehicles, hurricane relief, disabled access, renewable resources electricity production, employer social security, orphan drug, new markets, employer provided child care facilities and services, biodiesel fuels, low sulfur diesel fuel production, distilled spirits and the advanced nuclear power facilities credit.",
        "label": "General Business Tax Credit Carryforward [Member]",
        "terseLabel": "General Business [Member]"
       }
      }
     },
     "localname": "GeneralBusinessMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r1007",
      "r1008",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1094"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]",
        "terseLabel": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [
      "r1007",
      "r1008",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]",
        "terseLabel": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r373",
      "r553",
      "r1001",
      "r1099",
      "r1134",
      "r1196",
      "r1203"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r555",
      "r1099"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r245",
      "r1202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r72",
      "r419",
      "r484",
      "r495",
      "r501",
      "r504",
      "r527",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r600",
      "r602",
      "r604",
      "r605",
      "r887",
      "r1087",
      "r1216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgeFundsMultistrategyMember": {
     "auth_ref": [
      "r1121",
      "r1246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in registered hedge funds structured to implement multiple investment strategies with the purpose of portfolio diversification.",
        "label": "Hedge Funds, Multi-strategy [Member]",
        "terseLabel": "Multi-strategy hedge funds [Member]",
        "verboseLabel": "Other Types of Investments, Multi-strategy hedge funds [Member]"
       }
      }
     },
     "localname": "HedgeFundsMultistrategyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r280",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r73",
      "r101",
      "r269",
      "r438",
      "r439",
      "r440",
      "r441",
      "r453",
      "r456"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Operating income from continuing operations",
        "totalLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r421",
      "r830"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r68",
      "r311",
      "r323",
      "r349",
      "r484",
      "r495",
      "r501",
      "r504",
      "r1008",
      "r1087"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r421",
      "r830"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r484",
      "r495",
      "r501",
      "r504",
      "r1087"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income from continuing operations before income taxes",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r66",
      "r322",
      "r324",
      "r345",
      "r409",
      "r433",
      "r438",
      "r439",
      "r440",
      "r441",
      "r451",
      "r454",
      "r455",
      "r869",
      "r1006"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r66",
      "r345",
      "r348",
      "r409",
      "r433",
      "r438",
      "r439",
      "r440",
      "r441",
      "r451",
      "r454",
      "r455",
      "r456",
      "r869",
      "r1006",
      "r1014"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r14",
      "r20",
      "r270"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income from discontinued operations and dispositions"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r69",
      "r346",
      "r348",
      "r409",
      "r452",
      "r454",
      "r455",
      "r1357",
      "r1359"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Income from discontinued operations and dispositions",
        "verboseLabel": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r273",
      "r452",
      "r454",
      "r455"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Income from discontinued operations and dispositions",
        "verboseLabel": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r1123",
      "r1126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r19",
      "r21",
      "r22",
      "r23",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table]",
        "verboseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r569",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Income Statement and Other Comprehensive Income (Loss) Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SummaryOperatingResultsofDiscontinuedOperationsforthePeriodsPriortoDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r422",
      "r800",
      "r808",
      "r815",
      "r826",
      "r831",
      "r834",
      "r835",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r423",
      "r444",
      "r445",
      "r482",
      "r798",
      "r827",
      "r832",
      "r1015"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      },
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation": {
     "auth_ref": [
      "r827",
      "r1326"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for continuing operations, discontinued operations, other comprehensive income, and items charged (credited) directly to shareholders' equity.",
        "label": "Income Tax Expense (Benefit), Intraperiod Tax Allocation",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitIntraperiodTaxAllocation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "auth_ref": [
      "r831"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "negatedTerseLabel": "Income Tax Holiday, Aggregate Dollar Amount"
       }
      }
     },
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayTerminationDate": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date on which the special tax status will terminate.",
        "label": "Income Tax Holiday, Termination Date",
        "terseLabel": "Income Tax Holiday, Termination Date"
       }
      }
     },
     "localname": "IncomeTaxHolidayTerminationDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r401",
      "r796",
      "r797",
      "r808",
      "r809",
      "r814",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r1317"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1317"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "verboseLabel": "Non-U.S. rate differential, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r799"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Tax at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r1317"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r1317"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r1317"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Prior year tax matters"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r1317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1317"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "auth_ref": [
      "r1317"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "negatedTerseLabel": "Federal tax credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r96",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "auth_ref": [
      "r1173"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "terseLabel": "Increase (Decrease) in Contract with Customer, Asset"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r986",
      "r1173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Increase (Decrease) in Contract with Customer, Liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "verboseLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities which (used) provided cash, excluding effects from companies purchased and divested:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInUnbilledReceivables": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts.",
        "label": "Increase (Decrease) in Unbilled Receivables",
        "terseLabel": "Increase (Decrease) in Unbilled Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInUnbilledReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Non-amortizing intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndustryOfCounterpartyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The industry of the party or parties having primary responsibility to meet the obligations of the arrangement with the entity.",
        "label": "Industry of Counterparty [Domain]",
        "terseLabel": "Industry of Counterparty [Domain]"
       }
      }
     },
     "localname": "IndustryOfCounterpartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r142",
      "r147"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Totals"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of the entity to which the long-term intercompany foreign balances of the entity relate.",
        "label": "Intercompany Foreign Currency Balance by Description [Axis]",
        "terseLabel": "Intercompany Foreign Currency Balance by Description [Axis]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceByDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name or description of the foreign entity or investment that is of a long-term nature.",
        "label": "Intercompany Foreign Currency Balance, Name [Domain]",
        "terseLabel": "Intercompany Foreign Currency Balance, Name [Domain]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r309",
      "r326",
      "r405",
      "r478",
      "r919"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 8.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense",
        "verboseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r1175"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r411",
      "r413",
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest Paid, Excluding Capitalized Interest, Operating Activities"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwaptionMember": {
     "auth_ref": [
      "r1132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option granting the owner the right but not the obligation to enter into an interest rate swap.",
        "label": "Interest Rate Swaption [Member]",
        "terseLabel": "Interest Rate Swaption"
       }
      }
     },
     "localname": "InterestRateSwaptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS) [Member]"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories, Net"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InventoriesNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r140",
      "r1075"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/InventoriesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "verboseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r386",
      "r1072",
      "r1134"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/InventoriesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/InventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r368",
      "r385",
      "r462",
      "r550",
      "r551",
      "r552",
      "r988",
      "r1082"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r140",
      "r1077"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/InventoriesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "verboseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r140",
      "r1076"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/InventoriesNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "verboseLabel": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r77",
      "r477"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r874"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "negatedTerseLabel": "Marketable securities"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r1223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r1342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesDetails",
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r1342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesDetails",
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor entity's leasing arrangements for operating, capital and leveraged leases.",
        "label": "Leases of Lessor Disclosure [Text Block]",
        "terseLabel": "Leases of Lessor Disclosure [Text Block]"
       }
      }
     },
     "localname": "LeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalEntityTypeOfCounterpartyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of the other party participating in a financial transaction.",
        "label": "Legal Entity Type of Counterparty [Domain]",
        "terseLabel": "Legal Entity Type of Counterparty [Domain]"
       }
      }
     },
     "localname": "LegalEntityTypeOfCounterpartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "terseLabel": "Legal Fees"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r940",
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Lessor, Leases [Policy Text Block]",
        "terseLabel": "Lessor, Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit issued and outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r419",
      "r527",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r600",
      "r602",
      "r604",
      "r605",
      "r850",
      "r852",
      "r853",
      "r887",
      "r1086",
      "r1216",
      "r1346",
      "r1347"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r38",
      "r319",
      "r342",
      "r1134",
      "r1179",
      "r1193",
      "r1337"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r47",
      "r367",
      "r419",
      "r527",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r600",
      "r602",
      "r604",
      "r605",
      "r850",
      "r852",
      "r853",
      "r887",
      "r1134",
      "r1216",
      "r1346",
      "r1347"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r161",
      "r364",
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r156",
      "r161",
      "r364",
      "r365"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Current liabilities of discontinued operations",
        "verboseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r154",
      "r161",
      "r364",
      "r365"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent",
        "terseLabel": "Long-term liabilities of discontinued operations",
        "verboseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r1223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "terseLabel": "License"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licenses [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r28",
      "r318",
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Revolving credit facility outstanding balance",
        "verboseLabel": "Aggregate borrowings under the amended facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Unsecured revolving credit facility, amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Unsecured Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation Settlement, Expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r1189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Accounts Receivable, Net"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r28",
      "r318",
      "r340",
      "r619",
      "r634",
      "r1107",
      "r1108"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "negatedTotalLabel": "Total",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r183",
      "r427",
      "r1220"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 6.0,
       "parentTag": "pki_LongTermDebtBeforeUnamortizedDiscount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "2027 and Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r183",
      "r427",
      "r624"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 1.0,
       "parentTag": "pki_LongTermDebtBeforeUnamortizedDiscount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r183",
      "r427",
      "r624"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 5.0,
       "parentTag": "pki_LongTermDebtBeforeUnamortizedDiscount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r183",
      "r427",
      "r624"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 4.0,
       "parentTag": "pki_LongTermDebtBeforeUnamortizedDiscount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r183",
      "r427",
      "r624"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 3.0,
       "parentTag": "pki_LongTermDebtBeforeUnamortizedDiscount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r183",
      "r427",
      "r624"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/DebtDetails": {
       "order": 2.0,
       "parentTag": "pki_LongTermDebtBeforeUnamortizedDiscount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.",
        "label": "Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate",
        "terseLabel": "Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongtermDebtPercentageBearingFixedInterestAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Amount",
        "terseLabel": "Long-term Debt, Percentage Bearing Fixed Interest, Amount"
       }
      }
     },
     "localname": "LongtermDebtPercentageBearingFixedInterestAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtPercentageBearingVariableInterestAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.",
        "label": "Long-Term Debt, Percentage Bearing Variable Interest, Amount",
        "terseLabel": "Long-term Debt, Percentage Bearing Variable Interest, Amount"
       }
      }
     },
     "localname": "LongtermDebtPercentageBearingVariableInterestAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r49",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r587",
      "r1156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r1212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Loss Contingency Accrual, Period Increase (Decrease)"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Abstract]",
        "terseLabel": "Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "MarketableSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Marketable Securities, Noncurrent"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities and Investments [Policy Text Block]"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Marketable Securities and Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-Term Debt [Abstract]",
        "terseLabel": "Maturities of Long-term Debt [Abstract]"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum maturity period for foreign exchange contracts, in months"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r1335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "terseLabel": "Warranty reserve activity"
       }
      }
     },
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": {
     "auth_ref": [
      "r1172"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations",
        "totalLabel": "Net cash used in investing activities of continuing operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r95",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "auth_ref": [
      "r95",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "totalLabel": "Net cash provided by operating activities of continuing operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r70",
      "r101",
      "r325",
      "r347",
      "r365",
      "r396",
      "r399",
      "r404",
      "r419",
      "r433",
      "r438",
      "r439",
      "r440",
      "r441",
      "r444",
      "r445",
      "r453",
      "r484",
      "r495",
      "r501",
      "r504",
      "r527",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r600",
      "r602",
      "r604",
      "r605",
      "r869",
      "r887",
      "r1087",
      "r1216"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r362",
      "r431",
      "r432",
      "r435",
      "r436",
      "r446",
      "r447",
      "r448",
      "r518",
      "r519",
      "r533",
      "r534",
      "r823",
      "r824",
      "r825",
      "r865",
      "r871",
      "r872",
      "r873",
      "r894",
      "r895",
      "r896",
      "r927",
      "r928",
      "r945",
      "r951",
      "r997",
      "r998",
      "r999",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Total net long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedLabel": "Interest and other expense (income), net",
        "negatedTotalLabel": "Total interest and other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotionalAmountOfNonderivativeInstruments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on a nonderivative instrument.",
        "label": "Notional Amount of Nonderivative Instruments",
        "terseLabel": "Notional Amount of Nonderivative Instruments"
       }
      }
     },
     "localname": "NotionalAmountOfNonderivativeInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r1187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCycle1": {
     "auth_ref": [
      "r989",
      "r991",
      "r992"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating cycle, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Cycle",
        "terseLabel": "Operating Cycle"
       }
      }
     },
     "localname": "OperatingCycle1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r484",
      "r495",
      "r501",
      "r504",
      "r1087"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income from continuing operations",
        "totalLabel": "Operating income from continuing operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r934",
      "r1133"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r930"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails",
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r930"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r932",
      "r935"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesDetails",
      "http://www.perkinelmer.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r929"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r938",
      "r1133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r937",
      "r1133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next 12 Months",
        "terseLabel": "Operating Leases, Future Minimum Payments Due, Next Twelve Months"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesMinimumRentalCommitmentsUnderNoncancelableOperatingLeasesUnderASC840Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Five Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesMinimumRentalCommitmentsUnderNoncancelableOperatingLeasesUnderASC840Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Four Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesMinimumRentalCommitmentsUnderNoncancelableOperatingLeasesUnderASC840Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Three Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesMinimumRentalCommitmentsUnderNoncancelableOperatingLeasesUnderASC840Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Two Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesMinimumRentalCommitmentsUnderNoncancelableOperatingLeasesUnderASC840Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesMinimumRentalCommitmentsUnderNoncancelableOperatingLeasesUnderASC840Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year",
        "terseLabel": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesMinimumRentalCommitmentsUnderNoncancelableOperatingLeasesUnderASC840Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued operating expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r387",
      "r1134"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r375"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r56",
      "r59",
      "r714"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Unrecognized prior service costs, net of tax, current year change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r55",
      "r59",
      "r900",
      "r902",
      "r907"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": {
     "auth_ref": [
      "r59",
      "r62",
      "r395",
      "r714"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Unrecognized prior service credit (cost), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r61",
      "r65",
      "r403",
      "r908",
      "r910",
      "r914",
      "r1164"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Current year change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax": {
     "auth_ref": [
      "r59",
      "r62",
      "r63",
      "r395",
      "r906"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r59",
      "r62",
      "r63",
      "r395",
      "r906"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r65",
      "r188",
      "r397",
      "r400",
      "r407",
      "r908",
      "r913",
      "r914",
      "r1004",
      "r1012",
      "r1164",
      "r1165"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r59",
      "r62",
      "r138",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r59",
      "r62",
      "r395",
      "r714"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r391",
      "r392"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized (losses) gains on securities, net of tax, current year change",
        "verboseLabel": "Unrealized gains (losses) on securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r282",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets [Member]"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r195",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Interest and Other Expense (Income), Net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r28",
      "r318",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-Term Debt",
        "terseLabel": "Other Long-term Debt"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtCurrent": {
     "auth_ref": [
      "r26",
      "r27"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.",
        "label": "Other Long-Term Debt, Current",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Other Long-term Debt, Current"
       }
      }
     },
     "localname": "OtherLongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.",
        "label": "Other Long-Term Debt, Noncurrent",
        "terseLabel": "Other Long-term Debt, Noncurrent"
       }
      }
     },
     "localname": "OtherLongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPensionPlansDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Other Pension Plan [Member]",
        "terseLabel": "Other Pension Plan [Member]"
       }
      }
     },
     "localname": "OtherPensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r199",
      "r669",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r719",
      "r721",
      "r724",
      "r727",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r743",
      "r744",
      "r745",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefit Plans, Defined Benefit [Member]",
        "verboseLabel": "Other Postretirement Benefits Plan [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r1101",
      "r1102",
      "r1103",
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring [Member]"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment for Contingent Consideration Liability, Financing Activities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Payment for Contingent Consideration Liability, Operating Activities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r414",
      "r1171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "terseLabel": "Payments for Hedge, Financing Activities"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for Legal Settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromHedgeFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for (Proceeds from) Hedge, Financing Activities",
        "negatedTerseLabel": "Settlement of cash flow hedges",
        "terseLabel": "Payments for (Proceeds from) Hedge, Financing Activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "terseLabel": "Payments of Additional Prepaid Royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payments of debt financing and equity issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r84",
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Business Acquisition, Cost of Acquired Entity, Cash Paid"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Payments to Acquire Intangible Assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedTerseLabel": "Payments to Acquire Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r410",
      "r1329",
      "r1330",
      "r1331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Payments to Acquire Productive Assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "terseLabel": "Payments to Acquire Property, Plant, and Equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)",
        "terseLabel": "Pension and other post-retirement (income) expense"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r694",
      "r696",
      "r702",
      "r720",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r740",
      "r741",
      "r743",
      "r749",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r27",
      "r669",
      "r670",
      "r693",
      "r1121"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r29",
      "r669",
      "r670",
      "r693",
      "r1121"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r206",
      "r211",
      "r212",
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Change in Accounting for Pension and Other Postretirement Benefits [Policy Text Block]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits.",
        "label": "Pension Cost (Reversal of Cost)",
        "terseLabel": "Pension expense"
       }
      }
     },
     "localname": "PensionExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r198",
      "r669",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r719",
      "r721",
      "r724",
      "r727",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r743",
      "r744",
      "r748",
      "r1121",
      "r1122",
      "r1126",
      "r1127",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans, Defined Benefit"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r721",
      "r1119",
      "r1120",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsAssetsandLiabilitiesCarriedatFairValueMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r32",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r32",
      "r1134"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock\u2014$1 par value per share, authorized 1,000,000 shares; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidRoyalties": {
     "auth_ref": [
      "r1073",
      "r1098",
      "r1195"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Royalties",
        "terseLabel": "Prepaid Royalties"
       }
      }
     },
     "localname": "PrepaidRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from Collection of Notes Receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [
      "r1170"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Investing Activities",
        "terseLabel": "Proceeds from Derivative Instrument, Investing Activities"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "terseLabel": "Proceeds from sale of senior debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r87",
      "r222"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.",
        "label": "Proceeds from Issuance of Unsecured Debt",
        "verboseLabel": "Gross proceeds from the issuance of debt instrument"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfUnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLifeInsurancePolicies": {
     "auth_ref": [
      "r83",
      "r94"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow for proceeds from settlement of corporate-owned life insurance policy, classified as investing activities. Includes, but is not limited to, bank-owned life insurance policy.",
        "label": "Proceeds from Life Insurance Policy",
        "terseLabel": "Proceeds from surrender of life insurance policies"
       }
      }
     },
     "localname": "ProceedsFromLifeInsurancePolicies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-Term Lines of Credit",
        "terseLabel": "Proceeds from Long-term Lines of Credit"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfOtherDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) for debt classified as other.",
        "label": "Proceeds from (Repayments of) Other Debt",
        "terseLabel": "Proceeds from (Repayments of) Other Debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfOtherDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from dispositions of property, plant and equipment, net"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r87",
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received from option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r1112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product [Member]"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantiesDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties Disclosures [Abstract]",
        "terseLabel": "Product Warranties Disclosures [Abstract]"
       }
      }
     },
     "localname": "ProductWarrantiesDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r179",
      "r180",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance end of period",
        "periodStartLabel": "Balance beginning of period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.",
        "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties",
        "terseLabel": "Adjustments to previously provided warranties, net"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provision charged to income"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Warranty Reserves"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReserves"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r164",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r158",
      "r371"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r160",
      "r343",
      "r1009",
      "r1134"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Total property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Property, Plant and Equipment, Net [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r160",
      "r1035",
      "r1036"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life, Maximum"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialDataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Data [Abstract]",
        "terseLabel": "Quarterly Financial Data [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]",
        "terseLabel": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r113",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Quarterly Financial Information (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesBillingStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid.",
        "label": "Receivables Billing Status [Domain]",
        "terseLabel": "Receivables Billing Status [Domain]"
       }
      }
     },
     "localname": "ReceivablesBillingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r61",
      "r65",
      "r403",
      "r908",
      "r912",
      "r914",
      "r1164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r123",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Total Assets by Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RegulatoryEnvironmentalCostsPolicy": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for liabilities for remediation of environmental matters. The accounting policy may specify the conditions under which rate actions of a regulator provide reasonable assurance of the existence of an asset pertaining thereto.",
        "label": "Regulatory Environmental Costs, Policy [Policy Text Block]",
        "terseLabel": "Environmental Matters [Policy Text Block]"
       }
      }
     },
     "localname": "RegulatoryEnvironmentalCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r90",
      "r1178"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Payments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r563",
      "r564",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r563",
      "r564",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r227",
      "r352",
      "r1354"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expenses [Member ]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r1158",
      "r1176",
      "r1355",
      "r1358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r1158",
      "r1176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted Cash, Current"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r1031",
      "r1159",
      "r1176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted Cash, Noncurrent"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r572",
      "r574",
      "r577",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Contract Termination Charges, Net"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "verboseLabel": "Restructuring and Related Cost, Number of Positions Eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r100",
      "r578",
      "r580",
      "r1209"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "negatedTerseLabel": "Restructuring and other costs, net",
        "terseLabel": "Restructuring and other costs, net"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r573",
      "r574",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]",
        "verboseLabel": "Restructuring Cost and Reserve [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r574",
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accrued restructuring and contract termination costs"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r574",
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Change in estimates"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r1161",
      "r1210",
      "r1211"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Accrued restructuring and contract termination costs"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r1162",
      "r1210",
      "r1211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring Reserve, Noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r35",
      "r193",
      "r341",
      "r1023",
      "r1028",
      "r1134"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r359",
      "r428",
      "r429",
      "r430",
      "r434",
      "r443",
      "r445",
      "r532",
      "r789",
      "r790",
      "r791",
      "r821",
      "r822",
      "r867",
      "r1019",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanFundingStatusAxis": {
     "auth_ref": [
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Axis]",
        "terseLabel": "Retirement Plan Funding Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanFundingStatusDomain": {
     "auth_ref": [
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Domain]",
        "terseLabel": "Retirement Plan Funding Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r669",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r719",
      "r721",
      "r724",
      "r727",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r743",
      "r744",
      "r745",
      "r748",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r669",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r719",
      "r721",
      "r724",
      "r727",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r743",
      "r744",
      "r745",
      "r748",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r475",
      "r476",
      "r494",
      "r499",
      "r500",
      "r506",
      "r507",
      "r510",
      "r663",
      "r664",
      "r990"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomer"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r1083",
      "r1084"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r406",
      "r419",
      "r475",
      "r476",
      "r494",
      "r499",
      "r500",
      "r506",
      "r507",
      "r510",
      "r527",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r600",
      "r602",
      "r604",
      "r605",
      "r887",
      "r1008",
      "r1216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Sales by Geographic Area [Line Items]",
        "verboseLabel": "Long-lived assets by Geographic Area [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r936",
      "r1133"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of Stock, Price Per Share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetAccountsReceivableNetTables",
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetAccountsReceivableNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r61",
      "r1340",
      "r1341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Components of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r1121",
      "r1274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r249",
      "r250",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r249",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Fair Values of the Business Combinations and Allocations for the Acquisitions Completed"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable": {
     "auth_ref": [
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting pension and other postretirement benefit arrangements with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]",
        "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansNonqualifiedDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSavingsPlanDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetBenefitCostsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r19",
      "r21",
      "r22",
      "r23",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r1248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.",
        "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r220",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Total Compensation Recognized Related to Outstanding Equity Awards"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r1099",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in the Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r1180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r25",
      "r39",
      "r40",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Net Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InventoriesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Components of Net Periodic Benefit Cost (Credit)"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.",
        "label": "Schedule of Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Net Funded Status"
       }
      }
     },
     "localname": "ScheduleOfNetFundedStatusTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r108",
      "r109",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ChangesinAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Interest and Other Expense (Income), Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Warranty Reserve Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/PropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Quarterly Financial Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r573",
      "r574",
      "r575",
      "r576",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r166",
      "r167",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminaitonChargesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r165",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminaitonChargesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r71",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r67",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Sales by Geographic Area [Table]",
        "verboseLabel": "Long-lived assets by Geographic Area [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofLongLivedAssetsbyGeographicLocationDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r121",
      "r122",
      "r124",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "verboseLabel": "Schedule of Total Assets, by segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r121",
      "r122",
      "r124",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r750",
      "r752",
      "r754",
      "r755",
      "r756",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Award Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r215",
      "r216",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r28",
      "r318",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r472",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r510",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r576",
      "r582",
      "r1099",
      "r1361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r484",
      "r487",
      "r498",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r509",
      "r510",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Industry Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Line Items]",
        "verboseLabel": "Schedule of Total Assets, by segment [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting [Policy Text Block]"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative and other expenses [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r1112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service [Member]"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r1130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Option vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Shares, forfeited",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value, forfeited (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares/units granted",
        "verboseLabel": "Shares, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant-date fair value of stock granted (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of year",
        "periodStartLabel": "Nonvested at beginning of year",
        "terseLabel": "Awards/units outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted stock award activity"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted-average grant-date fair value, nonvested at end of year (per share)",
        "periodStartLabel": "Weighted-average grant-date fair value, nonvested at beginning of year (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Shares, vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r773"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of restricted stock awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value, vested (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansWeightedAverageAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansWeightedAverageAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansWeightedAverageAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofTotalCompensationRecognizedRelatedtoOutstandingStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r1131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares authorized under plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant under employee stock purchase plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Shares exercisable at end of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average price, exercisable at end of year (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r773"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Shares canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Shares forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r1297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value for stock options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares outstanding at end of year",
        "periodStartLabel": "Shares outstanding at beginning of the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock option activity"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-average price, outstanding at end of year (per share)",
        "periodStartLabel": "Weighted-average price, outstanding at beginning of year (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of vested and expected to vest stock options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of shares vested and expected to vest in the future"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r754",
      "r755",
      "r756",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails",
      "http://www.perkinelmer.com/role/StockPlansSummaryofRestrictedStockAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-average price, exercised (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-average price, canceled (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average price, forfeited (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-average price, granted (per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r757",
      "r776",
      "r777",
      "r778",
      "r779",
      "r782",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation [Policy Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected lives, years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansWeightedAverageAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value for stock options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options exercisable (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term for options vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShippingAndHandlingCostPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.",
        "label": "Shipping and Handling Cost, Policy [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs [Policy Text Block]"
       }
      }
     },
     "localname": "ShippingAndHandlingCostPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermDebtTerms": {
     "auth_ref": [
      "r1160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the short-term debt arrangement, and disclosures pertaining to the underlying arrangements, including repayment terms, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements.",
        "label": "Short-Term Debt, Terms",
        "terseLabel": "Short-term Debt, Terms"
       }
      }
     },
     "localname": "ShortTermDebtTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, the maximum amount borrowed at any time during the period.",
        "label": "Short-Term Debt, Maximum Amount Outstanding During Period",
        "terseLabel": "Short-term Debt, Maximum Amount Outstanding During Period"
       }
      }
     },
     "localname": "ShorttermDebtMaximumAmountOutstandingDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r107",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/LeasesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.",
        "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency and acquisitions"
       }
      }
     },
     "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/WarrantyReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Warranty Costs [Policy Text Block]"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r1180",
      "r1316",
      "r1323"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "State total"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsoftheProvisionBenefitsfromIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r363",
      "r472",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r510",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r570",
      "r576",
      "r582",
      "r1099",
      "r1361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetChangesintheCarryingAmountofGoodwillDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails",
      "http://www.perkinelmer.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofDepreciationAmortizationandCapitalExpendituresDetails",
      "http://www.perkinelmer.com/role/IndustrySegmentandGeographicAreaInformationScheduleofTotalAssetsbySegmentDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails",
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails",
      "http://www.perkinelmer.com/role/ScheduleofSalesandOperatingIncomefromContinuingOperationsbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r419",
      "r451",
      "r452",
      "r454",
      "r456",
      "r466",
      "r467",
      "r527",
      "r593",
      "r596",
      "r597",
      "r598",
      "r604",
      "r605",
      "r635",
      "r636",
      "r639",
      "r643",
      "r650",
      "r887",
      "r1049",
      "r1153",
      "r1177",
      "r1185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/CoverPage",
      "http://www.perkinelmer.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r52",
      "r188",
      "r359",
      "r402",
      "r403",
      "r404",
      "r428",
      "r429",
      "r430",
      "r434",
      "r443",
      "r445",
      "r465",
      "r532",
      "r651",
      "r789",
      "r790",
      "r791",
      "r821",
      "r822",
      "r867",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r914",
      "r950",
      "r1019",
      "r1020",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r428",
      "r429",
      "r430",
      "r465",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofOperations",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/InterestandOtherExpenseIncomeNet_2",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r32",
      "r33",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Stock Issued During Period, Shares, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r32",
      "r33",
      "r188",
      "r193",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Shares exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockPlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r52",
      "r188",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "negatedTerseLabel": "Stock Issued During Period, Value, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r32",
      "r33",
      "r188",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for employee benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock repurchase program, number of shares authorized to be repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock repurchase program, number of shares remained available for repurchase"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r32",
      "r33",
      "r188",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Number of common stock repurchased in open market"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r32",
      "r33",
      "r188",
      "r193"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "verboseLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r33",
      "r36",
      "r37",
      "r129",
      "r1134",
      "r1179",
      "r1193",
      "r1337"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets",
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r194",
      "r418",
      "r636",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r649",
      "r651",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r915",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r915",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r915",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r915",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails",
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofExpectedBenefitPaymentsOtherPostretirementBenefitsDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofNetFundedStatusPensionPlansDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails",
      "http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails",
      "http://www.perkinelmer.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events [Policy Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r952",
      "r954"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r232",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of Income Tax Contingencies [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalEmployeeRetirementPlanDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide limited group of employees with supplemental retirement benefits, in addition to other pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Supplemental Employee Retirement Plan [Member]",
        "terseLabel": "Supplemental Employee Retirement Plans, Defined Benefit [Member]"
       }
      }
     },
     "localname": "SupplementalEmployeeRetirementPlanDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansSupplementalExecutiveRetirementPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r228",
      "r229"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "terseLabel": "Tax Adjustments, Settlements, and Unusual Provisions"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesIncomeBeforeIncometaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseDetails",
      "http://www.perkinelmer.com/role/QuarterlyFinancialInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax Credit Carryforward, Amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardExpirationDate": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the tax credit carryforward, in YYYY-MM-DD format.",
        "label": "Tax Credit Carryforward, Expiration Date",
        "terseLabel": "Tax Credit Carryforward, Expiration Date"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails",
      "http://www.perkinelmer.com/role/IncomeTaxesSummaryofLossandTaxCreditCarryforwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r1117",
      "r1222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r1117",
      "r1222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ToolsDiesAndMoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale.",
        "label": "Tools, Dies and Molds [Member]",
        "terseLabel": "Tools, Dies and Molds [Member]"
       }
      }
     },
     "localname": "ToolsDiesAndMoldsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesFairValuesoftheBusinessCombinationsandAllocationsfortheAcquisitionsCompletedDetails",
      "http://www.perkinelmer.com/role/BusinessCombinationsandAssetPurchasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which the entity trades for its own profit, which may include, but is not limited to, mortgage-backed and asset-backed securities, loans, interest rate swaps, credit derivatives, commodity contracts, foreign exchange contracts and equity swaps. Excludes debt and equity securities.",
        "label": "Trading Assets, Excluding Debt and Equity Securities [Member]",
        "terseLabel": "Trading Assets, Excluding Debt and Equity Securities [Member]"
       }
      }
     },
     "localname": "TradingAssetsExcludingDebtAndEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r1117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]",
        "terseLabel": "Transferred at Point in Time [Member]"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r1117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time [Member]"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r521",
      "r522",
      "r631",
      "r648",
      "r856",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r1190",
      "r1191",
      "r1192",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]",
        "verboseLabel": "Major Types of Trading Securities and Assets [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofAllocationofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/InvestmentsDebtandEquitySecuritiesDetails",
      "http://www.perkinelmer.com/role/MarketableSecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r1338",
      "r1339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r433",
      "r434",
      "r435",
      "r437",
      "r446",
      "r516",
      "r517",
      "r529",
      "r530",
      "r531",
      "r532",
      "r535",
      "r536",
      "r789",
      "r790",
      "r791",
      "r819",
      "r820",
      "r821",
      "r822",
      "r842",
      "r843",
      "r844",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r897",
      "r898",
      "r917",
      "r918",
      "r923",
      "r924",
      "r925",
      "r926",
      "r944",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r994",
      "r995",
      "r996",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r573",
      "r574",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetNarrativeDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetRestructuringandContractTerminationChargesNetScheduleofInitialChargesDetails",
      "http://www.perkinelmer.com/role/RestructuringandContractTerminationChargesNetScheduleofRestructuringPlanActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized Debt Issuance Expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails",
      "http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesNarrativeDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r987"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled Contracts Receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/RevenuefromContractwithCustomerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r332",
      "r350",
      "r794",
      "r836"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed Earnings of Foreign Subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Unrealized Gain (Loss) on Derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r795",
      "r802"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits, end of period",
        "periodStartLabel": "Unrecognized tax benefits, beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r803"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Gross decreases - tax positions in prior period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r805"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r801"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Income Tax Penalties and Interest Accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r801"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Income Tax Penalties and Interest Expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Unrecognized Tax Benefits, Increase Resulting from Acquisition"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r804"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Gross increases - current-period tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Gross increases - tax positions in prior period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r1318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "terseLabel": "Interest on income taxes accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "auth_ref": [
      "r1318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "terseLabel": "Interest on income taxes expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r806"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Lapse of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r807"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Uncertain tax benefits if recognized that could affect the continuing operations effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r28",
      "r318",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r468",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Accounting Policies and Estimates [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/NatureofOperationsandAccountingPoliciesNatureofOperationsandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r813"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VentureCapitalFundsMember": {
     "auth_ref": [
      "r1246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funds that primarily invests in early stage enterprises or provides expansion capital in exchange for an equity stake and active management role in the invested enterprise.",
        "label": "Venture Capital Funds [Member]",
        "terseLabel": "Venture Capital Funds [Member]",
        "verboseLabel": "Other Types of Investments, Venture Capital Funds [Member]"
       }
      }
     },
     "localname": "VentureCapitalFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofChangesinFairValueofPlanAssetsPensionPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsOtherPostretirementBenefitPlansDetails",
      "http://www.perkinelmer.com/role/EmployeeBenefitPlansScheduleofEffectofSignificantUnobservableInputsChangesinPlanAssetsPensionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r450",
      "r456"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Number of common shares-diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r449",
      "r456"
     ],
     "calculation": {
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Number of common shares-basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perkinelmer.com/role/EarningsPerShareScheduleofReconciliationofNumberofSharesUtilizedinEarningsPerShareCalculationsDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(9))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1049": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1051": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1052": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1053": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1054": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1055": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1056": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1057": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1058": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1059": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1061": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1404",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1062": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1404",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1063": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1064": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1065": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1066": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1067": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1068": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1069": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1073": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(5)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1074": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1075": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1076": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1077": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1078": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1079": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921830-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921833-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1099": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "https://asc.fasb.org/topic&trid=2126967",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1141": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1142": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1143": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1144": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1145": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1146": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1147": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1148": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1149": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1150": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1151": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1152": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1365": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1366": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1367": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1368": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1369": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1370": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1371": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1372": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1373": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1374": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(4))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "https://asc.fasb.org/topic&trid=49130413",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "https://asc.fasb.org/topic&trid=2122503",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28511-109314",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28446-109314",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "410",
   "Subparagraph": "(SAB Topic 10.F)",
   "Topic": "980",
   "URI": "https://asc.fasb.org/extlink&oid=122136391&loc=d3e660557-123036",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "https://asc.fasb.org/topic&trid=2208923",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5066-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "https://asc.fasb.org/subtopic&trid=2175671",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080552-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155636-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54406-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=SL120155248-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}